CHEBI ONTOLOGY - ANNOTATIONS |
|
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
| Term: | enamide |
|
| Accession: | CHEBI:51751
|
browse the term
|
| Definition: | An α,β-unsaturated carboxylic acid amide of general formula R1R2C=CR3‒C(=O)NR4R5 in which the amide C=O function is conjugated to a C=C double bond at the α,β position. |
| Synonyms: | related_synonym: | enamides |
| | chemrof_formula: | C3NOR5 |
| | chemrof_smiles: | [1*]/C([2*])=C(/[3*])C(=O)N([4*])[5*] |
|
|
|
|
| G
|
1700009N14Rikl
|
RIKEN cDNA 1700009N14 gene like
|
increases expression
|
EXP
|
Acrylamide results in increased expression of 1700009N14RIKL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:59,252,092...59,253,468
Ensembl chr 5:59,251,970...59,265,163
|
|
| G
|
2610318N02Rikl
|
RIKEN cDNA 2610318N02 gene like
|
increases expression
|
EXP
|
Acrylamide results in increased expression of 2610318N02RIKL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:97,383,363...97,400,092
Ensembl chr11:97,386,733...97,400,088
|
|
| G
|
6430548M08Rikl
|
RIKEN cDNA 6430548M08 gene like
|
increases expression
|
EXP
|
Acrylamide results in increased expression of 6430548M08RIKL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:65,076,626...65,125,185
Ensembl chr19:65,077,790...65,125,177
|
|
| G
|
9330159F19Rikl
|
RIKEN cDNA 9330159F19 gene like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KIAA0408 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:30,444,202...30,469,195
Ensembl chr 1:30,444,208...30,453,155
|
|
| G
|
9530082P21Rikl
|
RIKEN cDNA 9530082P21 gene like
|
increases expression
|
EXP
|
Acrylamide results in increased expression of 9530082P21RIKL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:13,275,611...13,276,535
Ensembl chr10:13,275,611...13,276,535
|
|
| G
|
A1cf
|
APOBEC1 complementation factor
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of A1CF mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 1:239,149,436...239,242,460
Ensembl chr 1:239,149,493...239,236,817
|
|
| G
|
A2m
|
alpha-2-macroglobulin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of A2M mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868
|
|
| G
|
Aaas
|
aladin WD repeat nucleoporin
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AAAS mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:135,342,901...135,362,545
Ensembl chr 7:135,342,901...135,362,545
|
|
| G
|
Aagab
|
alpha- and gamma-adaptin binding protein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AAGAB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:72,978,719...73,017,275
Ensembl chr 8:72,978,741...73,017,278
|
|
| G
|
Aard
|
alanine and arginine rich domain containing protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AARD mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:85,254,322...85,259,163
Ensembl chr 7:85,253,992...85,259,163
|
|
| G
|
Aars2
|
alanyl-tRNA synthetase 2, mitochondrial
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AARS2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:22,981,880...22,993,536
Ensembl chr 9:22,794,978...22,993,536
|
|
| G
|
Aass
|
aminoadipate-semialdehyde synthase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AASS mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 4:52,572,146...52,628,811
Ensembl chr 4:52,572,147...52,657,600
|
|
| G
|
Abca2
|
ATP binding cassette subfamily A member 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ABCA2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:28,642,660...28,662,689
Ensembl chr 3:28,642,758...28,662,681
|
|
| G
|
Abca4
|
ATP binding cassette subfamily A member 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ABCA4 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 2:212,849,470...212,986,730
Ensembl chr 2:212,755,803...212,986,729
|
|
| G
|
Abca7
|
ATP binding cassette subfamily A member 7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ABCA7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:10,342,092...10,362,094
Ensembl chr 7:10,342,092...10,361,989
|
|
| G
|
Abca8a
|
ATP-binding cassette, subfamily A (ABC1), member 8a
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ABCA8A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:95,501,798...95,571,770
Ensembl chr10:95,501,798...95,571,873
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ABCB1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Abcb6
|
ATP binding cassette subfamily B member 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ABCB6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:84,117,222...84,125,939
Ensembl chr 9:84,117,220...84,125,526
|
|
| G
|
Abcb7
|
ATP binding cassette subfamily B member 7
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ABCB7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:73,361,296...73,502,464
Ensembl chr X:73,361,310...73,502,547
|
|
| G
|
Abcc10
|
ATP binding cassette subfamily C member 10
|
increases expression decreases expression
|
ISO
|
Acrylamide results in increased expression of ABCC10 mRNA Acrylamide results in decreased expression of ABCC10 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr 9:22,154,811...22,174,743
Ensembl chr 9:22,154,804...22,174,743
|
|
| G
|
Abcc3
|
ATP binding cassette subfamily C member 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ABCC3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
|
|
| G
|
Abcc4
|
ATP binding cassette subfamily C member 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ABCC4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
|
|
| G
|
Abcc6
|
ATP binding cassette subfamily C member 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ABCC6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:105,583,682...105,637,895
|
|
| G
|
Abcc8
|
ATP binding cassette subfamily C member 8
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ABCC8 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:105,734,992...105,815,982
|
|
| G
|
Abcd1
|
ATP binding cassette subfamily D member 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ABCD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:156,579,669...156,601,448
Ensembl chr X:156,579,785...156,601,446
|
|
| G
|
Abcd2
|
ATP binding cassette subfamily D member 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ABCD2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:124,142,597...124,191,202
Ensembl chr 7:124,142,595...124,191,202
|
|
| G
|
Abcd3
|
ATP binding cassette subfamily D member 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ABCD3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:212,536,791...212,590,379
Ensembl chr 2:212,536,791...212,590,504
|
|
| G
|
Abcf1
|
ATP binding cassette subfamily F member 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ABCF1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr20:2,807,315...2,820,240
Ensembl chr20:2,807,106...2,820,240
|
|
| G
|
Abhd14a
|
abhydrolase domain containing 14A
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ABHD14A mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 8:115,957,853...115,965,697
Ensembl chr 8:115,957,858...115,965,697
|
|
| G
|
Abhd14b
|
abhydrolase domain containing 14b
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ABHD14B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:115,966,792...115,970,829
Ensembl chr 8:115,965,932...115,970,833
|
|
| G
|
Abhd16a
|
abhydrolase domain containing 16A, phospholipase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ABHD16A mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr20:3,723,756...3,738,617
Ensembl chr20:3,723,757...3,738,736
|
|
| G
|
Abhd18
|
abhydrolase domain containing 18
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ABHD18 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:125,800,488...125,850,167
Ensembl chr 2:125,800,392...125,850,166
|
|
| G
|
Abhd3
|
abhydrolase domain containing 3, phospholipase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ABHD3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:1,996,010...2,051,311
Ensembl chr18:1,993,525...2,075,492
|
|
| G
|
Abhd4
|
abhydrolase domain containing 4, N-acyl phospholipase B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ABHD4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:31,674,090...31,686,051
Ensembl chr15:31,674,143...31,687,007
|
|
| G
|
Abhd5
|
abhydrolase domain containing 5, lysophosphatidic acid acyltransferase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ABHD5 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr 8:130,877,834...130,903,947
Ensembl chr 8:130,877,703...130,903,947
|
|
| G
|
Abhd8
|
abhydrolase domain containing 8
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ABHD8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:18,178,441...18,185,178
Ensembl chr16:18,178,441...18,191,638
|
|
| G
|
Abi1
|
abl-interactor 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ABI1 protein
|
CTD |
PMID:20025956 |
|
NCBI chr17:90,006,917...90,088,002
Ensembl chr17:90,006,925...90,087,827
|
|
| G
|
Abo
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ABO mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:30,560,172...30,604,758
|
|
| G
|
Abra
|
actin-binding Rho activating protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ABRA mRNA
|
CTD |
PMID:28606764 PMID:28959563 |
|
NCBI chr 7:74,855,008...74,859,076
Ensembl chr 7:74,855,007...74,859,076
|
|
| G
|
Abracl
|
ABRA C-terminal like
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ABRACL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:14,474,802...14,484,992
Ensembl chr 1:14,474,803...14,485,055
|
|
| G
|
Abtb1
|
ankyrin repeat and BTB domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ABTB1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:122,856,558...122,862,895
Ensembl chr 4:122,856,564...122,862,789
|
|
| G
|
Acaca
|
acetyl-CoA carboxylase alpha
|
multiple interactions
|
ISO
|
[Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased phosphorylation of ACACA protein; [Acrylamide co-treated with Dietary Fats] results in decreased phosphorylation of ACACA protein
|
CTD |
PMID:30409764 |
|
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888
|
|
| G
|
Acacb
|
acetyl-CoA carboxylase beta
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACACB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:48,026,394...48,138,214
Ensembl chr12:48,026,394...48,138,214
|
|
| G
|
Acad9
|
acyl-CoA dehydrogenase family, member 9
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACAD9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:120,871,329...120,894,306
Ensembl chr 2:120,871,227...120,894,709
|
|
| G
|
Acap2
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ACAP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:83,043,442...83,159,105
Ensembl chr11:83,043,511...83,159,107
|
|
| G
|
Acap3
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACAP3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:171,783,382...171,797,709
Ensembl chr 5:171,783,382...171,798,191
|
|
| G
|
Acat1
|
acetyl-CoA acetyltransferase 1
|
multiple interactions decreases expression
|
ISO
|
Acrylamide inhibits the reaction [Streptozocin results in decreased expression of ACAT1 mRNA] Acrylamide results in decreased expression of ACAT1 mRNA
|
CTD |
PMID:34896238 |
|
NCBI chr 8:62,876,003...62,905,080
Ensembl chr 8:62,876,003...62,905,042
|
|
| G
|
Acat2
|
acetyl-CoA acetyltransferase 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ACAT2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095
|
|
| G
|
Acbd4
|
acyl-CoA binding domain containing 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACBD4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:88,548,146...88,558,588
Ensembl chr10:88,548,158...88,558,587
|
|
| G
|
Acd
|
ACD, shelterin complex subunit and telomerase recruitment factor
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:50,496,634...50,499,397
Ensembl chr19:50,496,635...50,499,326
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACE mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Acer2
|
alkaline ceramidase 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ACER2 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 5:106,437,773...106,488,572
Ensembl chr 5:106,437,796...106,488,583
|
|
| G
|
Ache
|
acetylcholinesterase
|
increases activity decreases expression increases expression multiple interactions
|
EXP
|
Acrylamide results in increased activity of ACHE protein Acrylamide results in decreased expression of ACHE protein Acrylamide results in increased expression of ACHE mRNA; Acrylamide results in increased expression of ACHE protein Curcumin inhibits the reaction [Acrylamide results in increased activity of ACHE protein]; geraniol inhibits the reaction [Acrylamide results in increased activity of ACHE protein]; Rutin inhibits the reaction [Acrylamide results in increased expression of ACHE protein]
|
CTD |
PMID:25199698 PMID:28959563 PMID:34509579 PMID:36657526 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Acin1
|
apoptotic chromatin condensation inducer 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACIN1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr15:32,072,121...32,117,004
Ensembl chr15:32,072,123...32,117,166
|
|
| G
|
Acmsd
|
aminocarboxymuconate semialdehyde decarboxylase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ACMSD mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:41,752,894...41,798,427
Ensembl chr13:41,752,875...41,798,427
|
|
| G
|
Acot2
|
acyl-CoA thioesterase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACOT2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:109,342,646...109,350,502
|
|
| G
|
Acot4
|
acyl-CoA thioesterase 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ACOT4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:109,399,032...109,405,138
Ensembl chr 6:109,399,578...109,405,138
|
|
| G
|
Acot7
|
acyl-CoA thioesterase 7
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ACOT7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:167,969,284...168,062,033
Ensembl chr 5:167,968,895...168,062,033
|
|
| G
|
Acox2
|
acyl-CoA oxidase 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ACOX2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:19,090,820...19,122,392
Ensembl chr15:19,090,926...19,122,392
|
|
| G
|
Acp2
|
acid phosphatase 2, lysosomal
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ACP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:97,630,654...97,642,601
Ensembl chr 3:97,631,326...97,642,565
|
|
| G
|
Acp6
|
acid phosphatase 6, lysophosphatidic
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACP6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:187,400,786...187,421,877
Ensembl chr 2:187,349,186...187,422,743
|
|
| G
|
Acsf2
|
acyl-CoA synthetase family member 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACSF2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:80,001,389...80,043,796
Ensembl chr10:80,001,389...80,045,050
|
|
| G
|
Acss1
|
acyl-CoA synthetase short-chain family member 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ACSS1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:159,910,809...159,960,748
|
|
| G
|
Acss2
|
acyl-CoA synthetase short-chain family member 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACSS2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830
|
|
| G
|
Acta1
|
actin, alpha 1, skeletal muscle
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ACTA1 mRNA
|
CTD |
PMID:28606764 |
|
NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178
|
|
| G
|
Acta2
|
actin alpha 2, smooth muscle
|
affects expression increases expression
|
EXP ISO
|
Acrylamide affects the expression of ACTA2 mRNA Acrylamide results in increased expression of ACTA2 mRNA
|
CTD |
PMID:28959563 PMID:38554842 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
| G
|
Actb
|
actin, beta
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACTB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242
|
|
| G
|
Actg1
|
actin, gamma 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACTG1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951
|
|
| G
|
Actl6b
|
actin-like 6B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACTL6B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:24,761,660...24,778,193
Ensembl chr12:24,761,693...24,778,151
|
|
| G
|
Actn2
|
actinin alpha 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ACTN2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:62,835,055...62,902,331
Ensembl chr17:62,812,988...62,903,552
|
|
| G
|
Actr1b
|
actin related protein 1B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACTR1B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:46,424,677...46,434,341
Ensembl chr 9:46,424,678...46,434,341
|
|
| G
|
Actr5
|
actin related protein 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ACTR5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:167,702,299...167,715,736
Ensembl chr 3:167,702,482...167,715,730
|
|
| G
|
Acvr2b
|
activin A receptor type 2B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ACVR2B mRNA; Acrylamide results in decreased expression of SCGB2A2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:128,016,526...128,048,171
|
|
| G
|
Acy1
|
aminoacylase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ACY1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:115,951,068...115,956,471
Ensembl chr 8:115,951,068...115,956,405
|
|
| G
|
Acyp2
|
acylphosphatase 2
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ACYP2 mRNA Acrylamide results in increased expression of ACYP2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr14:108,402,837...108,572,367
Ensembl chr14:108,402,544...108,633,318
|
|
| G
|
Ada
|
adenosine deaminase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293
|
|
| G
|
Adam11
|
ADAM metallopeptidase domain 11
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADAM11 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:88,224,185...88,242,865
Ensembl chr10:88,224,347...88,242,864
|
|
| G
|
Adam17
|
ADAM metallopeptidase domain 17
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ADAM17 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:46,601,583...46,649,344
|
|
| G
|
Adam18
|
ADAM metallopeptidase domain 18
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ADAM18 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:74,054,974...74,127,861
Ensembl chr16:74,055,008...74,127,864
|
|
| G
|
Adam19
|
ADAM metallopeptidase domain 19
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADAM19 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:30,992,713...31,084,455
Ensembl chr10:30,992,754...31,084,455
|
|
| G
|
Adam23
|
ADAM metallopeptidase domain 23
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ADAM23 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:72,356,479...72,503,545
Ensembl chr 9:72,356,479...72,503,545
|
|
| G
|
Adam4
|
a disintegrin and metalloprotease domain 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ADAM4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:106,854,533...106,856,979
|
|
| G
|
Adam5
|
ADAM metallopeptidase domain 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ADAM5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:73,925,345...74,001,354
Ensembl chr16:73,925,734...74,001,346
|
|
| G
|
Adam9
|
ADAM metallopeptidase domain 9
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ADAM9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:73,725,186...73,804,284
Ensembl chr16:73,725,114...73,804,646
|
|
| G
|
Adamts13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADAMTS13 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:30,697,354...30,736,539
Ensembl chr 3:30,697,942...30,736,540
|
|
| G
|
Adamts15
|
ADAM metallopeptidase with thrombospondin type 1 motif, 15
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ADAMTS15 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:37,566,064...37,589,446
Ensembl chr 8:37,566,065...37,589,446
|
|
| G
|
Adamts2
|
ADAM metallopeptidase with thrombospondin type 1 motif, 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of ADAMTS2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:35,422,030...35,627,483
Ensembl chr10:35,422,030...35,627,483
|
|
| G
|
Adamts20
|
ADAM metallopeptidase with thrombospondin type 1 motif, 20
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ADAMTS20 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 7:127,275,538...127,407,325
Ensembl chr 7:127,275,538...127,407,296
|
|
| G
|
Adamts5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADAMTS5 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr11:38,486,945...38,533,516
Ensembl chr11:38,486,955...38,533,516
|
|
| G
|
Adamts6
|
ADAM metallopeptidase with thrombospondin type 1 motif, 6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ADAMTS6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:37,155,260...37,367,077
Ensembl chr 2:37,155,288...37,367,070
|
|
| G
|
Adamts7
|
ADAM metallopeptidase with thrombospondin type 1 motif, 7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADAMTS7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:99,584,529...99,624,132
Ensembl chr 8:99,584,529...99,624,132
|
|
| G
|
Adamts8
|
ADAM metallopeptidase with thrombospondin type 1 motif, 8
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ADAMTS8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:37,607,001...37,626,597
Ensembl chr 8:37,607,001...37,626,597
|
|
| G
|
Adamtsl4
|
ADAMTS-like 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ADAMTSL4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:185,924,582...185,936,039
Ensembl chr 2:185,924,594...185,935,796
|
|
| G
|
Adamtsl5
|
ADAMTS-like 5
|
affects expression
|
EXP
|
Acrylamide affects the expression of ADAMTSL5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:10,013,306...10,021,924
Ensembl chr 7:10,013,929...10,021,924
|
|
| G
|
Adarb2
|
adenosine deaminase RNA specific B2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ADARB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:66,660,586...67,211,104
Ensembl chr17:66,665,506...67,210,749
|
|
| G
|
Adat3
|
adenosine deaminase, tRNA-specific 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ADAT3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:9,759,758...9,761,127
Ensembl chr 7:9,758,671...9,764,582
|
|
| G
|
Adck5
|
aarF domain containing kinase 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADCK5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:110,182,275...110,200,088
Ensembl chr 7:110,181,981...110,200,088
|
|
| G
|
Adcy1
|
adenylate cyclase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADCY1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:86,125,119...86,234,459
Ensembl chr14:86,124,850...86,261,075
|
|
| G
|
Adcy2
|
adenylate cyclase 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ADCY2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:36,204,054...36,650,645
Ensembl chr 1:36,204,054...36,650,645
|
|
| G
|
Adcy5
|
adenylate cyclase 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADCY5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:78,976,861...79,123,343
Ensembl chr11:78,976,861...79,123,343
|
|
| G
|
Adcy6
|
adenylate cyclase 6
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ADCY6 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:131,621,860...131,642,923
Ensembl chr 7:131,621,860...131,642,770
|
|
| G
|
Adcy7
|
adenylate cyclase 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ADCY7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:34,913,154...34,972,366
Ensembl chr19:34,914,322...34,936,743
|
|
| G
|
Adcyap1
|
adenylate cyclase activating polypeptide 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADCYAP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:120,550,236...120,569,096
Ensembl chr 9:120,550,328...120,556,383
|
|
| G
|
Adcyap1r1
|
ADCYAP receptor type I
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADCYAP1R1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:85,924,171...85,972,973
Ensembl chr 4:85,924,100...85,972,973
|
|
| G
|
Add2
|
adducin 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ADD2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:120,001,977...120,101,090
Ensembl chr 4:120,002,054...120,101,091
|
|
| G
|
Add3
|
adducin 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADD3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:262,154,996...262,260,504
|
|
| G
|
Adgra3
|
adhesion G protein-coupled receptor A3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ADGRA3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:65,085,418...65,188,949
Ensembl chr14:65,087,380...65,188,959
|
|
| G
|
Adgrb1
|
adhesion G protein-coupled receptor B1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADGRB1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:108,293,681...108,365,892
Ensembl chr 7:108,293,818...108,365,870
|
|
| G
|
Adgrb2
|
adhesion G protein-coupled receptor B2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADGRB2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:147,581,573...147,646,726
Ensembl chr 5:147,611,580...147,646,726
|
|
| G
|
Adgre1
|
adhesion G protein-coupled receptor E1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ADGRE1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 9:2,329,398...2,484,959
Ensembl chr 9:2,329,438...2,484,959
|
|
| G
|
Adgre4
|
adhesion G protein-coupled receptor E4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EMR4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:10,085,258...10,240,346
Ensembl chr 9:10,085,352...10,240,229
|
|
| G
|
Adgre5
|
adhesion G protein-coupled receptor E5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ADGRE5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:41,302,687...41,332,183
Ensembl chr19:41,303,213...41,324,641
|
|
| G
|
Adgrg1
|
adhesion G protein-coupled receptor G1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of ADGRG1 mRNA Acrylamide results in decreased expression of ADGRG1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 PMID:35690182 |
|
NCBI chr19:10,009,983...10,047,138
Ensembl chr19:10,010,031...10,047,124
|
|
| G
|
Adgrg5
|
adhesion G protein-coupled receptor G5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ADGRG5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:10,080,800...10,104,659
Ensembl chr19:10,085,388...10,103,220
|
|
| G
|
Adgrl2
|
adhesion G protein-coupled receptor L2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ADGRL2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:240,356,176...240,987,246
Ensembl chr 2:240,356,177...240,855,933
|
|
| G
|
Adh1c
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ADH1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:229,470,703...229,482,291
|
|
| G
|
Adh4
|
alcohol dehydrogenase 4 (class II), pi polypeptide
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ADH4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:229,622,095...229,641,879
|
|
| G
|
Adhfe1
|
alcohol dehydrogenase, iron containing, 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of ADHFE1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:14,488,784...14,515,405
Ensembl chr 5:14,488,788...14,515,835
|
|
| G
|
Adi1
|
acireductone dioxygenase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ADI1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:51,035,267...51,042,229
Ensembl chr 6:51,034,931...51,042,855
|
|
| G
|
Adm2
|
adrenomedullin 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ADM2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:122,272,808...122,274,594
Ensembl chr 7:122,272,808...122,274,594
|
|
| G
|
Adnp2
|
ADNP homeobox 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ADNP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:75,846,860...75,871,638
Ensembl chr18:75,847,165...75,903,317
|
|
| G
|
Adora2a
|
adenosine A2a receptor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ADORA2A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802
|
|
| G
|
Adora2b
|
adenosine A2B receptor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ADORA2B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:47,439,712...47,456,092
Ensembl chr10:47,439,701...47,456,091
|
|
| G
|
Adora3
|
adenosine A3 receptor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ADORA3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:196,077,042...196,080,686
Ensembl chr 2:196,077,042...196,080,686
|
|
| G
|
Adprhl1
|
ADP-ribosylhydrolase like 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ADPRHL1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:82,985,355...83,017,240
|
|
| G
|
Adra2a
|
adrenoceptor alpha 2A
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ADRA2A mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:263,065,278...263,069,871
|
|
| G
|
Adra2c
|
adrenoceptor alpha 2C
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ADRA2C mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr14:79,695,514...79,697,476
Ensembl chr14:79,694,995...79,706,656
|
|
| G
|
Adrb2
|
adrenoceptor beta 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ADRB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803
|
|
| G
|
Adrm1
|
ADRM1 26S proteasome ubiquitin receptor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ADRM1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:187,643,043...187,647,805
Ensembl chr 3:187,642,654...187,648,483
|
|
| G
|
Adss1
|
adenylosuccinate synthase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ADSS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:137,500,549...137,523,087
Ensembl chr 6:137,501,001...137,523,086
|
|
| G
|
Afap1l1
|
actin filament associated protein 1-like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AFAP1L1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:57,454,120...57,514,584
Ensembl chr18:57,454,121...57,514,480
|
|
| G
|
Afap1l2
|
actin filament associated protein 1-like 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AFAP1L2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:265,969,368...266,065,951
Ensembl chr 1:265,969,368...266,065,943
|
|
| G
|
Aff3
|
ALF transcription elongation factor 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AFF3 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 9:47,894,903...48,352,380
Ensembl chr 9:47,894,903...48,353,000
|
|
| G
|
Aff4
|
ALF transcription elongation factor 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AFF4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:37,998,319...38,080,580
Ensembl chr10:37,999,579...38,080,580
|
|
| G
|
Afg1l
|
AFG1 like ATPase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AFG1L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:47,380,582...47,550,307
Ensembl chr20:47,380,583...47,550,126
|
|
| G
|
Aga
|
aspartylglucosaminidase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AGA mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:45,191,215...45,249,537
Ensembl chr16:45,223,339...45,249,551
|
|
| G
|
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AGAP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:64,782,618...64,799,624
Ensembl chr 7:64,782,612...64,799,640
|
|
| G
|
Agbl3
|
AGBL carboxypeptidase 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AGBL3 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 4:64,416,139...64,498,987
Ensembl chr 4:64,421,397...64,498,985
|
|
| G
|
Agbl4
|
AGBL carboxypeptidase 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AGBL4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:130,483,551...131,762,906
|
|
| G
|
Agbl5
|
AGBL carboxypeptidase 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AGBL5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:31,192,281...31,213,494
Ensembl chr 6:31,191,635...31,210,676
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AGER mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Agfg2
|
ArfGAP with FG repeats 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of AGFG2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:24,649,008...24,692,069
Ensembl chr12:24,649,038...24,685,197
|
|
| G
|
Aggf1
|
angiogenic factor with G patch and FHA domains 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AGGF1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:28,354,073...28,380,794
Ensembl chr 2:28,354,073...28,380,759
|
|
| G
|
Agl
|
amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AGL mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:207,389,949...207,445,959
Ensembl chr 2:207,389,949...207,445,724
|
|
| G
|
Agmat
|
agmatinase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AGMAT mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:159,326,680...159,357,300
Ensembl chr 5:159,343,160...159,357,299
|
|
| G
|
Ago1
|
argonaute RISC component 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AGO1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:144,006,618...144,064,740
Ensembl chr 5:144,006,618...144,041,624
|
|
| G
|
Ago4
|
argonaute RISC component 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AGO4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:144,064,949...144,110,422
Ensembl chr 5:144,064,949...144,110,402
|
|
| G
|
Agpat2
|
1-acylglycerol-3-phosphate O-acyltransferase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AGPAT2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:29,814,924...29,826,569
Ensembl chr 3:29,814,924...29,826,581
|
|
| G
|
Agpat5
|
1-acylglycerol-3-phosphate O-acyltransferase 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AGPAT5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:77,641,887...77,688,148
Ensembl chr16:77,641,887...77,688,148
|
|
| G
|
Agrn
|
agrin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AGRN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:172,031,528...172,064,539
|
|
| G
|
Agxt2
|
alanine-glyoxylate aminotransferase 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AGXT2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:61,063,416...61,104,828
Ensembl chr 2:61,063,419...61,105,090
|
|
| G
|
Ahcy
|
adenosylhomocysteinase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AHCY mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:164,029,338...164,044,562
Ensembl chr 3:164,029,338...164,044,587
|
|
| G
|
Ahcyl1
|
adenosylhomocysteinase-like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AHCYL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:197,982,335...198,016,770
Ensembl chr 2:197,982,344...198,033,930
|
|
| G
|
Ahnak2
|
AHNAK nucleoprotein 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of AHNAK2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 6:137,648,867...137,697,580
Ensembl chr 6:137,652,537...137,675,546
|
|
| G
|
Ahrr
|
aryl-hydrocarbon receptor repressor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AHRR mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866
|
|
| G
|
Ahsa1
|
activator of Hsp90 ATPase activity 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AHSA1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:112,644,287...112,652,290
Ensembl chr 6:112,644,479...112,655,595
|
|
| G
|
Ahsg
|
alpha-2-HS-glycoprotein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AHSG mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:91,625,975...91,632,583
Ensembl chr11:91,625,975...91,634,039
|
|
| G
|
Aicda
|
activation-induced cytidine deaminase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AICDA mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:157,446,120...157,455,958
Ensembl chr 4:157,444,697...157,456,356
|
|
| G
|
Aif1l
|
allograft inflammatory factor 1-like
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of AIF1L mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:35,627,239...35,651,793
Ensembl chr 3:35,627,239...35,651,793
|
|
| G
|
Aifm2
|
AIF family member 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AIFM2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:30,195,781...30,222,014
Ensembl chr20:30,193,829...30,220,957
|
|
| G
|
Aimp2
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AIMP2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr12:15,814,854...15,824,432
Ensembl chr12:15,814,878...15,824,431
|
|
| G
|
Aire
|
autoimmune regulator
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AIRE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:10,635,775...10,650,709
Ensembl chr20:10,635,775...10,650,709
|
|
| G
|
Ajap1
|
adherens junctions associated protein 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AJAP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:169,190,477...169,302,938
Ensembl chr 5:169,190,477...169,304,515
|
|
| G
|
Ak1
|
adenylate kinase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AK1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:36,310,197...36,320,757
|
|
| G
|
Ak2
|
adenylate kinase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AK2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:146,609,469...146,649,008
Ensembl chr 5:146,630,445...146,650,610
|
|
| G
|
Ak4
|
adenylate kinase 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AK4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:121,154,572...121,214,401
|
|
| G
|
Ak6
|
adenylate kinase 6
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AK6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:33,528,388...33,540,445
Ensembl chr 2:33,528,035...33,540,441 Ensembl chr20:33,528,035...33,540,441
|
|
| G
|
Ak8
|
adenylate kinase 8
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AK8 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 3:32,426,892...32,542,432
Ensembl chr 3:32,426,421...32,542,431
|
|
| G
|
Ak9
|
adenylate kinase 9
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AK9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:46,307,100...46,523,537
Ensembl chr20:46,307,119...46,523,536
|
|
| G
|
Akap1
|
A-kinase anchoring protein 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AKAP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:74,118,232...74,151,366
Ensembl chr10:74,119,124...74,138,190
|
|
| G
|
Akap11
|
A-kinase anchoring protein 11
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AKAP11 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:60,320,839...60,365,480
Ensembl chr15:60,320,839...60,365,335
|
|
| G
|
Akap12
|
A-kinase anchoring protein 12
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of AKAP12 mRNA
|
CTD |
PMID:21319176 PMID:28959563 |
|
NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557
|
|
| G
|
Akap14
|
A-kinase anchoring protein 14
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AKAP14 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:121,261,195...121,276,376
Ensembl chr X:121,259,899...121,276,376
|
|
| G
|
Akap17a
|
A-kinase anchoring protein 17A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AKAP17A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:21,424,202...21,428,308
Ensembl chr12:21,424,202...21,428,247
|
|
| G
|
Akap6
|
A-kinase anchoring protein 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AKAP6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:75,919,350...76,359,667
Ensembl chr 6:75,919,513...76,355,036
|
|
| G
|
Akap7
|
A-kinase anchoring protein 7
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of AKAP7 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:21,906,503...22,168,663
Ensembl chr 1:21,906,676...22,037,090
|
|
| G
|
Akap9
|
A-kinase anchoring protein 9
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AKAP9 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:31,011,475...31,147,338
Ensembl chr 4:31,011,475...31,147,338
|
|
| G
|
Akip1
|
A-kinase interacting protein 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AKIP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:173,169,520...173,178,445
Ensembl chr 1:173,169,458...173,178,445
|
|
| G
|
Akirin1
|
akirin 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AKIRIN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:141,274,174...141,289,617
Ensembl chr 5:141,274,175...141,289,575
|
|
| G
|
Akirin2
|
akirin 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of AKIRIN2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:53,897,792...53,918,873
Ensembl chr 5:53,904,285...53,918,934
|
|
| G
|
Akna
|
AT-hook transcription factor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AKNA mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:81,792,928...81,839,936
Ensembl chr 5:81,792,929...81,831,528
|
|
| G
|
Akr1c14
|
aldo-keto reductase family 1, member C14
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AKR1C14 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:71,066,197...71,083,184
Ensembl chr17:71,066,200...71,083,157
|
|
| G
|
Akr1c2
|
aldo-keto reductase family 1, member C2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AKR1C2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686
|
|
| G
|
Akr7a2
|
aldo-keto reductase family 7, member A2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AKR7A2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:156,835,589...156,844,127
Ensembl chr 5:156,835,551...156,844,109
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
decreases phosphorylation increases expression multiple interactions
|
EXP ISO
|
Acrylamide results in decreased phosphorylation of AKT1 protein Acrylamide results in increased expression of AKT1 mRNA; Acrylamide results in increased expression of AKT1 protein Taurine inhibits the reaction [Acrylamide results in decreased phosphorylation of AKT1 protein]
|
CTD |
PMID:29607694 PMID:33421551 PMID:38152866 PMID:38242491 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Akt1s1
|
AKT1 substrate 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AKT1S1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:104,469,823...104,476,168
Ensembl chr 1:104,469,803...104,476,167
|
|
| G
|
Akt2
|
AKT serine/threonine kinase 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AKT2 mRNA
|
CTD |
PMID:31644924 |
|
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420
|
|
| G
|
Alb
|
albumin
|
decreases expression multiple interactions
|
EXP
|
Acrylamide results in decreased expression of ALB protein vinpocetine inhibits the reaction [Acrylamide results in decreased expression of ALB protein]
|
CTD |
PMID:38348719 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Aldh16a1
|
aldehyde dehydrogenase 16 family, member A1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ALDH16A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:104,763,200...104,776,270
Ensembl chr 1:104,763,055...104,776,270
|
|
| G
|
Aldh18a1
|
aldehyde dehydrogenase 18 family, member A1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of ALDH18A1 mRNA Acrylamide results in decreased expression of ALDH18A1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:249,325,082...249,357,383
Ensembl chr 1:249,325,082...249,357,383
|
|
| G
|
Aldh1b1
|
aldehyde dehydrogenase 1 family, member B1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of ALDH1B1 mRNA Acrylamide results in decreased expression of ALDH1B1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365
|
|
| G
|
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ALDH1L1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:124,617,182...124,663,674
Ensembl chr 4:124,617,217...124,664,704
|
|
| G
|
Aldh1l2
|
aldehyde dehydrogenase 1 family, member L2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ALDH1L2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:22,141,872...22,193,403
Ensembl chr 7:22,141,842...22,193,398
|
|
| G
|
Aldh2
|
aldehyde dehydrogenase 2 family member
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ALDH2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
|
|
| G
|
Aldh3b3
|
aldehyde dehydrogenase 3 family, member B3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ALDH3B3 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:210,617,090...210,629,886
Ensembl chr 1:210,622,639...210,629,879
|
|
| G
|
Aldh4a1
|
aldehyde dehydrogenase 4 family, member A1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ALDH4A1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:157,163,189...157,188,673
Ensembl chr 5:157,162,945...157,188,673
|
|
| G
|
Aldh5a1
|
aldehyde dehydrogenase 5 family, member A1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of ALDH5A1 mRNA Acrylamide results in decreased expression of ALDH5A1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr17:40,560,373...40,586,711
Ensembl chr17:40,558,347...40,586,714
|
|
| G
|
Aldh7a1
|
aldehyde dehydrogenase 7 family, member A1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ALDH7A1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:52,208,035...52,240,293
Ensembl chr18:52,204,161...52,240,467
|
|
| G
|
Aldh8a1
|
aldehyde dehydrogenase 8 family, member A1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ALDH8A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:18,003,507...18,022,952
Ensembl chr 1:18,003,514...18,023,883
|
|
| G
|
Aldoa
|
aldolase, fructose-bisphosphate A
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ALDOA mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
|
|
| G
|
Aldoart2
|
aldolase 1 A retrogene 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ALDOART2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:78,674,945...78,676,635
Ensembl chr 6:78,673,353...78,680,406
|
|
| G
|
Aldoc
|
aldolase, fructose-bisphosphate C
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of ALDOC mRNA Acrylamide results in decreased expression of ALDOC mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,715,489...63,719,133
|
|
| G
|
Alg11
|
ALG11, alpha-1,2-mannosyltransferase
|
affects expression
|
EXP
|
Acrylamide affects the expression of ALG11 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:76,642,979...76,654,052
Ensembl chr16:76,646,795...76,654,040
|
|
| G
|
Alg12
|
ALG12, alpha-1,6-mannosyltransferase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ALG12 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:121,774,796...121,789,175
Ensembl chr 7:121,768,234...121,788,983
|
|
| G
|
Alkbh1
|
alkB homolog 1, histone H2A dioxygenase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ALKBH1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:112,799,234...112,819,708
Ensembl chr 6:112,799,234...112,819,708
|
|
| G
|
Alkbh3
|
alkB homolog 3, alpha-ketoglutarate-dependent dioxygenase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ALKBH3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:100,394,942...100,429,466
Ensembl chr 3:100,380,273...100,427,294
|
|
| G
|
Alkbh7
|
alkB homolog 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ALKBH7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:1,925,896...1,928,048
Ensembl chr 9:1,925,743...1,928,048
|
|
| G
|
Alox12
|
arachidonate 12-lipoxygenase, 12S type
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ALOX12 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr10:55,456,923...55,469,239
Ensembl chr10:55,456,928...55,469,199
|
|
| G
|
Alox15
|
arachidonate 15-lipoxygenase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ALOX15 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,559,061...55,567,723
|
|
| G
|
Alox5
|
arachidonate 5-lipoxygenase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ALOX5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
|
|
| G
|
Alpk1
|
alpha-kinase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ALPK1 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 2:218,801,425...218,924,013
Ensembl chr 2:218,780,189...218,921,646
|
|
| G
|
Alpl
|
alkaline phosphatase, biomineralization associated
|
decreases expression multiple interactions
|
EXP ISO
|
Acrylamide results in decreased expression of ALPL mRNA [[Volatile Organic Compounds results in increased abundance of Acrylamide] which results in increased abundance of N-acetyl-S-(2-carbamoylethyl)cysteine] which results in increased expression of ALPL protein
|
CTD |
PMID:28959563 PMID:34668566 |
|
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167
|
|
| G
|
Als2
|
alsin Rho guanine nucleotide exchange factor ALS2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ALS2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 9:68,107,310...68,180,192
Ensembl chr 9:68,107,528...68,179,660
|
|
| G
|
Alyref
|
Aly/REF export factor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of THOC4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:106,369,750...106,373,395
Ensembl chr10:106,369,750...106,373,395
|
|
| G
|
Ambn
|
ameloblastin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AMBN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:19,885,802...19,898,422
Ensembl chr14:19,885,743...19,898,433
|
|
| G
|
Ambp
|
alpha-1-microglobulin/bikunin precursor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AMBP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:81,583,621...81,593,938
Ensembl chr 5:81,583,622...81,593,850
|
|
| G
|
Amdhd2
|
amidohydrolase domain containing 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AMDHD2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:13,692,136...13,700,632
Ensembl chr10:13,692,146...13,700,632
|
|
| G
|
Amelx
|
amelogenin, X-linked
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AMELX mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr X:28,648,803...28,660,099
Ensembl chr X:28,648,803...28,660,099
|
|
| G
|
Amigo1
|
adhesion molecule with Ig like domain 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AMIGO1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:198,511,285...198,516,744
Ensembl chr 2:198,511,039...198,521,146
|
|
| G
|
Amigo2
|
adhesion molecule with Ig like domain 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AMIGO2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:130,270,639...130,273,735
Ensembl chr 7:130,270,554...130,282,218
|
|
| G
|
Amigo3
|
adhesion molecule with Ig like domain 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AMIGO3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:117,620,499...117,622,025
Ensembl chr 8:117,616,629...117,626,577
|
|
| G
|
Amotl2
|
angiomotin like 2
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of AMOTL2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 8:112,182,060...112,198,032
Ensembl chr 8:112,181,863...112,198,030
|
|
| G
|
Amt
|
aminomethyltransferase
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of AMT mRNA Acrylamide results in decreased expression of AMT mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 8:117,859,700...117,866,692
Ensembl chr 8:117,860,345...117,866,803
|
|
| G
|
Amy2a3
|
amylase 2a3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AMY1A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:204,005,840...204,014,412
Ensembl chr 2:204,005,840...204,014,413
|
|
| G
|
Angel1
|
angel homolog 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ANGEL1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:112,080,074...112,117,178
Ensembl chr 6:112,080,075...112,113,453
|
|
| G
|
Angptl1
|
angiopoietin-like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ANGPTL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:71,463,913...71,531,810
Ensembl chr13:71,511,727...71,531,818
|
|
| G
|
Angptl2
|
angiopoietin-like 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ANGPTL2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 3:36,914,876...36,944,715
Ensembl chr 3:36,914,745...36,945,876
|
|
| G
|
Angptl6
|
angiopoietin-like 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ANGPTL6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:27,689,804...27,696,172
Ensembl chr 8:27,689,806...27,696,111
|
|
| G
|
Ank1
|
ankyrin 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ANK1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr16:75,578,824...75,757,464
Ensembl chr16:75,578,824...75,757,464
|
|
| G
|
Ankar
|
ankyrin and armadillo repeat containing
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ANKAR mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:55,633,681...55,709,721
Ensembl chr 9:55,633,566...55,707,369
|
|
| G
|
Ankfn1
|
ankyrin-repeat and fibronectin type III domain containing 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ANKFN1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr10:74,711,284...75,099,954
|
|
| G
|
Ankfy1
|
ankyrin repeat and FYVE domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ANKFY1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:57,810,781...57,882,495
Ensembl chr10:57,810,781...57,882,495
|
|
| G
|
Ankk1
|
ankyrin repeat and kinase domain containing 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ANKK1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:58,676,327...58,685,012
Ensembl chr 8:58,676,327...58,684,489
|
|
| G
|
Ankle2
|
ankyrin repeat and LEM domain containing 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ANKLE2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:52,077,863...52,110,775
Ensembl chr12:52,077,480...52,108,708
|
|
| G
|
Ankrd11
|
ankyrin repeat domain containing 11
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ANKRD11 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:67,848,836...68,007,491
Ensembl chr19:67,848,844...68,007,491
|
|
| G
|
Ankrd12
|
ankyrin repeat domain 12
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ANKRD12 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:113,030,127...113,134,816
Ensembl chr 9:113,030,919...113,134,762
|
|
| G
|
Ankrd13b
|
ankyrin repeat domain 13B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ANKRD13B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:62,817,791...62,836,456
Ensembl chr10:62,817,778...62,836,635
|
|
| G
|
Ankrd13c
|
ankyrin repeat domain 13C
|
affects expression
|
EXP
|
Acrylamide affects the expression of ANKRD13C mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:249,679,752...249,729,272
Ensembl chr 2:249,681,872...249,729,272
|
|
| G
|
Ankrd2
|
ankyrin repeat domain 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ANKRD2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:250,796,419...250,805,867
Ensembl chr 1:250,796,409...250,805,870
|
|
| G
|
Ankrd22
|
ankyrin repeat domain 22
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ANKRD22 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:241,052,235...241,083,737
Ensembl chr 1:241,052,237...241,105,559
|
|
| G
|
Ankrd23
|
ankyrin repeat domain 23
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ANKRD23 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:46,269,107...46,274,578
Ensembl chr 9:46,269,107...46,274,510
|
|
| G
|
Ankrd28
|
ankyrin repeat domain 28
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ANKRD28 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:6,924,868...7,056,593
Ensembl chr16:6,924,882...7,056,593
|
|
| G
|
Ankrd29
|
ankyrin repeat domain 29
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ANKRD29 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:3,711,052...3,768,997
Ensembl chr18:3,711,059...3,769,098
|
|
| G
|
Ankrd33b
|
ankyrin repeat domain 33B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ANKRD33B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:83,988,505...84,070,311
Ensembl chr 2:83,993,974...84,070,936
|
|
| G
|
Ankrd34a
|
ankyrin repeat domain 34A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ANKRD34A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:186,818,496...186,823,921
Ensembl chr 2:186,817,216...186,824,467
|
|
| G
|
Ankrd35
|
ankyrin repeat domain 35
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ANKRD35 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:186,895,896...186,915,903
Ensembl chr 2:186,895,945...186,915,902
|
|
| G
|
Ankrd37
|
ankyrin repeat domain 37
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ANKRD37 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr16:53,001,487...53,004,545
Ensembl chr16:52,994,740...53,004,545
|
|
| G
|
Ankrd40
|
ankyrin repeat domain 40
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ANKRD40 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:79,778,966...79,792,212
Ensembl chr10:56,415,260...56,416,345 Ensembl chr10:56,415,260...56,416,345
|
|
| G
|
Ankrd42
|
ankyrin repeat domain 42
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ANKRD42 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:156,060,516...156,103,543
Ensembl chr 1:156,060,516...156,103,517
|
|
| G
|
Ankrd55
|
ankyrin repeat domain 55
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ANKRD55 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:45,617,011...45,717,086
Ensembl chr 2:45,617,177...45,717,057
|
|
| G
|
Ankrd61
|
ankyrin repeat domain 61
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ANKRD61 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:15,832,567...15,836,925
Ensembl chr12:15,832,108...15,836,923
|
|
| G
|
Ankrd65
|
ankyrin repeat domain 65
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ANKRD65 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:171,680,597...171,682,854
Ensembl chr 5:171,680,597...171,683,431
|
|
| G
|
Ankrd9
|
ankyrin repeat domain 9
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ANKRD9 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:135,827,355...135,830,002
Ensembl chr 6:135,775,869...135,837,893
|
|
| G
|
Anks4b
|
ankyrin repeat and sterile alpha motif domain containing 4B
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of ANKS4B mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 1:183,934,528...183,989,127
Ensembl chr 1:183,978,769...183,989,122
|
|
| G
|
Anks6
|
ankyrin repeat and sterile alpha motif domain containing 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ANKS6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:66,104,770...66,146,186
Ensembl chr 5:66,104,773...66,146,186
|
|
| G
|
Anp32e
|
acidic nuclear phosphoprotein 32 family member E
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ANP32E mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:186,161,520...186,177,984
Ensembl chr 2:186,161,532...186,177,986
|
|
| G
|
Antkmt
|
adenine nucleotide translocase lysine methyltransferase
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of ANTKMT mRNA Acrylamide results in decreased expression of ANTKMT mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:15,316,797...15,320,950
Ensembl chr10:15,316,772...15,318,656
|
|
| G
|
Antxr1
|
ANTXR cell adhesion molecule 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ANTXR1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892
|
|
| G
|
Anxa5
|
annexin A5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ANXA5 protein
|
CTD |
PMID:22543296 |
|
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400
|
|
| G
|
Anxa8
|
annexin A8
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ANXA8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:9,403,267...9,418,317
Ensembl chr16:9,403,353...9,418,310
|
|
| G
|
Aoc2-ps1
|
amine oxidase, copper containing 2, pseudogene 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AOC2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:86,767,268...86,768,734
|
|
| G
|
Aoc3
|
amine oxidase, copper containing 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AOC3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:86,773,018...86,780,961
|
|
| G
|
Aopep
|
aminopeptidase O
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AOPEP mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:1,817,001...2,133,008
Ensembl chr17:1,817,001...2,133,104
|
|
| G
|
Ap1b1
|
adaptor related protein complex 1 subunit beta 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AP1B1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:84,093,529...84,144,835
Ensembl chr14:84,093,559...84,144,892
|
|
| G
|
Ap1g1
|
adaptor related protein complex 1 subunit gamma 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AP1G1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr19:54,654,101...54,740,586
Ensembl chr19:54,620,807...54,740,586
|
|
| G
|
Ap1g2
|
adaptor related protein complex 1 subunit gamma 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AP1G2 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr15:32,541,528...32,549,392
Ensembl chr15:32,541,528...32,549,280
|
|
| G
|
Ap1m1
|
adaptor related protein complex 1 subunit mu 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AP1M1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:17,620,910...17,636,431
Ensembl chr16:17,616,187...17,636,462
|
|
| G
|
Ap1m2
|
adaptor related protein complex 1 subunit mu 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AP1M2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:28,114,748...28,132,767
Ensembl chr 8:28,114,748...28,132,642
|
|
| G
|
Ap1s2
|
adaptor related protein complex 1 subunit sigma 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AP1S2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:34,204,601...34,230,819
Ensembl chr X:34,204,603...34,228,529
|
|
| G
|
Ap1s3
|
adaptor related protein complex 1 subunit sigma 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AP1S3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:88,399,109...88,458,396
Ensembl chr 9:88,399,109...88,488,089
|
|
| G
|
Ap3m1
|
adaptor related protein complex 3 subunit mu 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AP3M1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:3,285,591...3,314,139
Ensembl chr15:3,295,444...3,313,104
|
|
| G
|
Ap3m2
|
adaptor related protein complex 3 subunit mu 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AP3M2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:75,908,459...75,937,915
Ensembl chr16:75,920,084...75,937,923
|
|
| G
|
Ap3s2
|
adaptor related protein complex 3 subunit sigma 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AP3S2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:143,228,131...143,268,573
Ensembl chr 1:143,228,135...143,268,573
|
|
| G
|
Ap4b1
|
adaptor related protein complex 4 subunit beta 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AP4B1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:194,006,926...194,018,971
Ensembl chr 2:194,006,919...194,018,968
|
|
| G
|
Ap4e1
|
adaptor related protein complex 4 subunit epsilon 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AP4E1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:134,726,338...134,792,820
Ensembl chr 3:134,726,287...134,792,818
|
|
| G
|
Ap4m1
|
adaptor related protein complex 4 subunit mu 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of AP4M1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr12:22,163,474...22,171,734
Ensembl chr12:22,163,466...22,171,731
|
|
| G
|
Ap5b1
|
adaptor related protein complex 5 subunit beta 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AP5B1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:212,305,612...212,309,643
Ensembl chr 1:212,305,604...212,309,629
|
|
| G
|
Ap5m1
|
adaptor related protein complex 5 subunit mu 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AP5M1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:24,835,122...24,864,854
Ensembl chr15:24,835,100...24,862,606
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of APAF1 mRNA Acrylamide results in increased expression of APAF1 mRNA
|
CTD |
PMID:21319176 PMID:28959563 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Apba1
|
amyloid beta precursor protein binding family A member 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of APBA1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:230,790,297...230,995,986
Ensembl chr 1:230,790,297...230,995,986
|
|
| G
|
Apba2
|
amyloid beta precursor protein binding family A member 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of APBA2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:127,465,026...127,698,124
Ensembl chr 1:127,465,009...127,698,117
|
|
| G
|
Apbb3
|
amyloid beta precursor protein binding family B member 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of APBB3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:28,547,205...28,554,383
Ensembl chr18:28,547,205...28,554,383
|
|
| G
|
Apc2
|
APC regulator of WNT signaling pathway 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of APC2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:10,043,010...10,065,037
Ensembl chr 7:10,043,010...10,065,210
|
|
| G
|
Apcdd1
|
APC down-regulated 1
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of APCDD1 mRNA Acrylamide results in decreased expression of APCDD1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr18:58,655,696...58,686,359
Ensembl chr18:58,655,919...58,686,356
|
|
| G
|
Apcs
|
amyloid P component, serum
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of APCS mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:87,905,532...87,906,508
Ensembl chr13:87,905,532...87,928,824
|
|
| G
|
Apeg3
|
antisense paternally expressed gene 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of APEG3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:76,154,484...76,155,415
Ensembl chr 1:76,154,982...76,155,263
|
|
| G
|
Apeh
|
acylaminoacyl-peptide hydrolase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of APEH mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:117,652,390...117,661,502
Ensembl chr 8:117,652,393...117,661,711
|
|
| G
|
Apex1
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of APEX1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329
|
|
| G
|
Apex2
|
apurinic/apyrimidinic endodeoxyribonuclease 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of APEX2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:22,914,943...22,937,713
Ensembl chr X:22,914,944...22,936,011
|
|
| G
|
Aph1a
|
aph-1 homolog A, gamma secretase subunit
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of APH1A mRNA
|
CTD |
PMID:28959563 PMID:30807115 PMID:32763439 |
|
NCBI chr 2:186,123,023...186,130,886
Ensembl chr 2:186,127,323...186,132,045
|
|
| G
|
Aph1b
|
aph-1 homolog B, gamma secretase subunit
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of APH1B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:76,310,380...76,334,146
Ensembl chr 8:76,310,380...76,331,428
|
|
| G
|
Apln
|
apelin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of APLN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:132,058,739...132,091,518
Ensembl chr X:132,081,759...132,091,246
|
|
| G
|
Aplnr
|
apelin receptor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of APLNR mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:90,624,055...90,627,700
Ensembl chr 3:90,624,012...90,627,908
|
|
| G
|
Apoa5
|
apolipoprotein A5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of APOA5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:55,446,329...55,460,509
Ensembl chr 8:55,456,899...55,460,507
|
|
| G
|
Apob
|
apolipoprotein B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of APOB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
|
|
| G
|
Apobec4
|
apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of APOBEC4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:67,436,883...67,444,928
Ensembl chr13:67,436,716...67,445,715
|
|
| G
|
Apod
|
apolipoprotein D
|
increases expression
|
ISO
|
Acrylamide results in increased expression of APOD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:82,936,216...82,957,264
Ensembl chr11:82,936,038...82,957,263
|
|
| G
|
Apol7b-ps1
|
apolipoprotein L7b, pseudogene 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of APOL7B-PS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:111,037,327...111,056,225
|
|
| G
|
Apold1
|
apolipoprotein L domain containing 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of APOLD1 mRNA
|
CTD |
PMID:32763439 PMID:35032568 |
|
NCBI chr 4:169,499,728...169,557,075
Ensembl chr 4:169,549,679...169,559,176
|
|
| G
|
Apoo
|
apolipoprotein O
|
increases expression
|
ISO
|
Acrylamide results in increased expression of APOO mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:63,151,736...63,256,696
Ensembl chr X:63,151,814...63,256,690
|
|
| G
|
Appbp2
|
amyloid beta precursor protein binding protein 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of APPBP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:70,555,212...70,597,267
Ensembl chr10:70,555,212...70,597,193
|
|
| G
|
Aprt
|
adenine phosphoribosyl transferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of APRT mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:67,534,737...67,537,027
|
|
| G
|
Aptr
|
Alu-mediated CDKN1A/p21 transcriptional regulator
|
increases expression
|
ISO
|
Acrylamide results in increased expression of APTR mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:15,030,417...15,031,719
|
|
| G
|
Aptx
|
aprataxin
|
increases expression
|
ISO
|
Acrylamide results in increased expression of APTX mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:60,593,338...60,618,946
Ensembl chr 5:60,597,648...60,618,790
|
|
| G
|
Aqp1
|
aquaporin 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AQP1 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504
|
|
| G
|
Aqp11
|
aquaporin 11
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of AQP11 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:161,457,752...161,467,918
Ensembl chr 1:161,457,754...161,467,945
|
|
| G
|
Aqp4
|
aquaporin 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AQP4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098
|
|
| G
|
Aqp6
|
aquaporin 6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AQP6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:132,611,069...132,614,004
Ensembl chr 7:132,611,065...132,614,049
|
|
| G
|
Ar
|
androgen receptor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AR mRNA
|
CTD |
PMID:32151602 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Araf
|
A-Raf proto-oncogene, serine/threonine kinase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARAF mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:3,780,932...3,845,919
Ensembl chr X:3,780,932...3,792,611
|
|
| G
|
Arap1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARAP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:165,160,701...165,226,219
Ensembl chr 1:165,160,678...165,226,218
|
|
| G
|
Arap3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARAP3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:30,058,739...30,085,415
Ensembl chr18:30,058,275...30,084,865
|
|
| G
|
Arc
|
activity-regulated cytoskeleton-associated protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ARC mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:108,444,692...108,451,220
|
|
| G
|
Arf2
|
ADP-ribosylation factor 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ARL17B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:89,367,843...89,389,644
Ensembl chr10:89,368,044...89,389,651
|
|
| G
|
Arf3
|
ARF GTPase 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARF3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:131,765,039...131,792,075
Ensembl chr 7:131,750,672...131,770,123
|
|
| G
|
Arf4
|
ARF GTPase 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARF4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:1,903,238...1,920,012
Ensembl chr16:1,903,371...1,920,011
|
|
| G
|
Arf6
|
ARF GTPase 6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARF6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:93,589,777...93,590,925
Ensembl chr 6:93,569,234...93,610,536
|
|
| G
|
Arfgap2
|
ARF GTPase activating protein 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARFGAP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:97,692,105...97,704,246
Ensembl chr 3:97,692,110...97,704,247
|
|
| G
|
Arfgef3
|
ARFGEF family member 3
|
affects expression
|
EXP
|
Acrylamide affects the expression of ARFGEF3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:15,058,574...15,223,742
Ensembl chr 1:15,058,579...15,223,742
|
|
| G
|
Arfrp1
|
ARF related protein 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARFRP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:188,844,013...188,851,473
Ensembl chr 3:188,845,511...188,851,431
|
|
| G
|
Arg1
|
arginase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ARG1 mRNA
|
CTD |
PMID:33872730 |
|
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
|
|
| G
|
Arg2
|
arginase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARG2 mRNA
|
CTD |
PMID:21319176 |
|
NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375
|
|
| G
|
Arhgap10
|
Rho GTPase activating protein 10
|
affects expression
|
EXP
|
Acrylamide affects the expression of ARHGAP10 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:47,352,783...47,614,532
Ensembl chr19:47,352,276...47,614,531
|
|
| G
|
Arhgap11a
|
Rho GTPase activating protein 11A
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of ARHGAP11A mRNA Acrylamide results in decreased expression of ARHGAP11A mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:121,045,187...121,071,985
Ensembl chr 3:121,045,187...121,061,468
|
|
| G
|
Arhgap20
|
Rho GTPase activating protein 20
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ARHGAP20 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:60,970,480...61,055,199
Ensembl chr 8:60,970,475...61,055,198
|
|
| G
|
Arhgap23
|
Rho GTPase activating protein 23
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ARHGAP23 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:82,891,021...82,993,230
Ensembl chr10:82,890,853...82,993,228
|
|
| G
|
Arhgap4
|
Rho GTPase activating protein 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARHGAP4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:156,787,566...156,802,841
Ensembl chr X:156,783,776...156,802,450
|
|
| G
|
Arhgap45
|
Rho GTPase activating protein 45
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ARHGAP45 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:10,325,515...10,340,955
Ensembl chr 7:10,325,539...10,341,890
|
|
| G
|
Arhgap5
|
Rho GTPase activating protein 5
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ARHGAP5 mRNA Acrylamide results in increased expression of ARHGAP5 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 6:75,711,199...75,774,636
Ensembl chr 6:75,711,515...75,774,636
|
|
| G
|
Arhgap8
|
Rho GTPase activating protein 8
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARHGAP8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:117,723,512...117,782,031
Ensembl chr 7:117,730,578...117,782,030
|
|
| G
|
Arhgap9
|
Rho GTPase activating protein 9
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ARHGAP9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:65,034,023...65,042,336
Ensembl chr 7:65,034,144...65,042,336
|
|
| G
|
Arhgdig
|
Rho GDP dissociation inhibitor gamma
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARHGDIG mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:15,723,525...15,725,719
Ensembl chr10:15,723,525...15,725,688
|
|
| G
|
Arhgef1
|
Rho guanine nucleotide exchange factor 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARHGEF1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:89,626,884...89,648,823
Ensembl chr 1:89,628,266...89,649,067
|
|
| G
|
Arhgef11
|
Rho guanine nucleotide exchange factor 11
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARHGEF11 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:175,372,269...175,493,852
Ensembl chr 2:175,372,290...175,493,852
|
|
| G
|
Arhgef15
|
Rho guanine nucleotide exchange factor 15
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ARHGEF15 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:54,149,372...54,162,128
Ensembl chr10:54,149,372...54,162,128
|
|
| G
|
Arhgef16
|
Rho guanine nucleotide exchange factor 16
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARHGEF16 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:170,126,573...170,148,624
Ensembl chr 5:170,126,575...170,148,624
|
|
| G
|
Arhgef25
|
Rho guanine nucleotide exchange factor 25
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARHGEF25 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:64,891,260...64,898,382
Ensembl chr 7:64,890,879...64,898,697
|
|
| G
|
Arhgef26
|
Rho guanine nucleotide exchange factor 26
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ARHGEF26 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:148,889,405...149,000,538
Ensembl chr 2:148,889,423...149,000,538
|
|
| G
|
Arhgef28
|
Rho guanine nucleotide exchange factor 28
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARHGEF28 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:30,998,292...31,294,757
Ensembl chr 2:30,998,295...31,294,853
|
|
| G
|
Arhgef38
|
Rho guanine nucleotide exchange factor 38
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ARHGEF38 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:224,284,238...224,413,974
Ensembl chr 2:224,284,238...224,413,974
|
|
| G
|
Arhgef4
|
Rho guanine nucleotide exchange factor 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARHGEF4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:44,357,716...44,500,959
Ensembl chr 9:44,357,736...44,501,550
|
|
| G
|
Arhgef40
|
Rho guanine nucleotide exchange factor 40
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARHGEF40 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:27,146,155...27,170,012
Ensembl chr15:27,146,197...27,170,012
|
|
| G
|
Arhgef7
|
Rho guanine nucleotide exchange factor 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ARHGEF7 mRNA
|
CTD |
PMID:15749267 PMID:28959563 |
|
NCBI chr16:84,373,123...84,484,759
Ensembl chr16:84,373,123...84,484,597
|
|
| G
|
Arid4b
|
AT-rich interaction domain 4B
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ARID4B mRNA Acrylamide results in increased expression of ARID4B mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr17:55,833,908...55,958,382
Ensembl chr17:55,833,908...55,958,382
|
|
| G
|
Arid5a
|
AT-rich interaction domain 5A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ARID5A mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 9:46,030,513...46,058,729
Ensembl chr 9:46,030,548...46,045,363
|
|
| G
|
Arih1
|
ariadne RBR E3 ubiquitin protein ligase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARIH1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:68,673,199...68,775,648
Ensembl chr 8:68,673,200...68,775,572
|
|
| G
|
Arih2
|
ariadne RBR E3 ubiquitin protein ligase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARIH2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:118,175,267...118,234,425
Ensembl chr 8:118,175,267...118,234,284
|
|
| G
|
Ark2n
|
arkadia (RNF111) N-terminal like PKA signaling regulator 2N
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ARK2N mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:73,431,104...73,520,759
Ensembl chr18:73,431,104...73,518,144
|
|
| G
|
Arl10
|
ARF like GTPase 10
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARL10 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:10,035,320...10,043,732
Ensembl chr17:10,035,320...10,043,981
|
|
| G
|
Arl15
|
ARF like GTPase 15
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARL15 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:47,171,377...47,555,666
Ensembl chr 2:47,094,900...47,555,666
|
|
| G
|
Arl16
|
ARF like GTPase 16
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARL16 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:106,235,792...106,237,968
Ensembl chr10:106,235,792...106,237,968
|
|
| G
|
Arl4a
|
ARF like GTPase 4A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ARL4A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:62,809,287...62,811,297
Ensembl chr 6:62,804,548...62,820,760
|
|
| G
|
Arl4d
|
ARF like GTPase 4D
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ARL4D mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:87,092,276...87,103,079
Ensembl chr10:87,077,523...87,106,199
|
|
| G
|
Arl6
|
ARF like GTPase 6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARL6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:54,180,271...54,207,136
Ensembl chr11:54,181,241...54,210,813
|
|
| G
|
Arl6ip1
|
ARL6 interacting reticulophagy regulator 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARL6IP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:181,864,717...181,874,232
Ensembl chr 1:181,864,746...181,874,232
|
|
| G
|
Arln
|
allregulin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARLN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:213,740,519...213,742,279
Ensembl chr 2:213,740,525...213,742,952
|
|
| G
|
Armc2
|
armadillo repeat containing 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ARMC2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr20:46,976,442...47,083,888
Ensembl chr20:46,977,421...47,084,160
|
|
| G
|
Armc6
|
armadillo repeat containing 6
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of ARMC6 mRNA Acrylamide results in decreased expression of ARMC6 mRNA
|
CTD |
PMID:28959563 PMID:30807115 PMID:32763439 |
|
NCBI chr16:19,225,058...19,235,479
Ensembl chr16:19,225,049...19,240,032
|
|
| G
|
Armc7
|
armadillo repeat containing 7
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARMC7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:101,222,056...101,238,598
Ensembl chr10:101,222,067...101,238,597
|
|
| G
|
Armc8
|
armadillo repeat containing 8
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARMC8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:108,916,274...109,010,877
Ensembl chr 8:108,916,274...109,010,717
|
|
| G
|
Armcx2
|
armadillo repeat containing, X-linked 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ARMCX2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr X:102,273,915...102,278,789
Ensembl chr X:102,273,565...102,278,905
|
|
| G
|
Armcx5
|
armadillo repeat containing, X-linked 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARMCX5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:103,501,552...103,505,978
Ensembl chr X:103,501,146...103,539,449
|
|
| G
|
Armcx6
|
armadillo repeat containing, X-linked 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ARMCX6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:102,222,288...102,229,871
Ensembl chr X:102,222,220...102,240,052
|
|
| G
|
Armh4
|
armadillo-like helical domain containing 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ARMH4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:25,455,478...25,556,569
Ensembl chr15:25,455,297...25,556,534
|
|
| G
|
Armt1
|
acidic residue methyltransferase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DCPH1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:43,299,916...43,323,675
Ensembl chr 1:43,299,826...43,323,670
|
|
| G
|
Arpc1b
|
actin related protein 2/3 complex, subunit 1B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARPC1B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:14,595,939...14,609,501
Ensembl chr12:14,595,678...14,609,504
|
|
| G
|
Arpc5l
|
actin related protein 2/3 complex, subunit 5-like
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ARPC5L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:43,169,518...43,177,224
Ensembl chr 3:43,169,462...43,177,240 Ensembl chr 9:43,169,462...43,177,240
|
|
| G
|
Arpin
|
actin-related protein 2/3 complex inhibitor
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARPIN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:143,273,590...143,282,426
Ensembl chr 1:143,273,590...143,282,532
|
|
| G
|
Arpp21
|
cAMP regulated phosphoprotein 21
|
affects expression
|
EXP
|
Acrylamide affects the expression of ARPP21 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:120,912,964...121,077,586
Ensembl chr 8:120,912,970...121,031,357
|
|
| G
|
Arrdc1
|
arrestin domain containing 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ARRDC1 mRNA Acrylamide results in increased expression of ARRDC1 mRNA
|
CTD |
PMID:28959563 PMID:30807115 PMID:32763439 |
|
NCBI chr 3:28,133,190...28,140,378
Ensembl chr 3:28,133,191...28,140,687
|
|
| G
|
Arrdc2
|
arrestin domain containing 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ARRDC2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:18,635,883...18,640,019
Ensembl chr16:18,635,883...18,640,158
|
|
| G
|
Arrdc3
|
arrestin domain containing 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ARRDC3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:12,873,202...12,885,716
Ensembl chr 2:12,873,202...12,885,875
|
|
| G
|
Arsa
|
arylsulfatase A
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ARSA mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:122,422,971...122,426,971
Ensembl chr 7:122,422,982...122,428,401
|
|
| G
|
Arsb
|
arylsulfatase B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARSB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:26,736,395...26,895,682
Ensembl chr 2:26,736,957...26,897,611
|
|
| G
|
Arsg
|
arylsulfatase G
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ARSG mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:94,912,094...95,063,021
Ensembl chr10:94,913,152...95,042,447
|
|
| G
|
Art1
|
ADP-ribosyltransferase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ART1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:165,890,032...165,899,154
Ensembl chr 1:165,890,086...165,899,146
|
|
| G
|
Art3
|
ADP-ribosyltransferase 3
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ART3 mRNA Acrylamide results in increased expression of ART3 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr14:15,921,540...16,003,764
Ensembl chr14:15,921,395...15,949,806
|
|
| G
|
Art5
|
ADP-ribosyltransferase 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ART5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:165,885,344...165,895,306
Ensembl chr 1:165,885,280...165,895,306
|
|
| G
|
Artn
|
artemin
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ARTN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:136,750,188...136,755,645
Ensembl chr 5:136,750,188...136,753,457
|
|
| G
|
Arvcf
|
ARVCF, delta catenin family member
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARVCF mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:96,092,451...96,150,144
Ensembl chr11:96,092,451...96,150,163
|
|
| G
|
Arx
|
aristaless related homeobox
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ARX mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:62,010,097...62,022,009
Ensembl chr X:62,010,097...62,022,002
|
|
| G
|
As3mt
|
arsenite methyltransferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AS3MT mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:255,536,879...255,569,245
Ensembl chr 1:255,537,109...255,569,249
|
|
| G
|
Asah2
|
N-acylsphingosine amidohydrolase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ASAH2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:239,278,994...239,386,598
Ensembl chr 1:239,278,994...239,382,024
|
|
| G
|
Asap2
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2
|
decreases expression increases expression
|
ISO
|
Acrylamide results in decreased expression of ASAP2 mRNA Acrylamide results in increased expression of ASAP2 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr 6:46,386,605...46,549,669
Ensembl chr 6:46,386,605...46,549,669
|
|
| G
|
Asap3
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of ASAP3 mRNA Acrylamide results in decreased expression of ASAP3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:153,716,988...153,757,787
Ensembl chr 5:153,716,988...153,757,787
|
|
| G
|
Asb10
|
ankyrin repeat and SOCS box-containing 10
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ASB10 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:11,522,531...11,531,946
Ensembl chr 4:11,522,887...11,531,505
|
|
| G
|
Asb14
|
ankyrin repeat and SOCS box-containing 14
|
decreases expression affects expression
|
EXP
|
Acrylamide results in decreased expression of ASB14 mRNA Acrylamide affects the expression of ASB14 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:2,102,303...2,131,379
Ensembl chr16:2,102,363...2,130,590
|
|
| G
|
Asb16
|
ankyrin repeat and SOCS box-containing 16
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ASB16 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:87,726,128...87,733,228
Ensembl chr10:87,726,056...87,735,059
|
|
| G
|
Asb18
|
ankyrin repeat and SOCS box-containing 18
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ASB18 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:97,979,018...98,043,609
Ensembl chr 9:97,979,264...98,043,540
|
|
| G
|
Asb5
|
ankyrin repeat and SOCS box-containing 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ASB5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:43,970,940...44,038,318
Ensembl chr16:43,970,940...44,010,437
|
|
| G
|
Ascc2
|
activating signal cointegrator 1 complex subunit 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ASCC2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:83,726,975...83,771,312
Ensembl chr14:83,727,049...83,771,316
|
|
| G
|
Ascl2
|
achaete-scute family bHLH transcription factor 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ASCL2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:207,578,447...207,665,126
Ensembl chr 1:207,578,449...207,580,856
|
|
| G
|
Asf1b
|
anti-silencing function 1B histone chaperone
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of ASF1B mRNA Acrylamide results in decreased expression of ASF1B mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr19:41,085,786...41,100,352
Ensembl chr19:41,086,114...41,100,352
|
|
| G
|
Asgr1
|
asialoglycoprotein receptor 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ASGR1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:55,274,299...55,278,323
Ensembl chr10:55,274,706...55,278,322
|
|
| G
|
Asic1
|
acid sensing ion channel subunit 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of ASIC1 mRNA Acrylamide results in decreased expression of ASIC1 mRNA
|
CTD |
PMID:28959563 PMID:30807115 PMID:32763439 |
|
NCBI chr 7:132,677,158...132,707,379
Ensembl chr 7:132,698,723...132,707,832
|
|
| G
|
Asic3
|
acid sensing ion channel subunit 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ASIC3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:11,652,946...11,657,415
Ensembl chr 4:11,652,946...11,657,367
|
|
| G
|
Asip
|
agouti signaling protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ASIP mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:163,933,768...164,021,377
Ensembl chr 3:164,015,903...164,021,378
|
|
| G
|
Asl
|
argininosuccinate lyase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ASL mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:32,295,779...32,313,257
Ensembl chr12:32,295,633...32,317,261
|
|
| G
|
Asmt
|
acetylserotonin O-methyltransferase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ASMT mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:21,418,477...21,423,336
Ensembl chr12:21,418,487...21,423,336
|
|
| G
|
Asns
|
asparagine synthetase (glutamine-hydrolyzing)
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ASNS mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050
|
|
| G
|
Asphd1
|
aspartate beta-hydroxylase domain containing 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ASPHD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:190,983,506...190,987,440
Ensembl chr 1:190,983,506...190,987,440
|
|
| G
|
Aspm
|
assembly factor for spindle microtubules
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ASPM mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489
|
|
| G
|
Ass1
|
argininosuccinate synthase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ASS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627
|
|
| G
|
Astn1
|
astrotactin 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ASTN1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:73,070,754...73,388,902
Ensembl chr13:73,071,267...73,388,895
|
|
| G
|
Astn2
|
astrotactin 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ASTN2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:83,772,988...84,759,439
Ensembl chr 5:83,773,633...84,759,485
|
|
| G
|
Atad5
|
ATPase family, AAA domain containing 5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ATAD5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:65,568,569...65,616,379
Ensembl chr10:65,568,591...65,616,376
|
|
| G
|
Ate1
|
arginyltransferase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ATE1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:194,391,843...194,514,284
Ensembl chr 1:194,391,843...194,511,348
|
|
| G
|
Atf3
|
activating transcription factor 3
|
multiple interactions decreases expression increases expression
|
ISO EXP
|
Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of and affects the localization of ATF3 protein]; Acrylamide results in increased expression of and affects the localization of ATF3 protein; ATF3 protein promotes the reaction [Acrylamide results in increased expression of CDKN1A protein]; ATF3 protein promotes the reaction [Acrylamide results in increased expression of TRP53 protein]; pyrazolanthrone inhibits the reaction [Acrylamide results in increased expression of ATF3 protein]; SB 203580 inhibits the reaction [Acrylamide results in increased expression of ATF3 protein] Acrylamide results in decreased expression of ATF3 mRNA Polysorbates inhibits the reaction [Acrylamide results in decreased expression of ATF3 mRNA] Acrylamide results in increased expression of ATF3 mRNA
|
CTD |
PMID:25531190 PMID:28959563 PMID:32763439 PMID:35032568 PMID:38309685 |
|
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
|
|
| G
|
Atf4
|
activating transcription factor 4
|
multiple interactions increases expression
|
ISO EXP
|
4-phenylbutyric acid inhibits the reaction [Acrylamide results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of ATF4 protein] [INS co-treated with Acrylamide] results in increased expression of ATF4 protein; GSK2656157 inhibits the reaction [[INS co-treated with Acrylamide] results in increased expression of ATF4 protein]; INS promotes the reaction [Acrylamide results in increased expression of ATF4 mRNA]; salubrinal inhibits the reaction [Acrylamide results in increased expression of ATF4 protein] Acrylamide results in increased expression of ATF4 mRNA; Acrylamide results in increased expression of ATF4 protein
|
CTD |
PMID:27634458 PMID:33421551 PMID:38604440 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
| G
|
Atf6
|
activating transcription factor 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ATF6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
| G
|
Atf6b
|
activating transcription factor 6 beta
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ATF6B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:4,095,534...4,103,534
Ensembl chr20:4,095,534...4,106,032
|
|
| G
|
Atf7ip2
|
activating transcription factor 7 interacting protein 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ATF7IP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:5,909,898...5,952,844
Ensembl chr10:5,909,658...5,952,995
|
|
| G
|
Atg10
|
autophagy related 10
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ATG10 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:23,843,695...24,133,459
Ensembl chr 2:23,844,482...24,133,368
|
|
| G
|
Atg16l2
|
autophagy related 16-like 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ATG16L2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:165,100,946...165,123,307
Ensembl chr 1:165,102,936...165,115,473
|
|
| G
|
Atg2a
|
autophagy related 2A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ATG2A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:212,971,822...212,991,505
Ensembl chr 1:212,971,844...212,991,528
|
|
| G
|
Atg2b
|
autophagy related 2B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ATG2B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:130,286,979...130,357,109
Ensembl chr 6:130,286,986...130,357,109
|
|
| G
|
Atg3
|
autophagy related 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ATG3 mRNA
|
CTD |
PMID:34569336 |
|
NCBI chr11:69,130,948...69,159,280
Ensembl chr11:69,121,952...69,159,280
|
|
| G
|
Atg4a
|
autophagy related 4A, cysteine peptidase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ATG4A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:109,453,712...109,553,758
Ensembl chr X:109,453,689...109,553,760
|
|
| G
|
Atg5
|
autophagy related 5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ATG5 mRNA
|
CTD |
PMID:32763439 PMID:34569336 |
|
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821
|
|
| G
|
Atg9b
|
autophagy related 9B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ATG9B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:11,678,548...11,686,097
Ensembl chr 4:11,678,299...11,686,079
|
|
| G
|
Atl2
|
atlastin GTPase 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of ATL2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:20,891,220...20,932,644
Ensembl chr 6:20,891,227...20,933,320
|
|
| G
|
Atm
|
ATM serine/threonine kinase
|
multiple interactions
|
ISO
|
[[Caffeine results in decreased activity of ATR protein] co-treated with [Caffeine results in decreased activity of ATM protein]] results in decreased susceptibility to Acrylamide
|
CTD |
PMID:20734998 |
|
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629
|
|
| G
|
Atoh8
|
atonal bHLH transcription factor 8
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ATOH8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:105,818,203...105,850,379
Ensembl chr 4:105,818,203...105,850,379
|
|
| G
|
Atosa
|
atos homolog A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ATOSA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:84,575,360...84,653,103
Ensembl chr 8:84,575,370...84,653,091
|
|
| G
|
Atp11a
|
ATPase phospholipid transporting 11A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ATP11A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:83,359,884...83,469,807
Ensembl chr16:83,359,884...83,469,767
|
|
| G
|
Atp11b
|
ATPase phospholipid transporting 11B (putative)
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ATP11B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:120,513,535...120,619,249
Ensembl chr 2:120,513,552...120,619,249
|
|
| G
|
Atp13a1
|
ATPase 13A1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ATP13A1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr16:19,649,065...19,665,126
Ensembl chr16:19,649,066...19,665,120
|
|
| G
|
Atp13a2
|
ATPase cation transporting 13A2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ATP13A2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:158,575,727...158,595,157
Ensembl chr 5:158,575,749...158,595,156
|
|
| G
|
Atp13a4
|
ATPase 13A4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ATP13A4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:84,727,014...84,864,747
Ensembl chr11:84,731,041...84,864,747
|
|
| G
|
Atp1a2
|
ATPase Na+/K+ transporting subunit alpha 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ATP1A2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:87,261,964...87,286,911
Ensembl chr13:87,261,968...87,286,911
|
|
| G
|
Atp1b1
|
ATPase Na+/K+ transporting subunit beta 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ATP1B1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:79,319,708...79,340,226
Ensembl chr13:79,319,706...79,340,549
|
|
| G
|
Atp1b2
|
ATPase Na+/K+ transporting subunit beta 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ATP1B2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:54,817,473...54,823,708
Ensembl chr10:54,817,476...54,823,708
|
|
| G
|
Atp1b4
|
ATPase Na+/K+ transporting family member beta 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ATP1B4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:121,952,923...121,974,146
Ensembl chr X:121,923,061...121,973,654
|
|
| G
|
Atp23
|
ATP23 metallopeptidase and ATP synthase assembly factor homolog
|
increases expression
|
EXP
|
Acrylamide results in increased expression of XRCC6BP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:64,600,100...64,615,240
Ensembl chr 7:64,600,100...64,615,392
|
|
| G
|
Atp2a1
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ATP2A1 mRNA Acrylamide results in increased expression of ATP2A1 mRNA
|
CTD |
PMID:28606764 PMID:32763439 |
|
NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:190,457,198...190,475,423
|
|
| G
|
Atp2a2
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of ATP2A2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934
|
|
| G
|
Atp2b4
|
ATPase plasma membrane Ca2+ transporting 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ATP2B4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:47,708,157...47,807,389
Ensembl chr13:47,711,121...47,758,876
|
|
| G
|
Atp2c1
|
ATPase secretory pathway Ca2+ transporting 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ATP2C1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:114,913,551...115,034,706
Ensembl chr 8:114,913,415...115,038,826
|
|
| G
|
Atp5f1a
|
ATP synthase F1 subunit alpha
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ATP5A1 protein
|
CTD |
PMID:39082229 |
|
NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922
|
|
| G
|
Atp5f1c
|
ATP synthase F1 subunit gamma
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ATP5F1C mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:73,333,584...73,355,872
Ensembl chr17:73,333,588...73,383,073
|
|
| G
|
Atp5f1e
|
ATP synthase F1 subunit epsilon
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ATP5F1E mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:183,677,270...183,680,172
Ensembl chr 3:183,677,273...183,680,214
|
|
| G
|
Atp5if1
|
ATP synthase inhibitory factor subunit 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of ATP5IF1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:150,022,960...150,026,677
Ensembl chr 5:150,022,960...150,026,677
|
|
| G
|
Atp6ap2
|
ATPase H+ transporting accessory protein 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ATP6AP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:12,856,708...12,883,670
Ensembl chr X:12,855,859...12,905,875
|
|
| G
|
Atp6v0a2
|
ATPase H+ transporting V0 subunit a2
|
affects methylation
|
ISO
|
Acrylamide affects the methylation of ATP6V0A2 gene
|
CTD |
PMID:35032568 |
|
NCBI chr12:37,608,211...37,640,860
Ensembl chr12:37,472,813...37,640,860
|
|
| G
|
Atp6v0b
|
ATPase H+ transporting V0 subunit B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ATP6V0B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:136,708,823...136,710,339
Ensembl chr 5:136,708,823...136,716,828
|
|
| G
|
Atp6v0d1
|
ATPase H+ transporting V0 subunit D1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ATP6V0D1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:50,313,268...50,357,248
Ensembl chr19:50,313,273...50,357,395
|
|
| G
|
Atp6v0d2
|
ATPase H+ transporting V0 subunit D2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ATP6V0D2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:38,133,151...38,182,245
Ensembl chr 5:38,133,158...38,182,245
|
|
| G
|
Atp6v0e1
|
ATPase H+ transporting V0 subunit e1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ATP6V0E1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:16,984,084...17,007,156
Ensembl chr10:16,984,084...17,028,858
|
|
| G
|
Atp6v0e2
|
ATPase, H+ transporting V0 subunit e2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ATP6V0E2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:78,815,771...78,818,919
Ensembl chr 4:78,813,129...78,819,680
|
|
| G
|
Atp6v1c1
|
ATPase H+ transporting V1 subunit C1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ATP6V1C1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:71,719,326...71,757,191
Ensembl chr 7:71,719,404...71,757,184
|
|
| G
|
Atp6v1d
|
ATPase H+ transporting V1 subunit D
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ATP6V1D mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:103,389,778...103,405,346
Ensembl chr 6:103,389,783...103,405,346
|
|
| G
|
Atp6v1h
|
ATPase H+ transporting V1 subunit H
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ATP6V1H mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:19,176,849...19,282,516
Ensembl chr 5:19,176,849...19,282,516
|
|
| G
|
Atp7b
|
ATPase copper transporting beta
|
increases expression decreases expression
|
ISO
|
Acrylamide results in increased expression of ATP7B mRNA Acrylamide results in decreased expression of ATP7B mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr16:76,654,725...76,726,092
Ensembl chr16:76,653,660...76,728,801
|
|
| G
|
Atp8a1
|
ATPase phospholipid transporting 8A1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ATP8A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:40,668,932...40,911,465
Ensembl chr14:40,731,846...40,911,463
|
|
| G
|
Atp8b1
|
ATPase phospholipid transporting 8B1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ATP8B1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:60,286,605...60,427,862
Ensembl chr18:60,288,464...60,427,027
|
|
| G
|
Atp9b
|
ATPase phospholipid transporting 9B (putative)
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ATP9B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:76,451,821...76,643,931
Ensembl chr18:76,451,821...76,643,893
|
|
| G
|
Atpsckmt
|
ATP synthase c subunit lysine N-methyltransferase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ATPSCKMT mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:84,313,991...84,329,195
Ensembl chr 2:84,313,921...84,329,194
|
|
| G
|
Atr
|
ATR serine/threonine kinase
|
multiple interactions
|
ISO
|
[[Caffeine results in decreased activity of ATR protein] co-treated with [Caffeine results in decreased activity of ATM protein]] results in decreased susceptibility to Acrylamide
|
CTD |
PMID:20734998 |
|
NCBI chr 8:105,306,299...105,403,742
Ensembl chr 8:105,306,305...105,403,718
|
|
| G
|
Atraid
|
all-trans retinoic acid-induced differentiation factor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ATRAID mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:31,035,194...31,039,779
Ensembl chr 6:31,035,194...31,040,946
|
|
| G
|
Atrn
|
attractin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ATRN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:138,563,271...138,697,360
Ensembl chr 3:138,563,312...138,697,360
|
|
| G
|
Atrnl1
|
attractin like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ATRNL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:266,676,051...267,216,847
Ensembl chr 1:266,675,852...267,216,842
|
|
| G
|
Atrx
|
ATRX, chromatin remodeler
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ATRX mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:74,916,548...75,062,880
Ensembl chr X:74,916,548...75,062,880
|
|
| G
|
Atxn7l2
|
ataxin 7-like 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ATXN7L2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:198,527,066...198,535,899
Ensembl chr 2:198,527,066...198,534,062
|
|
| G
|
Aunip
|
aurora kinase A and ninein interacting protein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AUNIP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:152,006,021...152,018,614
Ensembl chr 5:152,006,042...152,020,190
|
|
| G
|
Aurka
|
aurora kinase A
|
affects localization
|
ISO
|
Acrylamide affects the localization of AURKA protein modified form
|
CTD |
PMID:39082229 |
|
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771
|
|
| G
|
Aurkb
|
aurora kinase B
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of AURKB mRNA Acrylamide results in decreased expression of AURKB mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285
|
|
| G
|
Aurkc
|
aurora kinase C
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AURKC mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:75,876,773...75,882,893
Ensembl chr 1:75,876,773...75,897,426
|
|
| G
|
Aven
|
apoptosis and caspase activation inhibitor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of AVEN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:119,753,395...119,886,009
Ensembl chr 3:119,872,661...119,886,008
|
|
| G
|
Avil
|
advillin
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of AVIL mRNA Acrylamide results in increased expression of AVIL mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:64,711,294...64,729,436
Ensembl chr 7:64,711,403...64,729,436
|
|
| G
|
Avpr1a
|
arginine vasopressin receptor 1A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of AVPR1A mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:59,999,738...60,003,837
|
|
| G
|
Awat2
|
acyl-CoA wax alcohol acyltransferase 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of AWAT2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:69,521,778...69,530,664
Ensembl chr X:69,521,778...69,530,664
|
|
| G
|
Axl
|
Axl receptor tyrosine kinase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AXL mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:90,392,864...90,424,123
Ensembl chr 1:90,392,864...90,424,009
|
|
| G
|
Azi2
|
5-azacytidine induced 2
|
decreases expression increases expression
|
ISO
|
Acrylamide results in decreased expression of AZI2 mRNA Acrylamide results in increased expression of AZI2 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr 8:126,651,268...126,674,795
Ensembl chr 8:126,651,206...126,676,182
|
|
| G
|
Azin2
|
antizyme inhibitor 2
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of AZIN2 mRNA Acrylamide results in decreased expression of AZIN2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:146,568,187...146,594,777
Ensembl chr 5:146,565,437...146,594,777
|
|
| G
|
B3galt1
|
Beta-1,3-galactosyltransferase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of B3GALT1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:72,661,410...73,234,447
Ensembl chr 3:72,660,801...73,235,276
|
|
| G
|
B3galt2
|
Beta-1,3-galactosyltransferase 2
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of B3GALT2 mRNA Acrylamide results in increased expression of B3GALT2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr13:57,939,724...57,948,735
Ensembl chr13:57,930,539...57,956,539
|
|
| G
|
B3galt5
|
Beta-1,3-galactosyltransferase 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of B3GALT5 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr11:49,053,959...49,100,398
Ensembl chr11:49,006,560...49,101,283
|
|
| G
|
B3galt6
|
Beta-1,3-galactosyltransferase 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of B3GALT6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:171,866,428...171,868,564
Ensembl chr 5:171,864,094...171,874,789
|
|
| G
|
B3gat2
|
beta-1,3-glucuronyltransferase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of B3GAT2 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr 9:33,663,482...33,746,466
Ensembl chr 9:33,663,482...33,746,466
|
|
| G
|
B3glct
|
beta 3-glucosyltransferase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of B3GLCT mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:10,291,910...10,383,190
Ensembl chr12:10,291,910...10,426,357
|
|
| G
|
B3gnt3
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of B3GNT3 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr16:18,434,114...18,444,851
Ensembl chr16:18,435,378...18,444,738
|
|
| G
|
B3gnt4
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of B3GNT4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:38,729,653...38,734,911
Ensembl chr12:38,728,889...38,734,744
|
|
| G
|
B3gnt6
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of B3GNT6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:161,897,504...161,915,046
Ensembl chr 1:161,898,323...161,903,354
|
|
| G
|
B3gnt7
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7
|
increases expression
|
ISO
|
Acrylamide results in increased expression of B3GNT7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:94,404,197...94,408,148
Ensembl chr 9:94,404,135...94,408,147
|
|
| G
|
B3gntl1
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of B3GNTL1 mRNA Acrylamide results in decreased expression of QTGAL mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:107,363,036...107,431,988
Ensembl chr10:107,371,442...107,431,908
|
|
| G
|
B4galt3
|
beta-1,4-galactosyltransferase 3
|
affects expression
|
EXP
|
Acrylamide affects the expression of B4GALT3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:86,223,827...86,229,886
Ensembl chr13:86,223,899...86,229,888
|
|
| G
|
B4galt6
|
beta-1,4-galactosyltransferase 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of B4GALT6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:12,233,350...12,290,204
Ensembl chr18:12,233,351...12,290,204
|
|
| G
|
B4galt7
|
beta-1,4-galactosyltransferase 7
|
increases expression
|
EXP
|
Acrylamide results in increased expression of B4GALT7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:9,023,667...9,032,742
Ensembl chr17:9,023,618...9,032,745
|
|
| G
|
B4gat1
|
beta-1,4-glucuronyltransferase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of B4GAT1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:211,772,644...211,774,866
Ensembl chr 1:211,772,606...211,775,442
|
|
| G
|
Baat
|
bile acid CoA:amino acid N-acyltransferase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BAAT mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:68,647,166...68,656,137
Ensembl chr 5:68,646,203...68,656,181
|
|
| G
|
Babam1
|
BRISC and BRCA1 A complex member 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BABAM1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:18,102,885...18,108,916
Ensembl chr16:18,102,815...18,108,932
|
|
| G
|
Bace2
|
beta-secretase 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BACE2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:50,176,852...50,258,948
Ensembl chr11:50,176,621...50,259,008
|
|
| G
|
Bach1
|
BTB domain and CNC homolog 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BACH1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:40,425,721...40,461,118
Ensembl chr11:40,425,664...40,461,277
|
|
| G
|
Bag2
|
BAG cochaperone 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BAG2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:43,465,993...43,476,637
Ensembl chr 9:43,465,995...43,476,752
|
|
| G
|
Bag3
|
BAG cochaperone 3
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of BAG3 mRNA Acrylamide results in increased expression of BAG3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280
|
|
| G
|
Bag4
|
BAG cochaperone 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BAG4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:72,991,407...73,008,620
Ensembl chr16:72,991,362...73,013,273
|
|
| G
|
Bahcc1
|
BAH domain and coiled-coil containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BAHCC1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:106,020,534...106,081,698
Ensembl chr10:106,020,575...106,080,285
|
|
| G
|
Bahd1
|
bromo adjacent homology domain containing 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BAHD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:126,341,853...126,368,281
Ensembl chr 3:126,345,371...126,368,278
|
|
| G
|
Baiap2l1
|
BAR/IMD domain containing adaptor protein 2 like 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BAIAP2L1 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr12:15,364,090...15,453,602
Ensembl chr12:15,364,109...15,453,605
|
|
| G
|
Baiap2l2
|
BAR/IMD domain containing adaptor protein 2 like 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BAIAP2L2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:112,704,798...112,731,691
Ensembl chr 7:112,704,682...112,731,127
|
|
| G
|
Baiap3
|
BAI1-associated protein 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BAIAP3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:14,764,768...14,777,516
Ensembl chr10:14,756,693...14,777,516
|
|
| G
|
Banp
|
Btg3 associated nuclear protein
|
decreases expression increases expression
|
ISO
|
Acrylamide results in decreased expression of BANP mRNA Acrylamide results in increased expression of BANP mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr19:66,916,417...66,994,286
Ensembl chr19:66,916,267...66,991,317
|
|
| G
|
Bap1
|
BRCA1 associated deubiquitinase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BAP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:6,453,126...6,461,952
Ensembl chr16:6,452,974...6,461,952
|
|
| G
|
Bard1
|
BRCA1 associated RING domain 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BARD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:80,069,960...80,144,167
Ensembl chr 9:80,069,960...80,176,873
|
|
| G
|
Barhl2
|
BarH-like homeobox 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BARHL2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:3,485,309...3,490,206
Ensembl chr14:3,485,309...3,490,197
|
|
| G
|
Basp1
|
brain abundant, membrane attached signal protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BASP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:77,546,092...77,597,178
|
|
| G
|
Batf3
|
basic leucine zipper ATF-like transcription factor 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BATF3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:105,220,782...105,232,365
Ensembl chr13:105,220,390...105,232,369
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions
|
EXP ISO
|
Acrylamide results in increased expression of BAX mRNA; Acrylamide results in increased expression of BAX protein TFEB protein inhibits the reaction [Acrylamide results in increased expression of BAX protein] [INS co-treated with Acrylamide] results in increased expression of BAX protein; alpha-Tocopherol inhibits the reaction [Acrylamide results in increased expression of BAX protein]; epigallocatechin gallate inhibits the reaction [Acrylamide results in increased expression of BAX mRNA]; epigallocatechin gallate inhibits the reaction [Acrylamide results in increased expression of BAX protein]; GSK2656157 inhibits the reaction [[INS co-treated with Acrylamide] results in increased expression of BAX protein]; INS promotes the reaction [Acrylamide results in increased expression of BAX mRNA]; naringin inhibits the reaction [Acrylamide results in increased expression of BAX protein]; notoginsenoside R1 inhibits the reaction [Acrylamide results in increased expression of BAX protein]; salubrinal inhibits the reaction [Acrylamide results in increased expression of BAX protein]; Taurine inhibits the reaction [Acrylamide results in increased expression of BAX protein]; TXN1 protein inhibits the reaction [Acrylamide results in increased expression of BAX protein]
|
CTD |
PMID:27920337 PMID:28056603 PMID:28067054 PMID:28959563 PMID:29607694 PMID:31971015 PMID:32763439 PMID:34906654 PMID:36598108 PMID:37172712 PMID:38242491 PMID:38604440 PMID:39082229 More...
|
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bbs1
|
Bardet-Biedl syndrome 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of BBS1 mRNA Acrylamide results in decreased expression of BBS1 mRNA
|
CTD |
PMID:28959563 PMID:30807115 PMID:32763439 |
|
NCBI chr 1:211,614,195...211,633,504
Ensembl chr 1:211,615,533...211,633,468
|
|
| G
|
Bbs2
|
Bardet-Biedl syndrome 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BBS2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:10,915,566...10,950,911
Ensembl chr19:10,915,476...10,950,921
|
|
| G
|
Bbs4
|
Bardet-Biedl syndrome 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BBS4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:68,627,739...68,661,232
Ensembl chr 8:68,627,656...68,661,358
|
|
| G
|
Bbs5
|
Bardet-Biedl syndrome 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BBS5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:74,818,104...74,839,658
Ensembl chr 3:74,818,473...74,857,023
|
|
| G
|
Bbs7
|
Bardet-Biedl syndrome 7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BBS7 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 2:121,362,884...121,402,473
Ensembl chr 2:121,362,885...121,402,473
|
|
| G
|
Bcan
|
brevican
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of BCAN mRNA Acrylamide results in decreased expression of BCAN mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:175,752,333...175,765,766
Ensembl chr 2:175,752,336...175,765,314
|
|
| G
|
Bcap29
|
B-cell receptor-associated protein 29
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BCAP29 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:53,910,209...53,950,206
Ensembl chr 6:53,910,216...53,949,963
|
|
| G
|
Bcap31
|
B-cell receptor-associated protein 31
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of BCAP31 mRNA Acrylamide results in increased expression of BCAP31 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr X:156,548,911...156,581,002
Ensembl chr X:156,548,911...156,579,371
|
|
| G
|
Bcar1
|
BCAR1 scaffold protein, Cas family member
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BCAR1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr19:56,588,500...56,623,190
Ensembl chr19:56,588,500...56,623,190
|
|
| G
|
Bcas2
|
BCAS2, pre-mRNA processing factor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BCAS2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:193,381,000...193,388,881
Ensembl chr 2:193,380,982...193,388,878
|
|
| G
|
Bcat2
|
branched chain amino acid transaminase 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BCAT2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:105,175,157...105,196,474
Ensembl chr 1:105,176,977...105,196,463
|
|
| G
|
Bcdin3d
|
BCDIN3 domain containing RNA methyltransferase
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of BCDIN3D mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:132,484,404...132,488,998
Ensembl chr 7:132,484,431...132,488,998
|
|
| G
|
Bche
|
butyrylcholinesterase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BCHE mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
| G
|
Bckdha
|
branched chain keto acid dehydrogenase E1 subunit alpha
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BCKDHA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:90,266,731...90,295,521
Ensembl chr 1:90,261,629...90,295,749
|
|
| G
|
Bckdhb
|
branched chain keto acid dehydrogenase E1 subunit beta
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BCKDHB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:93,725,277...93,907,799
Ensembl chr 8:93,725,275...93,907,798
|
|
| G
|
Bckdk
|
branched chain ketoacid dehydrogenase kinase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BCKDK mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:191,945,809...191,950,480
Ensembl chr 1:191,946,471...191,953,453
|
|
| G
|
Bcl10
|
BCL10, immune signaling adaptor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BCL10 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:237,501,134...237,511,829
|
|
| G
|
Bcl11a
|
BCL11 transcription factor A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BCL11A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:102,230,147...102,325,289
Ensembl chr14:102,231,113...102,325,623
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
EXP ISO
|
Acrylamide results in decreased expression of BCL2 mRNA; Acrylamide results in decreased expression of BCL2 protein TFEB protein inhibits the reaction [Acrylamide results in decreased expression of BCL2 protein] epigallocatechin gallate inhibits the reaction [Acrylamide results in decreased expression of BCL2 protein]; INS promotes the reaction [Acrylamide results in decreased expression of BCL2 mRNA]; notoginsenoside R1 inhibits the reaction [Acrylamide results in decreased expression of BCL2 protein]; Taurine inhibits the reaction [Acrylamide results in decreased expression of BCL2 protein]; TXN1 protein inhibits the reaction [Acrylamide results in decreased expression of BCL2 protein]
|
CTD |
PMID:27920337 PMID:28056603 PMID:28067054 PMID:28959563 PMID:29607694 PMID:31971015 PMID:32763439 PMID:34906654 PMID:37172712 PMID:38604440 PMID:39082229 More...
|
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
affects expression multiple interactions decreases expression
|
EXP
|
Acrylamide affects the expression of BCL2L1 mRNA alpha-Tocopherol inhibits the reaction [Acrylamide results in decreased expression of BCL2L1 protein]
|
CTD |
PMID:28959563 PMID:38242491 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Bcl2l12
|
Bcl2 like 12
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BCL2L12 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:104,608,753...104,617,472
Ensembl chr 1:104,608,753...104,617,472
|
|
| G
|
Bcl2l2
|
Bcl2-like 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BCL2L2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:32,326,686...32,337,834
Ensembl chr15:32,326,020...32,335,379
|
|
| G
|
Bcl6
|
BCL6, transcription repressor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BCL6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047
|
|
| G
|
Bcl6b
|
BCL6B, transcription repressor
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of BCL6B mRNA Acrylamide results in increased expression of BCL6B mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr10:55,439,566...55,444,631
Ensembl chr10:55,432,382...55,444,631
|
|
| G
|
Bco2
|
beta-carotene oxygenase 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BCO2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:59,778,571...59,803,597
Ensembl chr 8:59,778,575...59,799,168
|
|
| G
|
Bcorl1
|
BCL6 co-repressor-like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BCORL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:132,394,703...132,462,414
Ensembl chr X:132,397,069...132,461,976
|
|
| G
|
Bdh1
|
3-hydroxybutyrate dehydrogenase 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of BDH1 mRNA Acrylamide results in decreased expression of BDH1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr11:82,806,125...82,848,133
Ensembl chr11:82,807,503...82,842,636
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
decreases expression multiple interactions increases expression
|
EXP
|
Acrylamide results in decreased expression of BDNF mRNA; Acrylamide results in decreased expression of BDNF protein ferrostatin-1 promotes the reaction [Acrylamide results in increased expression of BDNF mRNA]
|
CTD |
PMID:33421551 PMID:36154307 PMID:36328537 PMID:36801352 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Bdp1
|
BDP1 general transcription factor IIIB subunit
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of BDP1 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 2:33,112,518...33,204,270
Ensembl chr 2:33,112,518...33,204,241
|
|
| G
|
Becn1
|
beclin 1
|
multiple interactions decreases expression increases expression
|
EXP ISO
|
3-methyladenine inhibits the reaction [Acrylamide results in increased expression of BECN1 protein]; PRKCD protein affects the reaction [Acrylamide results in increased expression of BECN1 protein]; Selenium inhibits the reaction [Acrylamide results in increased expression of BECN1 protein] Acrylamide results in decreased expression of BECN1 mRNA
|
CTD |
PMID:33545342 PMID:34569336 PMID:37987225 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bend4
|
BEN domain containing 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BEND4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:41,106,206...41,142,572
Ensembl chr14:41,106,763...41,136,979
|
|
| G
|
Bend5
|
BEN domain containing 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BEND5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:131,519,214...131,565,228
Ensembl chr 5:131,519,214...131,762,906
|
|
| G
|
Bend6
|
BEN domain containing 6
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BEND6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:43,576,982...43,631,437
Ensembl chr 9:43,576,982...43,631,194
|
|
| G
|
Bend7
|
BEN domain containing 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BEND7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:78,392,489...78,475,459
Ensembl chr17:78,393,601...78,475,223
|
|
| G
|
Best1
|
bestrophin 1
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of BEST1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:216,054,395...216,071,012
Ensembl chr 1:216,054,395...216,070,974
|
|
| G
|
Bet1l
|
Bet1 golgi vesicular membrane trafficking protein-like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BET1L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:205,361,041...205,365,036
Ensembl chr 1:205,361,041...205,364,706
|
|
| G
|
Bex2
|
brain expressed X-linked 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BEX1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:103,811,458...103,812,986
Ensembl chr X:103,808,935...103,812,092
|
|
| G
|
Bex4
|
brain expressed, X-linked 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BEX4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:103,923,609...103,925,041
Ensembl chr X:103,923,338...103,925,496
|
|
| G
|
Bex5l1
|
brain expressed X-linked 5 like 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BEX5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:119,181,370...119,202,904
|
|
| G
|
Bfsp1
|
beaded filament structural protein 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BFSP1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 3:151,648,588...151,706,153
Ensembl chr 3:151,648,588...151,682,837
|
|
| G
|
Bglap
|
bone gamma-carboxyglutamate protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BGLAP mRNA
|
CTD |
PMID:22197712 |
|
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318
|
|
| G
|
Bhlha15
|
basic helix-loop-helix family, member a15
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BHLHA15 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:15,534,123...15,538,299
Ensembl chr12:15,534,123...15,538,515
|
|
| G
|
Bhlhe23
|
basic helix-loop-helix family, member e23
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BHLHE23 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:188,266,572...188,268,786
Ensembl chr 3:188,238,188...188,269,089
|
|
| G
|
Bhlhe40
|
basic helix-loop-helix family, member e40
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BHLHE40 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783
|
|
| G
|
Bhlhe41
|
basic helix-loop-helix family, member e41
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BHLHE41 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:180,565,003...180,569,415
Ensembl chr 4:180,565,003...180,569,355
|
|
| G
|
Bhmt
|
betaine-homocysteine S-methyltransferase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BHMT mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:26,594,854...26,614,715
|
|
| G
|
Bicd2
|
BICD cargo adaptor 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BICD2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:15,449,011...15,511,423
Ensembl chr17:15,435,894...15,511,305
|
|
| G
|
Bicdl1
|
BICD family like cargo adaptor 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BICDL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:46,537,525...46,626,876
Ensembl chr12:46,538,396...46,628,866
|
|
| G
|
Bid
|
BH3 interacting domain death agonist
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BID mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
| G
|
Bin1
|
bridging integrator 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BIN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:24,282,840...24,341,461
Ensembl chr18:24,283,801...24,341,458
|
|
| G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BIRC5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
| G
|
Birc7
|
baculoviral IAP repeat-containing 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BIRC7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:188,425,392...188,430,174
Ensembl chr 3:188,425,392...188,430,174
|
|
| G
|
Bivm
|
basic, immunoglobulin-like variable motif containing
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BIVM mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:53,760,885...53,797,125
Ensembl chr 9:53,761,331...53,797,118
|
|
| G
|
Blm
|
BLM RecQ like helicase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BLM mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:143,819,072...143,905,300
Ensembl chr 1:143,819,090...143,905,210
|
|
| G
|
Blmh
|
bleomycin hydrolase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BLMH mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:62,270,170...62,313,349
Ensembl chr10:62,270,033...62,313,345
|
|
| G
|
Bltp2
|
bridge-like lipid transfer protein family member 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of BLTP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:63,654,072...63,683,282
Ensembl chr10:63,654,104...63,683,282
|
|
| G
|
Bltp3b
|
bridge-like lipid transfer protein family member 3B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BLTP3B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:26,068,948...26,149,033
Ensembl chr 7:26,068,955...26,149,083
|
|
| G
|
Blvra
|
biliverdin reductase A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BLVRA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:134,793,397...134,819,367
Ensembl chr 3:134,794,203...134,819,785
|
|
| G
|
Blvrb
|
biliverdin reductase B
|
affects expression
|
EXP
|
Acrylamide affects the expression of BLVRB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:91,866,258...91,883,921
Ensembl chr 1:91,866,258...91,884,225
|
|
| G
|
Bmal1
|
basic helix-loop-helix ARNT like 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of BMAL1 mRNA Acrylamide results in decreased expression of BMAL1 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739
|
|
| G
|
Bmal2
|
basic helix-loop-helix ARNT like 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BMAL2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:181,429,097...181,478,384
Ensembl chr 4:181,430,159...181,478,382
|
|
| G
|
Bmp15
|
bone morphogenetic protein 15
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BMP15 protein
|
CTD |
PMID:39082229 |
|
NCBI chr X:18,840,943...18,846,006
Ensembl chr X:18,840,829...18,847,438
|
|
| G
|
Bmp4
|
bone morphogenetic protein 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BMP4 mRNA
|
CTD |
PMID:29261810 |
|
NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172
|
|
| G
|
Bmp5
|
bone morphogenetic protein 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BMP5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:85,397,629...85,520,374
Ensembl chr 8:85,396,925...85,520,189
|
|
| G
|
Bmp8a
|
bone morphogenetic protein 8a
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BMP8A mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 5:140,874,942...140,902,881
Ensembl chr 5:140,874,503...140,902,881
|
|
| G
|
Bmpr1a
|
bone morphogenetic protein receptor type 1A
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BMPR1A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:9,740,751...9,786,861
Ensembl chr16:9,742,875...9,786,861
|
|
| G
|
Bmpr1b
|
bone morphogenetic protein receptor type 1B
|
affects expression
|
EXP
|
Acrylamide affects the expression of BMPR1B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:233,211,525...233,544,344
Ensembl chr 2:233,211,525...233,544,311
|
|
| G
|
Bnc2
|
basonuclin zinc finger protein 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BNC2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:103,724,934...104,061,890
Ensembl chr 5:103,724,934...104,125,428
|
|
| G
|
Bnip1
|
BCL2 interacting protein 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BNIP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:16,891,317...16,903,561
Ensembl chr10:16,891,317...16,903,561
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of BNIP3 mRNA Acrylamide results in decreased expression of BNIP3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
Boc
|
BOC cell adhesion associated, oncogene regulated
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BOC mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:69,628,703...69,704,009
Ensembl chr11:69,628,660...69,704,004
|
|
| G
|
Bod1
|
biorientation of chromosomes in cell division 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BOD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:16,497,918...16,504,259
Ensembl chr10:16,497,876...16,504,253
|
|
| G
|
Bola1
|
bolA family member 1
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of BOLA1 mRNA Acrylamide results in decreased expression of BOLA1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:186,447,386...186,448,402
Ensembl chr 2:186,443,583...186,501,358
|
|
| G
|
Bola2
|
bolA family member 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BOLA2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:190,722,535...190,723,401
Ensembl chr 8:64,800,454...64,800,714 Ensembl chr 1:64,800,454...64,800,714
|
|
| G
|
Bop1
|
BOP1 ribosomal biogenesis factor
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BOP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:110,052,716...110,076,529
Ensembl chr 7:110,052,720...110,076,529
|
|
| G
|
Borcs5
|
BLOC-1 related complex subunit 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BORCS5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:169,190,025...169,272,335
Ensembl chr 4:169,204,528...169,271,819
|
|
| G
|
Borcs8
|
BLOC-1 related complex subunit 8
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of BORCS8 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr16:19,308,247...19,314,910
Ensembl chr16:19,308,247...19,314,963
|
|
| G
|
Bpgm
|
bisphosphoglycerate mutase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BPGM mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:64,106,809...64,135,749
Ensembl chr 4:64,106,804...64,135,627
|
|
| G
|
Bpifa2f
|
BPI fold containing family A, member 2F
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BPIFA2F mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:162,981,414...162,993,621
Ensembl chr 3:162,985,040...162,993,621
|
|
| G
|
Bpifb2
|
BPI fold containing family B, member 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BPIFB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:162,818,223...162,837,219
Ensembl chr 3:162,818,223...162,837,210
|
|
| G
|
Bpnt2
|
3'(2'), 5'-bisphosphate nucleotidase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BPNT2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:22,573,241...22,600,126
Ensembl chr 5:22,570,165...22,600,126
|
|
| G
|
Bptf
|
bromodomain PHD finger transcription factor
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BPTF mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr10:92,480,007...92,582,485
Ensembl chr10:92,480,007...92,582,413
|
|
| G
|
Brca1
|
BRCA1, DNA repair associated
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BRCA1 mRNA
|
CTD |
PMID:28606764 |
|
NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763
|
|
| G
|
Brd2
|
bromodomain containing 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BRD2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:4,728,282...4,737,286
Ensembl chr20:4,728,951...4,737,290
|
|
| G
|
Brd3
|
bromodomain containing 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BRD3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:31,173,332...31,227,749
Ensembl chr 3:31,173,332...31,227,629
|
|
| G
|
Brd3os
|
BRD3 opposite strand
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BRD3OS mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:31,168,289...31,169,920
Ensembl chr 3:31,168,289...31,169,920
|
|
| G
|
Brf1
|
BRF1 general transcription factor IIIB subunit
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BRF1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:137,854,055...137,902,629
Ensembl chr 6:137,855,449...137,902,386
|
|
| G
|
Brf2
|
BRF2 general transcription factor 3B subunit
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BRF2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:71,626,146...71,635,909
Ensembl chr16:71,623,238...71,635,903
|
|
| G
|
Bri3
|
brain protein I3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BRI3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:15,454,673...15,478,319
Ensembl chr12:15,454,673...15,478,319
|
|
| G
|
Bricd5
|
BRICHOS domain containing 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BRICD5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:14,003,276...14,004,809
Ensembl chr10:14,003,130...14,004,809
|
|
| G
|
Brinp1
|
BMP/retinoic acid inducible neural specific 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BRINP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:87,363,621...87,565,580
Ensembl chr 5:87,364,050...87,508,256
|
|
| G
|
Brinp2
|
BMP/retinoic acid inducible neural specific 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BRINP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:72,964,498...73,065,312
Ensembl chr13:72,964,502...73,065,294
|
|
| G
|
Brip1
|
BRCA1 interacting DNA helicase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BRIP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:71,402,035...71,528,083
Ensembl chr10:71,401,151...71,575,206
|
|
| G
|
Brme1
|
break repair meiotic recombinase recruitment factor 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BRME1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:40,894,821...40,916,506
Ensembl chr19:40,894,100...40,916,546
|
|
| G
|
Brox
|
BRO1 domain and CAAX motif containing
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BROX mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:97,451,736...97,471,598
Ensembl chr13:97,451,737...97,471,519
|
|
| G
|
Brpf3
|
bromodomain and PHD finger containing, 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BRPF3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:6,866,378...6,904,456
Ensembl chr20:6,867,635...6,904,456
|
|
| G
|
Bsg
|
basigin
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BSG mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:10,643,789...10,651,005
|
|
| G
|
Bspry
|
B-box and SPRY domain containing
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BSPRY mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:80,942,974...80,965,157
Ensembl chr 5:80,942,979...80,988,154
|
|
| G
|
Bst1
|
bone marrow stromal cell antigen 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BST1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:71,466,179...71,482,671
Ensembl chr14:71,466,180...71,482,647
|
|
| G
|
Btbd1
|
BTB domain containing 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BTBD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:145,143,806...145,183,653
Ensembl chr 1:145,143,808...145,181,197
|
|
| G
|
Btbd17
|
BTB domain containing 17
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BTBD17 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:100,325,177...100,331,669
Ensembl chr10:100,325,177...100,331,771
|
|
| G
|
Btbd19
|
BTB domain containing 19
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BTBD19 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:135,834,251...135,843,679
Ensembl chr 5:135,834,508...135,840,903
|
|
| G
|
Btd
|
biotinidase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BTD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:6,869,448...6,900,711
Ensembl chr16:6,869,291...6,901,410
|
|
| G
|
Btg1
|
BTG anti-proliferation factor 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BTG1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406
|
|
| G
|
Btg3
|
BTG anti-proliferation factor 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BTG3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:30,517,068...30,532,981
Ensembl chr11:30,517,072...30,533,082
|
|
| G
|
Btg4
|
BTG anti-proliferation factor 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BTG4 mRNA
|
CTD |
PMID:36599426 PMID:36997053 |
|
NCBI chr 8:60,307,090...60,322,167
Ensembl chr 8:60,317,121...60,322,167
|
|
| G
|
Btk
|
Bruton tyrosine kinase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of BTK mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:102,016,070...102,055,448
Ensembl chr X:102,016,074...102,055,143
|
|
| G
|
Btnl7
|
butyrophilin-like 7
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BTN3A2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:4,303,002...4,315,445
Ensembl chr20:4,269,428...4,315,445
|
|
| G
|
Bub1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BUB1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:135,472,582...135,504,921
|
|
| G
|
Bub1b
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BUB1B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:126,017,045...126,069,796
|
|
| G
|
Bud13
|
BUD13 homolog
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of BUD13 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:55,471,818...55,487,652
Ensembl chr 8:55,471,810...55,487,649
|
|
| G
|
Bud31
|
BUD31 homolog
|
increases expression
|
ISO
|
Acrylamide results in increased expression of BUD31 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:14,576,602...14,584,132
Ensembl chr12:14,576,605...14,584,039
|
|
| G
|
Bzw1
|
basic leucine zipper and W2 domains 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of BZW1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:67,424,860...67,438,656
Ensembl chr 9:67,424,866...67,439,684
|
|
| G
|
C10h16orf90
|
similar to human chromosome 16 open reading frame 90
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C10H16ORF90 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:12,125,235...12,138,441
Ensembl chr10:12,125,212...12,128,109
|
|
| G
|
C10h17orf67
|
similar to human chromosome 17 open reading frame 67
|
increases expression
|
ISO
|
Acrylamide results in increased expression of C17ORF67 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:74,392,541...74,413,323
Ensembl chr10:74,392,541...74,413,323
|
|
| G
|
C10h1orf35
|
similar to human chromosome 1 open reading frame 35
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C10H1ORF35 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:44,494,385...44,496,847
Ensembl chr10:44,494,385...44,496,847
|
|
| G
|
C11h21orf91
|
similar to human chromosome 21 open reading frame 91
|
increases expression
|
EXP
|
Acrylamide results in increased expression of C11H21ORF91 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:30,716,034...30,749,292
Ensembl chr11:30,716,034...30,749,415
|
|
| G
|
C11h22orf39
|
similar to human chromosome 22 open reading frame 39
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of C22ORF39 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:95,660,135...95,665,750
Ensembl chr11:95,663,881...95,664,588
|
|
| G
|
C11h3orf70
|
similar to human chromosome 3 open reading frame 70
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C11H3ORF70 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:92,850,327...92,900,608
Ensembl chr11:92,850,327...92,900,608
|
|
| G
|
C12h12orf43
|
similar to human chromosome 12 open reading frame 43
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of C12ORF43 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:47,332,740...47,338,461
Ensembl chr12:47,332,027...47,338,359
|
|
| G
|
C13h1orf115
|
similar to human chromosome 1 open reading frame 115
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of C13H1ORF115 mRNA Acrylamide results in decreased expression of C1ORF115 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr13:98,953,841...98,963,577
Ensembl chr13:98,953,843...98,963,810
|
|
| G
|
C13h1orf226
|
similar to human chromosome 1 open reading frame 226
|
increases expression
|
ISO
|
Acrylamide results in increased expression of C1ORF226 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:85,063,350...85,071,435
Ensembl chr13:85,063,350...85,353,741
|
|
| G
|
C15h14orf93
|
similar to human chromosome 14 open reading frame 93
|
increases expression
|
EXP
|
Acrylamide results in increased expression of C15H14ORF93 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:32,007,591...32,034,337
Ensembl chr15:32,007,595...32,034,289
|
|
| G
|
C17h6orf52
|
similar to human chromosome 6 open reading frame 52
|
increases expression
|
ISO
|
Acrylamide results in increased expression of C6ORF52 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:23,959,124...23,981,978
Ensembl chr17:23,968,478...23,981,976
|
|
| G
|
C18h18orf32
|
similar to human chromosome 18 open reading frame 32
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C18H18ORF32 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:70,861,434...70,869,983
Ensembl chr18:70,861,435...70,869,983
|
|
| G
|
C18h18orf54
|
similar to human chromosome 18 open reading frame 54
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of C18ORF54 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:66,340,567...66,364,831
Ensembl chr18:66,340,567...66,362,348
|
|
| G
|
C18h5orf46
|
similar to human chromosome 5 open reading frame 46
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C18H5ORF46 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:36,199,309...36,220,409
Ensembl chr18:36,199,309...36,220,409
|
|
| G
|
C19h16orf74
|
similar to human chromosome 16 open reading frame 74
|
increases expression
|
ISO
|
Acrylamide results in increased expression of C16ORF74 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:65,568,997...65,594,994
Ensembl chr19:65,568,997...65,595,460
|
|
| G
|
C1h19orf47
|
similar to human chromosome 19 open reading frame 47
|
affects expression
|
EXP
|
Acrylamide affects the expression of C1H19ORF47 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:91,971,879...92,010,938
Ensembl chr 1:91,971,931...91,999,771
|
|
| G
|
C1h19orf81
|
similar to human chromosome 19 open reading frame 81
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of C19ORF81 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:103,993,832...104,008,301
Ensembl chr 1:103,993,832...104,008,577
|
|
| G
|
C1qc
|
complement C1q C chain
|
affects expression
|
EXP
|
Acrylamide affects the expression of C1QC mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:154,410,845...154,414,208
Ensembl chr 5:154,410,848...154,414,468
|
|
| G
|
C1ql1
|
complement C1q like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C1QL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:88,402,219...88,409,649
Ensembl chr10:88,402,219...88,409,649
|
|
| G
|
C1qtnf3
|
C1q and TNF related 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C1QTNF3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:61,644,225...61,666,640
Ensembl chr 2:61,644,276...61,666,559
|
|
| G
|
C1qtnf4
|
C1q and TNF related 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of C1QTNF4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:97,310,220...97,328,818
Ensembl chr 3:97,327,670...97,342,587
|
|
| G
|
C1qtnf5
|
C1q and TNF related 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of C1QTNF5 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 8:53,347,754...53,349,912
Ensembl chr 8:53,347,711...53,349,912
|
|
| G
|
C1qtnf6
|
C1q and TNF related 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C1QTNF6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:111,958,348...111,964,948
Ensembl chr 7:111,958,350...111,966,871
|
|
| G
|
C1r
|
complement C1r
|
increases expression
|
ISO
|
Acrylamide results in increased expression of C1RB mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 4:159,099,013...159,109,770
Ensembl chr 4:159,098,918...159,109,714
|
|
| G
|
C1rl
|
complement C1r subcomponent like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of C1RL mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:159,080,495...159,097,066
Ensembl chr 4:159,080,495...159,097,066
|
|
| G
|
C1s
|
complement C1s
|
increases expression
|
ISO
|
Acrylamide results in increased expression of C1S mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736
|
|
| G
|
C2
|
complement C2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of C2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:3,944,722...3,975,006
Ensembl chr20:3,955,776...3,981,740
|
|
| G
|
C20h21orf58
|
similar to human chromosome 21 open reading frame 58
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of C21ORF58 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:12,165,853...12,187,271
Ensembl chr20:12,174,928...12,186,503
|
|
| G
|
C20h6orf15
|
similar to human chromosome 6 open reading frame 15
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C20H6ORF15 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:3,177,040...3,178,596
Ensembl chr20:3,177,040...3,178,596
|
|
| G
|
C2cd4c
|
C2 calcium-dependent domain containing 4C
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of C2CD4C mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:10,742,534...10,746,033
Ensembl chr 7:10,742,545...10,751,973
|
|
| G
|
C2h1orf54
|
similar to human chromosome 1 open reading frame 54
|
increases expression
|
ISO
|
Acrylamide results in increased expression of C1ORF54 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:186,113,922...186,124,637
Ensembl chr 2:186,113,922...186,124,335
|
|
| G
|
C2h3orf33
|
similar to human chromosome 3 open reading frame 33
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C2H3ORF33 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:150,522,758...150,554,007
Ensembl chr 2:150,530,231...150,554,055
|
|
| G
|
C2h5orf34
|
similar to human chromosome 5 open reading frame 34
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of C2H5ORF34 mRNA Acrylamide results in increased expression of C5ORF34 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:53,287,353...53,309,804
Ensembl chr 2:53,287,957...53,309,806
|
|
| G
|
C3ar1
|
complement C3a receptor 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C3AR1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:157,747,419...157,756,609
Ensembl chr 4:157,746,089...157,776,323
|
|
| G
|
C3h11orf91
|
similar to human chromosome 11 open reading frame 91
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C3H11ORF91 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:110,934,488...110,941,511
Ensembl chr 3:110,939,526...110,941,508
|
|
| G
|
C4h12orf60
|
similar to human chromosome 12 open reading frame 60
|
increases expression
|
ISO
|
Acrylamide results in increased expression of C12ORF60 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:171,450,603...171,462,735
Ensembl chr 4:171,425,040...171,484,498
|
|
| G
|
C4h2orf42
|
similar to human chromosome 2 open reading frame 42
|
increases expression
|
ISO
|
Acrylamide results in increased expression of C2ORF42 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:120,445,032...120,474,227
Ensembl chr 4:120,445,830...120,474,396
|
|
| G
|
C4h2orf68
|
similar to human chromosome 2 open reading frame 68
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of C2ORF68 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:105,960,543...105,966,509
Ensembl chr 4:105,960,751...105,966,508
|
|
| G
|
C4h3orf20
|
similar to human chromosome 3 open reading frame 20
|
increases expression
|
ISO
|
Acrylamide results in increased expression of C3ORF20 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:125,976,326...126,027,796
Ensembl chr 4:125,980,430...126,027,791
|
|
| G
|
C5
|
complement C5
|
affects expression
|
EXP
|
Acrylamide affects the expression of C5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468
|
|
| G
|
C5ar2
|
complement C5a receptor 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C5AR2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:86,058,557...86,073,583
Ensembl chr 1:86,057,256...86,061,372
|
|
| G
|
C5h1orf159
|
similar to human chromosome 1 open reading frame 159
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of C5H1ORF159 mRNA Acrylamide results in decreased expression of C1ORF159 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:171,983,700...172,001,373
Ensembl chr 5:171,983,936...172,001,373
|
|
| G
|
C5h1orf50
|
similar to human chromosome 1 open reading frame 50
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of C1ORF50 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:138,122,595...138,126,973
Ensembl chr 5:138,122,236...138,127,240
|
|
| G
|
C6h14orf132
|
similar to human chromosome 14 open reading frame 132
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of C14ORF132 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:130,130,176...130,163,153
Ensembl chr 6:130,130,794...130,158,762
|
|
| G
|
C7
|
complement C7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:55,815,687...55,892,605
Ensembl chr 2:55,816,807...55,892,672
|
|
| G
|
C7h8orf82
|
similar to human chromosome 8 open reading frame 82
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of C8ORF82 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:110,324,408...110,326,752
Ensembl chr 7:110,324,409...110,326,752
|
|
| G
|
C8h11orf65
|
similar to human chromosome 11 open reading frame 65
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C8H11ORF65 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:62,692,123...62,720,951
Ensembl chr 8:62,692,568...62,720,946
|
|
| G
|
C8h11orf71
|
similar to human chromosome 11 open reading frame 71
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of C8H11ORF71 mRNA Acrylamide results in decreased expression of C11ORF71 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 8:57,735,075...57,735,489
Ensembl chr 8:57,734,900...57,738,597
|
|
| G
|
C8h11orf97
|
similar to human chromosome 11 open reading frame 97
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of C8H11ORF97 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:19,884,682...19,901,931
Ensembl chr 8:19,883,390...19,902,044
|
|
| G
|
C8h3orf18
|
similar to human chromosome 3 open reading frame 18
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of C8H3ORF18 mRNA Acrylamide results in decreased expression of C3ORF18 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 8:116,891,081...116,901,122
Ensembl chr 8:116,891,297...116,901,120
|
|
| G
|
C8h3orf62
|
similar to human chromosome 3 open reading frame 62
|
increases expression
|
ISO
|
Acrylamide results in increased expression of C3ORF62 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:117,958,583...117,963,137
Ensembl chr 8:117,958,576...117,963,201
|
|
| G
|
C9h2orf66
|
similar to human chromosome 2 open reading frame 66
|
increases expression
|
ISO
|
Acrylamide results in increased expression of C2ORF66 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:63,440,494...63,444,210
Ensembl chr 9:63,442,741...63,444,089
|
|
| G
|
C9h2orf88
|
similar to human chromosome 2 open reading frame 88
|
increases expression
|
ISO
|
Acrylamide results in increased expression of AKAP19 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:56,037,234...56,076,793
Ensembl chr 9:56,031,114...56,131,839
|
|
| G
|
Ca12
|
carbonic anhydrase 12
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CA12 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:76,169,723...76,225,465
Ensembl chr 8:76,169,815...76,225,465
|
|
| G
|
Ca13
|
carbonic anhydrase 13
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CAR13 protein
|
CTD |
PMID:20025956 |
|
NCBI chr 2:88,649,643...88,680,763
Ensembl chr 2:88,649,625...88,680,763
|
|
| G
|
Ca14
|
carbonic anhydrase 14
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CAR14 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:186,131,196...186,138,164
Ensembl chr 2:186,129,341...186,138,863
|
|
| G
|
Ca3
|
carbonic anhydrase 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CA3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524
|
|
| G
|
Ca6
|
carbonic anhydrase 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CAR6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:165,941,028...165,959,566
Ensembl chr 5:165,941,029...165,959,566
|
|
| G
|
Ca9
|
carbonic anhydrase 9
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CA9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:62,559,024...62,565,626
Ensembl chr 5:62,558,823...62,565,626
|
|
| G
|
Cab39l
|
calcium binding protein 39-like
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CAB39L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:37,782,778...37,885,191
Ensembl chr15:37,782,870...37,919,742
|
|
| G
|
Cabin1
|
calcineurin binding protein 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CABIN1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:12,892,750...13,014,801
Ensembl chr20:12,892,771...13,014,800
|
|
| G
|
Cabp7
|
calcium binding protein 7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CABP7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:83,822,322...83,832,667
Ensembl chr14:83,822,327...83,832,735
|
|
| G
|
Cacfd1
|
calcium channel flower domain containing 1
|
affects expression increases expression
|
EXP ISO
|
Acrylamide affects the expression of CACFD1 mRNA Acrylamide results in increased expression of CACFD1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:30,733,958...30,750,237
Ensembl chr 3:30,736,637...30,744,764
|
|
| G
|
Cacna1a
|
calcium voltage-gated channel subunit alpha1 A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CACNA1A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:40,425,560...40,724,810
Ensembl chr19:40,425,560...40,724,599
|
|
| G
|
Cacna1g
|
calcium voltage-gated channel subunit alpha1 G
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CACNA1G mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,851,896...79,919,634
|
|
| G
|
Cacna2d2
|
calcium voltage-gated channel auxiliary subunit alpha2delta 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CACNA2D2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:116,950,860...117,082,159
Ensembl chr 8:116,950,907...117,081,759
|
|
| G
|
Cacnb4
|
calcium voltage-gated channel auxiliary subunit beta 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CACNB4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:57,315,900...57,578,271
Ensembl chr 3:57,315,900...57,578,220
|
|
| G
|
Cacng6
|
calcium voltage-gated channel auxiliary subunit gamma 6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CACNG6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:74,648,342...74,663,351
Ensembl chr 1:74,648,063...74,662,753
|
|
| G
|
Cacng7
|
calcium voltage-gated channel auxiliary subunit gamma 7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CACNG7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:74,715,483...74,746,669
Ensembl chr 1:74,715,483...74,746,669
|
|
| G
|
Cacul1
|
CDK2-associated, cullin domain 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CACUL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:269,652,356...269,712,265
Ensembl chr 1:269,652,356...269,712,112
|
|
| G
|
Cacybp
|
calcyclin binding protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CACYBP mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:74,970,917...74,981,298
Ensembl chr13:74,970,923...74,981,505
|
|
| G
|
Cadps2
|
calcium dependent secretion activator 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CADPS2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:52,746,054...53,275,252
Ensembl chr 4:52,746,065...53,275,004
|
|
| G
|
Calb1
|
calbindin 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CALB1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:34,172,612...34,199,555
Ensembl chr 5:34,172,664...34,200,160
|
|
| G
|
Calca
|
calcitonin-related polypeptide alpha
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CALCA protein
|
CTD |
PMID:34509579 |
|
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
|
|
| G
|
Calcoco1
|
calcium binding and coiled coil domain 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CALCOCO1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:135,713,208...135,728,044
Ensembl chr 7:135,713,208...135,727,928
|
|
| G
|
Calcoco2
|
calcium binding and coiled-coil domain 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CALCOCO2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:81,552,084...81,568,266
|
|
| G
|
Cald1
|
caldesmon 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CALD1 mRNA Acrylamide results in decreased expression of CALD1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:64,232,906...64,414,085
Ensembl chr 4:64,233,171...64,414,085
|
|
| G
|
Calhm1
|
calcium homeostasis modulator 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CALHM1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:255,971,606...255,974,325
Ensembl chr 1:255,971,383...255,974,414
|
|
| G
|
Calhm2
|
calcium homeostasis modulator family member 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CALHM2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:255,963,661...255,969,387
Ensembl chr 1:255,963,663...255,969,387
|
|
| G
|
Calm1
|
calmodulin 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of CALM1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381
|
|
| G
|
Calml4
|
calmodulin-like 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CALML4 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 8:72,218,870...72,230,650
Ensembl chr 8:72,218,613...72,230,650
|
|
| G
|
Calml5
|
calmodulin-like 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CALML5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:71,304,326...71,305,245
Ensembl chr17:71,304,326...71,305,245
|
|
| G
|
Calu
|
calumenin
|
affects expression
|
EXP
|
Acrylamide affects the expression of CALU mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:58,914,456...58,941,957
Ensembl chr 4:58,914,421...58,941,956
|
|
| G
|
Caly
|
calcyon neuron-specific vesicular protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CALY mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:204,292,317...204,303,506
Ensembl chr 1:204,292,318...204,303,196
|
|
| G
|
Camk1
|
calcium/calmodulin-dependent protein kinase I
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CAMK1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:148,036,843...148,047,675
Ensembl chr 4:148,036,824...148,047,245
|
|
| G
|
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CAMK2A mRNA
|
CTD |
PMID:28959563 PMID:29261810 |
|
NCBI chr18:56,648,779...56,711,505
Ensembl chr18:56,649,025...56,711,504
|
|
| G
|
Camk2b
|
calcium/calmodulin-dependent protein kinase II beta
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CAMK2B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:85,059,166...85,148,121
Ensembl chr14:85,059,191...85,148,485
|
|
| G
|
Camk2d
|
calcium/calmodulin-dependent protein kinase II delta
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CAMK2D mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276
|
|
| G
|
Camk2g
|
calcium/calmodulin-dependent protein kinase II gamma
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CAMK2G mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:3,553,238...3,612,310
Ensembl chr15:3,553,294...3,612,310
|
|
| G
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CAMK2N2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:93,792,112...93,796,153
Ensembl chr11:93,794,095...93,795,222
|
|
| G
|
Camkk2
|
calcium/calmodulin-dependent protein kinase kinase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CAMKK2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:39,451,828...39,505,719
Ensembl chr12:39,451,834...39,514,964
|
|
| G
|
Camta2
|
calmodulin binding transcription activator 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CAMTA2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:55,882,071...55,900,575
Ensembl chr10:55,882,071...55,900,179
|
|
| G
|
Canx
|
calnexin
|
affects expression increases expression
|
EXP ISO
|
Acrylamide affects the expression of CANX mRNA Acrylamide results in increased expression of CANX protein Acrylamide results in increased expression of CANX mRNA
|
CTD |
PMID:28959563 PMID:32763439 PMID:37353096 |
|
NCBI chr10:35,124,941...35,157,954
Ensembl chr10:35,124,941...35,157,857
|
|
| G
|
Cap2
|
cyclase associated actin cytoskeleton regulatory protein 2
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CAP2 mRNA Acrylamide results in increased expression of CAP2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr17:18,260,462...18,409,681
Ensembl chr17:18,261,646...18,409,563
|
|
| G
|
Capg
|
capping actin protein, gelsolin like
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CAPG mRNA Acrylamide results in decreased expression of CAPG mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:106,152,912...106,170,010
Ensembl chr 4:106,152,890...106,170,672
|
|
| G
|
Capn1
|
calpain 1
|
affects expression multiple interactions decreases expression increases expression
|
EXP ISO
|
Acrylamide affects the expression of CAPN1 mRNA acetylleucyl-leucyl-norleucinal inhibits the reaction [Acrylamide results in increased expression of CAPN1 protein]; Acrylamide results in increased expression of and results in increased cleavage of CAPN1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Acrylamide results in increased expression of CAPN1 protein] Acrylamide results in decreased expression of CAPN1 mRNA calpeptin inhibits the reaction [Acrylamide results in increased expression of CAPN1 protein]
|
CTD |
PMID:28959563 PMID:30096436 PMID:32763439 PMID:37353096 |
|
NCBI chr 1:212,705,219...212,736,134
Ensembl chr 1:212,705,222...212,729,445
|
|
| G
|
Capn10
|
calpain 10
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CAPN10 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:100,943,665...100,957,910
Ensembl chr 9:100,945,551...100,957,912
|
|
| G
|
Capn15
|
calpain 15
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CAPN15 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:15,477,311...15,503,913
Ensembl chr10:15,477,313...15,503,913
|
|
| G
|
Capn2
|
calpain 2
|
increases expression multiple interactions
|
EXP ISO
|
Acrylamide results in increased expression of CAPN2 mRNA; Acrylamide results in increased expression of CAPN2 protein Acrylamide results in increased expression of and results in increased cleavage of CAPN2 protein; calpeptin inhibits the reaction [Acrylamide results in increased expression of CAPN2 protein]
|
CTD |
PMID:15749267 PMID:29524570 PMID:30096436 PMID:37353096 |
|
NCBI chr13:96,681,902...96,732,625
Ensembl chr13:96,681,848...96,732,625
|
|
| G
|
Capns2
|
calpain, small subunit 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CAPNS2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:30,277,324...30,278,266
|
|
| G
|
Capza1
|
capping actin protein of muscle Z-line subunit alpha 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CAPZA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:195,008,035...195,053,100
Ensembl chr 2:195,008,039...195,053,100
|
|
| G
|
Card19
|
caspase recruitment domain family, member 19
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CARD19 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:15,638,973...15,651,720
Ensembl chr17:15,639,012...15,651,720
|
|
| G
|
Card9
|
caspase recruitment domain family, member 9
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CARD9 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:29,569,907...29,578,402
Ensembl chr 3:29,569,959...29,578,402
|
|
| G
|
Carm1
|
coactivator-associated arginine methyltransferase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CARM1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:28,373,370...28,418,056
Ensembl chr 8:28,373,362...28,418,056
|
|
| G
|
Carmil3
|
capping protein regulator and myosin 1 linker 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CARMIL3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:32,948,228...32,965,829
Ensembl chr15:32,948,856...32,965,811
|
|
| G
|
Cars1
|
cysteinyl-tRNA synthetase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CARS1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:208,182,788...208,225,407
|
|
| G
|
Cartpt
|
CART prepropeptide
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CARTPT mRNA Acrylamide results in decreased expression of CARTPT mRNA
|
CTD |
PMID:28959563 PMID:35032568 |
|
NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:32,989,215...32,999,712
|
|
| G
|
Caskin1
|
CASK interacting protein 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CASKIN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:14,016,780...14,037,927
Ensembl chr10:14,018,012...14,037,924
|
|
| G
|
Casp1
|
caspase 1
|
increases expression multiple interactions
|
ISO EXP
|
Acrylamide results in increased expression of CASP1 protein N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Acrylamide results in increased expression of CASP1 protein]; NLRP3 gene mutant form inhibits the reaction [Acrylamide results in increased expression of CASP1 protein] Acrylamide results in increased expression of CASP1 mRNA
|
CTD |
PMID:31073625 PMID:32014472 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
|
|
| G
|
Casp12
|
caspase 12
|
decreases expression increases cleavage multiple interactions increases expression
|
ISO EXP
|
Acrylamide results in decreased expression of CASP12 mRNA Acrylamide results in increased cleavage of CASP12 protein [elaidic acid co-treated with Acrylamide] results in increased cleavage of CASP12 protein Acrylamide results in increased expression of CASP12 mRNA
|
CTD |
PMID:21319176 PMID:30807115 PMID:38740238 |
|
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions increases cleavage affects expression increases activity increases expression
|
ISO EXP
|
3,4-dihydroxyphenylethanol inhibits the reaction [Acrylamide results in increased activity of CASP3 protein]; salvin inhibits the reaction [Acrylamide results in increased expression of CASP3 mRNA]; tris(dicarboxymethylene)fullerene-C3 inhibits the reaction [Acrylamide results in increased activity of CASP3 protein] Acrylamide results in increased cleavage of CASP3 protein TFEB protein inhibits the reaction [Acrylamide results in increased cleavage of CASP3 protein] Acrylamide affects the expression of CASP3 mRNA [Acrylamide co-treated with INS protein] results in increased expression of CASP3 protein; [elaidic acid co-treated with Acrylamide] results in increased cleavage of CASP3 protein; [INS co-treated with Acrylamide] results in increased cleavage of CASP3 protein; Azithromycin inhibits the reaction [Acrylamide results in increased cleavage of CASP3 protein]; epigallocatechin gallate inhibits the reaction [Acrylamide results in increased activity of CASP3 protein]; epigallocatechin gallate inhibits the reaction [Acrylamide results in increased expression of CASP3 protein]; ERN1 protein promotes the reaction [[INS co-treated with Acrylamide] results in increased cleavage of CASP3 protein]; INS promotes the reaction [Acrylamide results in increased expression of CASP3 mRNA]; naringin inhibits the reaction [Acrylamide results in increased expression of CASP3 protein]; notoginsenoside R1 inhibits the reaction [Acrylamide results in increased expression of CASP3 protein]; Taurine inhibits the reaction [Acrylamide results in increased activity of CASP3 protein]; TXN1 protein inhibits the reaction [Acrylamide results in increased expression of CASP3 protein]; vinpocetine inhibits the reaction [Acrylamide results in increased expression of CASP3 protein]; Vitamin E inhibits the reaction [Acrylamide results in increased cleavage of CASP3 protein] Acrylamide results in increased expression of CASP3 mRNA; Acrylamide results in increased expression of CASP3 protein
|
CTD |
PMID:19475399 PMID:21777647 PMID:22459607 PMID:27920337 PMID:28056603 PMID:28067054 PMID:28159594 PMID:29607694 PMID:31971015 PMID:36598108 PMID:37172712 PMID:38043637 PMID:38348719 PMID:38604440 PMID:38740238 PMID:39082229 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp6
|
caspase 6
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CASP6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726
|
|
| G
|
Casp7
|
caspase 7
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CASP7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
| G
|
Casp8
|
caspase 8
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CASP8 mRNA Acrylamide results in decreased expression of CASP8 mRNA
|
CTD |
PMID:28959563 PMID:35032568 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp9
|
caspase 9
|
increases expression multiple interactions
|
ISO EXP
|
Acrylamide results in increased expression of CASP9 mRNA Acrylamide results in increased expression of CASP9 protein alpha-Tocopherol inhibits the reaction [Acrylamide results in increased expression of CASP9 protein]; notoginsenoside R1 inhibits the reaction [Acrylamide results in increased expression of CASP9 protein]; TXN1 protein inhibits the reaction [Acrylamide results in increased expression of CASP9 protein] salvin inhibits the reaction [Acrylamide results in increased expression of CASP9 mRNA]
|
CTD |
PMID:28159594 PMID:31971015 PMID:32763439 PMID:38242491 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Casq1
|
calsequestrin 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CASQ1 mRNA
|
CTD |
PMID:28606764 |
|
NCBI chr13:87,203,021...87,212,710
Ensembl chr13:87,202,485...87,213,463
|
|
| G
|
Cass4
|
Cas scaffold protein family member 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CASS4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:181,580,954...181,620,945
Ensembl chr 3:181,581,902...181,620,945
|
|
| G
|
Cast
|
calpastatin
|
multiple interactions increases cleavage
|
ISO EXP
|
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Acrylamide results in increased cleavage of CAST protein] Acrylamide results in increased expression of and results in increased cleavage of CAST protein
|
CTD |
PMID:37353096 |
|
NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:5,707,640...5,817,180
|
|
| G
|
Castor1
|
cytosolic arginine sensor for mTORC1 subunit 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CASTOR1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr14:83,309,710...83,314,123
Ensembl chr14:83,309,504...83,314,127
|
|
| G
|
Cat
|
catalase
|
increases expression multiple interactions decreases activity increases activity decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CAT mRNA [Acrylamide co-treated with Alcohols] results in decreased activity of CAT protein; Acrylamide promotes the reaction [Streptozocin results in decreased activity of CAT protein]; Curcumin inhibits the reaction [Acrylamide results in decreased activity of CAT protein] Acrylamide results in increased activity of CAT protein Acrylamide results in decreased expression of CAT mRNA salvin inhibits the reaction [Acrylamide results in decreased activity of CAT protein]; salvin inhibits the reaction [Acrylamide results in decreased expression of CAT mRNA] Acrylamide results in decreased expression of CAT protein [Acrylamide co-treated with Aluminum Chloride] results in decreased activity of CAT protein; [Aluminum Chloride co-treated with Acrylamide] results in decreased expression of CAT protein; boric acid inhibits the reaction [Acrylamide results in increased activity of CAT protein]; epigallocatechin gallate inhibits the reaction [Acrylamide results in decreased activity of CAT protein]; naringin inhibits the reaction [Acrylamide results in decreased activity of CAT protein]; Selenium inhibits the reaction [Acrylamide results in decreased activity of CAT protein]
|
CTD |
PMID:22459607 PMID:25034941 PMID:25858877 PMID:25934431 PMID:28056603 PMID:28159594 PMID:28959563 PMID:29913234 PMID:31081568 PMID:34896238 PMID:34906654 PMID:36598108 PMID:37987225 PMID:38242491 More...
|
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Catsper2
|
cation channel, sperm associated 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CATSPER2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:128,822,387...128,842,501
Ensembl chr 3:128,822,391...128,842,261
|
|
| G
|
Catsperg
|
cation channel sperm associated auxiliary subunit gamma
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CATSPERG1 mRNA Acrylamide results in increased expression of CATSPERG mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:93,616,209...93,646,970
Ensembl chr 1:93,616,209...93,661,618
|
|
| G
|
Cbfa2t2
|
CBFA2/RUNX1 partner transcriptional co-repressor 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CBFA2T2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:163,397,160...163,503,409
Ensembl chr 3:163,397,185...163,503,407
|
|
| G
|
Cblc
|
Cbl proto-oncogene C
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CBLC mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:88,567,930...88,584,709
Ensembl chr 1:88,567,932...88,584,709
|
|
| G
|
Cbll1
|
Cbl proto-oncogene like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CBLL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:53,798,712...53,812,890
Ensembl chr 6:53,798,712...53,813,880
|
|
| G
|
Cbln1
|
cerebellin 1 precursor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CBLN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:35,782,151...35,785,960
Ensembl chr19:35,781,952...35,785,960
|
|
| G
|
Cbln2
|
cerebellin 2 precursor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CBLN2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:82,215,210...82,222,648
Ensembl chr18:82,215,220...82,222,648
|
|
| G
|
Cbln3
|
cerebellin 3 precursor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CBLN3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:33,331,919...33,334,428
Ensembl chr15:33,331,919...33,334,428
|
|
| G
|
Cbr3
|
carbonyl reductase 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CBR3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:46,478,295...46,486,555
Ensembl chr11:46,478,274...46,486,558
|
|
| G
|
Cbx4
|
chromobox 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CBX4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:104,835,685...104,841,727
Ensembl chr10:104,835,685...104,841,727
|
|
| G
|
Cbx6
|
chromobox 6
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CBX6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:113,253,364...113,263,413
Ensembl chr 7:113,253,364...113,263,413
|
|
| G
|
Cbx7
|
chromobox 7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CBX7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:113,341,030...113,358,716
Ensembl chr 7:113,341,030...113,358,346
|
|
| G
|
Cby3
|
chibby family member 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CBY3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:35,179,316...35,183,834
Ensembl chr10:35,179,965...35,184,809
|
|
| G
|
Cc2d1a
|
coiled-coil and C2 domain containing 1A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CC2D1A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:40,916,587...40,931,702
Ensembl chr19:40,916,532...40,931,701
|
|
| G
|
Cc2d1b
|
coiled-coil and C2 domain containing 1B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CC2D1B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:128,581,962...128,596,045
Ensembl chr 5:128,581,994...128,596,022
|
|
| G
|
Ccdc102a
|
coiled-coil domain containing 102A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CCDC102A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:10,108,553...10,124,652
Ensembl chr19:10,109,364...10,124,652
|
|
| G
|
Ccdc112
|
coiled-coil domain containing 112
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CCDC112 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:41,184,769...41,218,958
Ensembl chr18:41,184,769...41,218,958
|
|
| G
|
Ccdc115
|
coiled-coil domain containing 115
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CCDC115 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:44,146,287...44,150,250
Ensembl chr 9:44,145,161...44,149,899
|
|
| G
|
Ccdc117
|
coiled-coil domain containing 117
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CCDC117 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr14:84,614,282...84,623,648
Ensembl chr14:84,614,283...84,624,087
|
|
| G
|
Ccdc121
|
coiled-coil domain containing 121
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CCDC121 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:30,690,831...30,693,437
Ensembl chr 6:30,690,831...30,693,437
|
|
| G
|
Ccdc127
|
coiled-coil domain containing 127
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CCDC127 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:30,757,010...30,764,473
Ensembl chr 1:30,757,010...30,764,473
|
|
| G
|
Ccdc136
|
coiled-coil domain containing 136
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCDC136 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:58,963,196...58,992,962
Ensembl chr 4:58,962,908...58,992,975
|
|
| G
|
Ccdc142
|
coiled-coil domain containing 142
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CCDC142 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:117,164,055...117,172,286
Ensembl chr 4:117,166,135...117,173,935
|
|
| G
|
Ccdc144b
|
coiled-coil domain containing 144B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CCDC144CP mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:120,790,909...120,852,758
Ensembl chr 2:120,793,728...120,852,850
|
|
| G
|
Ccdc146
|
coiled-coil domain containing 146
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCDC146 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 4:14,554,966...14,703,801
Ensembl chr 4:14,554,966...14,703,799
|
|
| G
|
Ccdc148
|
coiled-coil domain containing 148
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CCDC148 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:63,765,656...64,040,802
Ensembl chr 3:63,765,668...64,040,757
|
|
| G
|
Ccdc150
|
coiled-coil domain containing 150
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CCDC150 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:63,287,962...63,403,644
Ensembl chr 9:63,288,000...63,391,670
|
|
| G
|
Ccdc159
|
coiled-coil domain containing 159
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CCDC159 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:28,733,988...28,742,646
Ensembl chr 8:28,725,003...28,744,890
|
|
| G
|
Ccdc169
|
coiled-coil domain containing 169
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CCDC169 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:141,471,762...141,501,325
Ensembl chr 2:141,471,810...141,501,325
|
|
| G
|
Ccdc171
|
coiled-coil domain containing 171
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCDC171 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 5:102,965,763...103,449,740
Ensembl chr 5:102,965,911...103,533,290
|
|
| G
|
Ccdc172
|
coiled-coil domain containing 172
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCDC172 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:267,615,341...267,661,568
Ensembl chr 1:267,615,349...267,662,269
|
|
| G
|
Ccdc177
|
coiled-coil domain containing 177
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCDC177 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr 6:106,135,827...106,142,413
Ensembl chr 6:106,134,333...106,144,441
|
|
| G
|
Ccdc180
|
coiled-coil domain containing 180
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCDC180 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:64,950,522...65,019,127
Ensembl chr 5:64,950,515...65,019,127
|
|
| G
|
Ccdc184
|
coiled-coil domain containing 184
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CCDC184 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:131,178,732...131,180,136
Ensembl chr 7:131,176,373...131,183,680
|
|
| G
|
Ccdc190
|
coiled-coil domain containing 190
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCDC190 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr13:84,679,959...84,687,661
Ensembl chr13:84,679,986...84,687,658
|
|
| G
|
Ccdc200
|
coiled-coil domain containing 200
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCDC200 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:87,017,950...87,023,364
Ensembl chr10:87,017,838...87,023,439
|
|
| G
|
Ccdc22
|
coiled-coil domain containing 22
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCDC22 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:17,570,184...17,582,130
Ensembl chr X:17,535,659...17,582,130
|
|
| G
|
Ccdc3
|
coiled-coil domain containing 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CCDC3 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr17:77,941,148...78,044,820
Ensembl chr17:77,944,977...78,044,470
|
|
| G
|
Ccdc34
|
coiled-coil domain containing 34
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCDC34 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:117,007,652...117,042,885
Ensembl chr 3:117,005,760...117,042,226
|
|
| G
|
Ccdc39
|
coiled-coil domain 39 molecular ruler complex subunit
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CCDC39 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:118,593,881...118,631,584
Ensembl chr 2:118,593,881...118,631,647
|
|
| G
|
Ccdc47
|
coiled-coil domain containing 47
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CCDC47 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:91,630,101...91,648,626
Ensembl chr10:91,630,106...91,648,626
|
|
| G
|
Ccdc50
|
coiled-coil domain containing 50
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CCDC50 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:86,837,624...86,900,164
Ensembl chr11:86,837,624...86,899,980
|
|
| G
|
Ccdc51
|
coiled-coil domain containing 51
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CCDC51 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:118,601,002...118,619,943
Ensembl chr 8:118,601,019...118,619,943
|
|
| G
|
Ccdc54
|
coiled-coil domain containing 54
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CCDC54 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:63,693,017...63,696,114
Ensembl chr11:63,692,105...63,722,348
|
|
| G
|
Ccdc57
|
coiled-coil domain containing 57
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCDC57 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:106,591,106...106,694,740
Ensembl chr10:106,590,551...106,684,983
|
|
| G
|
Ccdc59
|
coiled-coil domain containing 59
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CCDC59 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:43,029,272...43,035,655
Ensembl chr 7:43,029,272...43,035,655
|
|
| G
|
Ccdc61
|
coiled-coil domain containing 61
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCDC61 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:87,665,541...87,685,732
Ensembl chr 1:87,665,541...87,685,732
|
|
| G
|
Ccdc62
|
coiled-coil domain containing 62
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CCDC62 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:38,284,089...38,320,828
Ensembl chr12:38,284,089...38,320,965
|
|
| G
|
Ccdc65
|
coiled-coil domain containing 65
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CCDC65 mRNA Acrylamide results in decreased expression of DRC2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:131,736,002...131,749,761
Ensembl chr 7:131,736,011...131,749,719
|
|
| G
|
Ccdc66
|
coiled-coil domain containing 66
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CCDC66 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr16:2,668,810...2,700,717
Ensembl chr16:2,658,131...2,701,012
|
|
| G
|
Ccdc78
|
coiled-coil domain containing 78
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCDC78 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:15,312,403...15,316,800
Ensembl chr10:15,311,868...15,319,425
|
|
| G
|
Ccdc8
|
coiled-coil domain containing 8
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CCDC8 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:86,807,607...86,810,935
Ensembl chr 1:86,806,942...86,814,204
|
|
| G
|
Ccdc82
|
coiled-coil domain containing 82
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CCDC82 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:18,509,293...18,665,008
Ensembl chr 8:18,509,382...18,550,529
|
|
| G
|
Ccdc88b
|
coiled-coil domain containing 88B
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CCDC88B mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:213,466,139...213,482,099
Ensembl chr 1:213,461,963...213,522,302
|
|
| G
|
Ccdc89
|
coiled-coil domain containing 89
|
affects expression
|
EXP
|
Acrylamide affects the expression of CCDC89 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:153,798,786...153,800,048
Ensembl chr 1:153,797,440...153,803,002
|
|
| G
|
Ccdc9
|
coiled-coil domain containing 9
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CCDC9 mRNA Acrylamide results in increased expression of CCDC9 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:86,105,717...86,119,811
Ensembl chr 1:86,105,800...86,119,884
|
|
| G
|
Ccer1
|
coiled-coil glutamate-rich protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CCER1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:34,371,735...34,413,638
Ensembl chr 7:34,370,172...34,408,806
|
|
| G
|
Cckbr
|
cholecystokinin B receptor
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCKBR mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:169,183,194...169,193,745
|
|
| G
|
Ccl12
|
C-C motif chemokine ligand 12
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CCL12 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:67,567,876...67,569,426
Ensembl chr10:67,567,876...67,569,426
|
|
| G
|
Ccl27
|
C-C motif chemokine ligand 27
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CCL27 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:61,737,261...61,744,375
Ensembl chr 5:61,737,261...61,743,522
|
|
| G
|
Ccl28
|
C-C motif chemokine ligand 28
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCL28 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 2:53,334,071...53,358,709
Ensembl chr 2:53,334,071...53,358,709
|
|
| G
|
Ccl3
|
C-C motif chemokine ligand 3
|
decreases expression
|
ISO
|
Acrylamide analog results in decreased expression of CCL3 mRNA; Acrylamide analog results in decreased expression of CCL3 protein
|
CTD |
PMID:18287786 |
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
|
|
| G
|
Ccl4
|
C-C motif chemokine ligand 4
|
decreases expression
|
ISO
|
Acrylamide analog results in decreased expression of CCL4 mRNA; Acrylamide analog results in decreased expression of CCL4 protein
|
CTD |
PMID:18287786 |
|
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722
|
|
| G
|
Ccn1
|
cellular communication network factor 1
|
decreases expression increases expression
|
ISO
|
Acrylamide results in decreased expression of CCN1 mRNA Acrylamide results in increased expression of CCN1 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883
|
|
| G
|
Ccn2
|
cellular communication network factor 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CCN2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976
|
|
| G
|
Ccna2
|
cyclin A2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CCNA2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
|
|
| G
|
Ccnb1
|
cyclin B1
|
increases expression
|
ISO EXP
|
Acrylamide results in increased expression of CCNB1 mRNA; Acrylamide results in increased expression of CCNB1 protein
|
CTD |
PMID:20025956 PMID:28959563 PMID:30807115 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
| G
|
Ccnb2
|
cyclin B2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CCNB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682
|
|
| G
|
Ccnd1
|
cyclin D1
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
Acrylamide analog results in decreased expression of CCND1 mRNA; Acrylamide analog results in decreased expression of CCND1 protein [FOXO3 mRNA co-treated with Acrylamide] results in decreased expression of CCND1 protein; FOXO3 protein promotes the reaction [Acrylamide results in decreased expression of CCND1 mRNA]; MIR193B mRNA inhibits the reaction [Acrylamide results in decreased expression of CCND1 mRNA]; MIR193B mRNA inhibits the reaction [Acrylamide results in decreased expression of CCND1 protein] Acrylamide results in decreased expression of CCND1 mRNA; Acrylamide results in decreased expression of CCND1 protein Curcumin inhibits the reaction [Acrylamide results in increased expression of CCND1 protein]; epigallocatechin gallate inhibits the reaction [Acrylamide results in increased expression of CCND1 protein]
|
CTD |
PMID:17317719 PMID:20734998 PMID:24508477 PMID:28959563 PMID:33582169 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccnd2
|
cyclin D2
|
affects expression
|
EXP
|
Acrylamide affects the expression of CCND2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301 Ensembl chr 4:161,653,048...161,680,301
|
|
| G
|
Ccne1
|
cyclin E1
|
decreases expression increases expression
|
ISO EXP
|
Acrylamide analog results in decreased expression of CCNE1 mRNA; Acrylamide analog results in decreased expression of CCNE1 protein Acrylamide results in increased expression of CCNE1 mRNA
|
CTD |
PMID:17317719 PMID:28959563 PMID:32763439 |
|
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822
|
|
| G
|
Ccng1
|
cyclin G1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CCNG1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766
|
|
| G
|
Ccng2
|
cyclin G2
|
affects expression
|
EXP
|
Acrylamide affects the expression of CCNG2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:15,088,694...15,097,190
Ensembl chr14:15,088,695...15,096,206
|
|
| G
|
Ccnk
|
cyclin K
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CCNK mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 6:132,854,428...132,877,604
Ensembl chr 6:132,854,700...132,877,602
|
|
| G
|
Ccnl1
|
cyclin L1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CCNL1 mRNA
|
CTD |
PMID:15749267 |
|
NCBI chr 2:152,495,169...152,508,855
Ensembl chr 2:152,495,172...152,507,468
|
|
| G
|
Ccr1
|
C-C motif chemokine receptor 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CCR1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:132,433,711...132,439,266
Ensembl chr 8:132,431,592...132,439,374
|
|
| G
|
Ccr10
|
C-C motif chemokine receptor 10
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CCR10 mRNA Acrylamide results in increased expression of CCR10 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:86,608,836...86,611,273
Ensembl chr10:86,608,836...86,611,273
|
|
| G
|
Ccr2
|
C-C motif chemokine receptor 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CCR2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059
|
|
| G
|
Ccr6
|
C-C motif chemokine receptor 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CCR6 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:55,022,037...55,055,857
Ensembl chr 1:55,021,833...55,046,059
|
|
| G
|
Ccr7
|
C-C motif chemokine receptor 7
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CCR7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,593,594...84,604,501
|
|
| G
|
Ccs
|
copper chaperone for superoxide dismutase
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CCS mRNA Acrylamide results in decreased expression of CCS mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:211,543,192...211,564,354
Ensembl chr 1:211,542,701...211,564,260
|
|
| G
|
Ccsap
|
centriole, cilia and spindle-associated protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CCSAP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:68,722,417...68,740,908
|
|
| G
|
Cct2
|
chaperonin containing TCP1 subunit 2
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CCT2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977
|
|
| G
|
Cct3
|
chaperonin containing TCP1 subunit 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CCT3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:176,063,529...176,088,180
Ensembl chr 2:176,063,526...176,089,925
|
|
| G
|
Cct4
|
chaperonin containing TCP1 subunit 4
|
affects expression increases expression
|
EXP ISO
|
Acrylamide affects the expression of CCT4 mRNA Acrylamide results in increased expression of CCT4 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr14:101,193,057...101,205,935
Ensembl chr14:101,192,772...101,205,770
|
|
| G
|
Cct5
|
chaperonin containing TCP1 subunit 5
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CCT5 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:84,302,621...84,313,773
Ensembl chr 2:84,302,623...84,313,779
|
|
| G
|
Cct6a
|
chaperonin containing TCP1 subunit 6A
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CCT6A mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr12:32,508,842...32,519,072
Ensembl chr12:32,508,675...32,519,119
|
|
| G
|
Cct8
|
chaperonin containing TCP1 subunit 8
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CCT8 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:40,196,619...40,208,328
Ensembl chr11:40,196,619...40,208,328
|
|
| G
|
Cd101
|
CD101 molecule
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CD101 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:191,109,782...191,148,184
Ensembl chr 2:191,110,637...191,148,149
|
|
| G
|
Cd160
|
CD160 molecule
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CD160 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:187,029,654...187,042,447
Ensembl chr 2:187,033,140...187,064,587
|
|
| G
|
Cd200r1
|
CD200 receptor 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CD200R1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:69,392,943...69,427,213
Ensembl chr11:69,392,975...69,427,128
|
|
| G
|
Cd209f
|
CD209f molecule
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CD209F mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:7,282,275...7,285,351
Ensembl chr12:7,282,371...7,285,351
|
|
| G
|
Cd24
|
CD24 molecule
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CD24 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785
|
|
| G
|
Cd2ap
|
CD2-associated protein
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CD2AP mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:25,580,071...25,679,968
Ensembl chr 9:25,583,975...25,679,968
|
|
| G
|
Cd300lb
|
CD300 molecule-like family member b
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CD300LB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:100,463,815...100,473,804
Ensembl chr10:100,463,815...100,473,804
|
|
| G
|
Cd320
|
CD320 molecule
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CD320 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:15,328,320...15,334,138
Ensembl chr 7:15,311,286...15,334,138
|
|
| G
|
Cd34
|
CD34 molecule
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CD34 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:109,008,786...109,029,317
Ensembl chr13:109,008,623...109,029,315
|
|
| G
|
Cd36
|
CD36 molecule
|
affects expression multiple interactions increases expression
|
EXP ISO
|
Acrylamide affects the expression of CD36 mRNA [Acrylamide co-treated with INS protein] results in increased expression of CD36 mRNA Acrylamide results in increased expression of CD36 mRNA Acrylamide inhibits the reaction [Streptozocin results in increased expression of CD36 mRNA]
|
CTD |
PMID:15749267 PMID:34896238 PMID:38604440 |
|
NCBI chr 4:18,209,088...18,302,142
|
|
| G
|
Cd38
|
CD38 molecule
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CD38 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:71,384,532...71,424,794
Ensembl chr14:71,384,532...71,424,505
|
|
| G
|
Cd3e
|
CD3 epsilon subunit of T-cell receptor complex
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CD3E mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:54,200,617...54,211,770
Ensembl chr 8:54,200,617...54,211,876
|
|
| G
|
Cd40
|
CD40 molecule
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CD40 mRNA
|
CTD |
PMID:31073625 |
|
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
|
|
| G
|
Cd44
|
CD44 molecule
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CD44 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424
|
|
| G
|
Cd46
|
CD46 molecule
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CD46 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:109,104,122...109,134,903
|
|
| G
|
Cd47
|
Cd47 molecule
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CD47 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:64,374,816...64,438,763
Ensembl chr11:64,377,926...64,438,272
|
|
| G
|
Cd48
|
Cd48 molecule
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CD48 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr13:86,717,960...86,741,540
Ensembl chr13:86,717,961...86,742,942
|
|
| G
|
Cd52
|
CD52 molecule
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CD52 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:151,603,537...151,605,096
Ensembl chr 5:151,603,524...151,605,086
|
|
| G
|
Cd55
|
CD55 molecule (Cromer blood group)
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CD55 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:44,409,574...44,438,913
Ensembl chr13:44,409,587...44,438,107
|
|
| G
|
Cd63
|
Cd63 molecule
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CD63 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:1,909,538...1,924,937
Ensembl chr 7:1,922,169...1,924,938
|
|
| G
|
Cd74
|
CD74 molecule
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CD74 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410
|
|
| G
|
Cd82
|
Cd82 molecule
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CD82 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:99,842,748...99,887,298
Ensembl chr 3:99,842,757...99,886,744
|
|
| G
|
Cd84
|
CD84 molecule
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CD84 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr13:86,859,979...86,899,984
Ensembl chr13:86,859,990...86,894,318
|
|
| G
|
Cd9
|
CD9 molecule
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CD9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:159,942,560...159,975,444
|
|
| G
|
Cd93
|
CD93 molecule
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CD93 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:156,345,019...156,351,537
Ensembl chr 3:156,345,019...156,351,537
|
|
| G
|
Cdan1
|
codanin 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CDAN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:128,129,664...128,143,520
Ensembl chr 3:128,129,301...128,143,549
|
|
| G
|
Cdc20
|
cell division cycle 20
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CDC20 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799
|
|
| G
|
Cdc25b
|
cell division cycle 25B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CDC25B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:138,860,130...138,870,492
|
|
| G
|
Cdc25c
|
cell division cycle 25C
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CDC25C mRNA Acrylamide results in decreased expression of CDC25C mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292
|
|
| G
|
Cdc26
|
cell division cycle 26
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CDC26 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:80,861,658...80,875,326
Ensembl chr 5:80,861,659...80,875,326
|
|
| G
|
Cdc27
|
cell division cycle 27
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CDC27 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:89,900,676...89,949,770
Ensembl chr10:89,900,684...89,949,770
|
|
| G
|
Cdc34
|
cell division cycle 34, ubiquitin conjugating enzyme
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CDC34 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:10,668,209...10,674,206
Ensembl chr 7:10,668,210...10,674,526
|
|
| G
|
Cdc42
|
cell division cycle 42
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CDC42 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627
|
|
| G
|
Cdc42bpa
|
CDC42 binding protein kinase alpha
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CDC42BPA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:94,215,359...94,435,681
Ensembl chr13:94,215,959...94,435,681
|
|
| G
|
Cdc42bpb
|
CDC42 binding protein kinase beta
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CDC42BPB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:136,154,905...136,241,259
Ensembl chr 6:136,154,905...136,237,570
|
|
| G
|
Cdc42bpg
|
CDC42 binding protein kinase gamma
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CDC42BPG mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:213,037,603...213,057,764
Ensembl chr 1:213,037,836...213,057,765
|
|
| G
|
Cdc42ep1
|
CDC42 effector protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CDC42EP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:112,275,759...112,283,665
Ensembl chr 7:112,275,792...112,283,664
|
|
| G
|
Cdc42ep2
|
CDC42 effector protein 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CDC42EP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:212,631,317...212,640,231
Ensembl chr 1:212,629,881...212,640,234
|
|
| G
|
Cdc42ep3
|
CDC42 effector protein 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CDC42EP3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:21,463,081...21,483,553
Ensembl chr 6:21,461,762...21,508,540
|
|
| G
|
Cdc45
|
cell division cycle 45
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CDC45 mRNA Acrylamide results in decreased expression of CDC45 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr11:95,689,702...95,714,980
Ensembl chr11:95,689,919...95,714,981
|
|
| G
|
Cdc6
|
cell division cycle 6
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CDC6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241
|
|
| G
|
Cdca2
|
cell division cycle associated 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CDCA2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:46,071,360...46,117,524
Ensembl chr15:46,071,360...46,116,639
|
|
| G
|
Cdca3
|
cell division cycle associated 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CDCA3 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068
|
|
| G
|
Cdca4
|
cell division cycle associated 4
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CDCA4 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 6:137,713,390...137,722,652
Ensembl chr 6:137,713,051...137,722,580
|
|
| G
|
Cdca5
|
cell division cycle associated 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CDCA5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:212,807,863...212,821,313
Ensembl chr 1:212,804,014...212,821,309
|
|
| G
|
Cdca7
|
cell division cycle associated 7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CDCA7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:77,730,315...77,740,950
Ensembl chr 3:77,729,970...77,740,947
|
|
| G
|
Cdca7l
|
cell division cycle associated 7 like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CDCA7L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:144,936,885...144,982,844
Ensembl chr 6:144,908,171...144,982,843
|
|
| G
|
Cdcp1
|
CUB domain containing protein 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CDCP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:131,706,140...131,742,799
Ensembl chr 8:131,706,140...131,742,877
|
|
| G
|
Cdh11
|
cadherin 11
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CDH11 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:2,152,961...2,312,140
Ensembl chr19:2,154,840...2,312,140
|
|
| G
|
Cdh12
|
cadherin 12
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CDH12 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:72,201,859...73,436,039
Ensembl chr 2:72,886,532...73,436,039
|
|
| G
|
Cdh13
|
cadherin 13
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CDH13 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:63,258,251...64,296,122
Ensembl chr19:63,258,122...64,296,119
|
|
| G
|
Cdh16
|
cadherin 16
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CDH16 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:367,202...377,710
Ensembl chr19:367,274...388,934
|
|
| G
|
Cdh23
|
cadherin-related 23
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CDH23 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr20:28,783,124...29,165,624
Ensembl chr20:28,783,564...29,165,332
|
|
| G
|
Cdh3
|
cadherin 3
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CDH3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr19:51,303,414...51,353,900
Ensembl chr19:51,300,083...51,354,257
|
|
| G
|
Cdh4
|
cadherin 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CDH4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:186,902,763...187,381,020
Ensembl chr 3:186,902,751...187,381,020
|
|
| G
|
Cdhr1
|
cadherin-related family member 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CDHR1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:12,863,696...12,883,579
Ensembl chr16:12,863,696...12,883,579
|
|
| G
|
Cdipt
|
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
|
affects expression
|
EXP
|
Acrylamide affects the expression of CDIPT mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:191,013,632...191,017,943
Ensembl chr 1:191,013,463...191,017,971
|
|
| G
|
Cdk1
|
cyclin-dependent kinase 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CDK1 mRNA Acrylamide results in decreased expression of CDK1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
|
|
| G
|
Cdk10
|
cyclin-dependent kinase 10
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CDK10 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:68,168,040...68,184,923
Ensembl chr19:68,169,874...68,177,599
|
|
| G
|
Cdk14
|
cyclin-dependent kinase 14
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CDK14 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:29,619,237...30,213,651
Ensembl chr 4:29,621,217...30,213,651
|
|
| G
|
Cdk16
|
cyclin-dependent kinase 16
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CDK16 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:4,046,330...4,057,825
Ensembl chr X:4,026,866...4,057,380
|
|
| G
|
Cdk17
|
cyclin-dependent kinase 17
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CDK17 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:29,570,982...29,677,613
Ensembl chr 7:29,570,816...29,652,008
|
|
| G
|
Cdk18
|
cyclin-dependent kinase 18
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CDK18 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:46,107,763...46,140,705
Ensembl chr13:46,108,911...46,140,865
|
|
| G
|
Cdk2
|
cyclin dependent kinase 2
|
increases expression decreases expression multiple interactions
|
ISO
|
Acrylamide results in increased expression of CDK2 protein Acrylamide results in decreased expression of CDK2 mRNA [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK2 protein Acrylamide analog results in decreased expression of CDK2 protein
|
CTD |
PMID:17317719 PMID:20734998 PMID:30409764 PMID:32763439 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
|
|
| G
|
Cdk4
|
cyclin-dependent kinase 4
|
decreases expression
|
ISO
|
Acrylamide analog results in decreased expression of CDK4 protein
|
CTD |
PMID:17317719 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
| G
|
Cdk5
|
cyclin-dependent kinase 5
|
increases expression decreases expression multiple interactions
|
EXP ISO
|
Acrylamide results in increased expression of CDK5 protein Acrylamide results in decreased expression of CDK5 mRNA calpeptin inhibits the reaction [Acrylamide results in increased expression of CDK5 protein]
|
CTD |
PMID:30096436 PMID:32763439 |
|
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777
|
|
| G
|
Cdk5r2
|
cyclin-dependent kinase 5 regulatory subunit 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CDK5R2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:83,864,922...83,866,390
Ensembl chr 9:83,864,726...83,867,618
|
|
| G
|
Cdk5rap1
|
CDK5 regulatory subunit associated protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CDK5RAP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:163,189,435...163,333,003
Ensembl chr 3:163,191,056...163,332,908
|
|
| G
|
Cdk5rap3
|
CDK5 regulatory subunit associated protein 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CDK5RAP3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:82,390,845...82,402,814
Ensembl chr10:82,390,845...82,400,001
|
|
| G
|
Cdkl2
|
cyclin dependent kinase like 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CDKL2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:16,312,154...16,347,524
Ensembl chr14:16,312,932...16,347,523
|
|
| G
|
Cdkl3
|
cyclin-dependent kinase-like 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CDKL3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:36,755,413...36,850,197
Ensembl chr10:36,764,377...36,878,660
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
Acrylamide results in decreased expression of CDKN1A protein modified form [FOXO3 mRNA co-treated with Acrylamide] results in increased expression of CDKN1A protein; FOXO3 protein promotes the reaction [Acrylamide results in increased expression of CDKN1A mRNA]; MIR193B mRNA inhibits the reaction [Acrylamide results in increased expression of CDKN1A mRNA]; MIR193B mRNA inhibits the reaction [Acrylamide results in increased expression of CDKN1A protein] Acrylamide results in increased expression of CDKN1A mRNA; Acrylamide results in increased expression of CDKN1A protein [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1A protein; ATF3 protein promotes the reaction [Acrylamide results in increased expression of CDKN1A protein] Acrylamide results in increased expression of CDKN1A protein modified form
|
CTD |
PMID:20734998 PMID:25531190 PMID:28959563 PMID:30409764 PMID:33582169 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Cdkn1b
|
cyclin-dependent kinase inhibitor 1B
|
decreases expression multiple interactions
|
ISO
|
Acrylamide results in decreased expression of CDKN1B protein [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein
|
CTD |
PMID:20734998 PMID:30409764 |
|
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
|
|
| G
|
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CDKN1C mRNA
|
CTD |
PMID:21319176 PMID:28959563 PMID:35032568 |
|
NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498
|
|
| G
|
Cdkn2aip
|
CDKN2A interacting protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CDKN2AIP mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:51,266,613...51,274,051
Ensembl chr16:51,268,896...51,274,049
|
|
| G
|
Cdnf
|
cerebral dopamine neurotrophic factor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CDNF mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:79,623,728...79,637,800
Ensembl chr17:79,611,623...79,665,922
|
|
| G
|
Cdpf1
|
cysteine rich, DPF motif domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CDPF1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:118,773,497...118,785,283
Ensembl chr 7:118,780,845...118,783,161
|
|
| G
|
Cdrt15l2
|
CMT1A duplicated region transcript 15 like 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CDRT15L2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:11,232,244...11,238,199
|
|
| G
|
Cds1
|
CDP-diacylglycerol synthase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CDS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:8,126,678...8,187,243
Ensembl chr14:8,124,838...8,187,218
|
|
| G
|
Cdyl2
|
chromodomain Y-like 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CDYL2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:61,500,702...61,691,746
Ensembl chr19:61,500,702...61,691,746
|
|
| G
|
Ceacam1
|
CEA cell adhesion molecule 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CEACAM1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:90,171,401...90,187,798
|
|
| G
|
Cebpa
|
CCAAT/enhancer binding protein alpha
|
multiple interactions
|
ISO
|
Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA mRNA]; Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein]; Acrylamide promotes the reaction [Dietary Fats results in increased expression of CEBPA mRNA]; Acrylamide promotes the reaction [Dietary Fats results in increased expression of CEBPA protein]
|
CTD |
PMID:30409764 |
|
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
|
|
| G
|
Cebpb
|
CCAAT/enhancer binding protein beta
|
multiple interactions increases expression
|
ISO
|
Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CEBPB protein]; Acrylamide promotes the reaction [Dietary Fats results in increased phosphorylation of CEBPB protein] Acrylamide results in increased expression of CEBPB mRNA
|
CTD |
PMID:30409764 PMID:32763439 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
|
|
| G
|
Cebpd
|
CCAAT/enhancer binding protein delta
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CEBPD mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824
|
|
| G
|
Cebpe
|
CCAAT/enhancer binding protein epsilon
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CEBPE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:32,139,716...32,141,476
Ensembl chr15:32,139,716...32,141,476
|
|
| G
|
Cebpg
|
CCAAT/enhancer binding protein gamma
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CEBPG mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:96,820,981...96,829,736
Ensembl chr 1:96,810,214...96,830,283
|
|
| G
|
Celsr2
|
cadherin, EGF LAG seven-pass G-type receptor 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CELSR2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:198,717,333...198,741,689
Ensembl chr 2:198,717,896...198,741,581
|
|
| G
|
Cenatac
|
centrosomal AT-AC splicing factor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CENATAC mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:53,632,777...53,639,661
Ensembl chr 8:53,632,044...53,639,650
|
|
| G
|
Cend1
|
cell cycle exit and neuronal differentiation 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CEND1 mRNA Acrylamide results in decreased expression of CEND1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:205,954,713...205,957,710
Ensembl chr 1:205,953,197...205,957,944
|
|
| G
|
Cenpa
|
centromere protein A
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CENPA mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:31,420,062...31,431,703
|
|
| G
|
Cenpb
|
centromere protein B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CENPB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:138,850,003...138,852,796
Ensembl chr 3:138,841,679...138,854,372
|
|
| G
|
Cenpe
|
centromere protein E
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CENPE mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636
|
|
| G
|
Cenpf
|
centromere protein F
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CENPF mRNA Acrylamide results in increased expression of CENPF mRNA
|
CTD |
PMID:28606764 PMID:28959563 PMID:32763439 |
|
NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886
|
|
| G
|
Cenpi
|
centromere protein I
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CENPI mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:101,809,192...101,860,935
Ensembl chr X:101,809,659...101,860,934
|
|
| G
|
Cenpk
|
centromere protein K
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CENPK mRNA Acrylamide results in decreased expression of CENPK mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:37,094,163...37,155,158
Ensembl chr 2:37,094,248...37,119,488
|
|
| G
|
Cenpl
|
centromere protein L
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CENPL mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:75,870,479...75,885,466
Ensembl chr13:75,870,489...75,905,250
|
|
| G
|
Cenpm
|
centromere protein M
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CENPM mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:115,628,117...115,639,401
Ensembl chr 7:115,628,129...115,643,866
|
|
| G
|
Cenpn
|
centromere protein N
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CENPN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:61,880,101...61,902,850
Ensembl chr19:61,877,148...61,902,918
|
|
| G
|
Cenpo
|
centromere protein O
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CENPO mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:32,923,127...32,937,879
Ensembl chr 6:32,908,025...32,937,853
|
|
| G
|
Cenpp
|
centromere protein P
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CENPP mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr17:15,220,521...15,395,741
Ensembl chr17:15,220,291...15,395,739
|
|
| G
|
Cenpq
|
centromere protein Q
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CENPQ mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:27,454,339...27,469,371
Ensembl chr 9:27,454,252...27,469,366
|
|
| G
|
Cenpt
|
centromere protein T
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CENPT mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:50,644,548...50,651,048
Ensembl chr19:50,634,368...50,651,037
|
|
| G
|
Cenpw
|
centromere protein W
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CENPW mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:29,353,939...29,359,109
Ensembl chr 1:29,353,970...29,359,109
|
|
| G
|
Cep112
|
centrosomal protein 112
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CEP112 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr10:93,865,630...94,332,679
Ensembl chr10:93,865,699...94,332,680
|
|
| G
|
Cep131
|
centrosomal protein 131
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CEP131 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:105,844,433...105,868,811
Ensembl chr10:105,844,433...105,868,797
|
|
| G
|
Cep135
|
centrosomal protein 135
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CEP135 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:31,884,774...31,950,050
Ensembl chr14:31,884,781...31,950,050
|
|
| G
|
Cep15
|
centrosomal protein 15
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CEP15 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:15,247,627...15,265,560
Ensembl chr15:15,247,932...15,265,475
|
|
| G
|
Cep152
|
centrosomal protein 152
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CEP152 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:133,243,979...133,332,271
Ensembl chr 3:133,263,174...133,331,655 Ensembl chr 3:133,263,174...133,331,655
|
|
| G
|
Cep192
|
centrosomal protein 192
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CEP192 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:63,643,816...63,728,264
Ensembl chr18:63,646,163...63,728,264
|
|
| G
|
Cep290
|
centrosomal protein 290
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CEP290 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:37,196,765...37,285,955
Ensembl chr 7:37,196,783...37,285,955
|
|
| G
|
Cep295nl
|
CEP295 N-terminal like
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CEP295NL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:104,066,652...104,079,787
Ensembl chr10:104,054,640...104,084,291
|
|
| G
|
Cep41
|
centrosomal protein 41
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CEP41 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:60,238,602...60,279,670
Ensembl chr 4:60,239,539...60,254,419
|
|
| G
|
Cep43
|
centrosomal protein 43
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CEP43 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:55,080,983...55,111,509
Ensembl chr 1:55,082,712...55,111,509
|
|
| G
|
Cep55
|
centrosomal protein 55
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CEP55 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:245,245,272...245,260,835
Ensembl chr 1:245,245,306...245,260,890
|
|
| G
|
Cep72
|
centrosomal protein 72
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CEP72 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:31,053,884...31,083,863
Ensembl chr 1:31,053,914...31,083,863
|
|
| G
|
Cep76
|
centrosomal protein 76
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CEP76 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:63,444,389...63,478,358
Ensembl chr18:63,443,746...63,478,358
|
|
| G
|
Cep78
|
centrosomal protein 78
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CEP78 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:222,674,193...222,702,124
Ensembl chr 1:222,674,194...222,702,120
|
|
| G
|
Cep89
|
centrosomal protein 89
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CEP89 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:97,195,116...97,237,015
Ensembl chr 1:97,195,135...97,237,016
|
|
| G
|
Cercam
|
cerebral endothelial cell adhesion molecule
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CERCAM mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:33,515,513...33,553,817
Ensembl chr 3:33,486,664...33,553,813
|
|
| G
|
Cers1
|
ceramide synthase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CERS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:19,131,271...19,146,480
Ensembl chr16:19,131,276...19,146,480
|
|
| G
|
Cers2
|
ceramide synthase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CERS2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:185,579,511...185,587,789
Ensembl chr 2:185,579,119...185,588,839
|
|
| G
|
Cers3
|
ceramide synthase 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CERS3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:129,728,136...129,833,182
Ensembl chr 1:129,677,781...129,833,181
|
|
| G
|
Cers5
|
ceramide synthase 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CERS5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:132,738,834...132,776,920
Ensembl chr 7:132,738,834...132,776,786
|
|
| G
|
Cers6
|
ceramide synthase 6
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CERS6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:74,038,520...74,287,544
Ensembl chr 3:74,038,851...74,287,544
|
|
| G
|
Ces1d
|
carboxylesterase 1D
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CES1D mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449
|
|
| G
|
Ces2a
|
carboxylesterase 2A
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CES2A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:135,885...142,935
Ensembl chr19:135,885...142,935
|
|
| G
|
Ces2h
|
carboxylesterase 2H
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CES2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752
|
|
| G
|
Ces3a
|
carboxylesterase 3a
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CES3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:49,902,312...49,910,484
|
|
| G
|
Ces4a
|
carboxylesterase 4A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CES4A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:49,921,643...49,942,838
Ensembl chr19:49,921,608...49,939,461
|
|
| G
|
Cetn1
|
centrin 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CETN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:924,428...925,130
Ensembl chr18:922,112...925,332
|
|
| G
|
Cfap144
|
cilia and flagella associated protein 144
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CFAP144 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:44,009,412...44,019,281
Ensembl chr10:44,009,412...44,019,281
|
|
| G
|
Cfap210
|
cilia and flagella associated protein 210
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CFAP210 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:74,928,368...74,962,508
Ensembl chr 3:74,927,880...74,962,497
|
|
| G
|
Cfap221
|
cilia and flagella associated protein 221
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CFAP221 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:33,599,322...33,669,721
Ensembl chr13:33,598,895...33,669,549
|
|
| G
|
Cfap251
|
cilia and flagella associated protein 251
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CFAP251 mRNA
|
CTD |
PMID:32763439 PMID:35032568 |
|
NCBI chr12:38,923,154...38,997,881
Ensembl chr12:38,922,330...38,954,783
|
|
| G
|
Cfap263
|
cilia and flagella associated protein 263
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CFAP263 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:9,503,062...9,522,957
Ensembl chr19:9,503,066...9,522,957
|
|
| G
|
Cfap298
|
cilia and flagella associated protein 298
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CFAP298 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:43,667,996...43,678,049
Ensembl chr11:43,668,014...43,677,382
|
|
| G
|
Cfap43
|
cilia and flagella associated protein 43
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CFAP43 mRNA Acrylamide results in increased expression of CFAP43 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:256,566,558...256,653,816
Ensembl chr 1:256,566,559...256,653,840
|
|
| G
|
Cfap44
|
cilia and flagella associated protein 44
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CFAP44 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:69,704,997...69,789,998
Ensembl chr11:69,705,719...69,789,905
|
|
| G
|
Cfap53
|
cilia and flagella associated protein 53
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CFAP53 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:70,159,900...70,227,543
Ensembl chr18:70,159,898...70,227,540
|
|
| G
|
Cfap61
|
cilia and flagella associated protein 61
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CFAP61 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:153,807,672...154,086,591
Ensembl chr 3:153,807,735...154,086,590
|
|
| G
|
Cfap68
|
cilia and flagella associated protein 68
|
increases expression
|
ISO EXP
|
Acrylamide results in increased expression of CFAP68 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 8:60,004,034...60,009,782
Ensembl chr 8:60,004,034...60,009,667
|
|
| G
|
Cfap77
|
cilia and flagella associated protein 77
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CFAP77 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:32,656,410...32,779,261
Ensembl chr 3:32,656,410...32,779,261
|
|
| G
|
Cfap95
|
cilia and flagella associated protein 95
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CFAP95 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:230,558,329...230,669,479
Ensembl chr 1:230,558,331...230,669,479
|
|
| G
|
Cfap97
|
cilia and flagella associated protein 97
|
affects expression
|
EXP
|
Acrylamide affects the expression of CFAP97 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:52,818,693...52,867,775
Ensembl chr16:52,818,697...52,868,061
|
|
| G
|
Cfb
|
complement factor B
|
affects expression increases expression
|
EXP ISO
|
Acrylamide affects the expression of CFB mRNA Acrylamide results in increased expression of CFB mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,955,776...3,981,740
|
|
| G
|
Cfc1
|
cripto, FRL-1, cryptic family 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CFC1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:44,234,997...44,247,846
Ensembl chr 9:44,235,020...44,247,845
|
|
| G
|
Cfl2
|
cofilin 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CFL2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:78,090,843...78,094,888
Ensembl chr 6:78,090,843...78,094,888
|
|
| G
|
Cflar
|
CASP8 and FADD-like apoptosis regulator
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CFLAR mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434
|
|
| G
|
Cfp
|
complement factor properdin
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CFP mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:3,715,551...3,721,113
Ensembl chr X:3,710,425...3,721,112
|
|
| G
|
Cgas
|
cyclic GMP-AMP synthase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CGAS mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:88,172,559...88,187,538
Ensembl chr 8:88,174,512...88,185,859
|
|
| G
|
Cgref1
|
cell growth regulator with EF hand domain 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CGREF1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:31,151,795...31,163,801
Ensembl chr 6:31,151,795...31,163,800
|
|
| G
|
Ch25h
|
cholesterol 25-hydroxylase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CH25H mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 1:241,428,048...241,429,366
Ensembl chr 1:241,331,619...241,431,190
|
|
| G
|
Chac1
|
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CHAC1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361
|
|
| G
|
Chaf1b
|
chromatin assembly factor 1 subunit B
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CHAF1B mRNA Acrylamide results in decreased expression of CHAF1B mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr11:46,670,560...46,690,739
Ensembl chr11:46,670,630...46,690,733
|
|
| G
|
Chat
|
choline O-acetyltransferase
|
decreases activity decreases expression multiple interactions
|
EXP ISO
|
Acrylamide results in decreased activity of CHAT protein Acrylamide results in decreased expression of CHAT mRNA Acrylamide results in decreased expression of CHAT mRNA; Acrylamide results in decreased expression of CHAT protein NTF3 protein inhibits the reaction [Acrylamide results in decreased activity of CHAT protein]; Rutin inhibits the reaction [Acrylamide results in decreased expression of CHAT protein]
|
CTD |
PMID:11779407 PMID:28959563 PMID:30807115 PMID:36657526 |
|
NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,663,665...7,723,416
|
|
| G
|
Chchd10
|
coiled-coil-helix-coiled-coil-helix domain containing 10
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CHCHD10 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:12,725,274...12,730,295
Ensembl chr20:12,725,277...12,745,677
|
|
| G
|
Chchd3
|
coiled-coil-helix-coiled-coil-helix domain containing 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CHCHD3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:62,327,574...62,584,085
Ensembl chr 4:62,327,576...62,584,035
|
|
| G
|
Chd2
|
chromodomain helicase DNA binding protein 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CHD2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:136,597,993...136,726,874
Ensembl chr 1:136,599,900...136,710,335
|
|
| G
|
Chd5
|
chromodomain helicase DNA binding protein 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CHD5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:168,130,851...168,181,705
Ensembl chr 5:168,130,575...168,179,441
|
|
| G
|
Chd7
|
chromodomain helicase DNA binding protein 7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CHD7 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 5:26,609,245...26,792,736
Ensembl chr 5:26,609,407...26,792,734
|
|
| G
|
Chdh
|
choline dehydrogenase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CHDH mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:5,199,738...5,232,067
Ensembl chr16:5,200,763...5,232,997
|
|
| G
|
Chek1
|
checkpoint kinase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CHEK1 protein
|
CTD |
PMID:20025956 |
|
NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:44,609,417...44,629,359
|
|
| G
|
Chek2
|
checkpoint kinase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CHEK2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667
|
|
| G
|
Chic1
|
cysteine-rich hydrophobic domain 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of CHIC1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:72,427,851...72,471,924
Ensembl chr X:72,427,851...72,471,924
|
|
| G
|
Chid1
|
chitinase domain containing 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CHID1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:206,024,059...206,059,259
Ensembl chr 1:205,998,801...206,059,227
|
|
| G
|
Chit1
|
chitinase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CHIT1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:48,117,886...48,165,645
Ensembl chr13:48,145,893...48,165,639
|
|
| G
|
Chka
|
choline kinase alpha
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CHKA mRNA Acrylamide results in decreased expression of CHKA mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:210,506,056...210,554,752
|
|
| G
|
Chkb
|
choline kinase beta
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CHKB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:122,380,592...122,385,102
Ensembl chr 7:122,380,594...122,383,949
|
|
| G
|
Chl1
|
cell adhesion molecule L1-like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CHL1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 4:137,847,648...138,062,077
Ensembl chr 4:137,847,895...138,062,077
|
|
| G
|
Chm
|
CHM Rab escort protein
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CHM mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr X:82,395,463...82,554,249
Ensembl chr X:82,396,816...82,568,642
|
|
| G
|
Chml
|
CHM like Rab escort protein
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CHML mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:90,141,880...90,152,097
Ensembl chr13:90,131,514...90,151,265
|
|
| G
|
Chmp5
|
charged multivesicular body protein 5
|
affects expression
|
EXP
|
Acrylamide affects the expression of CHMP5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:60,877,369...60,894,512
Ensembl chr 5:60,877,341...60,894,511
|
|
| G
|
Chmp6
|
charged multivesicular body protein 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CHMP6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:105,690,400...105,696,070
Ensembl chr10:105,690,398...105,696,333
|
|
| G
|
Chodl
|
chondrolectin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CHODL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:31,141,030...31,163,342
Ensembl chr11:31,141,021...31,163,334
|
|
| G
|
Chordc1
|
cysteine and histidine rich domain containing 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CHORDC1 mRNA Acrylamide results in increased expression of CHORDC1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:23,650,865...23,677,696
|
|
| G
|
Chp2
|
calcineurin-like EF hand protein 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CHP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:186,189,090...186,203,663
Ensembl chr 1:186,185,151...186,203,667
|
|
| G
|
Chpf
|
chondroitin polymerizing factor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CHPF mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:84,411,824...84,416,523
Ensembl chr 9:84,411,829...84,416,523
|
|
| G
|
Chpf2
|
chondroitin polymerizing factor 2
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CHPF2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:11,470,917...11,479,096
Ensembl chr 4:11,472,908...11,478,370
|
|
| G
|
Chrd
|
chordin
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CHRD mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr11:93,676,400...93,685,584
Ensembl chr11:93,676,400...93,685,278
|
|
| G
|
Chrdl1
|
chordin-like 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CHRDL1 mRNA
|
CTD |
PMID:28959563 PMID:29261810 |
|
NCBI chr X:111,685,864...111,789,684
Ensembl chr X:111,685,866...111,789,661
|
|
| G
|
Chrm2
|
cholinergic receptor, muscarinic 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CHRM2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 4:65,981,136...66,116,128
Ensembl chr 4:65,981,006...66,126,464
|
|
| G
|
Chrm3
|
cholinergic receptor, muscarinic 3
|
affects expression
|
EXP
|
Acrylamide affects the expression of CHRM3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:64,696,549...65,158,622
Ensembl chr17:64,696,066...65,173,304
|
|
| G
|
Chrna1
|
cholinergic receptor nicotinic alpha 1 subunit
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CHRNA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:78,862,286...78,877,353
Ensembl chr 3:78,862,286...78,877,353
|
|
| G
|
Chrna3
|
cholinergic receptor nicotinic alpha 3 subunit
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CHRNA3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:64,297,755...64,311,412
|
|
| G
|
Chrna4
|
cholinergic receptor nicotinic alpha 4 subunit
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CHRNA4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
|
|
| G
|
Chrna5
|
cholinergic receptor nicotinic alpha 5 subunit
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CHRNA5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:64,265,879...64,294,233
Ensembl chr 8:64,265,879...64,294,233
|
|
| G
|
Chrnb1
|
cholinergic receptor nicotinic beta 1 subunit
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CHRNB1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:54,999,943...55,015,137
Ensembl chr10:55,002,788...55,015,107
|
|
| G
|
Chrnb3
|
cholinergic receptor nicotinic beta 3 subunit
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CHRNB3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:71,411,847...71,454,225
Ensembl chr16:71,417,039...71,454,225
|
|
| G
|
Chrnb4
|
cholinergic receptor nicotinic beta 4 subunit
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CHRNB4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:64,313,669...64,333,248
|
|
| G
|
Chrnd
|
cholinergic receptor nicotinic delta subunit
|
affects expression
|
EXP
|
Acrylamide affects the expression of CHRND mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:95,310,316...95,318,734
Ensembl chr 9:95,310,298...95,318,745
|
|
| G
|
Chrne
|
cholinergic receptor nicotinic epsilon subunit
|
affects expression
|
EXP
|
Acrylamide affects the expression of CHRNE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:55,829,835...55,838,853
Ensembl chr10:55,829,836...55,834,154
|
|
| G
|
Chrng
|
cholinergic receptor nicotinic gamma subunit
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CHRNG mRNA Acrylamide results in increased expression of CHRNG mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 9:95,325,984...95,332,092
Ensembl chr 9:95,325,984...95,332,092
|
|
| G
|
Chst11
|
carbohydrate sulfotransferase 11
|
affects expression
|
EXP
|
Acrylamide affects the expression of CHST11 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:22,412,121...22,630,577
Ensembl chr 7:22,415,686...22,630,441
|
|
| G
|
Chst12
|
carbohydrate sulfotransferase 12
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CHST12 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr12:19,224,545...19,243,012
Ensembl chr12:19,220,141...19,243,047
|
|
| G
|
Chst2
|
carbohydrate sulfotransferase 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CHST2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 8:104,839,716...104,845,961
Ensembl chr 8:104,831,292...104,860,301
|
|
| G
|
Chst7
|
carbohydrate sulfotransferase 7
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CHST7 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr X:4,949,810...4,986,372
Ensembl chr X:4,938,757...4,986,907
|
|
| G
|
Chst9
|
carbohydrate sulfotransferase 9
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CHST9 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:6,850,874...7,125,222
Ensembl chr18:6,851,831...7,125,161
|
|
| G
|
Chtf18
|
chromosome transmission fidelity factor 18
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CHTF18 mRNA Acrylamide results in decreased expression of CHTF18 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:15,247,525...15,255,573
Ensembl chr10:15,246,362...15,255,685
|
|
| G
|
Chuk
|
component of inhibitor of nuclear factor kappa B kinase complex
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CHUK mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273
|
|
| G
|
Ciao3
|
cytosolic iron-sulfur assembly component 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CIAO3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:15,300,403...15,309,467
Ensembl chr10:15,300,471...15,309,468
|
|
| G
|
Cib2
|
calcium and integrin binding family member 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CIB2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:63,826,410...63,843,301
Ensembl chr 8:63,826,411...63,843,277
|
|
| G
|
Cib4
|
calcium and integrin binding family member 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CIB4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:31,560,105...31,623,403
Ensembl chr 6:31,562,489...31,623,464
|
|
| G
|
Cilp
|
cartilage intermediate layer protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CILP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:74,671,696...74,687,420
Ensembl chr 8:74,671,534...74,687,409
|
|
| G
|
Cilp2
|
cartilage intermediate layer protein 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CILP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:19,573,821...19,581,100
Ensembl chr16:19,573,908...19,581,100
|
|
| G
|
Cimap1a
|
ciliary microtubule associated protein 1A
|
increases expression affects methylation
|
EXP ISO
|
Acrylamide results in increased expression of CIMAP1A mRNA Acrylamide affects the methylation of CIMAP1A gene
|
CTD |
PMID:28959563 PMID:35032568 |
|
NCBI chr 1:205,355,601...205,358,882
Ensembl chr 1:205,355,675...205,358,882
|
|
| G
|
Cip2a
|
cellular inhibitor of PP2A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CIP2A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:65,255,123...65,285,914
Ensembl chr11:65,255,123...65,285,914
|
|
| G
|
Cirbp
|
cold inducible RNA binding protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CIRBP mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 7:10,184,515...10,189,623
|
|
| G
|
Cish
|
cytokine inducible SH2-containing protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CISH mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr 8:116,850,969...116,855,917
Ensembl chr 8:116,850,773...116,855,986
|
|
| G
|
Ckap2
|
cytoskeleton associated protein 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CKAP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352
|
|
| G
|
Ckap2l
|
cytoskeleton associated protein 2-like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CKAP2L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:136,950,390...136,977,503
Ensembl chr 3:136,950,381...136,977,565
|
|
| G
|
Ckap4
|
cytoskeleton-associated protein 4
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CKAP4 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 7:21,118,527...21,126,624
Ensembl chr 7:21,118,085...21,126,624
|
|
| G
|
Ckb
|
creatine kinase B
|
decreases activity affects methylation
|
ISO EXP
|
Acrylamide results in decreased activity of CKB protein Acrylamide affects the methylation of CKB gene
|
CTD |
PMID:15038071 PMID:35032568 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478
|
|
| G
|
Cklf
|
chemokine-like factor
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CKLF mRNA Acrylamide results in decreased expression of CKLF mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr19:704,528...712,998
Ensembl chr19:697,451...712,998
|
|
| G
|
Ckm
|
creatine kinase, M-type
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CKM mRNA
|
CTD |
PMID:28606764 |
|
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719
|
|
| G
|
Ckmt1
|
creatine kinase, mitochondrial 1
|
decreases activity decreases expression
|
ISO EXP
|
Acrylamide results in decreased activity of CKMT1 protein Acrylamide results in decreased expression of CKMT1B mRNA
|
CTD |
PMID:15038071 PMID:32763439 |
|
NCBI chr 3:128,783,408...128,789,485
Ensembl chr 3:128,783,597...128,789,483
|
|
| G
|
Ckmt2
|
creatine kinase, mitochondrial 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CKMT2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:24,815,008...24,845,511
Ensembl chr 2:24,815,008...24,845,511
|
|
| G
|
Cks1b
|
CDC28 protein kinase regulatory subunit 1B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CKS1B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365
|
|
| G
|
Cks2
|
CDC28 protein kinase regulatory subunit 2
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CKS2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519
|
|
| G
|
Clasp1
|
cytoplasmic linker associated protein 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CLASP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:32,046,362...32,267,954
Ensembl chr13:32,046,444...32,267,924
|
|
| G
|
Clba1
|
clathrin binding box of aftiphilin containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CLBA1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:137,703,947...137,710,743
Ensembl chr 6:137,703,619...137,710,742
|
|
| G
|
Clcn2
|
chloride voltage-gated channel 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CLCN2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:93,702,382...93,716,059
Ensembl chr11:93,702,360...93,716,059
|
|
| G
|
Clcn4
|
chloride voltage-gated channel 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CLCN4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:27,290,769...27,356,967
Ensembl chr X:27,290,868...27,356,939
|
|
| G
|
Clcn6
|
chloride voltage-gated channel 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CLCN6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:163,715,593...163,748,301
Ensembl chr 5:163,717,439...163,748,198
|
|
| G
|
Clcnkb
|
chloride voltage-gated channel Kb
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CLCNKB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:158,993,073...159,005,618
Ensembl chr 5:158,993,074...159,004,900
|
|
| G
|
Cldn15
|
claudin 15
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CLDN15 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:25,334,849...25,345,104
Ensembl chr12:25,334,849...25,343,477
|
|
| G
|
Cldn18
|
claudin 18
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CLDN18 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:109,125,819...109,145,110
Ensembl chr 8:109,126,949...109,152,701
|
|
| G
|
Cldn2
|
claudin 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CLDN2 mRNA
|
CTD |
PMID:28959563 PMID:35032568 |
|
NCBI chr X:108,248,383...108,258,847
Ensembl chr X:108,237,676...108,262,377
|
|
| G
|
Cldn23
|
claudin 23
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of CLDN23 mRNA Acrylamide results in decreased expression of CLDN23 mRNA
|
CTD |
PMID:28959563 PMID:35032568 |
|
NCBI chr16:63,117,045...63,118,769
Ensembl chr16:63,116,781...63,118,957
|
|
| G
|
Cldn34b
|
claudin 34B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CLDN34B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:44,396,219...44,402,241
Ensembl chr X:44,396,219...44,402,241
|
|
| G
|
Cldn4
|
claudin 4
|
affects expression
|
EXP
|
Acrylamide affects the expression of CLDN4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958
|
|
| G
|
Cldn7
|
claudin 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CLDN7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:55,188,670...55,190,871
Ensembl chr10:55,188,684...55,190,905
|
|
| G
|
Cldn9
|
claudin 9
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CLDN9 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr10:13,218,728...13,220,159
Ensembl chr10:13,218,729...13,220,178
|
|
| G
|
Clec11a
|
C-type lectin domain containing 11A
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CLEC11A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:103,938,029...103,941,170
Ensembl chr 1:103,935,185...103,946,784
|
|
| G
|
Clec14a
|
C-type lectin domain containing 14A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CLEC14A mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 6:81,616,414...81,619,556
Ensembl chr 6:81,612,953...81,619,614
|
|
| G
|
Clec1a
|
C-type lectin domain family 1, member A
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CLEC1A mRNA Acrylamide results in increased expression of CLEC1A mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 4:164,561,385...164,588,593
Ensembl chr 4:164,563,374...164,587,269
|
|
| G
|
Clec2dl1
|
C-type lectin domain family 2 member D-like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CLEC2DL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:163,949,688...163,960,935
|
|
| G
|
Clec4a3
|
C-type lectin domain family 4, member A3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CLEC4A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:157,885,899...157,896,728
Ensembl chr 4:157,885,895...157,896,727
|
|
| G
|
Clec4d
|
C-type lectin domain family 4, member D
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CLEC4D mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:158,275,287...158,286,978
Ensembl chr 4:158,275,341...158,287,055
|
|
| G
|
Clec7a
|
C-type lectin domain containing 7A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CLEC7A mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 4:164,588,737...164,599,953
Ensembl chr 4:164,588,754...164,599,919
|
|
| G
|
Clic3
|
chloride intracellular channel 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CLIC3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:28,670,176...28,672,166
Ensembl chr 3:28,670,229...28,675,723
|
|
| G
|
Clic4
|
chloride intracellular channel 4
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CLIC4 mRNA Acrylamide results in increased expression of CLIC4 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:152,737,371...152,797,118
Ensembl chr 5:152,737,371...152,797,118
|
|
| G
|
Clic6
|
chloride intracellular channel 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CLIC6 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr11:45,223,715...45,266,261
Ensembl chr11:45,223,669...45,267,344
|
|
| G
|
Clip1
|
CAP-GLY domain containing linker protein 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CLIP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:38,571,533...38,678,779
Ensembl chr12:38,571,834...38,678,779
|
|
| G
|
Clip4
|
CAP-GLY domain containing linker protein family, member 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CLIP4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:29,359,628...29,449,365 NCBI chr 6:29,349,245...29,351,890
Ensembl chr 6:29,348,918...29,449,271
|
|
| G
|
Clk1
|
CDC-like kinase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CLK1 mRNA
|
CTD |
PMID:32763439 PMID:35032568 |
|
NCBI chr 9:67,441,962...67,453,180
Ensembl chr 9:67,441,952...67,451,187
|
|
| G
|
Clmp
|
CXADR-like membrane protein
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CLMP mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 8:49,957,639...50,065,959
Ensembl chr 8:49,957,720...50,065,959
|
|
| G
|
Cln5
|
CLN5, intracellular trafficking protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CLN5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:86,308,286...86,321,679
Ensembl chr 2:67,620,667...67,622,952 Ensembl chr15:67,620,667...67,622,952
|
|
| G
|
Cln6
|
CLN6, transmembrane ER protein
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CLN6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:72,198,773...72,213,777
Ensembl chr 8:72,198,712...72,213,776
|
|
| G
|
Clp1
|
cleavage factor polyribonucleotide kinase subunit 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CLP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:90,213,461...90,217,165
Ensembl chr 3:90,213,465...90,217,538
|
|
| G
|
Clpsl2
|
colipase-like 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CLPSL2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:6,609,832...6,612,655
Ensembl chr20:6,608,490...6,612,655
|
|
| G
|
Clspn
|
claspin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CLSPN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:144,134,619...144,169,531
Ensembl chr 5:144,134,632...144,169,530
|
|
| G
|
Clstn3
|
calsyntenin 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CLSTN3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:159,017,795...159,051,069
Ensembl chr 4:159,017,795...159,051,069
|
|
| G
|
Cltb
|
clathrin, light chain B
|
affects expression
|
EXP
|
Acrylamide affects the expression of CLTB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:10,006,416...10,024,278
Ensembl chr17:10,006,656...10,024,915
|
|
| G
|
Cltc
|
clathrin heavy chain
|
multiple interactions
|
ISO
|
Acrylamide binds to and affects the metabolism of CLTC protein
|
CTD |
PMID:17698512 |
|
NCBI chr10:72,014,984...72,073,308
Ensembl chr10:72,014,986...72,070,691
|
|
| G
|
Cltrn
|
collectrin, amino acid transport regulator
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CLTRN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:33,993,825...34,027,124
Ensembl chr X:33,993,825...34,027,181
|
|
| G
|
Clu
|
clusterin
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CLU mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
|
|
| G
|
Cluap1
|
clusterin associated protein 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CLUAP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:12,094,346...12,159,440
Ensembl chr10:12,094,346...12,131,693
|
|
| G
|
Cluh
|
clustered mitochondria homolog
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CLUH mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:60,008,052...60,029,742
Ensembl chr10:60,008,119...60,029,742
|
|
| G
|
Clybl
|
citramalyl-CoA lyase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CLYBL mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:105,690,283...105,912,347
Ensembl chr15:105,690,295...105,912,345
|
|
| G
|
Cmbl
|
carboxymethylenebutenolidase homolog
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CMBL mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:84,280,128...84,301,878
Ensembl chr 2:84,242,512...84,301,880
|
|
| G
|
Cmtm3
|
CKLF-like MARVEL transmembrane domain containing 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CMTM3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:629,000...637,152
Ensembl chr19:628,895...636,225
|
|
| G
|
Cmtr1
|
cap methyltransferase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CMTR1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:7,724,286...7,784,787
Ensembl chr20:7,683,946...7,784,263
|
|
| G
|
Cmtr2
|
cap methyltransferase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CMTR2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:55,100,135...55,106,966
Ensembl chr19:55,099,843...55,124,234
|
|
| G
|
Cmya5
|
cardiomyopathy associated 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CMYA5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:26,014,545...26,113,273
Ensembl chr 2:26,014,177...26,113,376
|
|
| G
|
Cndp1
|
carnosine dipeptidase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CNDP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:80,254,499...80,305,845
Ensembl chr18:80,255,784...80,282,643
|
|
| G
|
Cnga1
|
cyclic nucleotide gated channel subunit alpha 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CNGA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:35,920,948...35,959,065
Ensembl chr14:35,926,854...35,959,056
|
|
| G
|
Cnga3
|
cyclic nucleotide gated channel subunit alpha 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CNGA3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:46,943,353...46,989,862
Ensembl chr 9:46,928,810...46,989,862
|
|
| G
|
Cnksr2
|
connector enhancer of kinase suppressor of Ras 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CNKSR2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:40,722,843...40,971,730
Ensembl chr X:40,722,996...40,965,604
|
|
| G
|
Cnksr3
|
Cnksr family member 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CNKSR3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:45,904,581...45,996,921
Ensembl chr 1:45,904,581...45,996,921
|
|
| G
|
Cnn2
|
calponin 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CNN2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:10,363,141...10,370,312
Ensembl chr 7:10,363,102...10,370,312
|
|
| G
|
Cnn3
|
calponin 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CNN3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:212,203,661...212,234,772
Ensembl chr 2:212,226,640...212,234,815
|
|
| G
|
Cnnm1
|
cyclin and CBS domain divalent metal cation transport mediator 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CNNM1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:252,245,377...252,304,205
Ensembl chr 1:252,245,623...252,304,205
|
|
| G
|
Cnnm2
|
cyclin and CBS domain divalent metal cation transport mediator 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CNNM2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:255,585,063...255,709,455
Ensembl chr 1:255,585,095...255,704,849
|
|
| G
|
Cnnm4
|
cyclin and CBS domain divalent metal cation transport mediator 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CNNM4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:46,207,602...46,246,817
Ensembl chr 9:46,207,551...46,246,817
|
|
| G
|
Cnot1
|
CCR4-NOT transcription complex, subunit 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CNOT1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:9,261,290...9,352,636
Ensembl chr19:9,261,294...9,352,636
|
|
| G
|
Cnot6l
|
CCR4-NOT transcription complex, subunit 6-like
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CNOT6L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:13,714,475...13,806,481
Ensembl chr14:13,714,475...13,806,481
|
|
| G
|
Cnpy2
|
canopy FGF signaling regulator 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CNPY2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:1,332,293...1,338,081
Ensembl chr 7:1,334,335...1,340,333
|
|
| G
|
Cnpy3
|
canopy FGF signaling regulator 3
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CNPY3 mRNA Acrylamide results in decreased expression of CNPY3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 9:21,731,088...21,745,448
Ensembl chr 9:21,730,791...21,745,505
|
|
| G
|
Cnpy4
|
canopy FGF signaling regulator 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CNPY4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:22,178,254...22,184,432
Ensembl chr12:22,178,160...22,184,425
|
|
| G
|
Cnr1
|
cannabinoid receptor 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CNR1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252
|
|
| G
|
Cnst
|
consortin, connexin sorting protein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CNST mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:93,828,694...93,905,497
Ensembl chr13:93,828,687...93,905,490
|
|
| G
|
Cntfr
|
ciliary neurotrophic factor receptor
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of CNTFR mRNA Acrylamide results in decreased expression of CNTFR mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:61,619,326...61,657,359
Ensembl chr 5:61,619,326...61,645,795
|
|
| G
|
Cntn2
|
contactin 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CNTN2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:46,497,269...46,528,112
Ensembl chr13:46,499,396...46,528,027
|
|
| G
|
Cntn3
|
contactin 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CNTN3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:136,397,575...136,770,765
Ensembl chr 4:136,398,572...136,770,717
|
|
| G
|
Cntnap4
|
contactin associated protein family member 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CNTNAP4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:57,477,447...57,765,173
Ensembl chr19:57,477,310...57,821,701
|
|
| G
|
Cntnap5b
|
contactin associated protein family member 5B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CNTNAP5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:18,378,255...19,281,711
Ensembl chr13:18,378,368...19,281,711
|
|
| G
|
Cntrob
|
centrobin, centriole duplication and spindle assembly protein
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CNTROB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:54,521,338...54,546,569
Ensembl chr10:54,521,663...54,543,657
|
|
| G
|
Coa3
|
cytochrome C oxidase assembly factor 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COA3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:86,720,454...86,721,435
Ensembl chr10:86,720,456...86,721,440
|
|
| G
|
Coa5
|
cytochrome C oxidase assembly factor 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COA5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:47,147,267...47,160,724
Ensembl chr 9:47,147,267...47,160,672
|
|
| G
|
Coch
|
cochlin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COCH mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:74,766,485...74,780,504
Ensembl chr 6:74,766,419...74,780,502
|
|
| G
|
Cog3
|
component of oligomeric golgi complex 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of COG3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:57,389,994...57,480,454
Ensembl chr15:57,390,238...57,480,097
|
|
| G
|
Cog7
|
component of oligomeric golgi complex 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COG7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:185,921,053...185,980,711
Ensembl chr 1:185,889,348...185,983,421
|
|
| G
|
Coil
|
coilin
|
increases expression
|
EXP
|
Acrylamide results in increased expression of COIL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:74,286,279...74,307,597
Ensembl chr10:74,286,840...74,307,595
|
|
| G
|
Col10a1
|
collagen type X alpha 1 chain
|
increases expression
|
EXP
|
Acrylamide results in increased expression of COL10A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:39,737,536...39,744,518
Ensembl chr20:39,716,822...39,751,440
|
|
| G
|
Col11a1
|
collagen type XI alpha 1 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL11A1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:204,509,136...204,702,264
Ensembl chr 2:204,509,136...204,702,264
|
|
| G
|
Col11a2
|
collagen type XI alpha 2 chain
|
increases expression
|
EXP
|
Acrylamide results in increased expression of COL11A2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:4,788,829...4,818,492
Ensembl chr20:4,788,829...4,817,648
|
|
| G
|
Col15a1
|
collagen type XV alpha 1 chain
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COL15A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:66,297,546...66,403,172
Ensembl chr 5:66,297,461...66,403,170
|
|
| G
|
Col16a1
|
collagen type XVI alpha 1 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL16A1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:147,672,559...147,727,007
Ensembl chr 5:147,672,601...147,727,011
|
|
| G
|
Col17a1
|
collagen type XVII alpha 1 chain
|
increases expression
|
EXP
|
Acrylamide results in increased expression of COL17A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:256,472,648...256,518,857
Ensembl chr 1:256,472,648...256,518,851
|
|
| G
|
Col19a1
|
collagen type XIX alpha 1 chain
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COL19A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:34,170,248...34,518,478
Ensembl chr 9:34,170,248...34,518,350
|
|
| G
|
Col1a1
|
collagen type I alpha 1 chain
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COL1A1 mRNA
|
CTD |
PMID:15749267 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
| G
|
Col1a2
|
collagen type I alpha 2 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL1A2 mRNA
|
CTD |
PMID:22543296 |
|
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995
|
|
| G
|
Col23a1
|
collagen type XXIII alpha 1 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL23A1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:36,050,327...36,337,279
Ensembl chr10:36,050,259...36,337,897
|
|
| G
|
Col24a1
|
collagen type XXIV alpha 1 chain
|
increases expression
|
EXP
|
Acrylamide results in increased expression of COL24A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:236,872,583...237,129,768
Ensembl chr 2:236,872,265...237,129,447
|
|
| G
|
Col27a1
|
collagen type XXVII alpha 1 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL27A1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 5:81,662,822...81,781,502
Ensembl chr 5:81,661,685...81,781,502
|
|
| G
|
Col3a1
|
collagen type III alpha 1 chain
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COL3A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
|
|
| G
|
Col4a1
|
collagen type IV alpha 1 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL4A1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482
|
|
| G
|
Col4a2
|
collagen type IV alpha 2 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL4A2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:84,749,672...84,885,520
Ensembl chr16:84,749,672...84,885,520
|
|
| G
|
Col4a5
|
collagen type IV alpha 5 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL4A5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:109,907,251...110,111,214
Ensembl chr X:109,907,346...110,111,214
|
|
| G
|
Col4a6
|
collagen type IV alpha 6 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL4A6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:109,554,945...109,905,987
Ensembl chr X:109,552,651...109,905,944
|
|
| G
|
Col5a2
|
collagen type V alpha 2 chain
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of COL5A2 mRNA Acrylamide results in increased expression of COL5A2 mRNA
|
CTD |
PMID:28959563 PMID:35032568 |
|
NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:54,940,764...55,090,150
|
|
| G
|
Col6a1
|
collagen type VI alpha 1 chain
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COL6A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,457...11,924,107
|
|
| G
|
Col6a2
|
collagen type VI alpha 2 chain
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COL6A2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,265...12,057,042
|
|
| G
|
Col6a3
|
collagen type VI alpha 3 chain
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COL6A3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:98,809,171...98,886,990
|
|
| G
|
Col6a5
|
collagen type VI alpha 5 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL6A5 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 8:115,362,532...115,462,844
Ensembl chr 8:115,361,906...115,462,859
|
|
| G
|
Col7a1
|
collagen type VII alpha 1 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL7A1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439
|
|
| G
|
Col8a1
|
collagen type VIII alpha 1 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL8A1 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr11:56,245,998...56,378,586
Ensembl chr11:56,369,868...56,376,229
|
|
| G
|
Col8a2
|
collagen type VIII alpha 2 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL8A2 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 5:143,870,754...143,897,372
Ensembl chr 5:143,870,742...143,897,884
|
|
| G
|
Col9a1
|
collagen type IX alpha 1 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL9A1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:34,081,364...34,164,552
Ensembl chr 9:34,003,905...34,164,543
|
|
| G
|
Col9a2
|
collagen type IX alpha 2 chain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COL9A2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:139,892,798...139,910,131
Ensembl chr 5:139,892,798...139,909,855
|
|
| G
|
Colq
|
collagen like tail subunit of asymmetric acetylcholinesterase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of COLQ mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:6,738,251...6,830,492
Ensembl chr16:6,738,251...6,793,501
|
|
| G
|
Commd2
|
COMM domain containing 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COMMD2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:143,998,672...144,002,918
Ensembl chr 2:143,998,672...144,002,918
|
|
| G
|
Commd7
|
COMM domain containing 7
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of COMMD7 mRNA Acrylamide results in decreased expression of COMMD7 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:162,559,762...162,574,543
Ensembl chr 3:162,554,374...162,574,692
|
|
| G
|
Commd8
|
COMM domain containing 8
|
increases expression
|
EXP
|
Acrylamide results in increased expression of COMMD8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:36,403,000...36,413,577
Ensembl chr14:36,403,022...36,413,574
|
|
| G
|
Commd9
|
COMM domain containing 9
|
increases expression
|
ISO
|
Acrylamide results in increased expression of COMMD9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:108,630,903...108,645,427
Ensembl chr 3:108,630,980...108,666,091
|
|
| G
|
Comp
|
cartilage oligomeric matrix protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COMP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:19,081,172...19,089,548
Ensembl chr16:19,081,172...19,089,605
|
|
| G
|
Comtd1
|
catechol-O-methyltransferase domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COMTD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:2,509,121...2,512,232
Ensembl chr15:2,509,032...2,512,232
|
|
| G
|
Cope
|
COPI coat complex subunit epsilon
|
increases expression
|
EXP
|
Acrylamide results in increased expression of COPE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:19,148,832...19,159,052
Ensembl chr16:19,148,832...19,159,212
|
|
| G
|
Cops7b
|
COP9 signalosome subunit 7B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COPS7B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:94,686,314...94,711,903
Ensembl chr 9:94,686,314...94,711,903
|
|
| G
|
Cops9
|
COP9 signalosome subunit 9
|
increases expression
|
ISO
|
Acrylamide results in increased expression of COPS9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:100,657,276...100,662,206
Ensembl chr 9:100,657,276...100,662,206
|
|
| G
|
Copz1
|
COPI coat complex subunit zeta 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of COPZ1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:136,287,696...136,314,131
Ensembl chr 7:136,288,032...136,314,135
|
|
| G
|
Coq10a
|
coenzyme Q10A
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of COQ10A mRNA Acrylamide results in decreased expression of COQ10A mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:1,376,591...1,387,694
Ensembl chr 7:1,376,591...1,382,722
|
|
| G
|
Coq10b
|
coenzyme Q10B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of COQ10B mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 9:64,048,168...64,068,082
Ensembl chr 9:64,048,103...64,068,322
|
|
| G
|
Coq2
|
coenzyme Q2, polyprenyltransferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COQ2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:9,245,777...9,265,784
Ensembl chr14:9,245,803...9,265,783
|
|
| G
|
Coq3
|
coenzyme Q3 methyltransferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COQ3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:40,226,313...40,257,383
Ensembl chr 5:40,226,368...40,257,617
|
|
| G
|
Coq4
|
coenzyme Q4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COQ4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:33,457,834...33,468,387
Ensembl chr 3:33,457,596...33,468,379
|
|
| G
|
Coq7
|
coenzyme Q7, hydroxylase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of COQ7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:182,270,570...182,285,959
Ensembl chr 1:182,269,399...182,285,508
|
|
| G
|
Coq8b
|
coenzyme Q8B
|
affects expression
|
EXP
|
Acrylamide affects the expression of COQ8B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:91,653,241...91,676,822
Ensembl chr 1:91,654,225...91,676,819
|
|
| G
|
Coq9
|
coenzyme Q9
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COQ9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:10,172,943...10,185,960
Ensembl chr19:10,172,949...10,185,937
|
|
| G
|
Coro2b
|
coronin 2B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CORO2B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:71,802,329...71,912,739
Ensembl chr 8:71,802,329...71,912,739
|
|
| G
|
Coro6
|
coronin 6
|
affects expression
|
EXP
|
Acrylamide affects the expression of CORO6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:62,808,172...62,817,788
Ensembl chr10:62,809,689...62,817,787
|
|
| G
|
Cort
|
cortistatin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CORT mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:164,843,682...164,845,796
|
|
| G
|
Cox20
|
cytochrome c oxidase assembly factor COX20
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COX20 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr13:92,592,260...92,604,129
Ensembl chr14:6,872,315...6,872,638
|
|
| G
|
Cox6a2
|
cytochrome c oxidase subunit 6A2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COX6A2 mRNA
|
CTD |
PMID:28606764 |
|
NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:192,218,970...192,219,716
|
|
| G
|
Cox8a
|
cytochrome c oxidase subunit 8A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COX8A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:213,831,302...213,833,623
Ensembl chr 1:213,831,298...213,833,623
|
|
| G
|
Cox8c
|
cytochrome c oxidase subunit 8C
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of COX8C mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:127,793,379...127,794,702
Ensembl chr 6:127,793,379...127,794,702
|
|
| G
|
Cp
|
ceruloplasmin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087
|
|
| G
|
Cpa1
|
carboxypeptidase A1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CPA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:60,224,801...60,230,928
Ensembl chr 4:60,224,801...60,230,928
|
|
| G
|
Cpa4
|
carboxypeptidase A4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CPA4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:60,155,675...60,179,644
Ensembl chr 4:60,118,682...60,183,448
|
|
| G
|
Cpa6
|
carboxypeptidase A6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CPA6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:13,309,660...13,671,429
Ensembl chr 5:13,309,660...13,671,429
|
|
| G
|
Cpeb1
|
cytoplasmic polyadenylation element binding protein 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CPEB1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:144,709,278...144,817,388
Ensembl chr 1:144,709,691...144,815,880
|
|
| G
|
Cpeb3
|
cytoplasmic polyadenylation element binding protein 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CPEB3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:244,161,690...244,343,765
Ensembl chr 1:244,161,690...244,343,561
|
|
| G
|
Cpeb4
|
cytoplasmic polyadenylation element binding protein 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CPEB4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:16,222,271...16,284,248
Ensembl chr10:16,225,672...16,283,787
|
|
| G
|
Cplane1
|
ciliogenesis and planar polarity effector complex subunit 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CPLANE1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:58,996,119...59,096,817
Ensembl chr 2:58,996,130...59,096,817
|
|
| G
|
Cplx2
|
complexin 2
|
multiple interactions decreases expression
|
ISO EXP
|
Acrylamide binds to and affects the metabolism of CPLX2 protein Acrylamide results in decreased expression of CPLX2 mRNA
|
CTD |
PMID:17698512 PMID:28959563 |
|
NCBI chr17:10,224,673...10,297,974
Ensembl chr17:10,228,449...10,297,467
|
|
| G
|
Cpne3
|
copine 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CPNE3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:37,811,566...37,860,840
Ensembl chr 5:37,811,566...37,861,062
|
|
| G
|
Cpne8
|
copine 8
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CPNE8 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:123,494,864...123,669,060
Ensembl chr 7:123,494,865...123,669,060
|
|
| G
|
Cps1
|
carbamoyl-phosphate synthase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CPS1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:76,063,863...76,186,739
Ensembl chr 9:76,000,754...76,186,734
|
|
| G
|
Cpsf1
|
cleavage and polyadenylation specific factor 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CPSF1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:110,200,078...110,210,644
Ensembl chr 7:110,199,066...110,210,644
|
|
| G
|
Cpsf3
|
cleavage and polyadenylation specific factor 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CPSF3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:46,564,855...46,592,776
Ensembl chr 6:46,564,735...46,594,136
|
|
| G
|
Cpt1a
|
carnitine palmitoyltransferase 1A
|
multiple interactions decreases expression
|
ISO
|
Acrylamide inhibits the reaction [Streptozocin results in increased expression of CPT1A mRNA] Acrylamide results in decreased expression of CPT1A mRNA
|
CTD |
PMID:34896238 |
|
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
|
|
| G
|
Cpxm1
|
carboxypeptidase X (M14 family), member 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CPXM1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:138,041,645...138,048,443
Ensembl chr 3:138,041,645...138,048,857
|
|
| G
|
Cpxm2
|
carboxypeptidase X (M14 family), member 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CPXM2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:196,266,930...196,377,350
Ensembl chr 1:196,266,930...196,377,347
|
|
| G
|
Cpz
|
carboxypeptidase Z
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CPZ mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:79,448,242...79,471,557
Ensembl chr14:79,448,139...79,471,556
|
|
| G
|
Cr1l
|
complement C3b/C4b receptor 1 like
|
affects expression
|
EXP
|
Acrylamide affects the expression of CR1L mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:109,138,132...109,189,068
Ensembl chr13:109,103,235...109,188,869
|
|
| G
|
Crabp1
|
cellular retinoic acid binding protein 1
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CRABP1 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 8:64,047,431...64,055,469
Ensembl chr 8:64,047,060...64,055,470
|
|
| G
|
Cracr2b
|
calcium release activated channel regulator 2B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CRACR2B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:205,987,957...205,993,515
Ensembl chr 1:205,990,507...205,993,516
|
|
| G
|
Cradd
|
CASP2 and RIPK1 domain containing adaptor with death domain
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CRADD mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:31,827,131...31,839,796
Ensembl chr 7:31,685,622...31,874,512
|
|
| G
|
Cramp1
|
cramped chromatin regulator homolog 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CRAMP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:14,488,292...14,536,844
Ensembl chr10:14,467,661...14,535,664
|
|
| G
|
Crb2
|
crumbs cell polarity complex component 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CRB2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:41,946,694...41,974,629
Ensembl chr 3:41,947,325...41,974,629
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
decreases phosphorylation
|
EXP
|
Acrylamide results in decreased phosphorylation of CREB1 protein
|
CTD |
PMID:33421551 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Creb3
|
cAMP responsive element binding protein 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CREB3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:62,613,652...62,619,019
Ensembl chr 5:62,613,638...62,619,500
|
|
| G
|
Creb3l4
|
cAMP responsive element binding protein 3-like 4
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CREB3L4 mRNA Acrylamide results in decreased expression of CREB3L4 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:177,987,981...177,994,568
Ensembl chr 2:177,987,981...177,993,485
|
|
| G
|
Crebrf
|
CREB3 regulatory factor
|
affects expression increases expression
|
EXP ISO
|
Acrylamide affects the expression of CREBRF mRNA Acrylamide results in increased expression of CREBRF mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:16,903,607...16,967,450
Ensembl chr10:16,903,547...16,966,430
|
|
| G
|
Crem
|
cAMP responsive element modulator
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CREM mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160
|
|
| G
|
Crip2
|
cysteine-rich protein 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CRIP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:138,042,175...138,047,121
Ensembl chr 6:138,041,906...138,047,120
|
|
| G
|
Cript
|
CXXC repeat containing interactor of PDZ3 domain
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CRIPT mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:13,334,978...13,342,934
Ensembl chr 6:13,334,954...13,345,044
|
|
| G
|
Crisp1
|
cysteine-rich secretory protein 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CRISP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:28,238,326...28,265,344
Ensembl chr 9:28,238,328...28,265,344
|
|
| G
|
Crlf1
|
cytokine receptor-like factor 1
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of CRLF1 mRNA Acrylamide results in decreased expression of CRLF1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr16:18,958,695...18,970,026
Ensembl chr16:18,957,956...18,969,970
|
|
| G
|
Crlf3
|
cytokine receptor-like factor 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CRLF3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:65,521,296...65,559,162
Ensembl chr10:65,521,492...65,558,804
|
|
| G
|
Crp
|
C-reactive protein
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CRP mRNA Acrylamide results in increased expression of CRP mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
| G
|
Crtap
|
cartilage associated protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CRTAP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:122,926,117...122,945,843
Ensembl chr 8:122,926,117...122,945,843
|
|
| G
|
Cry1
|
cryptochrome circadian regulator 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CRY1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:20,417,107...20,481,822
|
|
| G
|
Cry2
|
cryptochrome circadian regulator 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CRY2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:98,830,479...98,860,437
Ensembl chr 3:98,830,483...98,860,447
|
|
| G
|
Cryab
|
crystallin, alpha B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CRYAB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528
|
|
| G
|
Crybb1
|
crystallin, beta B1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CRYBB1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:50,030,146...50,043,756
Ensembl chr12:50,030,146...50,043,756
|
|
| G
|
Crybg1
|
crystallin beta-gamma domain containing 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CRYBG1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:49,007,673...49,204,040
Ensembl chr20:49,007,929...49,204,047
|
|
| G
|
Crybg3
|
crystallin beta-gamma domain containing 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CRYBG3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:54,218,399...54,330,962
Ensembl chr11:54,208,444...54,330,960
|
|
| G
|
Crygd
|
crystallin, gamma D
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CRYGD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:73,935,798...73,937,409
Ensembl chr 9:73,935,795...73,937,808
|
|
| G
|
Cryge
|
crystallin, gamma E
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CRYGE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:73,923,661...73,926,258
Ensembl chr 9:73,923,661...73,927,011
|
|
| G
|
Crygs
|
crystallin, gamma S
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CRYGS mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:91,711,755...91,716,858
Ensembl chr11:91,711,755...91,716,858
|
|
| G
|
Cs
|
citrate synthase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CS protein
|
CTD |
PMID:39082229 |
|
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938
|
|
| G
|
Csad
|
cysteine sulfinic acid decarboxylase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CSAD mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:135,187,175...135,216,495
Ensembl chr 7:135,187,175...135,215,581
|
|
| G
|
Csdc2
|
cold shock domain containing C2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CSDC2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:115,332,134...115,346,599
Ensembl chr 7:115,332,128...115,346,596
|
|
| G
|
Cse1l
|
chromosome segregation 1 like
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CSE1L mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:176,060,183...176,097,909
Ensembl chr 3:176,060,215...176,108,734
|
|
| G
|
Csf1r
|
colony stimulating factor 1 receptor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CSF1R mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:56,817,049...56,860,806
|
|
| G
|
Csf2
|
colony stimulating factor 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CSF2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
|
|
| G
|
Csf3
|
colony stimulating factor 3
|
increases secretion increases expression
|
ISO
|
Acrylamide results in increased secretion of CSF3 protein Acrylamide results in increased expression of CSF3 mRNA
|
CTD |
PMID:27836571 PMID:28526328 |
|
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860
|
|
| G
|
Csgalnact2
|
chondroitin sulfate N-acetylgalactosaminyltransferase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CSGALNACT2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:152,944,154...152,981,237
Ensembl chr 4:152,950,028...152,981,220
|
|
| G
|
Csnk1d
|
casein kinase 1, delta
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CSNK1D mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:106,713,497...106,754,953
Ensembl chr10:106,694,279...106,754,953
|
|
| G
|
Csnk1e
|
casein kinase 1, epsilon
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CSNK1E mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:112,863,726...112,887,338
Ensembl chr 7:112,863,731...112,884,101
|
|
| G
|
Csnk2a1
|
casein kinase 2 alpha 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CSNK2A1 mRNA
|
CTD |
PMID:21319176 |
|
NCBI chr 3:161,170,295...161,217,073
Ensembl chr 3:161,170,405...161,215,698
|
|
| G
|
Cspg4
|
chondroitin sulfate proteoglycan 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CSPG4 mRNA
|
CTD |
PMID:36328537 |
|
NCBI chr 8:66,160,942...66,195,987
Ensembl chr 8:66,160,942...66,200,806
|
|
| G
|
Cspg5
|
chondroitin sulfate proteoglycan 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CSPG5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:119,098,932...119,113,191
Ensembl chr 8:119,098,925...119,143,907
|
|
| G
|
Csrnp1
|
cysteine and serine rich nuclear protein 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CSRNP1 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr 8:128,582,364...128,594,163
Ensembl chr 8:128,582,365...128,588,469
|
|
| G
|
Csrp2
|
cysteine and glycine-rich protein 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CSRP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:48,235,415...48,254,049
Ensembl chr 7:48,235,383...48,266,238
|
|
| G
|
Cstf3
|
cleavage stimulation factor subunit 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CSTF3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:111,421,291...111,492,539
Ensembl chr 3:111,421,234...111,497,046
|
|
| G
|
Cstpp1
|
centriolar satellite-associated tubulin polyglutamylase complex regulator 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CSTPP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:97,704,176...97,872,084
Ensembl chr 3:97,695,898...97,872,001
|
|
| G
|
Ctdnep1
|
CTD nuclear envelope phosphatase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CTDNEP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:55,203,047...55,212,469
Ensembl chr10:55,203,543...55,212,852
|
|
| G
|
Ctdp1
|
CTD phosphatase subunit 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CTDP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:76,129,243...76,193,404
Ensembl chr18:76,129,243...76,190,578
|
|
| G
|
Ctdsp1
|
CTD small phosphatase 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CTDSP1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 9:83,422,755...83,428,411
Ensembl chr 9:83,423,051...83,428,412
|
|
| G
|
Cth
|
cystathionine gamma-lyase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CTH mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066
|
|
| G
|
Ctnna1
|
catenin alpha 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CTNNA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:27,002,330...27,135,009
Ensembl chr18:26,999,820...27,135,007
|
|
| G
|
Ctnna3
|
catenin alpha 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CTNNA3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:23,613,016...25,198,699
Ensembl chr20:23,613,016...25,198,805
|
|
| G
|
Ctnnal1
|
catenin alpha-like 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CTNNAL1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:76,309,546...76,375,869
Ensembl chr 5:76,309,546...76,364,637
|
|
| G
|
Ctnnb1
|
catenin beta 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CTNNB1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
| G
|
Ctnnbip1
|
catenin, beta-interacting protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CTNNBIP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:165,245,019...165,293,994
Ensembl chr 5:165,245,098...165,293,991
|
|
| G
|
Ctps1
|
CTP synthase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CTPS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:139,372,349...139,440,441
Ensembl chr 5:139,410,249...139,440,465
|
|
| G
|
Ctps2
|
CTP synthase 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CTPS2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:35,277,658...35,418,505
Ensembl chr X:35,277,658...35,418,505
|
|
| G
|
Ctrl
|
chymotrypsin-like
|
affects expression
|
EXP
|
Acrylamide affects the expression of CTRB1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:50,737,078...50,740,659
Ensembl chr19:50,737,079...50,738,979
|
|
| G
|
Cts7l1
|
cathepsin 7 like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CTS7L1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:3,313,381...3,317,312
Ensembl chr17:3,312,327...3,317,312
|
|
| G
|
Ctsb
|
cathepsin B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CTSB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
| G
|
Ctsc
|
cathepsin C
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CTSC mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082
|
|
| G
|
Ctsd
|
cathepsin D
|
multiple interactions decreases cleavage
|
ISO
|
TFEB protein affects the reaction [Acrylamide results in decreased cleavage of CTSD protein]
|
CTD |
PMID:37172712 |
|
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821
|
|
| G
|
Ctsk
|
cathepsin K
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CTSK mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582
|
|
| G
|
Ctsz
|
cathepsin Z
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CTSZ mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:183,643,077...183,653,847
Ensembl chr 3:183,643,077...183,657,012
|
|
| G
|
Cttn
|
cortactin
|
affects expression
|
EXP
|
Acrylamide affects the expression of CTTN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:209,029,048...209,064,577
Ensembl chr 1:209,029,048...209,058,211
|
|
| G
|
Ctu2
|
cytosolic thiouridylase subunit 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CTU2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:67,447,762...67,453,169
Ensembl chr19:67,447,487...67,453,163
|
|
| G
|
Cul3
|
cullin 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CUL3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:89,040,987...89,118,775
Ensembl chr 9:89,040,987...89,118,427
|
|
| G
|
Cul5
|
cullin 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CUL5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:62,909,150...62,974,641
Ensembl chr 8:62,912,193...62,965,463
|
|
| G
|
Cul7
|
cullin 7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CUL7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:21,816,703...21,830,344
Ensembl chr 9:21,816,703...21,830,344
|
|
| G
|
Cul9
|
cullin 9
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CUL9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:21,933,699...21,977,145
Ensembl chr 9:21,933,803...21,977,145
|
|
| G
|
Cux1
|
cut-like homeobox 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CUX1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:25,728,393...26,062,497
Ensembl chr12:25,743,733...26,062,497
|
|
| G
|
Cux2
|
cut-like homeobox 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CUX2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:40,168,402...40,368,303
Ensembl chr12:40,149,292...40,366,528
|
|
| G
|
Cwc25
|
CWC25 spliceosome-associated protein homolog
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CWC25 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:83,232,052...83,256,722
Ensembl chr10:83,232,052...83,256,722
|
|
| G
|
Cx3cl1
|
C-X3-C motif chemokine ligand 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CX3CL1 mRNA Acrylamide results in decreased expression of CX3CL1 mRNA
|
CTD |
PMID:28959563 PMID:29261810 |
|
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999
|
|
| G
|
Cxadrl1
|
coxsackie virus and adenovirus receptor-like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CXADRL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:108,444,792...108,470,345
Ensembl chr 8:108,444,792...108,470,345
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CXCL10 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CXCL12 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
| G
|
Cxcl13
|
C-X-C motif chemokine ligand 13
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CXCL13 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:13,912,858...13,917,920
Ensembl chr14:13,912,858...13,917,920
|
|
| G
|
Cxhxorf38
|
similar to human chromosome X open reading frame 38
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CXHXORF38 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:12,800,935...12,823,632
Ensembl chr X:12,802,377...12,814,198
|
|
| G
|
Cxxc4
|
CXXC finger protein 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CXXC4 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 2:225,329,044...225,363,347
|
|
| G
|
Cyb561
|
cytochrome b-561
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CYB561 mRNA Acrylamide results in decreased expression of CYB561 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:91,377,866...91,388,548
Ensembl chr10:91,377,866...91,385,097
|
|
| G
|
Cyb561d2
|
cytochrome b561 family, member D2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CYB561D2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:117,091,844...117,094,434
Ensembl chr 8:117,091,845...117,094,366
|
|
| G
|
Cyb5a
|
cytochrome b5 type A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CYB5A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094 Ensembl chr18:14,453,966...14,455,094
|
|
| G
|
Cyb5b
|
cytochrome b5 type B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CYB5B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:51,972,611...52,006,477
Ensembl chr19:51,972,547...52,026,980
|
|
| G
|
Cyb5d2
|
cytochrome b5 domain containing 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CYB5D2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:57,892,799...57,911,831
Ensembl chr10:57,895,296...57,912,030
|
|
| G
|
Cyb5r1
|
cytochrome b5 reductase 1
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CYB5R1 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr13:48,401,061...48,407,466
Ensembl chr13:48,399,106...48,407,465
|
|
| G
|
Cyb5r3
|
cytochrome b5 reductase 3
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CYB5R3 mRNA Acrylamide results in decreased expression of CYB5R3 mRNA
|
CTD |
PMID:28959563 PMID:30807115 PMID:32763439 |
|
NCBI chr 7:116,186,729...116,204,290
Ensembl chr 7:116,186,729...116,204,306
|
|
| G
|
Cybc1
|
cytochrome b-245 chaperone 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CYBC1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:106,997,018...107,003,895
Ensembl chr10:106,997,023...107,003,841
|
|
| G
|
Cycs
|
cytochrome c, somatic
|
increases expression multiple interactions
|
EXP
|
Acrylamide results in increased expression of CYCS mRNA; Acrylamide results in increased expression of CYCS protein epigallocatechin gallate inhibits the reaction [Acrylamide results in increased expression of CYCS protein]
|
CTD |
PMID:15749267 PMID:28056603 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
| G
|
Cycsl3
|
cytochrome c, somatic like 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CYCSL3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:26,251,236...26,251,532
|
|
| G
|
Cyfip2
|
cytoplasmic FMR1 interacting protein 2
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of CYFIP2 mRNA Acrylamide results in decreased expression of CYFIP2 mRNA
|
CTD |
PMID:28959563 PMID:29261810 |
|
NCBI chr10:31,122,653...31,242,440
Ensembl chr10:31,122,653...31,242,440
|
|
| G
|
Cyld
|
CYLD lysine 63 deubiquitinase
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of CYLD mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr19:34,487,491...34,547,311
Ensembl chr19:34,488,583...34,547,118
|
|
| G
|
Cym
|
chymosin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CYM mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:197,516,947...197,527,307
Ensembl chr 2:197,516,950...197,527,837
|
|
| G
|
Cyp11a1
|
cytochrome P450, family 11, subfamily a, polypeptide 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of CYP11A1 mRNA Acrylamide results in decreased expression of CYP11A1 mRNA; Acrylamide results in decreased expression of CYP11A1 protein Acrylamide results in increased expression of CYP11A1 mRNA
|
CTD |
PMID:15749267 PMID:22459607 PMID:34906654 PMID:35032568 PMID:36565847 PMID:39082229 More...
|
|
NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196
|
|
| G
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1
|
decreases expression multiple interactions
|
ISO EXP
|
Acrylamide results in decreased expression of CYP17A1 mRNA; Acrylamide results in decreased expression of CYP17A1 protein naringin inhibits the reaction [Acrylamide results in decreased expression of CYP17A1 mRNA]; Selenium inhibits the reaction [Acrylamide results in decreased expression of CYP17A1 mRNA]
|
CTD |
PMID:36565847 PMID:36598108 PMID:37987225 PMID:38614435 |
|
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974
|
|
| G
|
Cyp26b1
|
cytochrome P450, family 26, subfamily b, polypeptide 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CYP26B1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:118,599,356...118,616,176
|
|
| G
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CYP27A1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
|
|
| G
|
Cyp27b1
|
cytochrome P450, family 27, subfamily b, polypeptide 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CYP27B1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:64,756,626...64,761,570
Ensembl chr 7:64,756,626...64,761,570
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CYP2B3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp2c22
|
cytochrome P450, family 2, subfamily c, polypeptide 22
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CYP2C22 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:248,941,143...248,980,767
Ensembl chr 1:248,904,062...248,971,182
|
|
| G
|
Cyp2c23
|
cytochrome P450, family 2, subfamily c, polypeptide 23
|
affects expression
|
EXP
|
Acrylamide affects the expression of CYP2C23 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:252,838,427...252,863,081
Ensembl chr 1:252,838,433...252,863,067
|
|
| G
|
Cyp2c79
|
cytochrome P450, family 2, subfamily c, polypeptide 79
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CYP2C79 mRNA
|
CTD |
PMID:28959563 |
|
|
|
| G
|
Cyp2d1
|
cytochrome P450, family 2, subfamily d, polypeptide 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CYP2D7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:115,789,026...115,793,430
Ensembl chr 7:115,789,023...115,793,479
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
affects expression multiple interactions affects metabolic processing increases expression affects response to substance increases response to substance increases oxidation
|
ISO EXP
|
Acrylamide affects the expression of CYP2E1 mRNA acadesine inhibits the reaction [Acrylamide results in increased expression of CYP2E1 protein]; Acrylamide promotes the reaction [elaidic acid results in increased expression of CYP2E1 protein]; elaidic acid promotes the reaction [Acrylamide results in increased expression of CYP2E1 protein] CYP2E1 intron polymorphism affects the metabolism of Acrylamide Acrylamide results in increased expression of CYP2E1 mRNA; Acrylamide results in increased expression of CYP2E1 protein [CYP2E1 protein results in increased oxidation of Acrylamide] which results in increased abundance of glycidamide CYP2E1 protein affects the susceptibility to Acrylamide [CYP2E1 gene polymorphism co-treated with GSTM1 gene polymorphism co-treated with GSTT1 gene polymorphism] affects the metabolism of Acrylamide; [CYP2E1 gene polymorphism co-treated with GSTM1 gene polymorphism] affects the metabolism of Acrylamide; Acrylamide promotes the reaction [Polysorbates results in increased expression of CYP2E1 mRNA]; Curcumin inhibits the reaction [Acrylamide results in increased expression of CYP2E1 protein]; epigallocatechin gallate inhibits the reaction [Acrylamide results in increased expression of CYP2E1 protein] CYP2E1 protein results in increased susceptibility to Acrylamide CYP2E1 protein affects the metabolism of Acrylamide
|
CTD |
PMID:15355880 PMID:17267090 PMID:17979661 PMID:19131562 PMID:24508477 PMID:27174446 PMID:28606764 PMID:28959563 PMID:29748789 PMID:32763439 PMID:33545342 PMID:38309685 PMID:38740238 More...
|
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Cyp2f4
|
cytochrome P450, family 2, subfamily f, polypeptide 4
|
affects expression
|
EXP
|
Acrylamide affects the expression of CYP2F4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:91,543,768...91,557,553
Ensembl chr 1:91,543,768...91,557,553
|
|
| G
|
Cyp2j4
|
cytochrome P450, family 2, subfamily j, polypeptide 4
|
affects expression
|
EXP
|
Acrylamide affects the expression of CYP2J4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:116,295,694...116,323,042
|
|
| G
|
Cyp39a1
|
cytochrome P450, family 39, subfamily a, polypeptide 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of CYP39A1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:24,727,817...24,804,060
Ensembl chr 9:24,727,817...24,804,060
|
|
| G
|
Cyp3a23-3a1
|
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CYP3A23-3A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813
|
|
| G
|
Cyp3a73
|
cytochrome P450, family 3, subfamily a, polypeptide 73
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CYP3A73 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:14,069,393...14,108,893
Ensembl chr12:14,070,257...14,094,400
|
|
| G
|
Cyp3a9
|
cytochrome P450, family 3, subfamily a, polypeptide 9
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CYP3A9 mRNA
|
CTD |
PMID:15749267 |
|
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
|
|
| G
|
Cyp4a8
|
cytochrome P450, family 4, subfamily a, polypeptide 8
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CYP4A8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:133,938,882...133,970,226
Ensembl chr 5:133,938,883...133,970,226
|
|
| G
|
Cyp4f5
|
cytochrome P450, family 4, subfamily f, polypeptide 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CYP4F5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:12,194,567...12,209,495
Ensembl chr 7:12,195,022...12,209,965
|
|
| G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
increases expression decreases expression multiple interactions
|
EXP ISO
|
Acrylamide results in increased expression of CYP7A1 mRNA Acrylamide results in decreased expression of CYP7A1 mRNA Acrylamide inhibits the reaction [Streptozocin results in increased expression of CYP7A1 mRNA]
|
CTD |
PMID:15749267 PMID:34896238 |
|
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
|
|
| G
|
Cytl1
|
cytokine like 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of CYTL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:77,278,635...77,283,645
Ensembl chr14:77,278,636...77,283,645
|
|
| G
|
Cyyr1
|
cysteine and tyrosine rich 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of CYYR1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:38,044,003...38,150,391
Ensembl chr11:38,001,699...38,164,473
|
|
| G
|
D2hgdh
|
D-2-hydroxyglutarate dehydrogenase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of D2HGDH mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:101,796,287...101,815,727
Ensembl chr 9:101,797,895...101,815,727
|
|
| G
|
Da2-19
|
uncharacterized LOC302729
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DA2-19 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:48,737,647...48,754,889
Ensembl chr X:48,737,774...48,754,888
|
|
| G
|
Daam2
|
dishevelled associated activator of morphogenesis 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DAAM2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 9:18,926,620...19,044,672
Ensembl chr 9:18,926,623...19,044,671
|
|
| G
|
Dab2
|
DAB adaptor protein 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DAB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:57,241,947...57,294,893
Ensembl chr 2:57,242,064...57,294,888
|
|
| G
|
Dact2
|
dishevelled-binding antagonist of beta-catenin 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DACT2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:63,854,182...63,864,153
Ensembl chr 1:63,854,182...63,864,255
|
|
| G
|
Dad1
|
defender against cell death 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of DAD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:31,647,326...31,667,159
Ensembl chr15:31,647,326...31,667,287
|
|
| G
|
Dagla
|
diacylglycerol lipase, alpha
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DAGLA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:216,315,515...216,372,219
Ensembl chr 1:216,315,516...216,372,111
|
|
| G
|
Dalrd3
|
DALR anticodon binding domain containing 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DALRD3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:118,142,009...118,147,082
Ensembl chr 8:118,144,197...118,147,822
|
|
| G
|
Dapk2
|
death-associated protein kinase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DAPK2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:75,601,621...75,720,619
Ensembl chr 8:75,601,634...75,720,617
|
|
| G
|
Dapk3
|
death-associated protein kinase 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DAPK3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:9,174,903...9,183,272
Ensembl chr 7:9,174,904...9,183,272
|
|
| G
|
Dapl1
|
death associated protein-like 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DAPL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:64,369,734...64,389,677
Ensembl chr 3:64,369,546...64,389,677
|
|
| G
|
Dbf4b
|
DBF4B-CDC7 kinase regulatory subunit
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DBF4B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:88,209,913...88,219,336
|
|
| G
|
Dbn1
|
drebrin 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DBN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:9,155,729...9,170,121
Ensembl chr17:9,155,787...9,170,122
|
|
| G
|
Dbnl
|
drebrin-like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DBNL mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:84,880,085...84,895,122
Ensembl chr14:84,880,142...84,897,133
|
|
| G
|
Dbp
|
D-box binding PAR bZIP transcription factor
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of DBP mRNA Acrylamide results in increased expression of DBP mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205
|
|
| G
|
Dbr1
|
debranching RNA lariats 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DBR1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:109,018,364...109,030,092
Ensembl chr 8:109,018,325...109,031,406
|
|
| G
|
Dcaf16
|
DDB1 and CUL4 associated factor 16
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DCAF16 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:69,662,173...69,662,557
|
|
| G
|
Dcaf7
|
DDB1 and CUL4 associated factor 7
|
affects expression
|
EXP
|
Acrylamide affects the expression of DCAF7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:91,473,900...91,496,080
Ensembl chr10:91,473,900...91,496,080
|
|
| G
|
Dcaf8
|
DDB1 and CUL4 associated factor 8
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DCAF8 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:87,141,940...87,199,859
Ensembl chr13:87,142,525...87,202,099
|
|
| G
|
Dcakd
|
dephospho-CoA kinase domain containing
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of DCAKD mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:88,457,829...88,489,011
Ensembl chr10:88,457,829...88,480,118
|
|
| G
|
Dcc
|
DCC netrin 1 receptor
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DCC mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:67,144,272...68,248,159
Ensembl chr18:67,149,179...68,247,541
|
|
| G
|
Dchs1
|
dachsous cadherin-related 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DCHS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:169,516,758...169,550,789
Ensembl chr 1:169,516,762...169,536,639
|
|
| G
|
Dck
|
deoxycytidine kinase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DCK mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:19,589,298...19,610,326
Ensembl chr14:19,589,298...19,610,326
|
|
| G
|
Dclk3
|
doublecortin-like kinase 3
|
affects expression
|
EXP
|
Acrylamide affects the expression of DCLK3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:120,279,916...120,332,362
Ensembl chr 8:120,279,757...120,332,432
|
|
| G
|
Dclre1c
|
DNA cross-link repair 1C
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DCLRE1C mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:79,684,988...79,718,399
Ensembl chr17:79,678,698...79,718,734
|
|
| G
|
Dct
|
dopachrome tautomerase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DCT mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:101,469,159...101,508,029
Ensembl chr15:101,469,159...101,508,029
|
|
| G
|
Dctpp1
|
dCTP pyrophosphatase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DCTPP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:191,307,933...191,311,326
Ensembl chr 1:191,307,935...191,313,405
|
|
| G
|
Dcun1d2
|
defective in cullin neddylation 1 domain containing 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DCUN1D2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:82,956,493...82,983,308
Ensembl chr16:82,956,339...82,983,307
|
|
| G
|
Dcun1d3
|
defective in cullin neddylation 1 domain containing 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DCUN1D3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:183,674,364...183,717,002
Ensembl chr 1:75,527,981...75,529,932 Ensembl chr 1:75,527,981...75,529,932
|
|
| G
|
Dcun1d4
|
defective in cullin neddylation 1 domain containing 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DCUN1D4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:35,006,792...35,087,285
Ensembl chr14:35,006,792...35,088,520
|
|
| G
|
Dcun1d5
|
defective in cullin neddylation 1 domain containing 5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DCUN1D5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:12,697,160...12,718,242
Ensembl chr 8:12,697,127...12,718,991
|
|
| G
|
Dcx
|
doublecortin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DCX mRNA
|
CTD |
PMID:36328537 |
|
NCBI chr X:112,227,455...112,370,291
Ensembl chr X:112,227,455...112,304,161
|
|
| G
|
Ddah1
|
dimethylarginine dimethylaminohydrolase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DDAH1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:237,327,766...237,460,626
|
|
| G
|
Ddhd2
|
DDHD domain containing 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DDHD2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:73,022,136...73,051,746
Ensembl chr16:73,022,193...73,051,745
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
multiple interactions increases expression decreases expression
|
ISO EXP
|
4-phenylbutyric acid inhibits the reaction [Acrylamide results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of DDIT3 mRNA] 4-phenylbutyric acid inhibits the reaction [Acrylamide promotes the reaction [elaidic acid results in increased expression of DDIT3 protein]]; 4-phenylbutyric acid inhibits the reaction [elaidic acid promotes the reaction [Acrylamide results in increased expression of DDIT3 protein]]; [INS co-treated with Acrylamide] results in increased expression of DDIT3 protein; Acrylamide promotes the reaction [elaidic acid results in increased expression of DDIT3 protein]; elaidic acid promotes the reaction [Acrylamide results in increased expression of DDIT3 protein]; GSK2656157 inhibits the reaction [[INS co-treated with Acrylamide] results in increased expression of DDIT3 protein]; INS promotes the reaction [Acrylamide results in increased expression of DDIT3 mRNA]; salubrinal inhibits the reaction [Acrylamide results in increased expression of DDIT3 protein] Acrylamide results in increased expression of DDIT3 mRNA; Acrylamide results in increased expression of DDIT3 protein Acrylamide results in decreased expression of DDIT3 mRNA
|
CTD |
PMID:27634458 PMID:28959563 PMID:32763439 PMID:33421551 PMID:38604440 PMID:38740238 More...
|
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Ddit4
|
DNA-damage-inducible transcript 4
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of DDIT4 mRNA Acrylamide results in decreased expression of DDIT4 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037
|
|
| G
|
Ddit4l
|
DNA-damage-inducible transcript 4-like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DDIT4L mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 2:228,800,831...228,804,478
Ensembl chr 2:228,801,705...228,806,225
|
|
| G
|
Ddo
|
D-aspartate oxidase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DDO mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:45,673,486...45,693,056
Ensembl chr20:45,675,532...45,715,758
|
|
| G
|
Ddost
|
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DDOST mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:155,805,612...155,812,728
Ensembl chr 5:155,805,454...155,813,121
|
|
| G
|
Ddr2
|
discoidin domain receptor tyrosine kinase 2
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of DDR2 mRNA Acrylamide results in increased expression of DDR2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr13:84,726,412...84,851,032
Ensembl chr13:84,731,180...84,850,288
|
|
| G
|
Ddrgk1
|
DDRGK domain containing 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DDRGK1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:138,315,006...138,336,691
Ensembl chr 3:138,315,282...138,335,766
|
|
| G
|
Ddx11
|
DEAD/H-box helicase 11
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DDX11 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:113,204,886...113,309,692
Ensembl chr 9:113,276,985...113,316,152
|
|
| G
|
Ddx19a
|
DEAD-box helicase 19A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DDX19A mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr19:55,851,854...55,872,209
Ensembl chr19:55,851,854...55,872,209
|
|
| G
|
Ddx19b
|
DEAD-box helicase 19B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DDX19B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:55,877,567...55,910,134
Ensembl chr19:55,877,567...55,906,745
|
|
| G
|
Ddx25
|
DEAD-box helicase 25
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DDX25 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:42,152,046...42,168,635
Ensembl chr 8:42,152,047...42,168,080
|
|
| G
|
Ddx39a
|
DExD-box helicase 39A
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DDX39A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:41,323,465...41,331,413
Ensembl chr19:41,322,836...41,332,306
|
|
| G
|
Ddx41
|
DEAD-box helicase 41
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DDX41 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr17:9,108,030...9,113,562
Ensembl chr17:9,108,074...9,113,561
|
|
| G
|
Ddx51
|
DEAD-box helicase 51
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DDX51 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:51,671,078...51,675,900
Ensembl chr12:51,671,078...51,676,099
|
|
| G
|
Ddx52
|
DExD-box helicase 52
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DDX52 mRNA
|
CTD |
PMID:15749267 |
|
NCBI chr10:69,322,062...69,344,856
Ensembl chr10:69,322,114...69,428,714
|
|
| G
|
Ddx56
|
DEAD-box helicase 56
|
increases expression decreases expression
|
ISO
|
Acrylamide results in increased expression of DDX56 mRNA Acrylamide results in decreased expression of DDX56 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr14:85,325,942...85,336,262
Ensembl chr14:85,325,942...85,336,262
|
|
| G
|
Ddx6
|
DEAD-box helicase 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DDX6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:53,827,661...53,864,538
Ensembl chr 8:53,827,835...53,860,977
|
|
| G
|
Dedd2
|
death effector domain containing 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DEDD2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:89,916,906...89,934,663
Ensembl chr 1:89,919,524...89,936,804
|
|
| G
|
Def6
|
DEF6 guanine nucleotide exchange factor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DEF6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:6,270,323...6,291,724
Ensembl chr20:6,269,357...6,291,771
|
|
| G
|
Defa31
|
defensin alpha 31
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DEFA10 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:77,216,346...77,218,685
Ensembl chr16:77,216,346...77,217,475
|
|
| G
|
Defa5
|
defensin alpha 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DEFA6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:77,044,994...77,047,318
Ensembl chr16:77,044,994...77,047,318
|
|
| G
|
Defb105a
|
defensin beta 105A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DEFB12 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:76,838,686...76,841,113
Ensembl chr16:76,838,664...76,841,113
|
|
| G
|
Defb13
|
defensin beta 13
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of DEFB13 mRNA Acrylamide results in increased expression of DEFB107B mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr16:76,831,868...76,833,977
Ensembl chr16:76,831,868...76,833,977
|
|
| G
|
Dele1
|
DAP3 binding cell death enhancer 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DELE1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:30,325,369...30,349,285
Ensembl chr18:30,336,308...30,349,938
|
|
| G
|
Dennd11
|
DENN domain containing 11
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DENND11 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:70,163,869...70,232,731
Ensembl chr 4:70,163,869...70,195,800
|
|
| G
|
Dennd2b
|
DENN domain containing 2B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DENND2B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:172,978,895...173,129,623
Ensembl chr 1:172,978,895...173,129,810
|
|
| G
|
Dennd2c
|
DENN domain containing 2C
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DENND2C mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:193,310,822...193,378,986
Ensembl chr 2:193,335,230...193,378,978
|
|
| G
|
Dennd2d
|
DENN domain containing 2D
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DENND2D mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:196,661,465...196,680,505
Ensembl chr 2:196,661,345...196,682,397
|
|
| G
|
Dennd4b
|
DENN domain containing 4B
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of DENND4B mRNA Acrylamide results in decreased expression of DENND4B mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:178,018,095...178,034,054
Ensembl chr 2:178,018,358...178,034,054
|
|
| G
|
Dennd4c
|
DENN domain containing 4C
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DENND4C mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:106,316,942...106,421,484
Ensembl chr 5:106,318,281...106,415,489
|
|
| G
|
Dennd6b
|
DENN domain containing 6B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DENND6B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:122,139,159...122,154,720
Ensembl chr 7:122,141,317...122,153,131
|
|
| G
|
Depdc1
|
DEP domain containing 1
|
increases expression decreases expression
|
ISO
|
Acrylamide results in increased expression of DEPDC1A mRNA Acrylamide results in decreased expression of DEPDC1 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr 2:251,343,250...251,376,709
Ensembl chr 2:251,343,281...251,376,709
|
|
| G
|
Depdc1b
|
DEP domain containing 1B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DEPDC1B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:41,605,686...41,697,207
Ensembl chr 2:41,624,922...41,697,202
|
|
| G
|
Depdc5
|
DEP domain containing 5, GATOR1 subcomplex subunit
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of DEPDC5 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr14:81,956,777...82,087,392
Ensembl chr14:81,956,777...82,087,246
|
|
| G
|
Depp1
|
DEPP autophagy regulator 1
|
affects expression increases expression
|
EXP ISO
|
Acrylamide affects the expression of DEPP1 mRNA Acrylamide results in increased expression of DEPP1 mRNA
|
CTD |
PMID:28959563 PMID:35032568 |
|
NCBI chr 4:151,583,105...151,585,455
Ensembl chr 4:151,581,502...151,586,233
|
|
| G
|
Derl3
|
derlin 3
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of DERL3 mRNA Acrylamide results in decreased expression of DERL3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr20:12,753,926...12,766,478
Ensembl chr20:12,762,981...12,766,477
|
|
| G
|
Des
|
desmin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DES mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:84,298,447...84,307,347
|
|
| G
|
Dgat1
|
diacylglycerol O-acyltransferase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DGAT1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:110,098,906...110,115,016
|
|
| G
|
Dgcr6
|
DiGeorge syndrome critical region gene 6
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of DGCR6 mRNA Acrylamide results in decreased expression of DGCR6 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr11:96,432,024...96,442,766
Ensembl chr11:96,432,024...96,437,255
|
|
| G
|
Dgka
|
diacylglycerol kinase, alpha
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of DGKA mRNA Acrylamide results in decreased expression of DGKA mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:1,733,247...1,761,181
Ensembl chr 7:1,733,248...1,759,569
|
|
| G
|
Dgke
|
diacylglycerol kinase epsilon
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DGKE mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:74,348,931...74,374,509
Ensembl chr10:74,350,246...74,374,478
|
|
| G
|
Dgkq
|
diacylglycerol kinase, theta
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DGKQ mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:1,203,380...1,217,536
Ensembl chr14:1,203,565...1,218,024
|
|
| G
|
Dgkz
|
diacylglycerol kinase zeta
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DGKZ mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:98,359,804...98,401,847
Ensembl chr 3:98,359,804...98,401,951
|
|
| G
|
Dglucy
|
D-glutamate cyclase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DGLUCY mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:125,785,075...125,860,496
Ensembl chr 6:125,785,087...125,860,496
|
|
| G
|
Dhcr24
|
24-dehydrocholesterol reductase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DHCR24 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:126,573,338...126,599,936
|
|
| G
|
Dhcr7
|
7-dehydrocholesterol reductase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DHCR7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382
|
|
| G
|
Dhdds
|
dehydrodolichyl diphosphate synthase subunit
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DHDDS mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:151,482,139...151,508,248
Ensembl chr 5:151,481,429...151,508,129
|
|
| G
|
Dhdh
|
dihydrodiol dehydrogenase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DHDH mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:105,088,108...105,102,560
Ensembl chr 1:105,090,309...105,101,567
|
|
| G
|
Dhfr
|
dihydrofolate reductase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DHFR mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:25,320,895...25,346,004
|
|
| G
|
Dhps
|
deoxyhypusine synthase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DHPS mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:39,987,328...39,991,418
Ensembl chr19:39,987,324...39,991,432
|
|
| G
|
Dhrs1
|
dehydrogenase/reductase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DHRS1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:33,206,449...33,213,776
Ensembl chr15:33,206,451...33,213,734
|
|
| G
|
Dhrs11
|
dehydrogenase/reductase 11
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DHRS11 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:70,195,637...70,205,735
Ensembl chr10:70,195,637...70,205,893
|
|
| G
|
Dhrs2l1
|
dehydrogenase/reductase member 2 like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DHRS2L1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:32,605,149...32,608,039
Ensembl chr15:32,605,149...32,608,039
|
|
| G
|
Dhrs3
|
dehydrogenase/reductase 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DHRS3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:162,031,386...162,065,653
|
|
| G
|
Dhrs7b
|
dehydrogenase/reductase 7B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DHRS7B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:46,003,845...46,036,498
Ensembl chr10:46,003,845...46,036,499
|
|
| G
|
Dhx16
|
DEAH-box helicase 16
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DHX16 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:2,866,804...2,879,790
Ensembl chr20:2,866,804...2,879,751
|
|
| G
|
Dhx34
|
DExH-box helicase 34
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DHX34 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:86,009,047...86,034,477
Ensembl chr 1:86,008,388...86,033,293
|
|
| G
|
Dhx37
|
DEAH-box helicase 37
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DHX37 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:36,856,119...36,876,245
Ensembl chr12:36,849,701...36,876,240
|
|
| G
|
Dhx58
|
DEXH-box helicase 58
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DHX58 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:86,120,677...86,132,095
Ensembl chr10:86,120,677...86,131,844
|
|
| G
|
Diaph3
|
diaphanous-related formin 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DIAPH3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:68,951,992...69,421,623
Ensembl chr15:68,951,989...69,421,552
|
|
| G
|
Dio2
|
iodothyronine deiodinase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DIO2 mRNA
|
CTD |
PMID:18430446 |
|
NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:115,396,308...115,410,594
|
|
| G
|
Dip2b
|
disco-interacting protein 2 homolog B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DIP2B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:133,053,393...133,231,430
Ensembl chr 7:133,053,401...133,228,874
|
|
| G
|
Dip2c
|
disco-interacting protein 2 homolog C
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DIP2C mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:65,338,711...65,724,111
Ensembl chr17:65,338,711...65,723,344
|
|
| G
|
Dipk1b
|
divergent protein kinase domain 1B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DIPK1B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:29,852,710...29,862,248
Ensembl chr 3:29,853,973...29,862,255
|
|
| G
|
Diras1
|
DIRAS family GTPase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DIRAS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:9,338,660...9,343,524
Ensembl chr 7:9,327,335...9,347,881
|
|
| G
|
Dis3l2
|
DIS3-like 3'-5' exoribonuclease 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DIS3L2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:94,802,056...95,184,523
Ensembl chr 9:94,804,382...95,184,522
|
|
| G
|
Dkk2
|
dickkopf WNT signaling pathway inhibitor 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DKK2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:223,242,375...223,334,249
Ensembl chr 2:223,242,377...223,334,724
|
|
| G
|
Dkk3
|
dickkopf WNT signaling pathway inhibitor 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DKK3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:175,672,834...175,715,867
Ensembl chr 1:175,672,834...175,715,186
|
|
| G
|
Dkk4
|
dickkopf WNT signaling pathway inhibitor 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DKK4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:76,105,679...76,109,044
Ensembl chr16:76,105,679...76,109,044
|
|
| G
|
Dlg5
|
discs large MAGUK scaffold protein 5
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of DLG5 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr15:125,287...237,334
Ensembl chr15:125,290...237,332
|
|
| G
|
Dlgap5
|
DLG associated protein 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DLGAP5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:23,113,678...23,144,281
Ensembl chr15:23,113,678...23,144,176
|
|
| G
|
Dll1
|
delta like canonical Notch ligand 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DLL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:64,985,161...64,993,274
Ensembl chr 1:64,985,161...64,993,276
|
|
| G
|
Dll3
|
delta like canonical Notch ligand 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DLL3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:92,689,577...92,698,125
Ensembl chr 1:92,689,577...92,697,406
|
|
| G
|
Dll4
|
delta like canonical Notch ligand 4
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of DLL4 mRNA Acrylamide results in increased expression of DLL4 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:126,770,794...126,780,763
|
|
| G
|
Dmac1
|
distal membrane arm assembly component 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DMAC1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:94,288,900...94,290,053
Ensembl chr 5:94,280,654...94,290,119
|
|
| G
|
Dmbx1
|
diencephalon/mesencephalon homeobox 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of DMBX1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:134,630,968...134,639,781
Ensembl chr 5:134,630,968...134,639,781
|
|
| G
|
Dmd
|
dystrophin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DMD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:51,070,098...53,437,845
Ensembl chr X:51,070,273...53,437,835
|
|
| G
|
Dmgdh
|
dimethylglycine dehydrogenase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DMGDH mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:26,647,540...26,722,496
Ensembl chr 2:26,647,565...26,723,071
|
|
| G
|
Dmkn
|
dermokine
|
affects expression
|
EXP
|
Acrylamide affects the expression of DMKN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:95,140,737...95,158,676
Ensembl chr 1:95,141,620...95,157,439
|
|
| G
|
Dmrta1
|
DMRT-like family A1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DMRTA1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:109,531,704...109,538,244
Ensembl chr 5:109,531,586...109,538,246
|
|
| G
|
Dmxl1
|
Dmx-like 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DMXL1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:45,179,505...45,349,999
Ensembl chr18:45,179,551...45,356,406
|
|
| G
|
Dnaaf3
|
dynein, axonemal, assembly factor 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DNAAF3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:78,333,985...78,342,034
Ensembl chr 1:78,333,971...78,342,685
|
|
| G
|
Dnaaf5
|
dynein, axonemal, assembly factor 5
|
decreases expression increases expression
|
ISO EXP
|
Acrylamide results in decreased expression of DNAAF5 mRNA Acrylamide results in increased expression of DNAAF5 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr12:20,567,482...20,606,600
Ensembl chr12:20,531,267...20,607,607
|
|
| G
|
Dnah1
|
dynein, axonemal, heavy chain 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DNAH1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:6,462,419...6,523,545
Ensembl chr16:6,462,419...6,524,760
|
|
| G
|
Dnah10
|
dynein, axonemal, heavy chain 10
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DNAH10 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:37,484,444...37,607,810
Ensembl chr12:37,472,813...37,640,860
|
|
| G
|
Dnah11
|
dynein, axonemal, heavy chain 11
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of DNAH11 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 6:144,982,130...145,298,523
Ensembl chr 6:144,973,797...145,298,692
|
|
| G
|
Dnah12
|
dynein, axonemal, heavy chain 12
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DNAH12 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:1,932,776...2,099,391
Ensembl chr16:1,944,752...2,099,373
|
|
| G
|
Dnah6
|
dynein, axonemal, heavy chain 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DNAH6 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 4:106,622,235...106,842,461
Ensembl chr 4:106,612,973...106,842,417
|
|
| G
|
Dnah8
|
dynein, axonemal, heavy chain 8
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DNAH8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:8,694,371...8,948,849
Ensembl chr20:8,694,398...8,948,849
|
|
| G
|
Dnah9
|
dynein, axonemal, heavy chain 9
|
affects expression
|
EXP
|
Acrylamide affects the expression of DNAH9 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:50,996,796...51,363,977
Ensembl chr10:50,996,796...51,363,963
|
|
| G
|
Dnai1
|
dynein, axonemal, intermediate chain 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DNAI1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:61,526,079...61,596,806
Ensembl chr 5:61,525,999...61,596,810
|
|
| G
|
Dnai2
|
dynein, axonemal, intermediate chain 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DNAI2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:100,259,022...100,292,427
Ensembl chr10:100,258,994...100,292,426
|
|
| G
|
Dnai3
|
dynein axonemal intermediate chain 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DNAI3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:237,608,202...237,666,465
Ensembl chr 2:237,604,068...237,666,465
|
|
| G
|
Dnaja1
|
DnaJ heat shock protein family (Hsp40) member A1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DNAJA1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160
|
|
| G
|
Dnaja4
|
DnaJ heat shock protein family (Hsp40) member A4
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of DNAJA4 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 8:63,975,177...63,998,836
Ensembl chr 8:63,981,559...63,998,836
|
|
| G
|
Dnajb1
|
DnaJ heat shock protein family (Hsp40) member B1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DNAJB1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416
|
|
| G
|
Dnajb11
|
DnaJ heat shock protein family (Hsp40) member B11
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of DNAJB11 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr11:91,656,334...91,672,800
Ensembl chr11:91,656,335...91,672,800
|
|
| G
|
Dnajb2
|
DnaJ heat shock protein family (Hsp40) member B2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DNAJB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:84,179,702...84,187,942
Ensembl chr 9:84,179,695...84,187,942
|
|
| G
|
Dnajb4
|
DnaJ heat shock protein family (Hsp40) member B4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DNAJB4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042
|
|
| G
|
Dnajb5
|
DnaJ heat shock protein family (Hsp40) member B5
|
affects expression
|
EXP
|
Acrylamide affects the expression of DNAJB5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:61,972,637...61,981,887
Ensembl chr 5:61,972,706...61,981,860
|
|
| G
|
Dnajb6
|
DnaJ heat shock protein family (Hsp40) member B6
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DNAJB6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:6,010,081...6,232,052
Ensembl chr 4:6,128,070...6,232,005
|
|
| G
|
Dnajb8
|
DnaJ heat shock protein family (Hsp40) member B8
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DNAJB8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:122,239,209...122,242,277
Ensembl chr 4:122,227,595...122,247,526
|
|
| G
|
Dnajc12
|
DnaJ heat shock protein family (Hsp40) member C12
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DNAJC12 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:25,245,475...25,266,238
Ensembl chr20:25,222,298...25,266,251
|
|
| G
|
Dnajc13
|
DnaJ heat shock protein family (Hsp40) member C13
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DNAJC13 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:113,646,573...113,756,104
Ensembl chr 8:113,646,573...113,756,104
|
|
| G
|
Dnajc14
|
DnaJ heat shock protein family (Hsp40) member C14
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DNAJC14 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:1,818,360...1,831,642
Ensembl chr 7:1,820,247...1,831,658
|
|
| G
|
Dnajc17
|
DnaJ heat shock protein family (Hsp40) member C17
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DNAJC17 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:126,616,043...126,649,599
Ensembl chr 3:126,616,051...126,649,656
|
|
| G
|
Dnajc22
|
DnaJ heat shock protein family (Hsp40) member C22
|
affects expression
|
EXP
|
Acrylamide affects the expression of DNAJC22 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:132,136,516...132,141,802
Ensembl chr 7:132,136,545...132,142,758
|
|
| G
|
Dnajc28
|
DnaJ heat shock protein family (Hsp40) member C28
|
affects expression
|
EXP
|
Acrylamide affects the expression of DNAJC28 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:44,341,528...44,344,348
Ensembl chr11:44,338,646...44,344,482
|
|
| G
|
Dnajc3
|
DnaJ heat shock protein family (Hsp40) member C3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DNAJC3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:102,432,667...102,475,643
Ensembl chr15:102,432,663...102,475,643
|
|
| G
|
Dnajc30
|
DnaJ heat shock protein family (Hsp40) member C30
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DNAJC30 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:27,264,861...27,265,940
Ensembl chr12:27,262,802...27,266,169
|
|
| G
|
Dnajc5b
|
DnaJ heat shock protein family (Hsp40) member C5 beta
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DNAJC5B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:103,889,863...103,982,413
Ensembl chr 2:103,889,919...103,982,423
|
|
| G
|
Dnajc7
|
DnaJ heat shock protein family (Hsp40) member C7
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DNAJC7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:86,018,977...86,055,419
Ensembl chr10:86,018,961...86,055,489
|
|
| G
|
Dnali1
|
dynein, axonemal, light intermediate chain 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DNALI1 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 5:142,603,132...142,611,970
Ensembl chr 5:142,603,134...142,611,993
|
|
| G
|
Dnase1l1
|
deoxyribonuclease 1-like 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DNASE1L1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:157,208,230...157,216,812
Ensembl chr X:157,208,230...157,216,711
|
|
| G
|
Dnase2
|
deoxyribonuclease 2, lysosomal
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DNASE2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:40,149,505...40,152,225
Ensembl chr19:40,149,505...40,152,225
|
|
| G
|
Dnmt1
|
DNA methyltransferase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DNMT1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119
|
|
| G
|
Dnmt3a
|
DNA methyltransferase 3 alpha
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DNMT3A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970
|
|
| G
|
Dnmt3b
|
DNA methyltransferase 3 beta
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DNMT3B mRNA
|
CTD |
PMID:30807115 PMID:32763439 PMID:35032568 |
|
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313
|
|
| G
|
Dnph1
|
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DNPH1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:21,978,894...21,981,631
Ensembl chr 9:21,978,894...21,981,631
|
|
| G
|
Dnttip2
|
deoxynucleotidyltransferase, terminal, interacting protein 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DNTTIP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:213,058,975...213,071,020
Ensembl chr 2:213,058,962...213,071,016
|
|
| G
|
Doc2a
|
double C2 domain alpha
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DOC2A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:190,887,306...190,893,057
Ensembl chr 1:190,888,214...190,893,384
|
|
| G
|
Doc2g
|
double C2-like domains, gamma
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DOC2G mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:210,724,868...210,729,352
Ensembl chr 1:210,725,748...210,730,048
|
|
| G
|
Dock1
|
dedicator of cyto-kinesis 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DOCK1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:198,897,021...199,413,636
Ensembl chr 1:198,897,045...199,413,627
|
|
| G
|
Dock5
|
dedicator of cytokinesis 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DOCK5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:46,155,124...46,334,127
Ensembl chr15:46,155,125...46,334,042
|
|
| G
|
Dock6
|
dedicator of cytokinesis 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DOCK6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:28,618,523...28,670,741
Ensembl chr 8:28,618,523...28,670,648
|
|
| G
|
Dok4
|
docking protein 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DOK4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:10,152,511...10,163,182
Ensembl chr19:10,152,458...10,164,190
|
|
| G
|
Dok5
|
docking protein 5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DOK5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:179,934,419...180,071,334
Ensembl chr 3:179,934,552...180,071,333
|
|
| G
|
Dorip1
|
dopamine receptor interacting protein 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DORIP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:88,701,651...88,710,204
Ensembl chr 6:88,701,818...88,708,820
|
|
| G
|
Dpcd
|
deleted in primary ciliary dyskinesia
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DPCD mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:254,357,755...254,375,918
Ensembl chr 1:254,357,778...254,375,918
|
|
| G
|
Dpep1
|
dipeptidase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DPEP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:68,118,270...68,143,781
Ensembl chr19:68,118,453...68,143,775
|
|
| G
|
Dpep2
|
dipeptidase 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DPEP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:50,795,322...50,806,320
Ensembl chr19:50,795,327...50,801,757 Ensembl chr19:50,795,327...50,801,757
|
|
| G
|
Dph1
|
diphthamide biosynthesis 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DPH1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:60,526,417...60,538,102
Ensembl chr10:60,527,680...60,535,816
|
|
| G
|
Dph2
|
diphthamide biosynthesis 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DPH2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:136,713,868...136,716,828
|
|
| G
|
Dph6
|
diphthamine biosynthesis 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DPH6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:121,761,495...121,891,727
Ensembl chr 3:121,676,141...121,891,658
|
|
| G
|
Dpm2
|
dolichyl-phosphate mannosyltransferase subunit 2, regulatory
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DPM2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:36,253,548...36,256,592
|
|
| G
|
Dpm3
|
dolichyl-phosphate mannosyltransferase subunit 3, regulatory
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of DPM3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:176,974,290...176,974,805
Ensembl chr15:52,612,418...52,612,696
|
|
| G
|
Dppa3
|
developmental pluripotency-associated 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DPPA3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:157,523,426...157,526,810
Ensembl chr 5:93,143,318...93,144,472 Ensembl chr 4:93,143,318...93,144,472
|
|
| G
|
Dppa3l1
|
developmental pluripotency associated 3-like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DPPA3L1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:65,317,653...65,318,321
Ensembl chr 8:65,317,869...65,318,321
|
|
| G
|
Dppa4
|
developmental pluripotency associated 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DPPA4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:66,033,256...66,041,754
Ensembl chr11:66,033,256...66,041,754
|
|
| G
|
Dpysl2
|
dihydropyrimidinase-like 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DPYSL2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065
|
|
| G
|
Dpysl3
|
dihydropyrimidinase-like 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DPYSL3 mRNA
|
CTD |
PMID:36328537 |
|
NCBI chr18:35,625,357...35,731,152
Ensembl chr18:35,625,357...35,731,152
|
|
| G
|
Drc12
|
dynein regulatory complex subunit 12 homolog
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of OR1S2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:53,468,344...53,481,168
Ensembl chr 8:53,472,849...53,486,567
|
|
| G
|
Drc7
|
dynein regulatory complex subunit 7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DRC7 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr19:9,949,484...9,967,296
Ensembl chr19:9,949,486...9,967,192
|
|
| G
|
Drd1
|
dopamine receptor D1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DRD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,545,111...10,567,166
|
|
| G
|
Drd3
|
dopamine receptor D3
|
affects binding
|
ISO
|
Acrylamide analog binds to DRD3 protein
|
CTD |
PMID:15185375 |
|
NCBI chr11:70,385,586...70,437,793
Ensembl chr11:70,385,586...70,446,760
|
|
| G
|
Drd4
|
dopamine receptor D4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DRD4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:205,826,049...205,830,458
|
|
| G
|
Drg2
|
developmentally regulated GTP binding protein 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DRG2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:45,755,072...45,769,493
Ensembl chr10:45,755,059...45,769,523
|
|
| G
|
Drgx
|
dorsal root ganglia homeobox
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DRGX mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:7,861,024...7,891,607
Ensembl chr16:7,861,157...7,906,904
|
|
| G
|
Drp2
|
dystrophin related protein 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DRP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:101,900,743...101,951,403
Ensembl chr X:101,901,011...101,951,403
|
|
| G
|
Dsc3
|
desmocollin 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DSC3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:11,654,833...11,688,871
Ensembl chr18:11,653,832...11,688,871
|
|
| G
|
Dscam
|
DS cell adhesion molecule
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DSCAM mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:49,391,385...49,976,861
Ensembl chr11:49,347,531...49,976,238
|
|
| G
|
Dse
|
dermatan sulfate epimerase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DSE mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:26,661,326...26,740,011
Ensembl chr20:26,661,326...26,740,114
|
|
| G
|
Dsel
|
dermatan sulfate epimerase-like
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DSEL mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:194,738...200,959
Ensembl chr13:179,618...200,993
|
|
| G
|
Dsg4
|
desmoglein 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DSG4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:11,995,902...12,032,908
Ensembl chr18:11,995,902...12,032,908
|
|
| G
|
Dsn1
|
DSN1 component of MIS12 kinetochore complex
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DSN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:166,072,775...166,089,029
Ensembl chr 3:166,074,033...166,085,890
|
|
| G
|
Dsp
|
desmoplakin
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DSP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:26,829,153...26,877,419
Ensembl chr17:26,829,153...26,877,121
|
|
| G
|
Dstn
|
destrin, actin depolymerizing factor
|
affects expression
|
EXP
|
Acrylamide affects the expression of DSTN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:151,737,711...151,764,752
Ensembl chr 3:151,737,849...151,764,769
|
|
| G
|
Dtl
|
denticleless E3 ubiquitin protein ligase homolog
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of DTL mRNA Acrylamide results in decreased expression of DTL mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr13:105,646,908...105,685,921
Ensembl chr13:105,646,908...105,686,174
|
|
| G
|
Dtna
|
dystrobrevin, alpha
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DTNA mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr18:14,862,801...15,218,993
Ensembl chr18:14,862,818...15,218,993
|
|
| G
|
Dtwd1
|
DTW domain containing 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DTWD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:133,845,768...133,859,965
Ensembl chr 3:133,841,935...133,860,316
|
|
| G
|
Dtwd2
|
DTW domain containing 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DTWD2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:45,003,242...45,088,595
Ensembl chr18:45,003,644...45,088,419
|
|
| G
|
Dtx2
|
deltex E3 ubiquitin ligase 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DTX2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:26,279,899...26,319,541
Ensembl chr12:26,279,899...26,319,507
|
|
| G
|
Duox2
|
dual oxidase 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of DUOX2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:129,680,543...129,698,886
Ensembl chr 3:129,680,546...129,699,203
|
|
| G
|
Dus1l
|
dihydrouridine synthase 1-like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DUS1L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:106,553,841...106,560,977
Ensembl chr10:106,553,238...106,561,285
|
|
| G
|
Dus2
|
dihydrouridine synthase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DUS2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:50,816,306...50,864,559
Ensembl chr19:50,816,310...50,864,559
|
|
| G
|
Dus3l
|
dihydrouridine synthase 3-like
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DUS3L mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:1,680,619...1,685,784
Ensembl chr 9:1,675,819...1,686,367
|
|
| G
|
Dusp1
|
dual specificity phosphatase 1
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of DUSP1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644
|
|
| G
|
Dusp10
|
dual specificity phosphatase 10
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DUSP10 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:98,145,317...98,183,304
Ensembl chr13:98,145,893...98,183,304
|
|
| G
|
Dusp13b
|
dual specificity phosphatase 13B
|
increases expression decreases expression
|
ISO EXP
|
Acrylamide results in increased expression of DUSP13B mRNA Acrylamide results in decreased expression of DUSP13B mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr15:2,616,761...2,624,434
Ensembl chr15:2,609,049...2,624,887
|
|
| G
|
Dusp14
|
dual specificity phosphatase 14
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of DUSP14 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:69,433,949...69,463,863
Ensembl chr10:69,426,730...69,462,837
|
|
| G
|
Dusp2
|
dual specificity phosphatase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DUSP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:135,009,636...135,011,821
Ensembl chr 3:135,009,590...135,011,809
|
|
| G
|
Dusp3
|
dual specificity phosphatase 3
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of DUSP3 mRNA Acrylamide results in increased expression of DUSP3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:87,420,213...87,434,202
Ensembl chr10:87,419,494...87,434,063
|
|
| G
|
Dusp5
|
dual specificity phosphatase 5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DUSP5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417
|
|
| G
|
Dusp6
|
dual specificity phosphatase 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DUSP6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833
|
|
| G
|
Dusp8
|
dual specificity phosphatase 8
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of DUSP8 mRNA Acrylamide results in increased expression of DUSP8 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 1:206,596,912...206,613,728
Ensembl chr 1:206,598,942...206,612,441
|
|
| G
|
Dut
|
deoxyuridine triphosphatase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DUT mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:132,952,394...132,964,956
|
|
| G
|
Dvl1
|
dishevelled segment polarity protein 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DVL1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:171,738,911...171,750,967
Ensembl chr 5:171,739,133...171,750,966
|
|
| G
|
Dydc2
|
DPY30 domain containing 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DYDC2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:16,962,273...16,976,034
Ensembl chr16:16,962,290...16,970,258
|
|
| G
|
Dync2i1
|
dynein 2 intermediate chain 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DYNC2I1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:143,276,441...143,333,006
Ensembl chr 6:143,276,441...143,331,773
|
|
| G
|
Dync2i2
|
dynein 2 intermediate chain 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DYNC2I2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:33,703,882...33,719,960
Ensembl chr 3:33,703,882...33,719,960
|
|
| G
|
Dync2li1
|
dynein cytoplasmic 2 light intermediate chain 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DYNC2LI1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:15,745,350...15,778,166
Ensembl chr 6:15,745,350...15,778,166
|
|
| G
|
Dynll1
|
dynein light chain LC8-type 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DYNLL1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:46,945,291...46,976,867
Ensembl chr12:46,973,050...46,976,861
|
|
| G
|
Dynlrb1
|
dynein light chain roadblock-type 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of DYNLRB1 mRNA
|
CTD |
PMID:15749267 |
|
NCBI chr 3:164,197,892...164,224,409
Ensembl chr 3:164,202,953...164,224,409
|
|
| G
|
Dynlt2
|
dynein light chain Tctex-type 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DYNLT2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:64,644,404...64,656,368
Ensembl chr 1:64,644,404...64,656,368
|
|
| G
|
Dyrk1a
|
dual specificity tyrosine phosphorylation regulated kinase 1A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of DYRK1A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:47,360,824...47,479,033
Ensembl chr11:47,360,850...47,479,033
|
|
| G
|
Dyrk1b
|
dual specificity tyrosine phosphorylation regulated kinase 1B
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of DYRK1B mRNA Acrylamide results in increased expression of DYRK1B mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:92,606,743...92,624,089
Ensembl chr 1:92,607,303...92,614,744
|
|
| G
|
Dzip1-ps1
|
DAZ interacting protein 1, pseudogene 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DZIP1-PS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:20,506,475...20,508,533
Ensembl chr14:20,506,475...20,508,533
|
|
| G
|
Dzip1l
|
DAZ interacting zinc finger protein 1-like
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of DZIP1L mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:109,067,466...109,108,390
Ensembl chr 8:109,067,775...109,108,393
|
|
| G
|
E2f1
|
E2F transcription factor 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of E2F1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563
|
|
| G
|
E2f2
|
E2F transcription factor 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of E2F2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:153,682,789...153,706,087
Ensembl chr 5:153,682,789...153,706,087
|
|
| G
|
E2f6
|
E2F transcription factor 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of E2F6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:45,320,993...45,337,437
Ensembl chr 6:45,320,996...45,337,428
|
|
| G
|
E2f7
|
E2F transcription factor 7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of E2F7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:48,036,881...48,079,055
Ensembl chr 7:48,037,749...48,079,055
|
|
| G
|
Eaf1
|
ELL associated factor 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EAF1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:6,704,727...6,719,476
Ensembl chr16:6,704,727...6,719,476
|
|
| G
|
Eaf2
|
ELL associated factor 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EAF2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:77,465,585...77,509,993
Ensembl chr11:77,406,020...77,509,993
|
|
| G
|
Eapp
|
E2F-associated phosphoprotein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EAPP mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:77,879,634...77,929,653
Ensembl chr 6:77,907,485...77,928,930
|
|
| G
|
Ebf3
|
EBF transcription factor 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EBF3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:201,426,446...201,544,444
Ensembl chr 1:201,426,450...201,544,305
|
|
| G
|
Ebf4
|
EBF family member 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EBF4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:137,951,310...138,019,682
Ensembl chr 3:137,951,335...138,019,665
|
|
| G
|
Ebna1bp2
|
EBNA1 binding protein 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EBNA1BP2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 5:137,433,534...137,438,100
Ensembl chr 5:137,433,226...137,438,637
|
|
| G
|
Ebp
|
EBP, cholestenol delta-isomerase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EBP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:16,971,372...16,977,782
Ensembl chr X:16,971,405...16,977,781
|
|
| G
|
Ecd
|
ecdysoneless cell cycle regulator
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ECD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:4,016,411...4,047,899
Ensembl chr15:4,016,403...4,047,897
|
|
| G
|
Ece1
|
endothelin converting enzyme 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ECE1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:155,360,639...155,462,719
|
|
| G
|
Echdc2
|
enoyl CoA hydratase domain containing 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ECHDC2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:128,144,241...128,163,611
Ensembl chr 5:128,144,425...128,163,610
|
|
| G
|
Echdc3
|
enoyl CoA hydratase domain containing 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ECHDC3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:76,980,112...77,002,934
Ensembl chr17:76,980,083...77,002,934
|
|
| G
|
Eci2
|
enoyl-CoA delta isomerase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ECI2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:30,056,274...30,092,169
Ensembl chr17:30,076,524...30,092,161
|
|
| G
|
Eci3
|
enoyl-Coenzyme A delta isomerase 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ECI3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:30,127,425...30,149,249
Ensembl chr17:30,128,588...30,149,137
|
|
| G
|
Ecm1
|
extracellular matrix protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ECM1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:185,976,439...185,981,656
Ensembl chr 2:185,976,440...185,981,606
|
|
| G
|
Ecpas
|
Ecm29 proteasome adaptor and scaffold
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ECPAS mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:78,398,449...78,509,077
Ensembl chr 5:78,398,718...78,512,908
|
|
| G
|
Ecrg4
|
ECRG4 augurin precursor
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ECRG4 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 9:53,485,040...53,504,691
Ensembl chr 9:53,485,040...53,504,703
|
|
| G
|
Eddm3b
|
epididymal protein 3B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EDDM3B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:26,817,508...26,820,274
Ensembl chr15:26,786,199...26,820,294
|
|
| G
|
Ednra
|
endothelin receptor type A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EDNRA mRNA
|
CTD |
PMID:38554842 |
|
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284
|
|
| G
|
Ednrb
|
endothelin receptor type B
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of EDNRB mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765
|
|
| G
|
Eea1
|
early endosome antigen 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EEA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:32,441,281...32,608,808
Ensembl chr 7:32,441,272...32,608,476
|
|
| G
|
Eef1akmt2
|
EEF1A lysine methyltransferase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EEF1AKMT2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:197,009,919...197,071,033
Ensembl chr 1:197,046,930...197,071,013
|
|
| G
|
Eef2
|
eukaryotic translation elongation factor 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EEF2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544
|
|
| G
|
Eeig2
|
EEIG family member 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EEIG2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:199,296,582...199,351,449
Ensembl chr 2:199,296,582...199,351,449
|
|
| G
|
Eepd1
|
endonuclease/exonuclease/phosphatase family domain containing 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of EEPD1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 8:32,233,834...32,340,148
Ensembl chr 8:32,233,070...32,340,147
|
|
| G
|
Efcab14
|
EF-hand calcium binding domain 14
|
affects expression
|
EXP
|
Acrylamide affects the expression of EFCAB14 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:134,454,908...134,493,714
Ensembl chr 5:134,454,924...134,495,384
|
|
| G
|
Efcab7
|
EF-hand calcium binding domain 7
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EFCAB7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:119,640,841...119,691,566
Ensembl chr 5:119,640,761...119,691,563
|
|
| G
|
Efcc1
|
EF-hand and coiled-coil domain containing 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of EFCC1 mRNA Acrylamide results in increased expression of EFCC1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:121,745,547...121,778,475
Ensembl chr 4:121,745,633...121,775,220
|
|
| G
|
Efemp2
|
EGF containing fibulin extracellular matrix protein 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of EFEMP2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:212,211,057...212,218,739
Ensembl chr 1:212,210,972...212,218,739
|
|
| G
|
Efhb
|
EF hand domain family, member B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EFHB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:6,608,791...6,680,104
Ensembl chr 9:6,608,794...6,678,827
|
|
| G
|
Efna4
|
ephrin A4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EFNA4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:177,046,463...177,050,713
Ensembl chr 2:177,046,463...177,050,713
|
|
| G
|
Efna5
|
ephrin A5
|
affects expression
|
EXP
|
Acrylamide affects the expression of EFNA5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:109,763,786...110,042,396
Ensembl chr 9:109,767,252...110,042,348
|
|
| G
|
Efnb1
|
ephrin B1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EFNB1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:68,297,529...68,310,335
Ensembl chr X:68,297,492...68,349,546
|
|
| G
|
Efnb2
|
ephrin B2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EFNB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:87,485,215...87,529,224
Ensembl chr16:87,485,198...87,529,208
|
|
| G
|
Efnb3
|
ephrin B3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EFNB3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:54,773,282...54,780,727
Ensembl chr10:54,773,282...54,797,651
|
|
| G
|
Efr3a
|
EFR3 homolog A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EFR3A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:99,441,764...99,522,454
Ensembl chr 7:99,441,767...99,522,454
|
|
| G
|
Eftud2
|
elongation factor Tu GTP binding domain containing 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EFTUD2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:88,304,992...88,352,229
Ensembl chr10:88,304,992...88,346,299
|
|
| G
|
Egfl7
|
EGF-like-domain, multiple 7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EGFL7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:29,802,481...29,814,966
Ensembl chr 3:29,802,690...29,814,951
|
|
| G
|
Egfr
|
epidermal growth factor receptor
|
affects phosphorylation multiple interactions increases expression decreases phosphorylation
|
ISO
|
Acrylamide analog affects the phosphorylation of EGFR protein Curcumin inhibits the reaction [Acrylamide results in increased expression of EGFR protein]; epigallocatechin gallate inhibits the reaction [Acrylamide results in increased expression of EGFR protein] Acrylamide analog results in decreased phosphorylation of EGFR protein
|
CTD |
PMID:10753475 PMID:11462982 PMID:24508477 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
| G
|
Egln3
|
egl-9 family hypoxia-inducible factor 3
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of EGLN3 mRNA Acrylamide results in decreased expression of EGLN3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:77,385,549...77,411,015
|
|
| G
|
Egr1
|
early growth response 1
|
decreases expression increases expression
|
ISO EXP
|
Acrylamide results in decreased expression of EGR1 mRNA Acrylamide results in increased expression of EGR1 mRNA
|
CTD |
PMID:29261810 PMID:30807115 PMID:32763439 PMID:36328537 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Egr2
|
early growth response 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EGR2 mRNA
|
CTD |
PMID:32151602 |
|
NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748
|
|
| G
|
Egr3
|
early growth response 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EGR3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:51,560,482...51,565,778
Ensembl chr15:51,560,344...51,565,712
|
|
| G
|
Ehbp1l1
|
EH domain binding protein 1-like 1
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of EHBP1L1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:212,423,444...212,444,357
Ensembl chr 1:212,423,447...212,443,598
|
|
| G
|
Ehd4
|
EH-domain containing 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EHD4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:127,511,973...127,575,856
Ensembl chr 3:127,511,954...127,576,072
|
|
| G
|
Ehhadh
|
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EHHADH mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:92,746,409...92,779,647
Ensembl chr11:92,746,420...92,779,662
|
|
| G
|
Eid1
|
EP300 interacting inhibitor of differentiation 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EID1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:133,376,389...133,378,108
Ensembl chr 3:133,370,474...133,378,434
|
|
| G
|
Eid2b
|
EP300 interacting inhibitor of differentiation 2B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EID2B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:92,673,119...92,674,899
|
|
| G
|
Eid3
|
EP300 interacting inhibitor of differentiation 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EID3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:22,747,645...22,748,967
Ensembl chr 7:22,747,656...22,749,177
|
|
| G
|
Eif1
|
eukaryotic translation initiation factor 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EIF1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:85,747,064...85,749,447
Ensembl chr 5:25,895,968...25,896,654 Ensembl chr10:25,895,968...25,896,654
|
|
| G
|
Eif1ad
|
eukaryotic translation initiation factor 1A domain containing
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EIF1AD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:212,103,715...212,109,015
Ensembl chr 1:212,103,892...212,109,017
|
|
| G
|
Eif1ax
|
eukaryotic translation initiation factor 1A, X-linked
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EIF1AX mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:39,307,320...39,322,023
Ensembl chr X:39,307,137...39,322,021
|
|
| G
|
Eif1b
|
eukaryotic translation initiation factor 1B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EIF1B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:129,080,497...129,083,772
Ensembl chr 8:129,078,293...129,083,772 Ensembl chr 5:129,078,293...129,083,772
|
|
| G
|
Eif2a
|
eukaryotic translation initiation factor 2A
|
increases expression multiple interactions increases phosphorylation
|
EXP
|
Acrylamide results in increased expression of EIF2A mRNA 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of EIF2A protein]; [INS co-treated with Acrylamide] results in increased phosphorylation of EIF2A protein; Acetylcysteine inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of EIF2A protein]; GSK2656157 inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of EIF2A protein]; INS promotes the reaction [Acrylamide results in increased expression of EIF2A mRNA] Acrylamide results in increased phosphorylation of EIF2A protein
|
CTD |
PMID:38604440 |
|
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201
|
|
| G
|
Eif2ak2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of EIF2AK2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:21,941,147...21,977,115
Ensembl chr 6:21,952,631...21,977,116
|
|
| G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
decreases expression increases expression multiple interactions increases phosphorylation
|
EXP
|
Acrylamide results in decreased expression of EIF2AK3 mRNA Acrylamide results in increased expression of EIF2AK3 mRNA 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of EIF2AK3 protein]; [INS co-treated with Acrylamide] results in increased phosphorylation of EIF2AK3 protein; Acetylcysteine inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of EIF2AK3 protein]; INS promotes the reaction [Acrylamide results in increased expression of EIF2AK3 mRNA] Acrylamide results in increased phosphorylation of EIF2AK3 protein
|
CTD |
PMID:28959563 PMID:33421551 PMID:38604440 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
| G
|
Eif2b3
|
eukaryotic translation initiation factor 2B subunit gamma
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of EIF2B3 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 5:135,728,764...135,795,276
Ensembl chr 5:135,728,959...135,799,914
|
|
| G
|
Eif2b4
|
eukaryotic translation initiation factor 2B subunit delta
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EIF2B4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:30,903,148...30,908,803
Ensembl chr 6:30,903,219...30,908,800
|
|
| G
|
Eif2d
|
eukaryotic translation initiation factor 2D
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EIF2D mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr13:45,168,161...45,189,362
Ensembl chr13:45,139,967...45,191,974
|
|
| G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
increases expression increases phosphorylation multiple interactions
|
EXP ISO
|
Acrylamide results in increased expression of EIF2S1 mRNA Acrylamide results in increased phosphorylation of EIF2S1 protein Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of EIF2S1 protein]
|
CTD |
PMID:15749267 PMID:27634458 PMID:33421551 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
| G
|
Eif3j
|
eukaryotic translation initiation factor 3, subunit J
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EIF3J mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:129,438,715...129,460,953
Ensembl chr 3:129,438,722...129,462,246
|
|
| G
|
Eif4b
|
eukaryotic translation initiation factor 4B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EIF4B mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 7:135,085,259...135,107,054
Ensembl chr 7:135,085,066...135,107,064
|
|
| G
|
Eif4e
|
eukaryotic translation initiation factor 4E
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EIF4E mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:229,739,897...229,774,105
|
|
| G
|
Eif4e3
|
eukaryotic translation initiation factor 4E family member 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EIF4E3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:133,709,802...133,858,398
Ensembl chr 4:133,625,768...133,885,647
|
|
| G
|
Eif5
|
eukaryotic translation initiation factor 5
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of EIF5 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 6:136,410,333...136,418,827
Ensembl chr 6:136,407,440...136,418,821
|
|
| G
|
Eif5a
|
eukaryotic translation initiation factor 5A
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EIF5A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:55,138,821...55,143,272
Ensembl chr10:55,138,823...55,143,330
|
|
| G
|
Eif5a2
|
eukaryotic translation initiation factor 5A2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EIF5A2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:113,656,748...113,674,598
Ensembl chr 2:113,657,797...113,674,594
|
|
| G
|
Elac2
|
elaC ribonuclease Z 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ELAC2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:50,131,449...50,154,755
Ensembl chr10:50,131,521...50,155,069
|
|
| G
|
Elavl4
|
ELAV like RNA binding protein 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ELAVL4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:130,285,418...130,429,106
Ensembl chr 5:130,285,418...130,429,096
|
|
| G
|
Ell
|
elongation factor for RNA polymerase II
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ELL mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:18,877,751...18,925,449
Ensembl chr16:18,877,751...18,925,076
|
|
| G
|
Ell3
|
elongation factor for RNA polymerase II 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ELL3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:128,866,755...128,870,896
Ensembl chr 3:128,864,777...128,870,852
|
|
| G
|
Elmod2
|
ELMO domain containing 2
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of ELMOD2 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr19:41,690,713...41,710,194
Ensembl chr19:41,690,762...41,710,194 Ensembl chr18:41,690,762...41,710,194
|
|
| G
|
Eln
|
elastin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ELN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:27,604,983...27,648,413
Ensembl chr12:27,604,680...27,648,413
|
|
| G
|
Elovl1
|
ELOVL fatty acid elongase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ELOVL1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:137,246,781...137,251,351
Ensembl chr 5:137,246,849...137,251,352
|
|
| G
|
Elovl2
|
ELOVL fatty acid elongase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ELOVL2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:23,750,350...23,790,601
Ensembl chr17:23,750,350...23,790,601
|
|
| G
|
Elovl5
|
ELOVL fatty acid elongase 5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ELOVL5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:87,671,164...87,737,618
Ensembl chr 8:87,671,159...87,737,616
|
|
| G
|
Elp4
|
elongator acetyltransferase complex subunit 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ELP4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:112,617,020...112,839,963
Ensembl chr 3:112,617,035...112,839,963
|
|
| G
|
Elp6
|
elongator acetyltransferase complex subunit 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ELP6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:119,158,380...119,173,483
Ensembl chr 8:119,158,396...119,174,244
|
|
| G
|
Emb
|
embigin
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of EMB mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 2:50,803,468...50,858,001
Ensembl chr 2:50,801,973...50,862,920
|
|
| G
|
Emc7
|
ER membrane protein complex subunit 7
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EMC7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:119,714,617...119,728,748
Ensembl chr 3:119,718,357...119,730,486
|
|
| G
|
Emc9
|
ER membrane protein complex subunit 9
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EMC9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:33,041,840...33,046,056
Ensembl chr15:33,041,842...33,046,102
|
|
| G
|
Emg1
|
EMG1 N1-specific pseudouridine methyltransferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EMG1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:159,195,545...159,203,826
Ensembl chr 4:159,195,564...159,203,826
|
|
| G
|
Emid1
|
EMI domain containing 1
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of EMID1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr14:84,214,530...84,257,628
Ensembl chr14:84,214,530...84,257,579
|
|
| G
|
Emilin3
|
elastin microfibril interfacer 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EMILIN3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:169,978,488...169,984,718
Ensembl chr 3:169,978,672...169,984,488
|
|
| G
|
Eml1
|
EMAP like 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EML1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:133,048,271...133,221,642
Ensembl chr 6:133,048,427...133,221,642
|
|
| G
|
Emp2
|
epithelial membrane protein 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EMP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:5,866,869...5,901,533
Ensembl chr10:5,866,922...5,901,532
|
|
| G
|
Emx1
|
empty spiracles homeobox 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EMX1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:119,282,692...119,300,822
Ensembl chr 4:119,282,692...119,300,817
|
|
| G
|
Emx2
|
empty spiracles homeobox 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EMX2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:268,612,663...268,619,671
Ensembl chr 1:268,612,663...268,619,671
|
|
| G
|
Emx2os
|
Emx2 opposite strand/antisense RNA
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EMX2OS mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:268,555,719...268,612,889
|
|
| G
|
Endog
|
endonuclease G
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ENDOG mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:33,846,935...33,849,531
Ensembl chr 3:33,846,885...33,849,573
|
|
| G
|
Enkur
|
enkurin, TRPC channel interacting protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ENKUR mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:88,599,057...88,622,668
Ensembl chr17:88,599,057...88,622,668
|
|
| G
|
Eno2
|
enolase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ENO2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:159,258,371...159,267,220
|
|
| G
|
Enosf1
|
enolase superfamily member 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ENOSF1 mRNA
|
CTD |
PMID:32763439 |
|
|
|
| G
|
Enpp2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ENPP2 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957
|
|
| G
|
Enpp6
|
ectonucleotide pyrophosphatase/phosphodiesterase 6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ENPP6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:51,898,557...52,026,789
Ensembl chr16:51,898,557...52,026,728
|
|
| G
|
Enpp7
|
ectonucleotide pyrophosphatase/phosphodiesterase 7
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ENPP7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:104,740,763...104,745,760
Ensembl chr10:104,740,763...104,745,760
|
|
| G
|
Enthd1
|
ENTH domain containing 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ENTHD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:113,875,018...113,989,970
Ensembl chr 7:113,875,027...113,989,461
|
|
| G
|
Entpd2
|
ectonucleoside triphosphate diphosphohydrolase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ENTPD2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:28,611,722...28,617,237
Ensembl chr 3:28,611,772...28,618,184
|
|
| G
|
Entpd3
|
ectonucleoside triphosphate diphosphohydrolase 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ENTPD3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:129,124,540...129,155,528
Ensembl chr 8:129,124,709...129,156,252
|
|
| G
|
Entpd5
|
ectonucleoside triphosphate diphosphohydrolase 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ENTPD5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:109,750,210...109,786,376
Ensembl chr 6:109,753,204...109,786,495
|
|
| G
|
Entr1
|
endosome associated trafficking regulator 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ENTR1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:29,599,059...29,605,780
Ensembl chr 3:29,599,059...29,605,898
|
|
| G
|
Entrep3
|
endosomal transmembrane epsin interactor 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ENTREP3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:176,886,903...176,893,047
Ensembl chr 2:176,887,135...176,893,047
|
|
| G
|
Eogt
|
EGF domain specific O-linked N-acetylglucosamine transferase
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of EOGT mRNA Acrylamide results in increased expression of EOGT mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:131,275,587...131,313,243
Ensembl chr 4:131,276,573...131,311,926
|
|
| G
|
Eomes
|
eomesodermin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EOMES mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:127,059,215...127,067,070
Ensembl chr 8:127,059,215...127,067,070
|
|
| G
|
Epb41l1
|
erythrocyte membrane protein band 4.1-like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EPB41L1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:165,389,295...165,512,821
Ensembl chr 3:165,389,293...165,510,498
|
|
| G
|
Epb41l3
|
erythrocyte membrane protein band 4.1-like 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EPB41L3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:116,502,864...116,707,274
Ensembl chr 9:116,462,807...116,707,274
|
|
| G
|
Epb41l5
|
erythrocyte membrane protein band 4.1 like 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EPB41L5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:33,221,705...33,321,400
Ensembl chr13:33,223,589...33,321,133
|
|
| G
|
Epb42
|
erythrocyte membrane protein band 4.2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EPB42 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:128,433,460...128,451,683
Ensembl chr 3:128,433,464...128,451,683
|
|
| G
|
Epc1
|
enhancer of polycomb homolog 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EPC1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:59,198,513...59,289,535
Ensembl chr17:59,197,677...59,289,519
|
|
| G
|
Epcam
|
epithelial cell adhesion molecule
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EPCAM mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:12,631,611...12,649,702
|
|
| G
|
Epdr1
|
ependymin related 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of EPDR1 mRNA Acrylamide results in increased expression of EPDR1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr17:50,029,591...50,054,254
Ensembl chr17:50,029,256...50,054,250
|
|
| G
|
Epha10
|
EPH receptor A10
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EPHA10 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:142,424,260...142,460,305
Ensembl chr 5:142,424,296...142,460,305
|
|
| G
|
Epha3
|
Eph receptor A3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EPHA3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:14,585,041...14,920,721
Ensembl chr11:14,586,727...14,920,425
|
|
| G
|
Epha4
|
Eph receptor A4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EPHA4 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 9:86,263,982...86,406,744
Ensembl chr 9:86,263,982...86,406,755
|
|
| G
|
Epha5
|
EPH receptor A5
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of EPHA5 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr14:24,007,400...24,374,854
Ensembl chr14:24,008,122...24,374,848
|
|
| G
|
Epha6
|
Eph receptor A6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EPHA6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:53,226,784...54,178,120
Ensembl chr11:53,226,954...54,166,987
|
|
| G
|
Epha7
|
Eph receptor A7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EPHA7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:47,771,776...47,925,189
Ensembl chr 5:47,771,865...47,925,058
|
|
| G
|
Ephb6
|
Eph receptor B6
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of EPHB6 mRNA Acrylamide results in decreased expression of EPHB6 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:71,458,632...71,473,889
Ensembl chr 4:71,458,971...71,476,659
|
|
| G
|
Ephx1
|
epoxide hydrolase 1
|
multiple interactions increases expression affects metabolic processing
|
ISO
|
[EPHX1 gene polymorphism affects the metabolism of Acrylamide] which affects the chemical synthesis of glycidamide analog Acrylamide results in increased expression of EPHX1 mRNA
|
CTD |
PMID:21402133 PMID:32763439 |
|
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981
|
|
| G
|
Ephx2
|
epoxide hydrolase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EPHX2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160
|
|
| G
|
Ephx3
|
epoxide hydrolase 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EPHX3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:11,857,367...11,862,674
Ensembl chr 7:11,857,367...11,862,674
|
|
| G
|
Ephx4
|
epoxide hydrolase 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EPHX4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:2,488,282...2,517,558
Ensembl chr14:2,488,290...2,517,757
|
|
| G
|
Epm2a
|
EPM2A glucan phosphatase, laforin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EPM2A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:7,547,369...7,673,449
Ensembl chr 1:7,547,342...7,669,604
|
|
| G
|
Epn3
|
epsin 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EPN3 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr10:79,935,857...79,946,121
Ensembl chr10:79,935,857...79,944,235
|
|
| G
|
Eps15
|
epidermal growth factor receptor pathway substrate 15
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EPS15 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:129,274,487...129,374,856
Ensembl chr 5:129,274,502...129,374,856
|
|
| G
|
Eps8
|
EGFR pathway substrate 8, signaling adaptor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EPS8 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:172,119,497...172,291,670
Ensembl chr 4:172,119,497...172,218,160
|
|
| G
|
Eps8l2
|
EPS8 signaling adaptor L2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EPS8L2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:205,875,825...205,901,109
Ensembl chr 1:205,875,801...205,901,101
|
|
| G
|
Epyc
|
epiphycan
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EPYC mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:34,323,332...34,360,845
Ensembl chr 7:34,323,273...34,361,032
|
|
| G
|
Eqtn
|
equatorin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EQTN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:114,851,981...114,880,683
Ensembl chr 5:114,862,608...114,878,954
|
|
| G
|
Erbb2
|
erb-b2 receptor tyrosine kinase 2
|
decreases phosphorylation decreases expression
|
ISO EXP
|
Acrylamide analog results in decreased phosphorylation of ERBB2 protein Acrylamide results in decreased expression of ERBB2 mRNA
|
CTD |
PMID:10753475 PMID:28959563 |
|
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481
|
|
| G
|
Erich2
|
glutamate-rich 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ERICH2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:75,718,573...75,755,447
Ensembl chr 3:75,718,720...75,755,446
|
|
| G
|
Erich4
|
glutamate-rich 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ERICH4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:90,251,345...90,253,085
Ensembl chr 1:90,251,345...90,253,085
|
|
| G
|
Erlec1
|
endoplasmic reticulum lectin 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ERLEC1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:108,856,661...108,894,511
Ensembl chr14:108,856,661...108,894,297
|
|
| G
|
Erlin2
|
ER lipid raft associated 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ERLIN2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:71,720,486...71,736,999
Ensembl chr16:71,721,364...71,736,503
|
|
| G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
increases expression increases phosphorylation multiple interactions
|
ISO EXP
|
Acrylamide results in increased expression of ERN1 mRNA Acrylamide results in increased phosphorylation of ERN1 protein 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of ERN1 protein]; [INS co-treated with Acrylamide] results in increased phosphorylation of ERN1 protein; Acetylcysteine inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of ERN1 protein]; Acrylamide promotes the reaction [elaidic acid results in increased phosphorylation of ERN1 protein]; elaidic acid promotes the reaction [Acrylamide results in increased phosphorylation of ERN1 protein]; ERN1 protein promotes the reaction [[INS co-treated with Acrylamide] results in increased cleavage of CASP3 protein]; ERN1 protein promotes the reaction [[INS co-treated with Acrylamide] results in increased expression of TRAF2 protein]; INS promotes the reaction [Acrylamide results in increased expression of ERN1 mRNA]
|
CTD |
PMID:32763439 PMID:38604440 PMID:38740238 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791
|
|
| G
|
Ero1b
|
endoplasmic reticulum oxidoreductase 1 beta
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ERO1B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:92,913,696...92,987,401
Ensembl chr17:92,814,368...92,987,555
|
|
| G
|
Erp27
|
endoplasmic reticulum protein 27
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ERP27 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:171,535,845...171,552,848
Ensembl chr 4:171,535,847...171,553,072
|
|
| G
|
Erp29
|
endoplasmic reticulum protein 29
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ERP29 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:40,750,177...40,756,607
Ensembl chr12:40,750,314...40,757,010
|
|
| G
|
Errfi1
|
ERBB receptor feedback inhibitor 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ERRFI1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432
|
|
| G
|
Esm1
|
endothelial cell-specific molecule 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ESM1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:46,609,253...46,617,991
Ensembl chr 2:46,609,204...46,617,990
|
|
| G
|
Espl1
|
extra spindle pole bodies like 1, separase
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of ESPL1 mRNA Acrylamide results in decreased expression of ESPL1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:135,302,460...135,329,570
Ensembl chr 7:135,302,716...135,329,570
|
|
| G
|
Espn
|
espin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ESPN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:167,909,271...167,943,168
Ensembl chr 5:167,909,271...167,942,984
|
|
| G
|
Esr2
|
estrogen receptor 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ESR2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Esrp2
|
epithelial splicing regulatory protein 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ESRP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:50,944,401...50,951,919
Ensembl chr19:50,944,401...50,951,568
|
|
| G
|
Esyt2
|
extended synaptotagmin 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ESYT2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:143,359,870...143,455,600
Ensembl chr 6:143,362,694...143,455,593
|
|
| G
|
Etf1
|
eukaryotic translation termination factor 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ETF1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:26,776,518...26,804,857
Ensembl chr18:26,777,858...26,804,613
|
|
| G
|
Etfdh
|
electron transfer flavoprotein dehydrogenase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ETFDH mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:167,038,707...167,060,758
Ensembl chr 2:167,025,823...167,060,770
|
|
| G
|
Ethe1
|
ETHE1, persulfide dioxygenase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ETHE1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:89,311,948...89,327,000
Ensembl chr 1:89,311,934...89,326,998
|
|
| G
|
Etnk1
|
ethanolamine kinase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ETNK1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:177,857,001...177,901,278
Ensembl chr 4:177,856,960...177,924,721
|
|
| G
|
Etnk2
|
ethanolamine kinase 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ETNK2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr13:47,362,964...47,381,100
Ensembl chr13:47,363,060...47,381,100
|
|
| G
|
Etnppl
|
ethanolamine-phosphate phospho-lyase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ETNPPL mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 2:221,847,210...221,868,827
Ensembl chr 2:221,847,250...221,866,357
|
|
| G
|
Ets1
|
ETS proto-oncogene 1, transcription factor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ETS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021
|
|
| G
|
Etv5
|
ETS variant transcription factor 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ETV5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:92,113,171...92,170,758
Ensembl chr11:92,113,224...92,170,767
|
|
| G
|
Etv6
|
ETS variant transcription factor 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ETV6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:168,580,405...168,819,817
Ensembl chr 4:168,580,138...168,819,802
|
|
| G
|
Eva1a
|
eva-1 homolog A, regulator of programmed cell death
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EVA1A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:116,151,595...116,200,827
Ensembl chr 4:116,151,173...116,200,827
|
|
| G
|
Evc2
|
EvC ciliary complex subunit 2
|
decreases expression increases expression
|
ISO
|
Acrylamide results in decreased expression of EVC2 mRNA Acrylamide results in increased expression of EVC2 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr14:77,591,581...77,679,286
Ensembl chr14:77,592,560...77,679,262
|
|
| G
|
Evl
|
Enah/Vasp-like
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EVL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:133,238,547...133,358,730
Ensembl chr 6:133,238,547...133,358,729
|
|
| G
|
Ewsr1
|
EWS RNA-binding protein 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EWSR1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:84,179,413...84,208,149
Ensembl chr14:84,179,618...84,208,095
|
|
| G
|
Exo1
|
exonuclease 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EXO1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:90,341,947...90,366,861
Ensembl chr13:90,342,018...90,366,861
|
|
| G
|
Exo5
|
exonuclease 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EXO5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:139,779,646...139,782,963
Ensembl chr 5:139,777,987...139,783,034
|
|
| G
|
Exoc3
|
exocyst complex component 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EXOC3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:30,919,871...30,950,624
|
|
| G
|
Exosc5
|
exosome component 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of EXOSC5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:90,295,495...90,305,047
Ensembl chr 1:90,293,797...90,305,046
|
|
| G
|
Exosc8
|
exosome component 8
|
increases expression
|
ISO
|
Acrylamide results in increased expression of EXOSC8 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:141,080,568...141,087,112
Ensembl chr 2:141,080,568...141,087,229
|
|
| G
|
Ext2
|
exostosin glycosyltransferase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EXT2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:100,120,776...100,253,424
Ensembl chr 3:100,120,776...100,253,596
|
|
| G
|
Extl1
|
exostosin-like glycosyltransferase 1
|
decreases expression affects expression
|
EXP
|
Acrylamide results in decreased expression of EXTL1 mRNA Acrylamide affects the expression of EXTL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:151,857,629...151,872,830
Ensembl chr 5:151,857,629...151,872,830
|
|
| G
|
Extl3
|
exostosin-like glycosyltransferase 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EXTL3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:43,469,293...43,559,760
Ensembl chr15:43,471,366...43,495,356
|
|
| G
|
Eya1
|
EYA transcriptional coactivator and phosphatase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of EYA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:9,646,599...9,884,609
Ensembl chr 5:9,646,591...9,884,614
|
|
| G
|
Eya2
|
EYA transcriptional coactivator and phosphatase 2
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of EYA2 mRNA Acrylamide results in decreased expression of EYA2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:174,754,772...174,938,035
Ensembl chr 3:174,818,554...174,938,034
|
|
| G
|
Ezh2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
increases expression
|
EXP
|
Acrylamide results in increased expression of EZH2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183
|
|
| G
|
F11r
|
F11 receptor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of F11R mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:86,406,229...86,429,819
Ensembl chr13:86,406,218...86,429,816
|
|
| G
|
F12
|
coagulation factor XII
|
increases expression
|
EXP
|
Acrylamide results in increased expression of F12 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,212,819...9,220,664
|
|
| G
|
F2r
|
coagulation factor II (thrombin) receptor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of F2R mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:28,604,066...28,620,579
|
|
| G
|
F3
|
coagulation factor III, tissue factor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of F3 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
|
|
| G
|
F5
|
coagulation factor V
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of F5 mRNA Acrylamide results in decreased expression of F5 mRNA
|
CTD |
PMID:28959563 PMID:35032568 |
|
NCBI chr13:79,046,657...79,116,247
Ensembl chr13:79,046,448...79,116,247
|
|
| G
|
F8a1
|
coagulation factor VIII-associated 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of F8A1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:155,977,859...155,979,373
Ensembl chr X:155,976,941...156,108,974
|
|
| G
|
Faah
|
fatty acid amide hydrolase
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of FAAH mRNA Acrylamide results in decreased expression of FAAH mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:134,716,545...134,735,396
Ensembl chr 5:134,716,545...134,735,396
|
|
| G
|
Faap100
|
FA core complex associated protein 100
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAAP100 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:106,140,820...106,152,500
Ensembl chr10:106,142,040...106,151,607
|
|
| G
|
Fabp7
|
fatty acid binding protein 7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FABP7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:37,667,125...37,673,299
Ensembl chr20:37,669,601...37,675,907
|
|
| G
|
Fadd
|
Fas associated via death domain
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FADD mRNA
|
CTD |
PMID:21319176 |
|
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
|
|
| G
|
Fads1
|
fatty acid desaturase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FADS1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615
|
|
| G
|
Fads2
|
fatty acid desaturase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FADS2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:216,132,277...216,172,190
Ensembl chr 1:216,133,676...216,172,066
|
|
| G
|
Fads2b
|
fatty acid desaturase 2B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FADS2B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:90,941,527...90,982,135
Ensembl chr 3:90,942,668...90,981,813
|
|
| G
|
Faf2
|
Fas associated factor family member 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FAF2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:9,952,329...9,994,596
Ensembl chr17:9,952,329...9,994,711
|
|
| G
|
Fahd2a
|
fumarylacetoacetate hydrolase domain containing 2A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAHD2A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:135,110,480...135,118,653
Ensembl chr 3:135,109,482...135,118,853
|
|
| G
|
Faim2
|
Fas apoptotic inhibitory molecule 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FAIM2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:132,512,095...132,539,192
Ensembl chr 7:132,512,210...132,538,026
|
|
| G
|
Fam110a
|
family with sequence similarity 110, member A
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of FAM110A mRNA Acrylamide results in decreased expression of FAM110A mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:160,934,815...160,945,405
Ensembl chr 3:160,931,777...160,949,897
|
|
| G
|
Fam110d
|
family with sequence similarity 110, member D
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FAM110D mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:151,754,773...151,757,743
Ensembl chr 5:151,753,891...151,757,768
|
|
| G
|
Fam111a
|
FAM111 trypsin like peptidase A
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of FAM111A mRNA Acrylamide results in decreased expression of FAM111A mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:219,065,542...219,081,213
Ensembl chr 1:219,065,601...219,081,211
|
|
| G
|
Fam117b
|
family with sequence similarity 117, member B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FAM117B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:68,834,334...68,902,543
Ensembl chr 9:68,834,354...68,902,543
|
|
| G
|
Fam118a
|
family with sequence similarity 118, member A
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FAM118A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:118,032,313...118,058,888
Ensembl chr 7:118,032,444...118,058,887
|
|
| G
|
Fam131b
|
family with sequence similarity 131, member B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAM131B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:72,167,667...72,176,924
Ensembl chr 4:72,165,578...72,176,858
|
|
| G
|
Fam13b
|
family with sequence similarity 13, member B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FAM13B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:26,314,440...26,395,260
Ensembl chr18:26,314,440...26,380,732
|
|
| G
|
Fam149a
|
family with sequence similarity 149, member A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FAM149A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:53,587,841...53,647,072
Ensembl chr16:53,587,841...53,647,072
|
|
| G
|
Fam151b
|
family with sequence similarity 151, member B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FAM151B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:25,409,382...25,446,225
Ensembl chr 2:25,409,383...25,445,466
|
|
| G
|
Fam162a
|
family with sequence similarity 162, member A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAM162A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:78,186,260...78,215,186
Ensembl chr11:78,185,852...78,216,560
|
|
| G
|
Fam163a
|
family with sequence similarity 163, member A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAM163A mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr13:70,813,129...70,891,410
Ensembl chr13:70,813,134...70,891,316
|
|
| G
|
Fam163b
|
family with sequence similarity 163, member B
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FAM163B mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:30,834,145...30,865,802
Ensembl chr 3:30,834,146...30,864,530
|
|
| G
|
Fam167a
|
family with sequence similarity 167, member A
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FAM167A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:41,861,271...41,891,427
Ensembl chr15:41,861,227...41,891,418
|
|
| G
|
Fam167b
|
family with sequence similarity 167, member B
|
affects expression
|
EXP
|
Acrylamide affects the expression of FAM167B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:147,205,018...147,206,660
Ensembl chr 5:147,204,653...147,206,652
|
|
| G
|
Fam169a
|
family with sequence similarity 169, member A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FAM169A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:30,115,307...30,175,972
Ensembl chr 2:30,119,381...30,175,962
|
|
| G
|
Fam178b
|
family with sequence similarity 178, member B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FAM178B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:46,301,734...46,409,571
Ensembl chr 9:46,301,734...46,410,686
|
|
| G
|
Fam181b
|
family with sequence similarity 181, member B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAM181B mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:156,578,821...156,580,318
Ensembl chr 1:156,491,094...156,595,845
|
|
| G
|
Fam186b
|
family with sequence similarity 186, member B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FAM186B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:132,287,686...132,303,188
Ensembl chr 7:132,287,692...132,303,123
|
|
| G
|
Fam193b
|
family with sequence similarity 193, member B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FAM193B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:9,071,974...9,104,659
Ensembl chr17:9,071,795...9,104,656
|
|
| G
|
Fam199x
|
family with sequence similarity 199, X-linked
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FAM199X mRNA Acrylamide results in increased expression of FAM199X mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr X:105,176,504...105,212,207
Ensembl chr X:105,176,504...105,212,207
|
|
| G
|
Fam20a
|
FAM20A, golgi associated secretory pathway pseudokinase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAM20A mRNA
|
CTD |
PMID:29261810 |
|
NCBI chr10:95,136,799...95,197,176
Ensembl chr10:95,142,458...95,197,053
|
|
| G
|
Fam210b
|
family with sequence similarity 210, member B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAM210B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:181,536,665...181,546,830
Ensembl chr 3:181,536,673...181,546,834
|
|
| G
|
Fam216a
|
family with sequence similarity 216, member A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAM216A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:39,859,307...39,868,450
Ensembl chr12:39,859,172...39,868,442
|
|
| G
|
Fam216b
|
family with sequence similarity 216, member B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FAM216B mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr15:59,878,665...59,905,887
Ensembl chr15:59,878,665...59,891,555
|
|
| G
|
Fam219a
|
family with sequence similarity 219, member A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FAM219A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:61,475,185...61,525,749
Ensembl chr 5:61,475,185...61,525,749
|
|
| G
|
Fam219b
|
family with sequence similarity 219, member B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FAM219B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:66,837,230...66,842,819
Ensembl chr 8:66,837,205...66,842,819
|
|
| G
|
Fam220a
|
family with sequence similarity 220, member A
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FAM220A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:16,111,593...16,127,584
Ensembl chr12:16,109,425...16,133,421
|
|
| G
|
Fam222a
|
family with sequence similarity 222, member A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAM222A mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr12:47,647,221...47,693,703
Ensembl chr12:47,647,405...47,693,703
|
|
| G
|
Fam234a
|
family with sequence similarity 234, member A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAM234A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:15,736,741...15,768,043
Ensembl chr10:15,736,742...15,749,835
|
|
| G
|
Fam234b
|
family with sequence similarity 234, member B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAM234B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:169,779,651...169,854,024
Ensembl chr 4:169,779,737...169,828,678
|
|
| G
|
Fam236d
|
family with sequence similarity 236 member D
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FAM236D mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:71,978,105...71,978,873
Ensembl chr X:71,977,939...71,978,795
|
|
| G
|
Fam241b
|
family with sequence similarity 241 member B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FAM241B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:30,595,082...30,598,007
Ensembl chr20:30,595,084...30,597,844 Ensembl chr 6:30,595,084...30,597,844
|
|
| G
|
Fam25a
|
family with sequence similarity 25, member A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FAM25A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:9,686,922...9,690,728
Ensembl chr16:9,686,922...9,690,728
|
|
| G
|
Fam3b
|
FAM3 metabolism regulating signaling molecule B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FAM3B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:50,300,926...50,333,296
Ensembl chr11:50,300,926...50,347,339
|
|
| G
|
Fam3c
|
FAM3 metabolism regulating signaling molecule C
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FAM3C mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 4:51,805,686...51,853,030
Ensembl chr 4:51,805,703...51,853,030
|
|
| G
|
Fam43a
|
family with sequence similarity 43, member A
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of FAM43A mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr11:83,633,165...83,636,313
Ensembl chr11:83,633,154...83,695,297
|
|
| G
|
Fam43b
|
family with sequence similarity 43, member B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAM43B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:155,893,961...155,896,359
Ensembl chr 5:155,893,968...155,898,755
|
|
| G
|
Fam53a
|
family with sequence similarity 53, member A
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FAM53A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:81,308,127...81,348,930
Ensembl chr14:81,319,375...81,348,923
|
|
| G
|
Fam53b
|
family with sequence similarity 53, member B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FAM53B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:196,930,170...197,021,290
Ensembl chr 1:196,930,175...197,021,290
|
|
| G
|
Fam53c
|
family with sequence similarity 53, member C
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FAM53C mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:26,638,781...26,652,294
Ensembl chr18:26,638,062...26,652,290
|
|
| G
|
Fam76b
|
family with sequence similarity 76, member B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FAM76B mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 8:18,971,357...18,993,442
Ensembl chr 8:18,971,100...18,995,039
|
|
| G
|
Fam78a
|
family with sequence similarity 78, member A
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FAM78A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:35,753,712...35,771,600
Ensembl chr 3:35,753,712...35,770,448
|
|
| G
|
Fam83d
|
family with sequence similarity 83, member D
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of FAM83D mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:167,841,748...167,861,062
Ensembl chr 3:167,841,791...167,861,061
|
|
| G
|
Fam83h
|
family with sequence similarity 83, member H
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAM83H mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:109,597,129...109,605,317
Ensembl chr 7:109,597,129...109,609,188
|
|
| G
|
Fam89b
|
family with sequence similarity 89, member B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FAM89B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:212,445,101...212,447,164
Ensembl chr 1:212,445,102...212,446,738
|
|
| G
|
Fam91a1
|
family with sequence similarity 91, member A1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FAM91A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:91,857,261...91,897,019
Ensembl chr 7:91,859,062...91,898,195
|
|
| G
|
Fan1
|
FANCD2 and FANCI associated nuclease 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FAN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:127,327,098...127,356,807
Ensembl chr 1:127,330,016...127,356,400
|
|
| G
|
Fanca
|
FA complementation group A
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of FANCA mRNA Acrylamide results in decreased expression of FANCA mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr19:68,210,562...68,271,080
Ensembl chr19:68,212,643...68,271,019
|
|
| G
|
Fancd2
|
FA complementation group D2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FANCD2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:148,234,633...148,299,035
Ensembl chr 4:148,234,708...148,299,035
|
|
| G
|
Fancf
|
FA complementation group F
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FANCF mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:110,585,054...110,587,870
Ensembl chr 1:110,576,389...110,587,863
|
|
| G
|
Fancg
|
FA complementation group G
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of FANCG mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 5:62,027,494...62,037,202
Ensembl chr 5:62,027,500...62,035,787
|
|
| G
|
Far1
|
fatty acyl CoA reductase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FAR1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:177,078,973...177,140,363
Ensembl chr 1:177,079,150...177,161,696
|
|
| G
|
Farsa
|
phenylalanyl-tRNA synthetase subunit alpha
|
increases expression decreases expression
|
ISO
|
Acrylamide results in increased expression of FARSA mRNA Acrylamide results in decreased expression of FARSA mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr19:40,196,255...40,205,830
Ensembl chr19:40,173,716...40,205,823
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FAS mRNA
|
CTD |
PMID:22459607 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Faslg
|
Fas ligand
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FASLG mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
| G
|
Fasn
|
fatty acid synthase
|
decreases expression multiple interactions
|
EXP ISO
|
Acrylamide results in decreased expression of FASN mRNA Acrylamide inhibits the reaction [Streptozocin results in increased expression of FASN mRNA]; Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN protein]; Acrylamide promotes the reaction [Dietary Fats results in increased expression of FASN protein]
|
CTD |
PMID:28959563 PMID:30409764 PMID:32763439 PMID:34896238 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
| G
|
Fastk
|
Fas-activated serine/threonine kinase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FASTK mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:11,624,697...11,628,769
Ensembl chr 4:11,624,689...11,629,867
|
|
| G
|
Fastkd2
|
FAST kinase domains 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FASTKD2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:72,659,961...72,681,986
Ensembl chr 9:72,661,764...72,721,338
|
|
| G
|
Fastkd5
|
FAST kinase domains 5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FASTKD5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:138,283,315...138,300,803
Ensembl chr 3:138,272,928...138,301,291
|
|
| G
|
Fat2
|
FAT atypical cadherin 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FAT2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:39,864,765...39,957,027
Ensembl chr10:39,864,766...39,956,902
|
|
| G
|
Fau
|
FAU ubiquitin like and ribosomal protein S30 fusion
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FAU mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:212,779,429...212,781,028
Ensembl chr 1:212,779,473...212,781,026 Ensembl chr 1:212,779,473...212,781,026
|
|
| G
|
Fblim1
|
filamin binding LIM protein 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FBLIM1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:159,167,004...159,198,578
Ensembl chr 5:159,167,004...159,196,853
|
|
| G
|
Fbln1
|
fibulin 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FBLN1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:118,190,478...118,269,965
|
|
| G
|
Fbln2
|
fibulin 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FBLN2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:125,261,464...125,321,030
Ensembl chr 4:125,261,607...125,321,029
|
|
| G
|
Fbln7
|
fibulin 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FBLN7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:136,564,825...136,601,205
Ensembl chr 3:136,564,917...136,601,198
|
|
| G
|
Fbn1
|
fibrillin 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FBN1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:133,007,693...133,204,277
Ensembl chr 3:133,008,361...133,204,283
|
|
| G
|
Fbn2
|
fibrillin 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FBN2 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr18:53,696,197...53,901,992
Ensembl chr18:53,697,708...53,902,191
|
|
| G
|
Fbp2
|
fructose-bisphosphatase 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FBP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:2,241,767...2,259,371
Ensembl chr17:2,241,975...2,259,366
|
|
| G
|
Fbxl13
|
F-box and leucine-rich repeat protein 13
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FBXL13 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:14,307,032...14,505,491
Ensembl chr 4:14,307,096...14,499,585
|
|
| G
|
Fbxl14
|
F-box and leucine-rich repeat protein 14
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FBXL14 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:154,334,820...154,338,638
Ensembl chr 4:154,334,092...154,377,959
|
|
| G
|
Fbxl15
|
F-box and leucine-rich repeat protein 15
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FBXL15 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:255,131,154...255,133,395
Ensembl chr 1:255,131,154...255,133,427
|
|
| G
|
Fbxl2
|
F-box and leucine-rich repeat protein 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FBXL2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:122,794,870...122,843,265
Ensembl chr 8:122,794,870...122,854,798
|
|
| G
|
Fbxo17
|
F-box protein 17
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FBXO17 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:93,129,776...93,151,983
Ensembl chr 1:93,129,849...93,151,981
|
|
| G
|
Fbxo27
|
F-box protein 27
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FBXO27 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:93,092,900...93,115,312
Ensembl chr 1:93,093,024...93,122,181
|
|
| G
|
Fbxo28
|
F-box protein 28
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FBXO28 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:96,527,667...96,553,138
Ensembl chr13:96,527,670...96,553,138
|
|
| G
|
Fbxo30
|
F-box protein 30
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FBXO30 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:7,475,636...7,491,719
Ensembl chr 1:7,475,575...7,493,199
|
|
| G
|
Fbxo31
|
F-box protein 31
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FBXO31 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:66,533,437...66,564,674
Ensembl chr19:66,533,437...66,564,674
|
|
| G
|
Fbxo34
|
F-box protein 34
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FBXO34 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:23,199,103...23,266,929
Ensembl chr15:23,171,312...23,270,071
|
|
| G
|
Fbxo43
|
F-box protein 43
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FBXO43 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:69,218,298...69,231,873
Ensembl chr 7:69,218,299...69,230,310
|
|
| G
|
Fbxo45
|
F-box protein 45
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FBXO45 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr11:82,056,457...82,072,080
Ensembl chr11:82,056,457...82,072,080
|
|
| G
|
Fbxo48
|
F-box protein 48
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FBXO48 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:95,582,493...95,583,950
Ensembl chr14:95,581,279...95,587,616
|
|
| G
|
Fbxo5
|
F-box protein 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FBXO5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:44,601,412...44,607,781
|
|
| G
|
Fbxw5
|
F-box and WD repeat domain containing 5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FBXW5 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 3:28,720,670...28,725,237
Ensembl chr 3:28,720,778...28,725,235
|
|
| G
|
Fbxw9
|
F-box and WD repeat domain containing 9
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FBXW9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:39,995,408...40,002,312
Ensembl chr19:39,995,408...40,002,312
|
|
| G
|
Fcer2
|
Fc epsilon receptor II
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FCER2A mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr12:6,540,697...6,552,364
Ensembl chr12:6,540,703...6,549,374
|
|
| G
|
Fcf1
|
Fcf1 rRNA-processing protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FCF1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:110,348,854...110,360,715
Ensembl chr 6:110,348,845...110,372,221
|
|
| G
|
Fcgbp
|
Fc gamma binding protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FCGBP mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:92,502,461...92,540,658
Ensembl chr 1:92,499,498...92,540,658
|
|
| G
|
Fcho1
|
FCH and mu domain containing endocytic adaptor 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FCHO1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:18,447,424...18,464,738
Ensembl chr16:18,447,424...18,464,698
|
|
| G
|
Fcmr
|
Fc mu receptor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FCMR mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:44,889,628...44,903,926
Ensembl chr13:44,889,697...44,906,314
|
|
| G
|
Fcnb
|
ficolin B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FCN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:31,791,750...31,800,188
Ensembl chr 3:31,791,750...31,800,188
|
|
| G
|
Fcsk
|
fucose kinase
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of FCSK mRNA Acrylamide results in decreased expression of FCSK mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr19:55,743,746...55,783,873
Ensembl chr19:55,739,842...55,800,496
|
|
| G
|
Fdcsp
|
follicular dendritic cell secreted protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FDCSP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:20,447,761...20,453,227
Ensembl chr14:20,448,935...20,453,227
|
|
| G
|
Fdps
|
farnesyl diphosphate synthase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FDPS mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136
|
|
| G
|
Fech
|
ferrochelatase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FECH mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:60,215,325...60,248,525
Ensembl chr18:60,215,325...60,249,546
|
|
| G
|
Fem1a
|
fem-1 homolog A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FEM1A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:1,178,857...1,181,063
Ensembl chr 9:1,177,543...1,188,006
|
|
| G
|
Fer1l5
|
fer-1-like family member 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FER1L5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:46,101,798...46,156,483
Ensembl chr 9:46,103,760...46,156,479
|
|
| G
|
Ferd3l
|
Fer3-like bHLH transcription factor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FERD3L mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:56,372,778...56,373,667
Ensembl chr 6:56,372,479...56,373,501
|
|
| G
|
Fermt1
|
FERM domain containing kindlin 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FERMT1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:140,624,434...140,666,419
Ensembl chr 3:140,624,434...140,666,419
|
|
| G
|
Fermt3
|
FERM domain containing kindlin 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FERMT3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:213,618,691...213,636,889
Ensembl chr 1:213,618,208...213,636,273
|
|
| G
|
Fev
|
FEV transcription factor, ETS family member
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FEV mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:83,887,844...83,891,718
Ensembl chr 9:83,887,844...83,891,737
|
|
| G
|
Fez1
|
fasciculation and elongation protein zeta 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FEZ1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:44,733,288...44,778,519
Ensembl chr 8:44,733,300...44,784,097
|
|
| G
|
Fezf1
|
Fez family zinc finger 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FEZF1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:52,728,385...52,733,315
Ensembl chr 4:52,728,391...52,731,718
|
|
| G
|
Fgb
|
fibrinogen beta chain
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FGB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434
|
|
| G
|
Fgd4
|
FYVE, RhoGEF and PH domain containing 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FGD4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:97,904,182...98,055,190
Ensembl chr11:97,904,182...98,055,190
|
|
| G
|
Fgf14
|
fibroblast growth factor 14
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FGF14 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:107,442,800...108,086,486
Ensembl chr15:107,451,634...108,085,808
|
|
| G
|
Fgf2
|
fibroblast growth factor 2
|
multiple interactions
|
ISO
|
Acrylamide analog inhibits the reaction [Trifluoroacetic Acid results in increased degradation of FGF2 protein]; Acrylamide analog promotes the reaction [FGF2 protein binds to FGF2 protein]
|
CTD |
PMID:14733594 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
| G
|
Fgf21
|
fibroblast growth factor 21
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FGF21 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056
|
|
| G
|
Fgf7
|
fibroblast growth factor 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FGF7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:133,734,673...133,786,328
|
|
| G
|
Fgf9
|
fibroblast growth factor 9
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FGF9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:36,325,552...36,369,995
Ensembl chr15:36,325,599...36,367,926
|
|
| G
|
Fgfbp1
|
fibroblast growth factor binding protein 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FGFBP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:71,316,171...71,319,965
Ensembl chr14:71,317,065...71,320,309
|
|
| G
|
Fgfbp3
|
fibroblast growth factor binding protein 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FGFBP3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:244,056,569...244,058,574
Ensembl chr 1:244,056,307...244,065,654
|
|
| G
|
Fgfr1
|
Fibroblast growth factor receptor 1
|
multiple interactions
|
ISO
|
Acrylamide analog promotes the reaction [FGFR1 protein binds to FGFR1 protein]
|
CTD |
PMID:14733594 |
|
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855
|
|
| G
|
Fgfr3
|
fibroblast growth factor receptor 3
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of FGFR3 mRNA Acrylamide results in decreased expression of FGFR3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr14:81,211,800...81,227,215
Ensembl chr14:81,211,800...81,227,209
|
|
| G
|
Fgfr4
|
fibroblast growth factor receptor 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FGFR4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:9,466,686...9,481,423
Ensembl chr17:9,466,692...9,481,389
|
|
| G
|
Fgl2
|
fibrinogen-like 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FGL2 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:14,602,771...14,608,405
|
|
| G
|
Fhip1b
|
FHF complex subunit HOOK interacting protein 1B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FHIP1B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:169,137,866...169,160,305
Ensembl chr 1:169,122,654...169,160,252
|
|
| G
|
Fhit
|
fragile histidine triad diadenosine triphosphatase
|
affects expression
|
EXP
|
Acrylamide affects the expression of FHIT mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:16,365,401...17,872,901
Ensembl chr15:16,747,338...17,872,621
|
|
| G
|
Fhl1
|
four and a half LIM domains 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FHL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:139,592,794...139,652,290
Ensembl chr X:139,592,604...139,652,282
|
|
| G
|
Fhl2
|
four and a half LIM domains 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FHL2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326
|
|
| G
|
Fhl3
|
four and a half LIM domains 3
|
affects expression
|
EXP
|
Acrylamide affects the expression of FHL3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:142,238,634...142,246,011
Ensembl chr 5:142,235,109...142,246,034
|
|
| G
|
Fhod3
|
formin homology 2 domain containing 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FHOD3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:16,267,830...16,700,508
Ensembl chr18:16,267,977...16,700,508
|
|
| G
|
Fibcd1
|
fibrinogen C domain containing 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FIBCD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:35,490,459...35,524,142
Ensembl chr 3:35,490,459...35,524,142
|
|
| G
|
Fibin
|
fin bud initiation factor homolog
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FIBIN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:117,396,973...117,399,244
Ensembl chr 3:117,391,724...117,399,479
|
|
| G
|
Fibp
|
FGF1 intracellular binding protein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FIBP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:212,197,216...212,201,732
Ensembl chr 1:212,197,416...212,201,731
|
|
| G
|
Fign
|
fidgetin, microtubule severing factor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FIGN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:69,045,918...69,169,148
Ensembl chr 3:69,045,050...69,169,988
|
|
| G
|
Fignl1
|
fidgetin-like 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FIGNL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:90,573,090...90,595,342
Ensembl chr14:90,581,771...90,592,316
|
|
| G
|
Fitm2
|
fat storage-inducing transmembrane protein 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FITM2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:172,560,781...172,567,291
Ensembl chr 3:172,560,781...172,567,291
|
|
| G
|
Fjx1
|
four-jointed box kinase 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of FJX1 mRNA Acrylamide results in decreased expression of FJX1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:109,229,223...109,231,324
Ensembl chr 3:109,227,170...109,232,479
|
|
| G
|
Fkbp10
|
FKBP prolyl isomerase 10
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of FKBP10 mRNA Acrylamide results in decreased expression of FKBP10 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:85,845,801...85,858,361
Ensembl chr10:85,844,703...85,858,355
|
|
| G
|
Fkbp11
|
FKBP prolyl isomerase 11
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of FKBP11 mRNA Acrylamide results in decreased expression of FKBP11 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:131,750,828...131,757,784
Ensembl chr 7:131,750,672...131,770,123
|
|
| G
|
Fkbp14
|
FKBP prolyl isomerase 14
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FKBP14 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 4:85,035,840...85,051,917
Ensembl chr 4:85,037,145...85,051,808
|
|
| G
|
Fkbp2
|
FKBP prolyl isomerase 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of FKBP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:213,596,931...213,599,606
Ensembl chr 1:213,596,931...213,600,790
|
|
| G
|
Fkbp4
|
FKBP prolyl isomerase 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FKBP4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:163,389,464...163,397,918
Ensembl chr 4:163,389,464...163,397,918
|
|
| G
|
Fkbp5
|
FKBP prolyl isomerase 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FKBP5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118
|
|
| G
|
Fkbp9
|
FKBP prolyl isomerase 9
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FKBP9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:87,436,439...87,486,909
Ensembl chr 4:87,436,478...87,508,940
|
|
| G
|
Fktn
|
fukutin
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FKTN mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:73,134,746...73,191,772
Ensembl chr 5:73,135,361...73,189,181
|
|
| G
|
Flacc1
|
flagellum associated containing coiled-coil domains 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FLACC1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 9:67,809,731...67,837,793
Ensembl chr 9:67,809,739...67,837,793
|
|
| G
|
Flcn
|
folliculin
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FLCN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:45,088,164...45,107,581
Ensembl chr10:45,088,167...45,107,309
|
|
| G
|
Flg
|
filaggrin
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FLG mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:181,583,801...181,596,464
Ensembl chr 2:181,583,808...181,595,968
|
|
| G
|
Fmnl1
|
formin-like 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FMNL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:88,615,290...88,643,411
Ensembl chr10:88,615,869...88,643,411
|
|
| G
|
Fmo3
|
flavin containing dimethylaniline monoxygenase 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FMO3 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr13:77,838,899...77,868,869
Ensembl chr13:77,842,602...77,861,256
|
|
| G
|
Fmo4
|
flavin containing dimethylaniline monoxygenase 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FMO4 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr13:77,687,909...77,706,100
Ensembl chr13:77,687,909...77,706,100
|
|
| G
|
Fmo9
|
flavin containing monooxygenase 9
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FMO9 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:81,353,044...81,374,033
Ensembl chr13:81,353,044...81,374,033
|
|
| G
|
Fmr1
|
fragile X messenger ribonucleoprotein 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FMR1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:152,284,857...152,322,686
Ensembl chr X:152,284,841...152,322,675
|
|
| G
|
Fnbp1
|
formin binding protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FNBP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:34,706,814...34,826,770
Ensembl chr 3:34,706,814...34,822,117
|
|
| G
|
Fnbp1l
|
formin binding protein 1-like
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FNBP1L mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:213,331,871...213,432,821
Ensembl chr 2:213,318,662...213,423,051
|
|
| G
|
Fndc1
|
fibronectin type III domain containing 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of FNDC1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:49,686,856...49,769,263
Ensembl chr 1:49,686,856...49,769,263
|
|
| G
|
Fndc10
|
fibronectin type III domain containing 10
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FNDC10 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:171,581,960...171,584,519
Ensembl chr 5:171,580,033...171,595,399
|
|
| G
|
Fndc11
|
fibronectin type III domain containing 11
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FNDC11 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:188,708,045...188,710,670
Ensembl chr 3:188,707,334...188,714,164
|
|
| G
|
Fndc5
|
fibronectin type III domain containing 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FNDC5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:146,765,951...146,775,611
Ensembl chr 5:146,751,416...146,778,540
|
|
| G
|
Fnip1
|
folliculin interacting protein 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FNIP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:39,068,432...39,151,552
Ensembl chr10:39,068,445...39,151,552
|
|
| G
|
Focad
|
focadhesin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FOCAD mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:107,610,489...107,932,485
Ensembl chr 5:107,610,416...107,933,109
|
|
| G
|
Folr1
|
folate receptor alpha
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FOLR1 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 1:165,631,462...165,650,430
Ensembl chr 1:165,631,462...165,642,669
|
|
| G
|
Folr2
|
folate receptor beta
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FOLR2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:165,612,047...165,630,382
Ensembl chr 1:165,612,063...165,617,731
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FOS mRNA Acrylamide results in increased expression of FOS mRNA
|
CTD |
PMID:22197712 PMID:30807115 PMID:32763439 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Fosb
|
FosB proto-oncogene, AP-1 transcription factor subunit
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FOSB mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:88,082,127...88,089,477
|
|
| G
|
Fosl1
|
FOS like 1, AP-1 transcription factor subunit
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FOSL1 protein Acrylamide results in increased expression of FOSL1 mRNA
|
CTD |
PMID:20025956 PMID:32763439 PMID:35690182 |
|
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391
|
|
| G
|
Fosl2
|
FOS like 2, AP-1 transcription factor subunit
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of FOSL2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:30,021,916...30,039,406
|
|
| G
|
Foxc2
|
forkhead box C2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FOXC2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:66,094,718...66,097,420
Ensembl chr19:66,094,700...66,153,977
|
|
| G
|
Foxj1
|
forkhead box J1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FOXJ1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:102,065,163...102,069,945
Ensembl chr10:102,065,170...102,069,241
|
|
| G
|
Foxk2
|
forkhead box K2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FOXK2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:107,040,933...107,090,860
Ensembl chr10:107,040,933...107,195,823
|
|
| G
|
Foxm1
|
forkhead box M1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FOXM1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:163,325,614...163,337,172
|
|
| G
|
Foxn4
|
forkhead box N4
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FOXN4 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr12:47,997,308...48,020,526
Ensembl chr12:48,000,257...48,020,526
|
|
| G
|
Foxo1
|
forkhead box O1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FOXO1 mRNA
|
CTD |
PMID:31644924 |
|
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
|
|
| G
|
Foxo3
|
forkhead box O3
|
multiple interactions increases expression
|
EXP
|
[FOXO3 mRNA co-treated with Acrylamide] results in decreased expression of CCND1 protein; [FOXO3 mRNA co-treated with Acrylamide] results in increased expression of CDKN1A protein; [MIR193B mRNA co-treated with Acrylamide] results in decreased expression of FOXO3 protein; FOXO3 protein promotes the reaction [Acrylamide results in decreased expression of CCND1 mRNA]; FOXO3 protein promotes the reaction [Acrylamide results in increased expression of CDKN1A mRNA]; MIR193B mRNA inhibits the reaction [Acrylamide results in increased expression of FOXO3 mRNA] Acrylamide results in increased expression of FOXO3 mRNA; Acrylamide results in increased expression of FOXO3 protein
|
CTD |
PMID:33582169 |
|
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845
|
|
| G
|
Foxo4
|
forkhead box O4
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of FOXO4 mRNA Acrylamide results in decreased expression of FOXO4 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr X:70,425,218...70,432,120
Ensembl chr X:70,425,563...70,432,120
|
|
| G
|
Foxp1
|
forkhead box P1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FOXP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:133,117,346...133,808,647
Ensembl chr 4:133,122,055...133,500,272
|
|
| G
|
Foxq1
|
forkhead box Q1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FOXQ1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:33,121,454...33,124,087
Ensembl chr17:33,121,545...33,123,720
|
|
| G
|
Foxred1
|
FAD-dependent oxidoreductase domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FOXRED1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:41,789,557...41,818,064
Ensembl chr 8:41,808,843...41,817,980
|
|
| G
|
Foxs1
|
forkhead box S1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FOXS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:161,857,264...161,858,548
Ensembl chr 3:161,850,782...161,858,662
|
|
| G
|
Fpr1
|
formyl peptide receptor 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FPR1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:67,417,991...67,429,813
Ensembl chr 1:67,421,313...67,422,520
|
|
| G
|
Fras1
|
Fraser extracellular matrix complex subunit 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FRAS1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:13,095,370...13,506,895
Ensembl chr14:13,095,370...13,504,664
|
|
| G
|
Frem1
|
Fras1 related extracellular matrix 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FREM1 mRNA
|
CTD |
PMID:32763439 PMID:35032568 |
|
NCBI chr 5:102,367,201...102,515,464
Ensembl chr 5:102,367,201...102,515,404
|
|
| G
|
Frem2
|
FRAS1 related extracellular matrix 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FREM2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:139,753,055...139,891,046
Ensembl chr 2:139,753,055...139,891,046
|
|
| G
|
Frey1
|
Frey regulator of sperm-oocyte fusion 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FREY1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:98,809,792...98,810,544
Ensembl chr 3:98,809,792...98,810,544
|
|
| G
|
Frmd3
|
FERM domain containing 3
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FRMD3 mRNA Acrylamide results in increased expression of FRMD3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:92,810,989...93,077,326
Ensembl chr 5:92,810,736...93,077,325
|
|
| G
|
Frmpd4
|
FERM and PDZ domain containing 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FRMPD4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:29,739,834...30,386,917
Ensembl chr X:29,368,849...30,384,621
|
|
| G
|
Frrs1l
|
ferric-chelate reductase 1-like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FRRS1L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:76,451,101...76,485,319
Ensembl chr 5:76,451,101...76,485,316
|
|
| G
|
Frs3
|
fibroblast growth factor receptor substrate 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FRS3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:20,786,096...20,800,905
Ensembl chr 9:20,786,096...20,794,761
|
|
| G
|
Fscn1
|
fascin actin-bundling protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FSCN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:16,710,601...16,723,734
Ensembl chr12:16,710,601...16,723,734
|
|
| G
|
Fscn3
|
fascin actin-bundling protein 3
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FSCN3 mRNA Acrylamide results in increased expression of FSCN3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:58,008,124...58,017,674
Ensembl chr 4:58,008,230...58,017,673
|
|
| G
|
Fsd1
|
fibronectin type III and SPRY domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FSD1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 9:905,418...908,938
Ensembl chr 9:905,430...915,364
|
|
| G
|
Fshb
|
follicle stimulating hormone subunit beta
|
decreases expression multiple interactions
|
EXP
|
Acrylamide results in decreased expression of FSHB protein naringin inhibits the reaction [Acrylamide results in decreased expression of FSHB protein]; Selenium inhibits the reaction [Acrylamide results in decreased expression of FSHB protein]
|
CTD |
PMID:22459607 PMID:36598108 PMID:37987225 |
|
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072
|
|
| G
|
Fstl1
|
follistatin-like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FSTL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:76,400,870...76,454,053
Ensembl chr11:76,391,315...76,455,126
|
|
| G
|
Fstl3
|
follistatin like 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FSTL3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:10,574,195...10,579,844
Ensembl chr 7:10,574,186...10,590,509
|
|
| G
|
Fth1
|
ferritin heavy chain 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FTH1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214
|
|
| G
|
Ftl1
|
ferritin light chain 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FTL mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:105,072,858...105,074,705
Ensembl chr X:45,399,355...45,399,915 Ensembl chr 2:45,399,355...45,399,915 Ensembl chr 1:45,399,355...45,399,915
|
|
| G
|
Fubp1
|
far upstream element binding protein 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FUBP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:243,819,529...243,846,544
Ensembl chr 2:243,819,218...243,846,428
|
|
| G
|
Fubp3
|
far upstream element binding protein 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FUBP3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:35,253,216...35,302,282
Ensembl chr 3:35,253,306...35,302,280
|
|
| G
|
Fundc1
|
FUN14 domain containing 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FUNDC1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:7,666,787...7,683,443
Ensembl chr X:7,666,759...7,683,441
|
|
| G
|
Fundc2
|
FUN14 domain containing 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of FUNDC2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:142,829...155,123
Ensembl chr18:142,640...155,674
|
|
| G
|
Fuom
|
fucose mutarotase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FUOM mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:204,318,180...204,322,690
Ensembl chr 1:204,316,354...204,322,690
|
|
| G
|
Furin
|
furin (paired basic amino acid cleaving enzyme)
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FURIN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:143,757,389...143,770,430
Ensembl chr 1:143,757,391...143,773,497
|
|
| G
|
Fus
|
Fus RNA binding protein
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FUS mRNA Acrylamide results in increased expression of FUS mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 1:192,007,011...192,020,887
Ensembl chr 1:192,007,006...192,020,884
|
|
| G
|
Fut4-ps1
|
fucosyltransferase 4, pseudogene 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of FUT6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:1,656,732...1,659,085
|
|
| G
|
Fuz
|
fuzzy planar cell polarity protein
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FUZ mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:104,515,782...104,524,591
Ensembl chr 1:104,516,049...104,521,038
|
|
| G
|
Fv1
|
Friend virus susceptibility 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of C19ORF48P mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:103,867,358...103,873,336
Ensembl chr 1:103,867,373...103,873,342
|
|
| G
|
Fxn
|
frataxin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FXN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:231,300,457...231,323,989
Ensembl chr 1:231,300,150...231,323,989
|
|
| G
|
Fxr1
|
FMR1 autosomal homolog 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FXR1 mRNA Acrylamide results in increased expression of FXR1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:118,812,287...118,865,813
Ensembl chr 2:118,811,980...118,867,027
|
|
| G
|
Fxyd1
|
FXYD domain-containing ion transport regulator 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FXYD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:95,414,556...95,418,645
Ensembl chr 1:95,414,557...95,418,591
|
|
| G
|
Fxyd6
|
FXYD domain-containing ion transport regulator 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FXYD6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:54,575,578...54,602,715
Ensembl chr 8:54,575,591...54,602,715
|
|
| G
|
Fyb2
|
FYN binding protein 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FYB2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:124,906,005...125,029,867
Ensembl chr 5:124,905,982...125,029,865
|
|
| G
|
Fyco1
|
FYVE and coiled-coil domain autophagy adaptor 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of FYCO1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 8:132,289,538...132,356,810
Ensembl chr 8:132,289,539...132,356,451
|
|
| G
|
Fzd2
|
frizzled class receptor 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of FZD2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:88,061,988...88,063,898
Ensembl chr10:88,061,667...88,065,396
|
|
| G
|
Fzd8
|
frizzled class receptor 8
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of FZD8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:62,007,849...62,015,485
Ensembl chr17:62,007,627...62,015,961
|
|
| G
|
Fzd9
|
frizzled class receptor 9
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of FZD9 mRNA Acrylamide results in decreased expression of FZD9 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr12:27,063,640...27,065,954
Ensembl chr12:27,063,415...27,074,485
|
|
| G
|
G2
|
G2 protein
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KIAA1549L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:110,961,478...111,237,308
Ensembl chr 3:110,961,478...111,237,223
|
|
| G
|
G2e3
|
G2/M-phase specific E3 ubiquitin protein ligase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of G2E3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:74,498,801...74,530,703
Ensembl chr 6:74,503,109...74,528,198
|
|
| G
|
G6pc1
|
glucose-6-phosphatase catalytic subunit 1
|
increases expression multiple interactions decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of G6PC mRNA; Acrylamide results in increased expression of G6PC1 mRNA [Acrylamide co-treated with INS protein] results in increased expression of G6PC mRNA Acrylamide results in decreased expression of G6PC1 mRNA Acrylamide inhibits the reaction [Streptozocin results in increased expression of G6PC1 mRNA]
|
CTD |
PMID:31644924 PMID:34896238 PMID:38604440 |
|
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
|
|
| G
|
G6pc3
|
glucose 6 phosphatase catalytic subunit 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of G6PC3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:87,647,149...87,651,385
Ensembl chr10:87,647,062...87,653,453
|
|
| G
|
Gaa
|
alpha glucosidase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GAA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:105,028,106...105,045,365
Ensembl chr10:105,028,307...105,045,366
|
|
| G
|
Gabarapl1
|
GABA type A receptor associated protein like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GABARAPL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:164,666,332...164,675,474
Ensembl chr 4:164,666,246...164,674,578
|
|
| G
|
Gabbr1
|
gamma-aminobutyric acid type B receptor subunit 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GABBR1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,469,779...1,498,607
|
|
| G
|
Gabbr2
|
gamma-aminobutyric acid type B receptor subunit 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GABBR2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:65,743,073...66,083,695
|
|
| G
|
Gabpb2
|
GA binding protein transcription factor subunit beta 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GABPB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:185,444,309...185,484,200
Ensembl chr 2:185,450,296...185,483,589
|
|
| G
|
Gabra2
|
gamma-aminobutyric acid type A receptor subunit alpha 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GABRA2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:37,451,218...37,587,458
Ensembl chr14:37,450,683...37,587,457
|
|
| G
|
Gabra5
|
gamma-aminobutyric acid type A receptor subunit alpha 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GABRA5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:117,404,446...117,517,424
Ensembl chr 1:117,404,494...117,516,635
|
|
| G
|
Gabrb2
|
gamma-aminobutyric acid type A receptor subunit beta 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GABRB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171
|
|
| G
|
Gabrd
|
gamma-aminobutyric acid type A receptor subunit delta
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GABRD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:171,240,813...171,252,709
Ensembl chr 5:171,240,789...171,253,094
|
|
| G
|
Gabrr2
|
gamma-aminobutyric acid type A receptor subunit rho 2
|
decreases expression increases expression
|
ISO
|
Acrylamide results in decreased expression of GABRR2 mRNA Acrylamide results in increased expression of GABRR2 mRNA
|
CTD |
PMID:29261810 PMID:32763439 |
|
NCBI chr 5:52,242,564...52,286,255
Ensembl chr 5:52,243,256...52,296,746
|
|
| G
|
Gad1
|
glutamate decarboxylase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GAD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759
|
|
| G
|
Gadd45a
|
growth arrest and DNA-damage-inducible, alpha
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GADD45A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
|
|
| G
|
Gadd45b
|
growth arrest and DNA-damage-inducible, beta
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GADD45B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718
|
|
| G
|
Gadd45g
|
growth arrest and DNA-damage-inducible, gamma
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of GADD45G mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369
|
|
| G
|
Galc
|
galactosylceramidase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GALC mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:123,182,636...123,252,024
Ensembl chr 6:123,182,643...123,245,578
|
|
| G
|
Gale
|
UDP-galactose-4-epimerase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GALE mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:153,477,420...153,481,926
Ensembl chr 5:153,478,325...153,481,922
|
|
| G
|
Galk1
|
galactokinase 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of GALK1 mRNA Acrylamide results in decreased expression of GALK1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:101,742,067...101,746,244
Ensembl chr10:101,735,061...101,746,258
|
|
| G
|
Galm
|
galactose mutarotase
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GALM mRNA
|
CTD |
PMID:28959563 PMID:35032568 |
|
NCBI chr 6:20,589,775...20,641,516
Ensembl chr 6:20,589,776...20,644,417
|
|
| G
|
Galnt10
|
polypeptide N-acetylgalactosaminyltransferase 10
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GALNT10 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:42,321,691...42,468,087
Ensembl chr10:42,322,161...42,468,087
|
|
| G
|
Galnt15
|
polypeptide N-acetylgalactosaminyltransferase 15
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GALNT15 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr16:7,233,524...7,273,290
Ensembl chr16:7,233,606...7,273,285
|
|
| G
|
Galnt16
|
polypeptide N-acetylgalactosaminyltransferase 16
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GALNT16 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:105,900,987...105,982,039
Ensembl chr 6:105,901,153...105,991,350
|
|
| G
|
Galnt7
|
polypeptide N-acetylgalactosaminyltransferase 7
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GALNT7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:37,589,368...37,713,911
Ensembl chr16:37,589,425...37,713,909
|
|
| G
|
Galnt9
|
polypeptide N-acetylgalactosaminyltransferase 9
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GALNT9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:51,710,176...51,788,388
Ensembl chr12:51,710,180...51,788,330
|
|
| G
|
Galr1
|
galanin receptor 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GALR1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:78,046,803...78,062,359
Ensembl chr18:78,046,805...78,062,359
|
|
| G
|
Galt
|
galactose-1-phosphate uridylyltransferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GALT mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:61,722,871...61,726,128
Ensembl chr 5:61,722,466...61,726,125
|
|
| G
|
Gap43
|
growth associated protein 43
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GAP43 mRNA
|
CTD |
PMID:15749267 PMID:28959563 PMID:32763439 |
|
NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797
|
|
| G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
multiple interactions decreases expression
|
ISO EXP
|
Acrylamide binds to and results in decreased activity of GAPDH protein Acrylamide results in decreased expression of GAPDH mRNA
|
CTD |
PMID:22084934 PMID:28959563 |
|
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377
|
|
| G
|
Gapdh-ps1
|
glyceraldehyde-3-phosphate dehydrogenase, pseudogene 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GAPDH-PS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:63,621,152...63,623,050
Ensembl chr 3:63,621,135...63,623,011
|
|
| G
|
Garem2
|
GRB2 associated regulator of MAPK1 subtype 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GAREM2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:31,949,877...31,961,591
Ensembl chr 6:31,949,877...31,961,790
|
|
| G
|
Garin1b
|
golgi associated RAB2 interactor 1B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GARIN1B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:58,880,537...58,903,966
Ensembl chr 4:58,880,594...58,903,961
|
|
| G
|
Gars1
|
glycyl-tRNA synthetase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GARS1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:85,493,753...85,542,876
|
|
| G
|
Gas1
|
growth arrest-specific 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GAS1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:4,487,716...4,490,701
Ensembl chr17:4,484,283...4,497,657
|
|
| G
|
Gas2l1
|
growth arrest-specific 2 like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GAS2L1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:84,169,398...84,175,514
Ensembl chr14:84,169,398...84,175,514
|
|
| G
|
Gas7
|
growth arrest specific 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GAS7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:52,651,690...52,882,244
Ensembl chr10:52,651,690...52,882,244
|
|
| G
|
Gas8
|
growth arrest specific 8
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of DRC4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:68,461,280...68,480,810
Ensembl chr19:68,461,304...68,480,806
|
|
| G
|
Gata1
|
GATA binding protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GATA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:17,193,291...17,209,462
Ensembl chr X:17,201,633...17,209,459
|
|
| G
|
Gatad2b
|
GATA zinc finger domain containing 2B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GATAD2B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:178,046,192...178,127,633
Ensembl chr 2:178,046,085...178,147,315
|
|
| G
|
Gatb
|
glutamyl-tRNA amidotransferase subunit B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GATB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:173,228,562...173,315,144
Ensembl chr 2:173,228,568...173,314,661
|
|
| G
|
Gatd1
|
glutamine amidotransferase class 1 domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GATD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:205,936,189...205,942,121
Ensembl chr 1:205,936,687...205,942,779
|
|
| G
|
Gatd3a
|
glutamine amidotransferase class 1 domain containing 3A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GATD3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:10,514,459...10,522,556
Ensembl chr20:10,514,443...10,522,555
|
|
| G
|
Gatm
|
glycine amidinotransferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GATM mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:130,112,509...130,129,355
|
|
| G
|
Gba1
|
glucosylceramidase beta 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GBA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:176,902,141...176,916,015
Ensembl chr 2:176,907,154...176,916,985
|
|
| G
|
Gba2
|
glucosylceramidase beta 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GBA2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:62,618,176...62,630,160
Ensembl chr 5:62,618,177...62,630,308
|
|
| G
|
Gcat
|
glycine C-acetyltransferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GCAT mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:112,475,572...112,481,920
Ensembl chr 7:112,475,496...112,482,664
|
|
| G
|
Gcdh
|
glutaryl-CoA dehydrogenase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GCDH mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:40,168,038...40,174,536
Ensembl chr19:40,168,141...40,175,686
|
|
| G
|
Gcgr
|
glucagon receptor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GCGR mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:106,306,803...106,314,970
Ensembl chr10:106,306,559...106,314,969
|
|
| G
|
Gch1
|
GTP cyclohydrolase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GCH1 mRNA
|
CTD |
PMID:38554842 |
|
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412
|
|
| G
|
Gck
|
glucokinase
|
decreases expression multiple interactions
|
EXP
|
Acrylamide results in decreased expression of GCK mRNA [Acrylamide co-treated with INS protein] results in decreased expression of GCK protein
|
CTD |
PMID:31644924 PMID:38604440 |
|
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949
|
|
| G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
increases expression multiple interactions
|
ISO
|
Acrylamide results in increased expression of GCLC mRNA IL1B gene mutant form inhibits the reaction [Acrylamide results in increased expression of GCLC mRNA]
|
CTD |
PMID:32763439 PMID:37540211 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
| G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
decreases expression increases expression multiple interactions
|
ISO
|
Acrylamide results in decreased expression of GCLM mRNA Acrylamide results in increased expression of GCLM mRNA salvin inhibits the reaction [Acrylamide results in decreased expression of GCLM mRNA]
|
CTD |
PMID:28159594 PMID:32763439 PMID:37971544 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
|
|
| G
|
Gcnt2
|
glucosaminyl (N-acetyl) transferase 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GCNT2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:24,002,592...24,107,339
Ensembl chr17:24,002,597...24,106,989
|
|
| G
|
Gcnt3
|
glucosaminyl (N-acetyl) transferase 3, mucin type
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GCNT3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:79,570,081...79,577,389
Ensembl chr 8:79,566,753...79,581,595
|
|
| G
|
Gcsam
|
germinal center-associated, signaling and motility
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GCSAM mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:68,658,350...68,669,598
Ensembl chr11:68,660,438...68,669,584
|
|
| G
|
Gdf11
|
growth differentiation factor 11
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GDF11 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:1,896,229...1,909,147
Ensembl chr 7:1,896,229...1,905,222
|
|
| G
|
Gdf15
|
growth differentiation factor 15
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of GDF15 mRNA
|
CTD |
PMID:28959563 PMID:30807115 PMID:32763439 PMID:35690182 |
|
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
|
|
| G
|
Gdf2
|
growth differentiation factor 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GDF2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:9,261,679...9,267,678
Ensembl chr16:9,261,662...9,267,677
|
|
| G
|
Gdf9
|
growth differentiation factor 9
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GDF9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:38,090,021...38,100,801
Ensembl chr10:38,089,878...38,100,797
|
|
| G
|
Gdnf
|
glial cell derived neurotrophic factor
|
multiple interactions increases expression
|
EXP
|
ferrostatin-1 promotes the reaction [Acrylamide results in increased expression of GDNF mRNA]
|
CTD |
PMID:36154307 |
|
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240
|
|
| G
|
Gdpd1
|
glycerophosphodiester phosphodiesterase domain containing 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GDPD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:72,318,716...72,381,143
Ensembl chr10:72,337,778...72,381,120
|
|
| G
|
Gem
|
GTP binding protein overexpressed in skeletal muscle
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GEM mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:30,011,641...30,022,554
Ensembl chr 5:30,011,592...30,022,542
|
|
| G
|
Gemin4
|
gem (nuclear organelle) associated protein 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GEMIN4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:61,560,172...61,571,765
Ensembl chr10:61,564,657...61,596,532
|
|
| G
|
Gemin5
|
gem (nuclear organelle) associated protein 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GEMIN5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:42,797,975...42,843,356
Ensembl chr10:42,797,982...42,843,356
|
|
| G
|
Gemin6
|
gem (nuclear organelle) associated protein 6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GEMIN6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:20,538,325...20,542,867
Ensembl chr 6:20,538,325...20,542,852
|
|
| G
|
Get3
|
guided entry of tail-anchored proteins factor 3, ATPase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GET3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:40,034,675...40,043,064
Ensembl chr19:40,034,967...40,043,061
|
|
| G
|
Gfap
|
glial fibrillary acidic protein
|
increases expression decreases expression
|
ISO EXP
|
Acrylamide results in increased expression of GFAP protein Acrylamide results in decreased expression of GFAP mRNA Acrylamide results in decreased expression of GFAP mRNA; Acrylamide results in decreased expression of GFAP protein
|
CTD |
PMID:19426797 PMID:32763439 PMID:36328537 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685
|
|
| G
|
Gfm2
|
GTP dependent ribosome recycling factor mitochondrial 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GFM2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:30,184,063...30,222,811
Ensembl chr 2:30,184,115...30,222,806
|
|
| G
|
Gfpt2
|
glutamine-fructose-6-phosphate transaminase 2
|
affects expression increases expression
|
EXP ISO
|
Acrylamide affects the expression of GFPT2 mRNA Acrylamide results in increased expression of GFPT2 mRNA
|
CTD |
PMID:28959563 PMID:30807115 PMID:32763439 |
|
NCBI chr10:34,616,146...34,662,420
Ensembl chr10:34,615,370...34,662,419
|
|
| G
|
Gfra1
|
GDNF family receptor alpha 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GFRA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:267,325,297...267,557,037
Ensembl chr 1:267,326,817...267,556,501
|
|
| G
|
Gfra2
|
GDNF family receptor alpha 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GFRA2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:52,351,499...52,443,369
Ensembl chr15:52,351,514...52,477,782
|
|
| G
|
Gga2
|
golgi associated, gamma adaptin ear containing, ARF binding protein 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GGA2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:185,983,302...186,016,582
Ensembl chr 1:185,983,223...186,057,074
|
|
| G
|
Ggct
|
gamma-glutamyl cyclotransferase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GGCT mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:85,453,387...85,459,597
Ensembl chr 4:85,453,387...85,470,224
|
|
| G
|
Ggcx
|
gamma-glutamyl carboxylase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GGCX mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:106,027,918...106,043,653
Ensembl chr 4:106,027,912...106,043,923
|
|
| G
|
Ggt1
|
gamma-glutamyltransferase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GGT1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050
|
|
| G
|
Gh1
|
growth hormone 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GH mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859
|
|
| G
|
Ghdc
|
GH3 domain containing
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GHDC mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:86,193,920...86,198,141
Ensembl chr10:86,193,929...86,198,141
|
|
| G
|
Ghitm
|
growth hormone inducible transmembrane protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GHITM mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:12,907,062...12,918,149
Ensembl chr16:12,905,806...12,918,123
|
|
| G
|
Ghr
|
growth hormone receptor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GHR mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:54,270,206...54,532,331
|
|
| G
|
Gimap6
|
GTPase, IMAP family member 6
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GIMAP6 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 4:78,984,597...78,990,006
Ensembl chr 4:78,983,504...78,990,010
|
|
| G
|
Gins4
|
GINS complex subunit 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GINS4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:75,489,990...75,502,455
Ensembl chr16:75,490,126...75,505,000
|
|
| G
|
Gipc2
|
GIPC PDZ domain containing family, member 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GIPC2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:243,690,742...243,770,199
Ensembl chr 2:243,690,748...243,770,199
|
|
| G
|
Gja1
|
gap junction protein, alpha 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GJA1 protein
|
CTD |
PMID:24928766 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
| G
|
Gja3
|
gap junction protein, alpha 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GJA3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:35,296,946...35,322,405
Ensembl chr15:35,295,523...35,322,809
|
|
| G
|
Gjb6
|
gap junction protein, beta 6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GJB6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:35,400,147...35,410,649
Ensembl chr15:35,398,770...35,410,849
|
|
| G
|
Gjc1
|
gap junction protein, gamma 1
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of GJC1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:88,262,840...88,285,646
Ensembl chr10:88,249,489...88,285,853
|
|
| G
|
Gjc2
|
gap junction protein, gamma 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GJC2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:44,462,203...44,470,924
Ensembl chr10:44,462,054...44,470,340
|
|
| G
|
Gjc3
|
gap junction protein, gamma 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GJC3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:22,009,560...22,024,567
Ensembl chr12:22,009,409...22,078,418
|
|
| G
|
Gjd3
|
gap junction protein, delta 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GJD3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:84,429,923...84,432,011
Ensembl chr10:84,429,036...84,433,870
|
|
| G
|
Gk5
|
glycerol kinase 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GK5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:105,562,018...105,630,975
Ensembl chr 8:105,562,050...105,631,978
|
|
| G
|
Gkap1
|
G kinase anchoring protein 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GKAP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:6,389,377...6,429,091
Ensembl chr17:6,389,377...6,438,279
|
|
| G
|
Gkn3
|
gastrokine 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GKN3 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 4:121,386,319...121,390,719
Ensembl chr 4:121,386,395...121,392,139
|
|
| G
|
Glb1l
|
galactosidase, beta 1-like
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GLB1L mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 9:84,141,993...84,154,176
Ensembl chr 9:84,143,841...84,154,176
|
|
| G
|
Glce
|
glucuronic acid epimerase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GLCE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:71,441,607...71,507,639
Ensembl chr 8:71,441,616...71,507,587
|
|
| G
|
Glg1
|
golgi glycoprotein 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GLG1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:56,034,248...56,133,538
Ensembl chr19:56,006,459...56,133,528
|
|
| G
|
Gli1
|
GLI family zinc finger 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GLI1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540
|
|
| G
|
Gli4
|
GLI family zinc finger 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GLI4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:109,205,812...109,211,650
Ensembl chr 7:109,205,953...109,211,648
|
|
| G
|
Glipr2
|
GLI pathogenesis-related 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GLIPR2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:62,966,163...62,998,016
Ensembl chr 5:62,966,195...62,998,716
|
|
| G
|
Glod5
|
glyoxalase domain containing 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GLOD5 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr X:17,145,936...17,160,733
Ensembl chr X:17,145,938...17,160,619
|
|
| G
|
Glra2
|
glycine receptor, alpha 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GLRA2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:32,651,931...32,873,277
Ensembl chr X:32,652,187...32,873,277
|
|
| G
|
Glrb
|
glycine receptor, beta
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GLRB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:168,432,736...168,505,614
Ensembl chr 2:168,432,736...168,505,614
|
|
| G
|
Glrx
|
glutaredoxin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GLRX mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543
|
|
| G
|
Glrx5
|
glutaredoxin 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GLRX5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:129,752,902...129,763,278
Ensembl chr 6:129,752,840...129,763,278
|
|
| G
|
Gls
|
glutaminase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GLS mRNA
|
CTD |
PMID:15749267 |
|
NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:56,836,584...56,908,861
|
|
| G
|
Gls2
|
glutaminase 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of GLS2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:1,201,757...1,218,014
Ensembl chr 7:1,201,838...1,218,013
|
|
| G
|
Gltp
|
glycolipid transfer protein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GLTP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:47,567,797...47,587,949
Ensembl chr12:47,567,770...47,587,946
|
|
| G
|
Glud1
|
glutamate dehydrogenase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GLUD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210
|
|
| G
|
Glul
|
glutamate-ammonia ligase
|
decreases expression increases expression
|
EXP
|
Acrylamide results in decreased expression of GLUL mRNA Acrylamide results in increased expression of GLUL mRNA
|
CTD |
PMID:12853321 PMID:28959563 |
|
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520
|
|
| G
|
Glyatl3
|
glycine-N-acyltransferase-like 3
|
affects expression
|
EXP
|
Acrylamide affects the expression of GLYATL3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:27,474,057...27,492,281
Ensembl chr 9:27,474,057...27,492,281
|
|
| G
|
Gmeb2
|
glucocorticoid modulatory element binding protein 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GMEB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:188,740,210...188,778,377
Ensembl chr 3:188,740,210...188,778,336
|
|
| G
|
Gmip
|
Gem-interacting protein
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GMIP mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr16:19,634,630...19,648,916
Ensembl chr16:19,634,630...19,647,933
|
|
| G
|
Gmppa
|
GDP-mannose pyrophosphorylase A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GMPPA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:84,375,373...84,382,917
Ensembl chr 9:84,375,425...84,382,916
|
|
| G
|
Gmppb
|
GDP-mannose pyrophosphorylase B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GMPPB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:117,616,029...117,622,866
|
|
| G
|
Gmpr2
|
guanosine monophosphate reductase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GMPR2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:33,135,455...33,144,923
Ensembl chr15:33,135,682...33,144,899
|
|
| G
|
Gna12
|
G protein subunit alpha 12
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GNA12 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr12:18,919,629...19,000,185
Ensembl chr12:18,919,629...19,000,185
|
|
| G
|
Gna14
|
G protein subunit alpha 14
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GNA14 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:223,141,802...223,324,210
Ensembl chr 1:223,141,802...223,324,210
|
|
| G
|
Gna15
|
G protein subunit alpha 15
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GNA15 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:8,835,396...8,856,269
Ensembl chr 7:8,835,357...8,856,268
|
|
| G
|
Gnao1
|
G protein subunit alpha o1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GNAO1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:11,040,788...11,198,437
Ensembl chr19:11,040,788...11,198,437
|
|
| G
|
Gnb1l
|
G protein subunit beta 1 like
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GNB1L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:95,933,994...96,011,933
Ensembl chr11:95,936,961...96,011,931
|
|
| G
|
Gnb5
|
G protein subunit beta 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GNB5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:84,956,629...84,985,576
Ensembl chr 8:84,953,815...84,986,888
|
|
| G
|
Gne
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GNE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:63,062,953...63,103,320
Ensembl chr 5:63,062,850...63,103,251
|
|
| G
|
Gng11
|
G protein subunit gamma 11
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GNG11 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:32,977,681...32,983,121
Ensembl chr 4:32,977,664...32,984,438
|
|
| G
|
Gng7
|
G protein subunit gamma 7
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GNG7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:9,348,148...9,411,924
Ensembl chr 7:9,348,218...9,411,923
|
|
| G
|
Gng8
|
G protein subunit gamma 8
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GNG8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:86,692,609...86,696,463
Ensembl chr 1:86,692,642...86,696,408
|
|
| G
|
Gngt1
|
G protein subunit gamma transducin 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GNGT1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:32,960,945...32,963,930
Ensembl chr 4:32,960,945...32,963,930
|
|
| G
|
Gnpat
|
glyceronephosphate O-acyltransferase
|
affects expression
|
EXP
|
Acrylamide affects the expression of GNPAT mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:69,719,707...69,746,244
Ensembl chr19:69,719,394...69,746,244
|
|
| G
|
Gnpda1
|
glucosamine-6-phosphate deaminase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GNPDA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:30,416,599...30,428,630
Ensembl chr18:30,416,607...30,428,630
|
|
| G
|
Gnptg
|
N-acetylglucosamine-1-phosphate transferase subunit gamma
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GNPTG mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:14,756,685...14,761,636
|
|
| G
|
Gnrh1
|
gonadotropin releasing hormone 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GNRH1 protein
|
CTD |
PMID:38614435 |
|
NCBI chr15:46,147,878...46,152,086
Ensembl chr15:46,148,301...46,148,977 Ensembl chr15:46,148,301...46,148,977
|
|
| G
|
Golgb1
|
golgin B1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GOLGB1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr11:77,348,573...77,406,165
Ensembl chr11:77,348,961...77,406,006
|
|
| G
|
Golim4
|
golgi integral membrane protein 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GOLIM4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:162,939,429...163,031,901
Ensembl chr 2:162,939,429...163,031,901
|
|
| G
|
Golt1b
|
golgi transport 1B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GOLT1B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:177,064,071...177,077,165
Ensembl chr 4:177,064,073...177,077,164
|
|
| G
|
Gon7
|
GON7 subunit of KEOPS complex
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GON7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:127,647,389...127,663,276
|
|
| G
|
Got1
|
glutamic-oxaloacetic transaminase 1
|
decreases expression multiple interactions
|
EXP
|
Acrylamide results in decreased expression of GOT1 mRNA [Acrylamide co-treated with INS protein] results in increased activity of GOT1 protein
|
CTD |
PMID:28959563 PMID:38604440 |
|
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
|
|
| G
|
Got2
|
glutamic-oxaloacetic transaminase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GOT2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:9,180,428...9,206,113
Ensembl chr19:9,180,431...9,206,111
|
|
| G
|
Gp1bb
|
glycoprotein Ib platelet subunit beta
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of GP1BB mRNA Acrylamide results in decreased expression of GP1BB mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr11:95,882,561...95,883,738
|
|
| G
|
Gp2
|
glycoprotein 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:183,228,395...183,243,954
Ensembl chr 1:183,228,395...183,243,954
|
|
| G
|
Gp5
|
glycoprotein V (platelet)
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GP5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:83,948,507...83,952,362
Ensembl chr11:83,948,507...83,952,367
|
|
| G
|
Gpaa1
|
glycosylphosphatidylinositol anchor attachment 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GPAA1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:109,932,556...109,936,139
Ensembl chr 7:109,932,544...109,936,138
|
|
| G
|
Gpatch2
|
G patch domain containing 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GPATCH2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:101,316,413...101,457,109
Ensembl chr13:101,316,413...101,457,109
|
|
| G
|
Gpatch3
|
G patch domain containing 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GPATCH3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:151,083,970...151,093,382
Ensembl chr 5:151,083,961...151,093,537
|
|
| G
|
Gpatch4
|
G patch domain containing 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GPATCH4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:175,797,503...175,816,547
Ensembl chr 2:175,807,682...175,817,358
|
|
| G
|
Gpbp1
|
GC-rich promoter binding protein 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GPBP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:44,756,861...44,824,281
Ensembl chr 2:44,756,861...44,824,315
|
|
| G
|
Gpc1
|
glypican 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GPC1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:100,843,645...100,871,458
Ensembl chr 9:100,843,645...100,879,933
|
|
| G
|
Gpc2
|
glypican 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GPC2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr12:22,391,489...22,397,822
Ensembl chr12:22,391,489...22,397,822
|
|
| G
|
Gpc3
|
glypican 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GPC3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:136,789,770...137,157,598
Ensembl chr X:136,789,770...137,157,639
|
|
| G
|
Gpc4
|
glypican 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GPC4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:136,565,536...136,676,142
Ensembl chr X:136,565,591...136,676,057
|
|
| G
|
Gpcpd1
|
glycerophosphocholine phosphodiesterase 1
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of GPCPD1 mRNA
|
CTD |
PMID:28959563 PMID:30807115 PMID:32763439 |
|
NCBI chr 3:140,240,574...140,285,469
Ensembl chr 3:140,240,575...140,285,372
|
|
| G
|
Gpd1l
|
glycerol-3-phosphate dehydrogenase 1 like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GPD1L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:123,469,282...123,498,948
Ensembl chr 8:123,466,667...123,498,908
|
|
| G
|
Gpd2
|
glycerol-3-phosphate dehydrogenase 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GPD2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:62,209,432...62,346,590
Ensembl chr 3:62,210,814...62,346,593
|
|
| G
|
Gpi
|
glucose-6-phosphate isomerase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GPI mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:95,965,389...95,996,932
Ensembl chr 1:95,965,396...95,993,261
|
|
| G
|
Gpkow
|
G patch domain and KOW motifs
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GPKOW mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:17,463,521...17,478,298
Ensembl chr X:17,463,525...17,478,298
|
|
| G
|
Gpn1
|
GPN-loop GTPase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GPN1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:30,667,337...30,685,011
Ensembl chr 6:30,666,868...30,685,011
|
|
| G
|
Gpn2
|
GPN-loop GTPase 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GPN2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:151,093,279...151,101,114
Ensembl chr 5:151,093,418...151,101,111
|
|
| G
|
Gpnmb
|
glycoprotein nmb
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GPNMB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240
|
|
| G
|
Gpr101
|
G protein-coupled receptor 101
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GPR101 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:140,575,818...140,579,734
Ensembl chr X:140,572,068...140,580,369
|
|
| G
|
Gpr132
|
G protein-coupled receptor 132
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GPR132 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:137,745,142...137,763,037
Ensembl chr 6:137,745,241...137,763,157
|
|
| G
|
Gpr137c
|
G protein-coupled receptor 137C
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GPR137C mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:20,905,923...20,972,318
Ensembl chr15:20,905,958...20,970,541
|
|
| G
|
Gpr150
|
G protein-coupled receptor 150
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GPR150 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:7,278,166...7,283,216
Ensembl chr 2:7,279,255...7,283,550
|
|
| G
|
Gpr151
|
G protein-coupled receptor 151
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GPR151 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:34,819,878...34,821,272
Ensembl chr18:34,819,878...34,821,272
|
|
| G
|
Gpr156
|
G protein-coupled receptor 156
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GPR156 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:76,228,104...76,320,890
Ensembl chr11:76,228,104...76,320,890
|
|
| G
|
Gpr26
|
G protein-coupled receptor 26
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GPR26 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:196,196,138...196,235,574
Ensembl chr 1:196,196,767...196,235,559
|
|
| G
|
Gpr3
|
G protein-coupled receptor 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GPR3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:150,695,406...150,698,526
Ensembl chr 5:150,695,251...150,706,529
|
|
| G
|
Gpr35
|
G protein-coupled receptor 35
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GPR35 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:100,974,580...100,995,330
Ensembl chr 9:100,962,538...100,986,985
|
|
| G
|
Gpr37l1
|
G protein-coupled receptor 37-like 1
|
affects methylation
|
ISO
|
Acrylamide affects the methylation of GPR37L1 gene
|
CTD |
PMID:35032568 |
|
NCBI chr13:49,150,355...49,157,204
Ensembl chr13:49,150,359...49,157,204
|
|
| G
|
Gpr45
|
G protein-coupled receptor 45
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GPR45 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:52,713,825...52,801,826
Ensembl chr 9:52,783,090...52,801,941
|
|
| G
|
Gpr50
|
G protein-coupled receptor 50
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GPR50 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:154,413,592...154,419,236
Ensembl chr X:154,413,689...154,418,275
|
|
| G
|
Gpr82
|
G protein-coupled receptor 82
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GPR82 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr X:11,751,846...11,757,526
Ensembl chr X:11,751,846...11,757,526
|
|
| G
|
Gpr84
|
G protein-coupled receptor 84
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GPR84 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:136,322,374...136,324,648
Ensembl chr 7:136,322,191...136,324,703
|
|
| G
|
Gpr85
|
G protein-coupled receptor 85
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GPR85 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:43,070,194...43,075,662
Ensembl chr 4:43,060,777...43,075,794
|
|
| G
|
Gpr88
|
G-protein coupled receptor 88
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GPR88 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:206,876,373...206,885,034
Ensembl chr 2:206,868,585...206,884,945
|
|
| G
|
Gpr89b
|
G protein-coupled receptor 89B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GPR89B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:187,096,970...187,134,391
Ensembl chr 2:187,080,020...187,134,391
|
|
| G
|
Gprasp2
|
G protein-coupled receptor associated sorting protein 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GPRASP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:103,609,304...103,615,450
Ensembl chr X:103,501,226...103,641,988
|
|
| G
|
Gprasp3
|
G protein-coupled receptor associated sorting protein family member 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GPRASP3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:103,639,366...103,644,561
Ensembl chr X:103,609,243...103,650,463
|
|
| G
|
Gprc5a
|
G protein-coupled receptor, class C, group 5, member A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GPRC5A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:169,634,896...169,653,627
Ensembl chr 4:169,634,748...169,653,625
|
|
| G
|
Gps1
|
G protein pathway suppressor 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GPS1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:106,548,646...106,553,729
Ensembl chr10:106,548,018...106,554,013
|
|
| G
|
Gpsm1
|
G-protein signaling modulator 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GPSM1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 3:29,538,929...29,565,921
Ensembl chr 3:29,526,802...29,565,920
|
|
| G
|
Gpsm2
|
G-protein signaling modulator 2
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of GPSM2 mRNA Acrylamide results in decreased expression of GPSM2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:199,015,250...199,063,788
Ensembl chr 2:199,015,250...199,063,056
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions increases activity
|
ISO EXP
|
[Acrylamide co-treated with Streptozocin] results in increased activity of GPT protein; Acrylamide promotes the reaction [Dietary Fats results in increased expression of GPT protein] [Acrylamide co-treated with INS protein] results in increased activity of GPT protein Acrylamide results in increased activity of GPT protein
|
CTD |
PMID:29658313 PMID:30409764 PMID:34896238 PMID:38604440 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gpt2
|
glutamic--pyruvic transaminase 2
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of GPT2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr19:37,700,023...37,734,551
Ensembl chr19:37,691,901...37,733,917
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
multiple interactions decreases expression decreases activity increases expression
|
ISO EXP
|
salvin inhibits the reaction [Acrylamide results in decreased expression of GPX1 mRNA] Acrylamide results in decreased expression of GPX1 protein Acrylamide results in decreased activity of GPX1 protein Acrylamide results in increased expression of GPX1 mRNA IL1B gene mutant form inhibits the reaction [Acrylamide results in increased expression of GPX1 mRNA] [Acrylamide co-treated with INS protein] results in decreased activity of GPX1 protein; epigallocatechin gallate inhibits the reaction [Acrylamide results in decreased activity of GPX1 protein]
|
CTD |
PMID:28056603 PMID:28159594 PMID:36599426 PMID:37540211 PMID:38242491 PMID:38604440 More...
|
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gpx2
|
glutathione peroxidase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GPX2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
|
|
| G
|
Gpx4
|
glutathione peroxidase 4
|
increases expression decreases expression multiple interactions
|
ISO EXP
|
Acrylamide results in increased expression of GPX4 mRNA Acrylamide results in decreased expression of GPX4 mRNA IL1B gene mutant form inhibits the reaction [Acrylamide results in increased expression of GPX4 mRNA]
|
CTD |
PMID:36154307 PMID:37540211 PMID:37971544 |
|
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
| G
|
Gpx7
|
glutathione peroxidase 7
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GPX7 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:128,373,881...128,381,866
Ensembl chr 5:128,372,875...128,381,725
|
|
| G
|
Gpx8
|
glutathione peroxidase 8
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GPX8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:46,409,646...46,413,401
Ensembl chr 2:46,409,139...46,413,406
|
|
| G
|
Grb10
|
growth factor receptor bound protein 10
|
affects expression increases expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of GRB10 mRNA Acrylamide results in increased expression of GRB10 mRNA Acrylamide results in decreased expression of GRB10 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr14:90,708,653...90,816,399
Ensembl chr14:90,708,653...90,816,387
|
|
| G
|
Grb14
|
growth factor receptor bound protein 14
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GRB14 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:69,976,331...70,091,921
Ensembl chr 3:69,976,339...70,091,921
|
|
| G
|
Greb1l
|
GREB1 like retinoic acid receptor coactivator
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GREB1L mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:1,665,468...1,902,291
Ensembl chr18:1,766,214...1,900,178
|
|
| G
|
Grem1
|
gremlin 1, DAN family BMP antagonist
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GREM1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:120,966,623...120,979,089
|
|
| G
|
Grem2
|
gremlin 2, DAN family BMP antagonist
|
affects expression
|
EXP
|
Acrylamide affects the expression of GREM2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:89,310,897...89,403,856
Ensembl chr13:89,310,662...89,404,312
|
|
| G
|
Grhl1
|
grainyhead-like transcription factor 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GRHL1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:46,935,947...46,986,126
Ensembl chr 6:46,935,967...46,980,264
|
|
| G
|
Grhl3
|
grainyhead-like transcription factor 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GRHL3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:153,057,760...153,089,890
Ensembl chr 5:153,057,760...153,089,890
|
|
| G
|
Gria1
|
glutamate ionotropic receptor AMPA type subunit 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GRIA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309
|
|
| G
|
Gria2
|
glutamate ionotropic receptor AMPA type subunit 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GRIA2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616
|
|
| G
|
Gria3
|
glutamate ionotropic receptor AMPA type subunit 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GRIA3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:125,103,975...125,369,690
Ensembl chr X:125,103,782...125,369,679
|
|
| G
|
Gria4
|
glutamate ionotropic receptor AMPA type subunit 4
|
affects expression
|
EXP
|
Acrylamide affects the expression of GRIA4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:9,845,421...10,320,021
Ensembl chr 8:9,847,052...10,319,881
|
|
| G
|
Grid1
|
glutamate ionotropic receptor delta type subunit 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GRID1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:10,145,018...10,894,184
Ensembl chr16:10,144,964...10,891,946
|
|
| G
|
Grin1
|
glutamate ionotropic receptor NMDA type subunit 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of GRIN1 mRNA Acrylamide results in decreased expression of GRIN1 mRNA
|
CTD |
PMID:28606764 PMID:32763439 |
|
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754
|
|
| G
|
Grin3a
|
glutamate ionotropic receptor NMDA type subunit 3A
|
affects expression
|
EXP
|
Acrylamide affects the expression of GRIN3A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:68,802,333...69,001,880
Ensembl chr 5:68,804,970...69,001,558
|
|
| G
|
Grip1
|
glutamate receptor interacting protein 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GRIP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:56,820,501...57,477,877
Ensembl chr 7:56,820,704...57,468,417
|
|
| G
|
Grip2
|
glutamate receptor interacting protein 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GRIP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:125,828,609...125,913,693
Ensembl chr 4:125,828,609...125,913,750
|
|
| G
|
Grk2
|
G protein-coupled receptor kinase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GRK2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:211,010,259...211,031,013
Ensembl chr 1:211,009,978...211,031,015
|
|
| G
|
Grk6
|
G protein-coupled receptor kinase 6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GRK6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:9,182,160...9,198,380
Ensembl chr17:9,182,160...9,197,954
|
|
| G
|
Grm1
|
glutamate metabotropic receptor 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GRM1 mRNA Acrylamide results in increased expression of GRM1 mRNA
|
CTD |
PMID:28959563 PMID:38554842 |
|
NCBI chr 1:6,878,542...7,273,447
Ensembl chr 1:6,878,545...7,273,443
|
|
| G
|
Grm2
|
glutamate metabotropic receptor 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GRM2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:116,158,810...116,171,857
Ensembl chr 8:116,158,810...116,171,857
|
|
| G
|
Grm3
|
glutamate metabotropic receptor 3
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GRM3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:25,319,218...25,600,721
Ensembl chr 4:25,319,942...25,564,764
|
|
| G
|
Grn
|
granulin precursor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GRN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,886,122...87,893,936
|
|
| G
|
Grpel2
|
GrpE-like 2, mitochondrial
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GRPEL2 mRNA Acrylamide results in increased expression of GRPEL2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr18:57,438,168...57,450,408
Ensembl chr18:57,438,168...57,450,717
|
|
| G
|
Grtp1
|
growth hormone regulated TBC protein 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GRTP1 mRNA Acrylamide results in increased expression of GRTP1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr16:83,034,931...83,056,589
|
|
| G
|
Gsg1
|
germ cell associated 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GSG1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:169,822,111...169,838,379
Ensembl chr 4:169,822,114...169,838,379
|
|
| G
|
Gsg1l
|
GSG1-like
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GSG1L mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:189,871,034...190,084,947
Ensembl chr 1:189,871,034...190,084,947
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
decreases phosphorylation increases expression
|
EXP
|
Acrylamide results in decreased phosphorylation of GSK3B protein Acrylamide results in increased expression of GSK3B mRNA
|
CTD |
PMID:33421551 PMID:38604440 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Gsn
|
gelsolin
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GSN mRNA Acrylamide results in increased expression of GSN mRNA
|
CTD |
PMID:28959563 PMID:38554842 |
|
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions increases expression increases activity
|
ISO
|
3,4-dihydroxyphenylethanol inhibits the reaction [Acrylamide results in increased activity of GSR protein] Acrylamide results in increased expression of GSR mRNA
|
CTD |
PMID:21777647 PMID:32763439 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gss
|
glutathione synthetase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GSS mRNA
|
CTD |
PMID:22459607 |
|
NCBI chr 3:164,508,005...164,538,343
Ensembl chr 3:164,508,005...164,538,306
|
|
| G
|
Gsta2
|
glutathione S-transferase alpha 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GSTA2 mRNA
|
CTD |
PMID:15749267 |
|
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092
|
|
| G
|
Gsta4
|
glutathione S-transferase alpha 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GSTA4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:87,930,566...87,964,488
|
|
| G
|
Gsta5
|
glutathione S-transferase alpha 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GSTA5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:87,985,768...87,997,766
Ensembl chr 8:87,985,258...87,997,765
|
|
| G
|
Gstm1
|
glutathione S-transferase mu 1
|
affects metabolic processing decreases expression increases expression multiple interactions
|
ISO EXP
|
GSTM1 gene polymorphism affects the metabolism of Acrylamide Acrylamide results in decreased expression of GSTM1 mRNA Acrylamide results in increased expression of GSTM1 mRNA Acrylamide results in increased expression of GSTM1 mRNA; Acrylamide results in increased expression of GSTM1 protein [CYP2E1 gene polymorphism co-treated with GSTM1 gene polymorphism co-treated with GSTT1 gene polymorphism] affects the metabolism of Acrylamide; [CYP2E1 gene polymorphism co-treated with GSTM1 gene polymorphism] affects the metabolism of Acrylamide; [GSTM1 gene polymorphism affects the metabolism of Acrylamide] which affects the chemical synthesis of N-acetyl-S-(2-carbamoylethyl)cysteine
|
CTD |
PMID:19131562 PMID:21402133 PMID:27836571 PMID:28526328 PMID:28959563 PMID:32763439 PMID:37971544 More...
|
|
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
|
|
| G
|
Gstm4
|
glutathione S-transferase mu 4
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of GSTM4 mRNA Acrylamide results in decreased expression of GSTM4 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:198,356,114...198,373,487
Ensembl chr 2:198,358,744...198,373,638
|
|
| G
|
Gstm6
|
glutathione S-transferase, mu 6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GSTM6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:198,267,734...198,272,508
|
|
| G
|
Gstm7
|
glutathione S-transferase, mu 7
|
affects expression
|
EXP
|
Acrylamide affects the expression of GSTM7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:198,254,872...198,260,365
Ensembl chr 2:198,254,875...198,260,373
|
|
| G
|
Gsto1
|
glutathione S-transferase omega 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GSTO1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167
|
|
| G
|
Gsto2
|
glutathione S-transferase omega 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GSTO2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:256,673,376...256,695,154
Ensembl chr 1:256,673,274...256,695,146
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GSTP1 mRNA
|
CTD |
PMID:15749267 PMID:28959563 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Gstt1
|
glutathione S-transferase theta 1
|
multiple interactions increases expression affects metabolic processing
|
ISO EXP
|
[CYP2E1 gene polymorphism co-treated with GSTM1 gene polymorphism co-treated with GSTT1 gene polymorphism] affects the metabolism of Acrylamide Acrylamide results in increased expression of GSTT1 mRNA GSTT1 gene polymorphism affects the metabolism of Acrylamide
|
CTD |
PMID:19131562 PMID:28959563 |
|
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019
|
|
| G
|
Gstz1
|
glutathione S-transferase zeta 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GSTZ1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:112,525,576...112,536,228
Ensembl chr 6:112,525,377...112,536,233
|
|
| G
|
Gtf2a1
|
general transcription factor 2A subunit 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GTF2A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:116,219,614...116,252,220
Ensembl chr 6:116,219,614...116,252,220
|
|
| G
|
Gtf2a2
|
general transcription factor 2A subunit 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GTF2A2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:79,542,682...79,556,484
Ensembl chr 8:79,547,307...79,565,408
|
|
| G
|
Gtf2h1
|
general transcription factor IIH subunit 1
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of GTF2H1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:106,457,692...106,485,729
Ensembl chr 1:106,457,394...106,485,727
|
|
| G
|
Gtf2h2
|
general transcription factor IIH subunit 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GTF2H2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 2:33,358,863...33,386,726
Ensembl chr 2:33,358,869...33,386,688
|
|
| G
|
Gtf2h4
|
general transcription factor 2H subunit 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GTF2H4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:3,076,110...3,081,805
Ensembl chr20:3,076,088...3,081,760
|
|
| G
|
Gtf2ird2
|
GTF2I repeat domain containing 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GTF2IRD2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:28,134,199...28,179,089
Ensembl chr12:28,133,792...28,172,876
|
|
| G
|
Gtf3a
|
general transcription factor III A
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GTF3A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:13,250,643...13,258,587
Ensembl chr12:13,250,644...13,258,587
|
|
| G
|
Gtf3c3
|
general transcription factor IIIC subunit 3
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of GTF3C3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 9:63,375,860...63,437,475
Ensembl chr 9:63,375,874...63,437,413
|
|
| G
|
Guca1a
|
guanylate cyclase activator 1A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of GUCA1A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:21,080,782...21,096,221
Ensembl chr 9:21,086,642...21,096,221
|
|
| G
|
Gucy1a1
|
guanylate cyclase 1 soluble subunit alpha 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of GUCY1A1 protein
|
CTD |
PMID:19903525 |
|
NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:169,716,709...169,779,737
|
|
| G
|
Gucy1b1
|
guanylate cyclase 1 soluble subunit beta 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of GUCY1B1 protein
|
CTD |
PMID:19903525 |
|
NCBI chr 2:169,646,897...169,697,060
Ensembl chr 2:169,646,898...169,696,987
|
|
| G
|
Gucy2f
|
guanylate cyclase 2F
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GUCY2F mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:110,507,183...110,605,017
Ensembl chr X:110,507,183...110,605,017
|
|
| G
|
Gulo
|
gulonolactone (L-) oxidase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GULO mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:44,381,226...44,403,314
Ensembl chr15:44,381,214...44,403,422
|
|
| G
|
Gulp1
|
GULP PTB domain containing engulfment adaptor 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GULP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:54,114,823...54,391,058
Ensembl chr 9:54,114,731...54,397,452
|
|
| G
|
Gusb
|
glucuronidase, beta
|
increases activity decreases expression
|
ISO EXP
|
Acrylamide results in increased activity of GUSB protein Acrylamide results in decreased expression of GUSB mRNA
|
CTD |
PMID:7073948 PMID:28959563 PMID:32763439 |
|
NCBI chr12:32,337,281...32,350,838
Ensembl chr12:32,334,075...32,363,024
|
|
| G
|
Gvin1
|
GTPase, very large interferon inducible 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GVIN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:169,689,178...169,718,522
Ensembl chr 1:169,691,586...169,718,522
|
|
| G
|
Gyg1
|
glycogenin 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GYG1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:104,540,927...104,583,038
Ensembl chr 2:104,540,533...104,582,818
|
|
| G
|
Gypa
|
glycophorin A
|
affects expression
|
EXP
|
Acrylamide affects the expression of GYPA mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:44,354,669...44,370,304
Ensembl chr19:44,354,706...44,370,291
|
|
| G
|
Gypc
|
glycophorin C
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of GYPC mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr18:24,434,921...24,467,592
Ensembl chr18:24,434,922...24,440,053
|
|
| G
|
Gys1
|
glycogen synthase 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of GYS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:105,051,916...105,071,763
Ensembl chr 1:105,051,961...105,072,419
|
|
| G
|
Gzf1
|
GDNF-inducible zinc finger protein 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of GZF1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:156,572,152...156,584,369
Ensembl chr 3:156,572,250...156,584,363
|
|
| G
|
Gzmc
|
granzyme C
|
increases expression
|
EXP
|
Acrylamide results in increased expression of GZMC mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:34,437,312...34,440,006
Ensembl chr15:34,437,317...34,440,048
|
|
| G
|
Gzmf
|
granzyme F
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of GZMF mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:33,975,543...33,997,505
Ensembl chr15:33,977,505...33,997,572
|
|
| G
|
Gzmk
|
granzyme K
|
affects expression
|
EXP
|
Acrylamide affects the expression of GZMK mRNA
|
CTD |
PMID:15749267 |
|
NCBI chr 2:46,573,997...46,582,015
Ensembl chr 2:46,573,997...46,582,015
|
|
| G
|
H19
|
H19 imprinted maternally expressed transcript
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of H19 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:207,160,175...207,162,851
|
|
| G
|
H1f0
|
H1.0 linker histone
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of H1F0 mRNA Acrylamide results in decreased expression of H1-0 mRNA Acrylamide results in increased expression of H1F0 mRNA
|
CTD |
PMID:28959563 PMID:30807115 PMID:32763439 |
|
NCBI chr 7:112,473,280...112,475,140
Ensembl chr 7:112,473,222...112,475,006
|
|
| G
|
H1f10
|
H1.10 linker histone
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of H1-10 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:121,997,834...121,998,897
Ensembl chr 4:121,997,831...121,998,966
|
|
| G
|
H1f5
|
H1.5 linker histone, cluster member
|
increases expression
|
EXP
|
Acrylamide results in increased expression of H1F5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:47,421,875...47,422,905
Ensembl chr17:47,421,843...47,477,387
|
|
| G
|
H2ac21
|
H2A clustered histone 21
|
increases expression
|
EXP
|
Acrylamide results in increased expression of H2AC21 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:186,468,224...186,468,657
|
|
| G
|
H2aj
|
H2A.J histone
|
affects expression increases expression
|
EXP
|
Acrylamide affects the expression of H2AJ mRNA Acrylamide results in increased expression of H2AJ mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:171,406,922...171,407,406
Ensembl chr 4:171,406,177...171,408,845
|
|
| G
|
H2ap
|
H2A.P histone
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of H2AP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:15,580,476...15,581,030
Ensembl chr X:15,580,359...15,581,315
|
|
| G
|
H2ax
|
H2A.X variant histone
|
increases expression multiple interactions
|
ISO EXP
|
Acrylamide results in increased expression of H2AX protein Selenium inhibits the reaction [Acrylamide results in increased expression of H2AX protein]
|
CTD |
PMID:36599426 PMID:36997053 PMID:37987225 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
H2bc12
|
H2B clustered histone 12
|
increases expression
|
ISO
|
Acrylamide results in increased expression of H2BC12 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:47,181,477...47,181,940
Ensembl chr17:47,121,467...47,182,816
|
|
| G
|
H2bc14
|
H2B clustered histone 14
|
increases expression
|
ISO
|
Acrylamide results in increased expression of H2BC5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:47,488,627...47,489,008
|
|
| G
|
H2bc6
|
H2B clustered histone 6
|
increases expression
|
ISO
|
Acrylamide results in increased expression of H2BC6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:41,948,813...41,949,276
Ensembl chr17:47,392,229...47,449,312
|
|
| G
|
H2bc8
|
H2B clustered histone 8
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of H2BC7 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr17:47,404,405...47,405,155
|
|
| G
|
H3c1
|
H3 clustered histone 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of H3C1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:41,796,236...41,796,759
Ensembl chr17:41,795,396...41,797,281 Ensembl chr17:41,795,396...41,797,281
|
|
| G
|
H3f3b
|
H3.3 histone B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of H3F3B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:101,755,404...101,764,616
Ensembl chr10:101,755,404...101,757,636
|
|
| G
|
H6pd
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of H6PD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:165,717,456...165,753,158
Ensembl chr 5:165,721,654...165,753,125
|
|
| G
|
Haao
|
3-hydroxyanthranilate 3,4-dioxygenase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HAAO mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:16,598,325...16,617,590
Ensembl chr 6:16,598,087...16,617,356
|
|
| G
|
Habp4
|
hyaluronan binding protein 4
|
affects methylation
|
ISO
|
Acrylamide affects the methylation of HABP4 gene
|
CTD |
PMID:35032568 |
|
NCBI chr17:940,672...963,358
Ensembl chr17:941,389...963,300
|
|
| G
|
Hacd3
|
3-hydroxyacyl-CoA dehydratase 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HACD3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:74,396,441...74,433,700
Ensembl chr 8:74,396,442...74,433,700
|
|
| G
|
Hacd4
|
3-hydroxyacyl-CoA dehydratase 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HACD4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:107,935,514...107,961,271
Ensembl chr 5:107,934,937...107,962,836
|
|
| G
|
Hagh
|
hydroxyacyl glutathione hydrolase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HAGH mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:14,379,400...14,394,046
Ensembl chr10:14,382,410...14,394,043
|
|
| G
|
Haghl
|
hydroxyacylglutathione hydrolase-like
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HAGHL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:15,309,469...15,313,910
Ensembl chr10:15,308,668...15,312,181
|
|
| G
|
Hamp
|
hepcidin antimicrobial peptide
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HAMP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297
|
|
| G
|
Hao1
|
hydroxyacid oxidase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HAO1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:142,102,873...142,281,527
Ensembl chr 3:142,224,612...142,281,494
|
|
| G
|
Hap1
|
huntingtin-associated protein 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HAP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:85,778,267...85,786,553
Ensembl chr10:85,778,267...85,786,503
|
|
| G
|
Hapln1
|
hyaluronan and proteoglycan link protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HAPLN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:22,366,967...22,431,709
Ensembl chr 2:22,366,967...22,429,098
|
|
| G
|
Hars1
|
histidyl-tRNA synthetase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HARS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:28,655,669...28,672,712
Ensembl chr18:28,655,671...28,672,712
|
|
| G
|
Has1
|
hyaluronan synthase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HAS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:67,366,460...67,378,686
Ensembl chr 1:67,366,460...67,378,444
|
|
| G
|
Has2
|
hyaluronan synthase 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HAS2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:90,002,929...90,028,933
Ensembl chr 7:90,002,929...90,018,535
|
|
| G
|
Haspin
|
histone H3 associated protein kinase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HASPIN mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr10:58,246,244...58,249,031
Ensembl chr10:58,240,447...58,249,249
|
|
| G
|
Hat1
|
histone acetyltransferase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HAT1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:76,624,442...76,672,701
Ensembl chr 3:76,624,869...76,672,696
|
|
| G
|
Haus4
|
HAUS augmin-like complex, subunit 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HAUS4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:31,964,555...31,976,853
Ensembl chr15:31,964,556...31,975,941
|
|
| G
|
Haus5
|
HAUS augmin-like complex, subunit 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HAUS5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:95,039,800...95,050,778
Ensembl chr 1:95,039,800...95,050,778
|
|
| G
|
Haus8
|
HAUS augmin-like complex, subunit 8
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HAUS8 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:17,964,813...17,979,313
Ensembl chr16:17,964,814...17,979,192
|
|
| G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
affects expression increases expression multiple interactions
|
EXP
|
Acrylamide affects the expression of HAVCR1 mRNA Acrylamide results in increased expression of HAVCR1 protein vinpocetine inhibits the reaction [Acrylamide results in increased expression of HAVCR1 protein]
|
CTD |
PMID:28959563 PMID:38348719 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268
|
|
| G
|
Hbegf
|
heparin-binding EGF-like growth factor
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of HBEGF mRNA Acrylamide results in increased expression of HBEGF mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220
|
|
| G
|
Hbs1l
|
HBS1-like translational GTPase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HBS1L mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:17,912,139...17,989,651
Ensembl chr 1:17,912,070...17,989,646
|
|
| G
|
Hbz
|
hemoglobin subunit zeta
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HBZ mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:15,848,279...15,849,757
Ensembl chr10:15,848,289...15,849,768
|
|
| G
|
Hcar2
|
hydroxycarboxylic acid receptor 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HCAR2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:38,387,163...38,389,149
Ensembl chr12:38,387,230...38,389,391
|
|
| G
|
Hccs
|
holocytochrome c synthase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HCCS mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:28,505,370...28,514,812
Ensembl chr X:28,505,417...28,514,812
|
|
| G
|
Hcrtr1
|
hypocretin receptor 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HCRTR1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 5:147,761,392...147,771,846
Ensembl chr 5:147,760,145...147,770,850
|
|
| G
|
Hdac1
|
histone deacetylase 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of HDAC1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387
|
|
| G
|
Hdac11
|
histone deacetylase 11
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of HDAC11 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:125,203,044...125,224,584
Ensembl chr 4:125,202,299...125,224,582
|
|
| G
|
Hdac4
|
histone deacetylase 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HDAC4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:99,950,972...100,200,994
Ensembl chr 9:99,955,116...100,197,637
|
|
| G
|
Hdac5
|
histone deacetylase 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HDAC5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,652,656...87,694,244
|
|
| G
|
Hdac6
|
histone deacetylase 6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HDAC6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:17,222,538...17,244,373
Ensembl chr X:17,222,856...17,244,370
|
|
| G
|
Hdac7
|
histone deacetylase 7
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HDAC7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:130,803,013...130,841,181
Ensembl chr 7:130,803,013...130,841,017
|
|
| G
|
Hdac9
|
histone deacetylase 9
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HDAC9 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 6:56,489,472...57,351,654
Ensembl chr 6:56,490,988...57,351,835
|
|
| G
|
Hdc
|
histidine decarboxylase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HDC mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:134,300,628...134,318,704
Ensembl chr 3:134,300,632...134,318,711
|
|
| G
|
Hddc3
|
HD domain containing 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HDDC3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:143,708,703...143,711,010
Ensembl chr 1:143,705,320...143,711,010
|
|
| G
|
Hdgf
|
heparin binding growth factor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HDGF mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:175,668,290...175,677,614
Ensembl chr 2:175,668,324...175,677,225
|
|
| G
|
Hdlbp
|
high density lipoprotein binding protein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HDLBP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:101,395,491...101,465,446
Ensembl chr 9:101,397,305...101,465,379
|
|
| G
|
Hdx
|
highly divergent homeobox
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HDX mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:80,739,615...80,881,621
Ensembl chr X:80,739,615...80,881,512
|
|
| G
|
Heatr1
|
HEAT repeat containing 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HEATR1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:62,745,008...62,785,609
Ensembl chr17:62,745,008...62,785,186
|
|
| G
|
Heatr4
|
HEAT repeat containing 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HEATR4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:109,305,459...109,338,331
Ensembl chr 6:109,304,557...109,342,693
|
|
| G
|
Heatr6
|
HEAT repeat containing 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HEATR6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:69,132,532...69,161,334
Ensembl chr10:69,132,181...69,162,945
|
|
| G
|
Hebp1
|
heme binding protein 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HEBP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:169,705,665...169,735,199
Ensembl chr 4:169,705,668...169,735,199
|
|
| G
|
Hebp2
|
heme binding protein 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HEBP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:15,014,729...15,021,523
Ensembl chr 1:15,014,729...15,021,523
|
|
| G
|
Hectd1
|
HECT domain E3 ubiquitin protein ligase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HECTD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:74,916,803...75,003,408
Ensembl chr 6:74,916,803...75,003,408
|
|
| G
|
Helb
|
DNA helicase B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HELB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:57,474,115...57,502,221
Ensembl chr 7:57,474,184...57,501,225
|
|
| G
|
Hells
|
helicase, lymphoid specific
|
increases expression
|
ISO EXP
|
Acrylamide results in increased expression of HELLS protein Acrylamide results in increased expression of HELLS mRNA
|
CTD |
PMID:20025956 PMID:28959563 |
|
NCBI chr 1:246,113,580...246,159,230
Ensembl chr 1:246,114,096...246,159,228
|
|
| G
|
Helq
|
helicase, POLQ-like
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HELQ mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:9,122,978...9,167,310
Ensembl chr14:9,122,978...9,167,310
|
|
| G
|
Helz2
|
helicase with zinc finger 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HELZ2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:188,716,370...188,730,776
Ensembl chr 3:188,716,370...188,730,716
|
|
| G
|
Hemk1
|
HemK methyltransferase family member 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HEMK1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:116,878,317...116,889,342
Ensembl chr 8:116,878,318...116,888,873
|
|
| G
|
Herc3
|
HECT and RLD domain containing E3 ubiquitin protein ligase 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HERC3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:89,282,374...89,372,656
Ensembl chr 4:89,282,445...89,372,652
|
|
| G
|
Herc4
|
HECT and RLD domain containing E3 ubiquitin protein ligase 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HERC4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:25,329,005...25,403,443
Ensembl chr20:25,328,822...25,403,372
|
|
| G
|
Herpud1
|
homocysteine inducible ER protein with ubiquitin like domain 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HERPUD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081
|
|
| G
|
Hes1
|
hes family bHLH transcription factor 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of HES1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061
|
|
| G
|
Hes6
|
hes family bHLH transcription factor 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HES6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:99,449,375...99,451,343
Ensembl chr 9:99,449,371...99,451,096
|
|
| G
|
Hexd
|
hexosaminidase D
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HEXD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:106,978,426...107,002,252
Ensembl chr10:106,978,165...106,997,083
|
|
| G
|
Hey2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of HEY2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:28,641,100...28,651,187
Ensembl chr 1:28,641,057...28,651,187
|
|
| G
|
Hfe
|
homeostatic iron regulator
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HFE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:41,841,302...41,849,359
Ensembl chr17:41,841,252...41,851,208
|
|
| G
|
Hgfac
|
HGF activator
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HGFAC mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:79,932,219...79,938,773
Ensembl chr14:79,932,222...79,939,029
|
|
| G
|
Hgh1
|
HGH1 homolog
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HGH1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:109,972,079...109,975,398
Ensembl chr 7:109,972,609...109,975,395
|
|
| G
|
Hgsnat
|
heparan-alpha-glucosaminide N-acetyltransferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HGSNAT mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:72,807,967...72,840,180
Ensembl chr16:72,807,849...72,840,176
|
|
| G
|
Hhatl
|
hedgehog acyltransferase-like
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HHATL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:130,324,510...130,331,580
Ensembl chr 8:130,324,510...130,331,509
|
|
| G
|
Hhipl2
|
HHIP like 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HHIPL2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:97,586,296...97,606,223
Ensembl chr13:97,586,341...97,606,223
|
|
| G
|
Hiat1-ps1
|
hippocampus abundant gene transcript 1, pseudogene 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HIAT1-PS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:75,789,216...75,792,142
|
|
| G
|
Hic1
|
HIC ZBTB transcriptional repressor 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HIC1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:60,512,855...60,517,812
Ensembl chr10:60,500,565...60,523,448
|
|
| G
|
Hic2
|
HIC ZBTB transcriptional repressor 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HIC2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:97,241,308...97,294,429
Ensembl chr11:97,240,704...97,271,713
|
|
| G
|
Hid1
|
HID1 domain containing
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HID1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:101,088,526...101,109,011
Ensembl chr10:101,088,526...101,109,011
|
|
| G
|
Hif3a
|
hypoxia inducible factor 3 subunit alpha
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HIF3A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:86,846,196...86,878,527
Ensembl chr 1:86,850,554...86,877,838
|
|
| G
|
Higd1b
|
HIG1 hypoxia inducible domain family, member 1B
|
affects expression
|
EXP
|
Acrylamide affects the expression of HIGD1B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:88,302,284...88,304,558
Ensembl chr10:88,302,790...88,304,558
|
|
| G
|
Hikeshi
|
heat shock protein nuclear import factor hikeshi
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HIKESHI mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:153,237,948...153,261,856
Ensembl chr 1:153,237,948...153,261,911
|
|
| G
|
Hilpda
|
hypoxia inducible lipid droplet-associated
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HILPDA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:58,836,463...58,839,423
Ensembl chr 4:58,836,463...58,839,423
|
|
| G
|
Hils1
|
histone linker H1 domain, spermatid-specific 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of H1F9 mRNA
|
CTD |
PMID:21319176 |
|
NCBI chr10:80,410,361...80,411,157
Ensembl chr10:80,399,812...80,411,157
|
|
| G
|
Hint1
|
histidine triad nucleotide binding protein 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HINT1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:39,490,225...39,493,970
Ensembl chr 4:93,430,926...93,431,642 Ensembl chr10:93,430,926...93,431,642
|
|
| G
|
Hint2
|
histidine triad nucleotide binding protein 2
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of HINT2 mRNA Acrylamide results in decreased expression of HINT2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:62,700,383...62,702,638
Ensembl chr 5:62,700,384...62,702,915
|
|
| G
|
Hip1r
|
huntingtin interacting protein 1 related
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HIP1R mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:38,251,085...38,279,756
Ensembl chr12:38,251,086...38,279,654
|
|
| G
|
Hipk2
|
homeodomain interacting protein kinase 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HIPK2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:68,399,358...68,586,404
Ensembl chr 4:68,369,099...68,586,108
|
|
| G
|
Hipk3
|
homeodomain interacting protein kinase 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HIPK3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:111,251,863...111,322,815
Ensembl chr 3:111,251,863...111,322,772
|
|
| G
|
Hirip3
|
HIRA interacting protein 3
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of HIRIP3 mRNA Acrylamide results in decreased expression of HIRIP3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:190,903,065...190,905,610
Ensembl chr 1:190,902,593...190,905,607
|
|
| G
|
Hk1
|
hexokinase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HK1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,773,220...30,874,814
|
|
| G
|
Hk2
|
hexokinase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HK2 mRNA
|
CTD |
PMID:21319176 PMID:32763439 |
|
NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:116,792,258...116,841,275
|
|
| G
|
Hlf
|
HLF transcription factor, PAR bZIP family member
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HLF mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:75,651,320...75,708,979
Ensembl chr10:75,654,534...75,708,619
|
|
| G
|
Hlx
|
H2.0-like homeobox
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of HLX mRNA Acrylamide results in increased expression of HLX mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr13:98,811,852...98,817,264
Ensembl chr13:98,811,856...98,817,264
|
|
| G
|
Hm13
|
histocompatibility minor 13
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HM13 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:161,606,059...161,641,382
Ensembl chr 3:161,606,052...161,644,805
|
|
| G
|
Hmga1
|
high mobility group AT-hook 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HMGA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:5,612,902...5,620,596
Ensembl chr20:5,613,471...5,620,593
|
|
| G
|
Hmga2
|
high mobility group AT-hook 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HMGA2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:57,762,710...57,884,555
Ensembl chr 7:57,765,675...57,880,341
|
|
| G
|
Hmgb3
|
high mobility group box 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HMGB3 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr X:154,341,106...154,346,087
Ensembl chr X:154,340,935...154,346,097
|
|
| G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
increases expression multiple interactions
|
EXP ISO
|
Acrylamide results in increased expression of HMGCR mRNA Acrylamide inhibits the reaction [Streptozocin results in increased expression of HMGCR mRNA]
|
CTD |
PMID:28959563 PMID:34896238 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
| G
|
Hmgcs2
|
3-hydroxy-3-methylglutaryl-CoA synthase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HMGCS2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242
|
|
| G
|
Hmgn3
|
high mobility group nucleosomal binding domain 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HMGN3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:92,902,555...92,939,980
|
|
| G
|
Hmgxb4
|
HMG-box containing 4
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of HMGXB4 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr19:13,370,559...13,409,306
Ensembl chr19:13,370,376...13,409,306
|
|
| G
|
Hmmr
|
hyaluronan-mediated motility receptor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HMMR mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,635,915...25,665,390
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
increases expression multiple interactions
|
ISO EXP
|
Acrylamide results in increased expression of HMOX1 mRNA; Acrylamide results in increased expression of HMOX1 protein [NLRP3 gene mutant form affects the susceptibility to Acrylamide] which results in increased expression of HMOX1 protein pyrazolanthrone inhibits the reaction [Acrylamide results in increased expression of HMOX1 mRNA]; U 0126 inhibits the reaction [Acrylamide results in increased expression of HMOX1 mRNA]
|
CTD |
PMID:27836571 PMID:28526328 PMID:28606764 PMID:29426002 PMID:32014472 PMID:32763439 PMID:33872730 More...
|
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hmx2
|
H6 family homeobox 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HMX2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:195,749,284...195,758,347
Ensembl chr 1:195,749,284...195,756,945
|
|
| G
|
Hnf1b
|
HNF1 homeobox B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HNF1B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:69,233,377...69,287,360
Ensembl chr10:69,233,131...69,287,361
|
|
| G
|
Hnf4a
|
hepatocyte nuclear factor 4, alpha
|
multiple interactions decreases expression
|
ISO EXP
|
Acrylamide inhibits the reaction [Streptozocin results in increased expression of HNF4A mRNA] Acrylamide results in decreased expression of HNF4A mRNA [Acrylamide co-treated with INS protein] results in decreased expression of HNF4A mRNA
|
CTD |
PMID:34896238 PMID:38604440 |
|
NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:172,606,220...172,667,758
|
|
| G
|
Hnmt
|
histamine N-methyltransferase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HNMT mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 3:26,978,274...27,010,291
Ensembl chr 3:26,977,933...27,010,482
|
|
| G
|
Hnrnpa2b1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HNRNPA2B1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:81,867,354...81,875,886
Ensembl chr 4:81,869,661...81,877,572
|
|
| G
|
Hnrnpa3
|
heterogeneous nuclear ribonucleoprotein A3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HNRNPA3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:80,984,470...80,999,413
Ensembl chr 3:80,985,969...80,996,043
|
|
| G
|
Hnrnpr
|
heterogeneous nuclear ribonucleoprotein R
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HNRNPR mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:153,826,482...153,872,272
Ensembl chr 5:153,826,692...153,858,344
|
|
| G
|
Hnrnpu
|
heterogeneous nuclear ribonucleoprotein U
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HNRNPU mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:92,609,791...92,618,580
Ensembl chr13:92,605,216...92,618,612
|
|
| G
|
Hnrnpul2
|
heterogeneous nuclear ribonucleoprotein U-like 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HNRNPUL2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:215,142,750...215,154,668
Ensembl chr 1:215,142,644...215,155,161
|
|
| G
|
Hoatz
|
HOATZ cilia and flagella associated protein
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HOATZ mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 8:60,284,745...60,306,687
Ensembl chr 8:60,283,904...60,305,377
|
|
| G
|
Hoxa2
|
homeobox A2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HOXA2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:82,593,389...82,597,589
Ensembl chr 4:82,593,389...82,595,692
|
|
| G
|
Hoxb2
|
homeobox B2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HOXB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:81,814,340...81,816,731
Ensembl chr10:81,814,340...81,816,726
|
|
| G
|
Hoxc6
|
homeo box C6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HOXC6 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 7:136,013,679...136,051,601
Ensembl chr 7:136,024,961...136,027,365
|
|
| G
|
Hoxc9
|
homeobox C9
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HOXC9 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:135,997,292...135,999,969
Ensembl chr 7:135,992,023...135,999,964
|
|
| G
|
Hpd
|
4-hydroxyphenylpyruvate dioxygenase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HPD mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:39,042,246...39,053,596
Ensembl chr12:39,042,238...39,053,612
|
|
| G
|
Hpdl
|
4-hydroxyphenylpyruvate dioxygenase-like
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HPDL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:135,523,258...135,524,864
Ensembl chr 5:135,523,262...135,535,704
|
|
| G
|
Hprt1
|
hypoxanthine phosphoribosyltransferase 1
|
increases mutagenesis increases expression
|
ISO EXP
|
Acrylamide results in increased mutagenesis of HPRT1 gene Acrylamide results in increased expression of HPRT1 mRNA
|
CTD |
PMID:15957192 PMID:18407966 PMID:20200216 PMID:32763439 |
|
NCBI chr X:137,655,744...137,687,718
Ensembl chr X:137,655,680...137,687,712
|
|
| G
|
Hps1
|
HPS1, biogenesis of lysosomal organelles complex 3 subunit 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of HPS1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:251,500,427...251,526,529
Ensembl chr 1:251,500,427...251,526,739
|
|
| G
|
Hps5
|
HPS5, biogenesis of lysosomal organelles complex 2 subunit 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HPS5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:106,417,902...106,457,220
Ensembl chr 1:106,417,902...106,452,859
|
|
| G
|
Hps6
|
HPS6, biogenesis of lysosomal organelles complex 2 subunit 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HPS6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:254,802,250...254,804,859
Ensembl chr 1:254,802,119...254,804,937
|
|
| G
|
Hpse
|
heparanase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HPSE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:9,200,971...9,241,377
Ensembl chr14:9,188,275...9,241,754
|
|
| G
|
Hpx
|
hemopexin
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HPX mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:169,344,647...169,352,155
Ensembl chr 1:169,344,583...169,352,156
|
|
| G
|
Hras
|
HRas proto-oncogene, GTPase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HRAS mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590
|
|
| G
|
Hrh3
|
histamine receptor H3
|
decreases expression affects methylation
|
ISO
|
Acrylamide results in decreased expression of HRH3 mRNA Acrylamide affects the methylation of HRH3 gene
|
CTD |
PMID:32763439 PMID:35032568 |
|
NCBI chr 3:187,569,174...187,575,263
Ensembl chr 3:187,569,175...187,574,259
|
|
| G
|
Hrh4
|
histamine receptor H4
|
affects methylation
|
ISO
|
Acrylamide affects the methylation of HRH4 gene
|
CTD |
PMID:35032568 |
|
NCBI chr18:4,440,977...4,457,132
Ensembl chr18:4,440,977...4,457,132
|
|
| G
|
Hrk
|
harakiri, BCL2 interacting protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HRK mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr12:44,048,402...44,070,561
Ensembl chr12:44,048,402...44,070,561
|
|
| G
|
Hrob
|
homologous recombination factor with OB-fold
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HROB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:87,705,846...87,722,635
Ensembl chr10:87,706,194...87,722,635
|
|
| G
|
Hs3st3a1
|
heparan sulfate-glucosamine 3-sulfotransferase 3A1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HS3ST3A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:49,593,208...49,679,854
Ensembl chr10:49,593,009...49,679,854
|
|
| G
|
Hs6st2
|
heparan sulfate 6-O-sulfotransferase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HS6ST2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:135,887,224...136,182,388
Ensembl chr X:135,888,472...136,182,353
|
|
| G
|
Hs6st3
|
heparan sulfate 6-O-sulfotransferase 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HS6ST3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:102,688,420...103,407,725
Ensembl chr15:102,688,365...103,408,384
|
|
| G
|
Hsbp1l1
|
heat shock factor binding protein 1-like 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HSBP1L1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:75,957,266...75,963,024
Ensembl chr18:75,957,266...75,963,024
|
|
| G
|
Hscb
|
HscB mitochondrial iron-sulfur cluster co-chaperone
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HSCB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:51,481,318...51,491,689
Ensembl chr12:51,481,326...51,501,507
|
|
| G
|
Hsd17b11
|
hydroxysteroid (17-beta) dehydrogenase 11
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HSD17B11 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:5,997,893...6,047,816
Ensembl chr14:5,997,906...6,047,811
|
|
| G
|
Hsd17b3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
decreases expression multiple interactions
|
EXP
|
Acrylamide results in decreased expression of HSD17B3 mRNA Selenium inhibits the reaction [Acrylamide results in decreased expression of HSD17B3 mRNA]
|
CTD |
PMID:37987225 PMID:38614435 |
|
NCBI chr17:1,032,958...1,064,283
Ensembl chr17:1,032,958...1,064,283
|
|
| G
|
Hsd17b6
|
hydroxysteroid (17-beta) dehydrogenase 6
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HSD17B6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:831,407...850,950
Ensembl chr 7:831,421...850,873
|
|
| G
|
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HSD3B1 mRNA
|
CTD |
PMID:34906654 |
|
NCBI chr 2:188,858,574...188,864,694
|
|
| G
|
Hsf1
|
heat shock transcription factor 1
|
increases phosphorylation
|
ISO
|
Acrylamide results in increased phosphorylation of HSF1 protein
|
CTD |
PMID:16129430 |
|
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665
|
|
| G
|
Hsf4
|
heat shock transcription factor 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HSF4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:50,057,331...50,068,134
Ensembl chr19:50,057,672...50,063,404
|
|
| G
|
Hsf5
|
heat shock transcription factor 5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HSF5 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr10:72,913,730...72,957,649
Ensembl chr10:72,914,382...72,957,648
|
|
| G
|
Hsp90aa1
|
heat shock protein 90 alpha family class A member 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HSP90AA1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499
|
|
| G
|
Hsp90ab1
|
heat shock protein 90 alpha family class B member 1
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of HSP90AB1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926
|
|
| G
|
Hspa12b
|
heat shock protein family A (Hsp70) member 12B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HSPA12B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:138,799,396...138,817,396
Ensembl chr 3:138,799,398...138,818,935
|
|
| G
|
Hspa13
|
heat shock protein family A (Hsp70) member 13
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HSPA13 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:27,862,717...27,876,898
Ensembl chr11:27,862,593...27,876,898
|
|
| G
|
Hspa14
|
heat shock protein family A (Hsp70) member 14
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HSPA14 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:79,638,106...79,658,888
Ensembl chr17:79,638,058...79,658,885
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of HSPA1A mRNA Acrylamide results in increased expression of HSPA1A mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa1b
|
heat shock protein family A (Hsp70) member 1B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HSPA1B mRNA
|
CTD |
PMID:32763439 PMID:35032568 |
|
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa1l
|
heat shock protein family A (Hsp70) member 1 like
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of HSPA1L mRNA Acrylamide results in increased expression of HSPA1L mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr20:3,853,496...3,860,223
Ensembl chr20:3,853,331...3,876,877
|
|
| G
|
Hspa2
|
heat shock protein family A (Hsp70) member 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of HSPA2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:100,864,553...100,867,133
|
|
| G
|
Hspa4
|
heat shock protein family A (Hsp70) member 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HSPA4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,908,866...37,949,835
|
|
| G
|
Hspa4l
|
heat shock protein family A (Hsp70) member 4 like
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HSPA4L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:125,668,346...125,726,404
Ensembl chr 2:125,668,236...125,720,986
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression multiple interactions
|
EXP
|
Acrylamide results in increased expression of HSPA5 mRNA; Acrylamide results in increased expression of HSPA5 protein 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Acrylamide promotes the reaction [elaidic acid results in increased expression of HSPA5 protein]]; 4-phenylbutyric acid inhibits the reaction [elaidic acid promotes the reaction [Acrylamide results in increased expression of HSPA5 protein]]; [INS co-treated with Acrylamide] results in increased expression of HSPA5 protein; Acetylcysteine inhibits the reaction [[INS co-treated with Acrylamide] results in increased expression of HSPA5 protein]; Acrylamide promotes the reaction [elaidic acid results in increased expression of HSPA5 protein]; elaidic acid promotes the reaction [Acrylamide results in increased expression of HSPA5 protein]; INS promotes the reaction [Acrylamide results in increased expression of HSPA5 mRNA]
|
CTD |
PMID:33421551 PMID:37353096 PMID:38604440 PMID:38740238 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Hspa6l-ps1
|
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HSPA6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:85,805,911...85,807,052
|
|
| G
|
Hspa8
|
heat shock protein family A (Hsp70) member 8
|
multiple interactions increases expression decreases expression
|
EXP ISO
|
Tacrolimus inhibits the reaction [Acrylamide results in decreased expression of HSPA8 protein] Acrylamide results in increased expression of HSPA8 mRNA
|
CTD |
PMID:15081597 PMID:28959563 PMID:32763439 |
|
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
|
|
| G
|
Hspa9
|
heat shock protein family A (Hsp70) member 9
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Acrylamide results in increased expression of HSPA9 mRNA Acrylamide promotes the reaction [elaidic acid promotes the reaction [ITPR1 protein binds to HSPA9 protein]]; Acrylamide promotes the reaction [elaidic acid promotes the reaction [VDAC1 protein binds to HSPA9 protein]]; Acrylamide promotes the reaction [ITPR1 protein binds to HSPA9 protein]; Acrylamide promotes the reaction [VDAC1 protein binds to HSPA9 protein]; elaidic acid promotes the reaction [Acrylamide promotes the reaction [ITPR1 protein binds to HSPA9 protein]]; elaidic acid promotes the reaction [Acrylamide promotes the reaction [VDAC1 protein binds to HSPA9 protein]] Acrylamide results in decreased expression of HSPA9 protein acetylleucyl-leucyl-norleucinal inhibits the reaction [Acrylamide results in decreased expression of HSPA9 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Acrylamide results in decreased expression of HSPA9 protein]
|
CTD |
PMID:32763439 PMID:37353096 PMID:38740238 |
|
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398
|
|
| G
|
Hspb1
|
heat shock protein family B (small) member 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of HSPB1 mRNA Acrylamide results in increased expression of HSPB1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301
|
|
| G
|
Hspb2
|
heat shock protein family B (small) member 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HSPB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:59,989,640...59,991,215
Ensembl chr 8:59,976,623...59,990,901
|
|
| G
|
Hspb3
|
heat shock protein family B (small) member 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HSPB3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:47,028,451...47,029,165
Ensembl chr 2:47,024,757...47,029,373
|
|
| G
|
Hspb6
|
heat shock protein family B (small) member 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HSPB6 mRNA
|
CTD |
PMID:32763439 PMID:35032568 |
|
NCBI chr 1:94,934,372...94,936,516
Ensembl chr 1:94,933,543...94,936,512
|
|
| G
|
Hspb7
|
heat shock protein family B (small) member 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HSPB7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:159,010,759...159,014,245
Ensembl chr 5:159,010,629...159,014,243
|
|
| G
|
Hspb8
|
heat shock protein family B (small) member 8
|
affects expression
|
EXP
|
Acrylamide affects the expression of HSPB8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:45,835,899...45,866,449
Ensembl chr12:45,837,066...45,851,937
|
|
| G
|
Hspb9
|
heat shock protein family B (small) member 9
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HSPB9 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:86,141,603...86,142,248
Ensembl chr10:86,141,269...86,147,839
|
|
| G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HSPD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
| G
|
Hspe1
|
heat shock protein family E (Hsp10) member 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HSPE1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:64,084,327...64,087,415
Ensembl chr 9:64,085,068...64,087,502
|
|
| G
|
Hspg2
|
heparan sulfate proteoglycan 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HSPG2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:154,960,818...155,061,971
Ensembl chr 5:154,960,846...155,061,971
|
|
| G
|
Hsph1
|
heat shock protein family H (Hsp110) member 1
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of HSPH1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891
|
|
| G
|
Htatip2
|
HIV-1 Tat interactive protein 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HTATIP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:108,609,424...108,624,810
Ensembl chr 1:108,605,811...108,624,815
|
|
| G
|
Htr2a
|
5-hydroxytryptamine receptor 2A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HTR2A mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:56,359,596...56,431,619
|
|
| G
|
Htr3a
|
5-hydroxytryptamine receptor 3A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HTR3A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:58,138,226...58,150,884
|
|
| G
|
Htr6
|
5-hydroxytryptamine receptor 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HTR6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:156,579,901...156,595,147
Ensembl chr 5:156,579,901...156,595,147
|
|
| G
|
Htra1
|
HtrA serine peptidase 1
|
increases expression decreases expression
|
ISO
|
Acrylamide results in increased expression of HTRA1 mRNA Acrylamide results in decreased expression of HTRA1 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr 1:194,928,069...194,977,619
Ensembl chr 1:194,927,687...194,977,620
|
|
| G
|
Hunk
|
hormonally upregulated Neu-associated kinase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HUNK mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:43,127,244...43,244,502
Ensembl chr11:43,127,244...43,244,502
|
|
| G
|
Hyal2
|
hyaluronidase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HYAL2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:117,121,802...117,125,494
Ensembl chr 8:117,121,787...117,125,493
|
|
| G
|
Hycc2
|
hyccin PI4KA lipid kinase complex subunit 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HYCC2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:67,551,064...67,623,353
Ensembl chr 9:67,551,064...67,587,186
|
|
| G
|
Hydin
|
Hydin, axonemal central pair apparatus protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HYDIN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:55,146,382...55,492,660
Ensembl chr19:55,146,466...55,492,660
|
|
| G
|
Hyi
|
hydroxypyruvate isomerase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of HYI mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:137,179,975...137,182,654
Ensembl chr 5:137,179,976...137,182,654
|
|
| G
|
Hypk
|
Huntingtin interacting protein K
|
increases expression
|
ISO
|
Acrylamide results in increased expression of HYPK mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:128,888,709...128,890,089
Ensembl chr 3:128,888,717...128,891,405
|
|
| G
|
Iah1
|
isoamyl acetate hydrolyzing esterase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IAH1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:46,594,177...46,601,394
Ensembl chr 6:46,594,080...46,601,392
|
|
| G
|
Iapp
|
islet amyloid polypeptide
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IAPP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:176,968,097...176,975,363
Ensembl chr 4:176,968,097...176,975,363
|
|
| G
|
Iars1
|
isoleucyl-tRNA synthetase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of IARS1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:15,147,357...15,193,716
Ensembl chr17:15,147,357...15,193,652
|
|
| G
|
Ica1
|
islet cell autoantigen 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ICA1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 4:37,622,759...37,771,055
Ensembl chr 4:37,622,759...37,770,569
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ICAM1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Icam5
|
intercellular adhesion molecule 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ICAM5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:27,843,563...27,851,767
Ensembl chr 8:27,844,780...27,857,104
|
|
| G
|
Id4
|
inhibitor of DNA binding 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ID4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:16,595,724...16,598,293
Ensembl chr17:16,595,724...16,598,492
|
|
| G
|
Ide
|
insulin degrading enzyme
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IDE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:244,415,495...244,516,925
Ensembl chr 1:244,416,343...244,514,526
|
|
| G
|
Idh1
|
isocitrate dehydrogenase (NADP(+)) 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IDH1 protein
|
CTD |
PMID:39082229 |
|
NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:74,027,892...74,049,555
|
|
| G
|
Idh2
|
isocitrate dehydrogenase (NADP(+)) 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IDH2 mRNA Acrylamide results in decreased expression of IDH2 protein
|
CTD |
PMID:32763439 PMID:39082229 |
|
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:143,439,323...143,467,248
|
|
| G
|
Idh3a
|
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IDH3A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:63,867,882...63,887,223
Ensembl chr 8:63,867,820...63,887,223
|
|
| G
|
Idi2l3
|
isopentenyl-diphosphate delta isomerase 2 like 3
|
affects expression
|
EXP
|
Acrylamide affects the expression of IDI2L3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:66,243,932...66,258,028
|
|
| G
|
Idua
|
alpha-L-iduronidase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IDUA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:1,175,994...1,203,913
Ensembl chr14:1,176,577...1,204,066
|
|
| G
|
Ier2
|
immediate early response 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of IER2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:40,399,373...40,400,897
Ensembl chr19:40,398,160...40,402,708
|
|
| G
|
Ier3
|
immediate early response 3
|
affects expression increases expression
|
ISO
|
Acrylamide affects the expression of IER3 mRNA Acrylamide results in increased expression of IER3 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377
|
|
| G
|
Ier5
|
immediate early response 5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of IER5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:69,820,450...69,822,542
Ensembl chr13:69,820,451...69,822,543
|
|
| G
|
Ier5l
|
immediate early response 5-like
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of IER5L mRNA Acrylamide results in increased expression of IER5L mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:34,141,866...34,143,457
Ensembl chr 3:34,139,672...34,144,452
|
|
| G
|
Ifi27
|
interferon, alpha-inducible protein 27
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of IFI27 mRNA Acrylamide results in increased expression of IFI27 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 6:128,355,312...128,361,783
Ensembl chr 6:128,355,079...128,361,781
|
|
| G
|
Ifit2
|
interferon-induced protein with tetratricopeptide repeats 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of IFIT2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:241,515,735...241,521,799
Ensembl chr 1:241,515,709...241,521,798
|
|
| G
|
Ifitm10
|
interferon induced transmembrane protein 10
|
increases expression
|
ISO
|
Acrylamide results in increased expression of IFITM10 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:206,936,979...206,954,594
Ensembl chr 1:206,936,444...206,954,629
|
|
| G
|
Ifna1
|
interferon, alpha 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IFNA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:108,143,240...108,143,809
Ensembl chr 5:108,143,240...108,143,809
|
|
| G
|
Ifng
|
interferon gamma
|
multiple interactions increases expression
|
EXP ISO
|
boric acid inhibits the reaction [Acrylamide results in increased expression of IFNG mRNA] Acrylamide results in increased expression of IFNG mRNA; Acrylamide results in increased expression of IFNG protein
|
CTD |
PMID:29913234 PMID:38152866 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Ifngr1
|
interferon gamma receptor 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IFNGR1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:16,152,811...16,171,439
Ensembl chr 1:16,152,879...16,171,437
|
|
| G
|
Ifrd2
|
interferon-related developmental regulator 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IFRD2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:117,139,612...117,144,834
Ensembl chr 8:117,139,550...117,144,836
|
|
| G
|
Ift122
|
intraflagellar transport 122
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IFT122 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:150,577,525...150,648,052
Ensembl chr 4:150,539,786...150,648,052
|
|
| G
|
Ift140
|
intraflagellar transport 140
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IFT140 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:14,537,134...14,624,926
Ensembl chr10:14,537,466...14,624,926
|
|
| G
|
Ift22
|
intraflagellar transport 22
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IFT22 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:25,397,092...25,405,522
Ensembl chr12:25,387,347...25,405,510
|
|
| G
|
Ift27
|
intraflagellar transport 27
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IFT27 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:111,619,145...111,635,129
Ensembl chr 7:111,619,077...111,634,936
|
|
| G
|
Ift70a1
|
intraflagellar transport 70A1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IFT70A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:81,309,158...81,312,612
|
|
| G
|
Igdcc3
|
immunoglobulin superfamily, DCC subclass, member 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IGDCC3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:74,556,348...74,603,136
Ensembl chr 8:74,556,348...74,603,136
|
|
| G
|
Igdcc4
|
immunoglobulin superfamily, DCC subclass, member 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IGDCC4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:74,517,082...74,552,834
Ensembl chr 8:74,517,086...74,552,834
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IGF1 mRNA
|
CTD |
PMID:15749267 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Igf2
|
insulin-like growth factor 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IGF2 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667
|
|
| G
|
Igf2r
|
insulin-like growth factor 2 receptor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of IGF2R mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:50,526,878...50,615,265
|
|
| G
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IGFALS mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:14,397,076...14,408,439
Ensembl chr10:14,403,399...14,407,138
|
|
| G
|
Igfbp2
|
insulin-like growth factor binding protein 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IGFBP2 mRNA
|
CTD |
PMID:32763439 PMID:35032568 |
|
NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171
|
|
| G
|
Igfbp4
|
insulin-like growth factor binding protein 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IGFBP4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:84,491,471...84,503,487
Ensembl chr10:84,485,775...84,503,473
|
|
| G
|
Igfbp5
|
insulin-like growth factor binding protein 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IGFBP5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390
|
|
| G
|
Igfbp6
|
insulin-like growth factor binding protein 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IGFBP6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:135,154,685...135,159,795
|
|
| G
|
Igfbp7
|
insulin-like growth factor binding protein 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IGFBP7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:31,091,681...31,151,623
Ensembl chr14:31,091,347...31,151,620
|
|
| G
|
Igfbpl1
|
insulin-like growth factor binding protein-like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IGFBPL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:64,872,056...64,887,461
Ensembl chr 5:64,872,057...64,887,461
|
|
| G
|
Igfn1
|
immunoglobulin-like and fibronectin type III domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IGFN1 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr13:49,947,330...49,979,203
Ensembl chr13:49,947,330...49,989,601
|
|
| G
|
Igkvl13
|
immunoglobulin kappa variable like 13
|
increases expression
|
ISO
|
Acrylamide results in increased expression of IGKV3OR2-268 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:102,982,819...102,983,403
Ensembl chr 4:102,982,819...102,983,403
|
|
| G
|
Iglc1
|
immunoglobulin lambda constant 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IGLL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:95,452,233...95,454,185
Ensembl chr11:95,452,341...95,454,353
|
|
| G
|
Iglon5
|
IgLON family member 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IGLON5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:103,017,985...103,035,512
Ensembl chr 1:103,018,518...103,035,870
|
|
| G
|
Igsf1
|
immunoglobulin superfamily, member 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IGSF1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:133,947,717...133,963,154
Ensembl chr X:133,947,429...133,962,962
|
|
| G
|
Igsf3
|
immunoglobulin superfamily, member 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IGSF3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:191,499,972...191,588,249
Ensembl chr 2:191,500,045...191,588,249
|
|
| G
|
Igsf5
|
immunoglobulin superfamily, member 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IGSF5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:49,155,990...49,198,872
Ensembl chr11:49,156,341...49,210,603
|
|
| G
|
Igsf8
|
immunoglobulin superfamily, member 8
|
affects methylation
|
ISO
|
Acrylamide affects the methylation of IGSF8 gene
|
CTD |
PMID:35032568 |
|
NCBI chr13:87,282,015...87,314,018
Ensembl chr13:87,302,536...87,310,941
|
|
| G
|
Igsf9
|
immunoglobulin superfamily, member 9
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IGSF9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:87,480,979...87,497,974
Ensembl chr13:87,481,279...87,497,974
|
|
| G
|
Ihh
|
Indian hedgehog signaling molecule
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of IHH mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 9:83,952,986...83,959,203
Ensembl chr 9:83,952,986...83,959,203
|
|
| G
|
Ikbkg
|
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IKBKG mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:157,367,639...157,392,757
|
|
| G
|
Ikzf1
|
IKAROS family zinc finger 1
|
decreases activity decreases expression multiple interactions
|
ISO
|
Acrylamide results in decreased activity of IKZF1 protein Acrylamide results in decreased expression of IKZF1 protein 4,5,6,7-tetrabromobenzotriazole inhibits the reaction [Acrylamide results in decreased activity of IKZF1 protein]
|
CTD |
PMID:20708675 |
|
NCBI chr14:90,468,696...90,556,522
Ensembl chr14:90,469,172...90,557,574
|
|
| G
|
Il10
|
interleukin 10
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IL10 mRNA; Acrylamide results in decreased expression of IL10 protein
|
CTD |
PMID:38242491 PMID:38614435 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il11
|
interleukin 11
|
increases expression
|
ISO
|
Acrylamide results in increased expression of IL11 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:78,096,930...78,104,915
|
|
| G
|
Il11ra1
|
interleukin 11 receptor subunit alpha 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IL11RA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:61,727,650...61,737,265
Ensembl chr 5:61,727,931...61,737,264
|
|
| G
|
Il13
|
interleukin 13
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IL13 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483
|
|
| G
|
Il13ra1
|
interleukin 13 receptor subunit alpha 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of IL13RA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:120,213,670...120,294,777
Ensembl chr X:120,214,075...120,274,461
|
|
| G
|
Il15
|
interleukin 15
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IL15 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:42,536,160...42,611,349
Ensembl chr19:42,545,346...42,611,348
|
|
| G
|
Il17ra
|
interleukin 17 receptor A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of IL17RA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:155,339,742...155,362,382
Ensembl chr 4:155,339,400...155,362,382
|
|
| G
|
Il17rb
|
interleukin 17 receptor B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IL17RB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:5,186,961...5,200,657
Ensembl chr16:5,186,961...5,200,694
|
|
| G
|
Il17rc
|
interleukin 17 receptor C
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IL17RC mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:148,174,573...148,187,071
Ensembl chr 4:148,174,578...148,187,068
|
|
| G
|
Il17re
|
interleukin 17 receptor E
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IL17RE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:148,160,384...148,173,830
Ensembl chr 4:148,159,475...148,173,827
|
|
| G
|
Il18
|
interleukin 18
|
multiple interactions increases expression
|
ISO EXP
|
N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Acrylamide results in increased expression of IL18 protein]; NLRP3 gene mutant form inhibits the reaction [Acrylamide results in increased expression of IL18 protein]; NLRP3 protein promotes the reaction [Acrylamide results in increased expression of IL18 protein] Acrylamide results in increased expression of IL18 mRNA; Acrylamide results in increased expression of IL18 protein
|
CTD |
PMID:31073625 PMID:32014472 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il18rap
|
interleukin 18 receptor accessory protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IL18RAP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:50,263,723...50,296,583
Ensembl chr 9:50,263,733...50,296,583
|
|
| G
|
Il1a
|
interleukin 1 alpha
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IL1A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
| G
|
Il1b
|
interleukin 1 beta
|
decreases expression increases response to substance multiple interactions increases secretion increases expression
|
ISO EXP
|
Acrylamide analog results in decreased expression of IL1B mRNA; Acrylamide analog results in decreased expression of IL1B protein IL1B gene mutant form results in increased susceptibility to Acrylamide [NFE2L2 protein affects the susceptibility to Acrylamide] which affects the expression of IL1B mRNA; Acrylamide inhibits the reaction [Streptozocin results in increased expression of IL1B mRNA]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Acrylamide results in increased secretion of IL1B protein]; IL1B gene mutant form inhibits the reaction [Acrylamide results in increased expression of GCLC mRNA]; IL1B gene mutant form inhibits the reaction [Acrylamide results in increased expression of GPX1 mRNA]; IL1B gene mutant form inhibits the reaction [Acrylamide results in increased expression of GPX4 mRNA]; LRRK2 promotes the reaction [Acrylamide results in increased secretion of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Acrylamide results in increased expression of IL1B protein modified form]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Acrylamide results in increased expression of IL1B protein]; NLRP3 gene mutant form inhibits the reaction [Acrylamide results in increased expression of IL1B protein modified form]; NLRP3 gene mutant form inhibits the reaction [Acrylamide results in increased expression of IL1B protein]; NLRP3 protein promotes the reaction [Acrylamide results in increased expression of IL1B protein modified form]; NLRP3 protein promotes the reaction [Acrylamide results in increased expression of IL1B protein] Acrylamide results in decreased expression of IL1B mRNA Acrylamide results in increased expression of IL1B mRNA; Acrylamide results in increased expression of IL1B protein; Acrylamide results in increased expression of IL1B protein modified form [Acrylamide co-treated with Aluminum Chloride] results in increased expression of IL1B mRNA; [Aluminum Chloride co-treated with Acrylamide] results in increased expression of IL1B mRNA; alpha-Tocopherol inhibits the reaction [Acrylamide results in increased expression of IL1B protein]; boric acid inhibits the reaction [Acrylamide results in increased expression of IL1B mRNA]; naringin inhibits the reaction [Acrylamide results in increased expression of IL1B protein]; Selenium inhibits the reaction [Acrylamide results in increased expression of IL1B protein]
|
CTD |
PMID:18287786 PMID:25858877 PMID:25934431 PMID:27836571 PMID:28526328 PMID:28959563 PMID:29913234 PMID:31073625 PMID:32014472 PMID:33872730 PMID:34896238 PMID:36598108 PMID:37037409 PMID:37540211 PMID:37987225 PMID:38242491 More...
|
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1r1
|
interleukin 1 receptor type 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IL1R1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:50,000,566...50,076,579
|
|
| G
|
Il1rapl1
|
interleukin 1 receptor accessory protein-like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IL1RAPL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:55,322,779...56,827,486
Ensembl chr X:55,328,964...56,826,613
|
|
| G
|
Il1rl1
|
interleukin 1 receptor-like 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of IL1RL1 protein
|
CTD |
PMID:20025956 |
|
NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891
|
|
| G
|
Il20rb
|
interleukin 20 receptor subunit beta
|
increases expression
|
ISO
|
Acrylamide results in increased expression of IL20RB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:109,858,108...109,896,066
Ensembl chr 8:109,854,012...109,889,363
|
|
| G
|
Il2rb
|
interleukin 2 receptor subunit beta
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IL2RB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:111,913,828...111,928,537
Ensembl chr 7:111,913,828...111,928,537
|
|
| G
|
Il33
|
interleukin 33
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IL33 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:237,115,572...237,150,901
|
|
| G
|
Il34
|
interleukin 34
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IL34 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:55,624,368...55,690,576
Ensembl chr19:55,624,369...55,673,376
|
|
| G
|
Il36rn
|
interleukin 36 receptor antagonist
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IL36RN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:27,442,679...27,449,306
Ensembl chr 3:27,442,709...27,449,306
|
|
| G
|
Il4r
|
interleukin 4 receptor
|
increases expression multiple interactions
|
ISO
|
Acrylamide results in increased expression of IL4R mRNA NFE2L2 protein affects the reaction [Acrylamide results in increased expression of IL4R mRNA]
|
CTD |
PMID:33872730 |
|
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions increases secretion increases expression
|
EXP ISO
|
[4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole co-treated with Acrylamide] results in decreased expression of IL6 mRNA; [Acrylamide co-treated with Aluminum Chloride] results in increased expression of IL6 mRNA; [Aluminum Chloride co-treated with Acrylamide] results in increased expression of IL6 mRNA; [pyrazolanthrone co-treated with Acrylamide] results in decreased expression of IL6 mRNA; [U 0126 co-treated with Acrylamide] results in decreased expression of IL6 mRNA; naringin inhibits the reaction [Acrylamide results in increased expression of IL6 protein]; Selenium inhibits the reaction [Acrylamide results in increased expression of IL6 protein] Acrylamide inhibits the reaction [Streptozocin results in increased expression of IL6 mRNA]; Gallic Acid inhibits the reaction [Acrylamide results in increased secretion of IL6 protein]; LRRK2 promotes the reaction [Acrylamide results in increased secretion of IL6 protein]; TLR2 protein promotes the reaction [Acrylamide results in increased secretion of IL6 protein] Acrylamide results in increased expression of IL6 mRNA Acrylamide results in increased expression of IL6 mRNA; Acrylamide results in increased expression of IL6 protein
|
CTD |
PMID:25858877 PMID:25934431 PMID:27836571 PMID:28526328 PMID:29426002 PMID:31073625 PMID:34896238 PMID:36598108 PMID:37037409 PMID:37987225 PMID:38614435 More...
|
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Ilf2
|
interleukin enhancer binding factor 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ILF2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:178,256,927...178,268,773
Ensembl chr 2:178,248,585...178,268,920
|
|
| G
|
Ilrun
|
inflammation and lipid regulator with UBA-like and NBR1-like domains
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ILRUN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:5,811,721...5,878,082
Ensembl chr20:5,811,734...5,877,978
|
|
| G
|
Ilvbl
|
ilvB acetolactate synthase like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of HACL2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:11,690,445...11,700,498
Ensembl chr 7:11,690,445...11,700,498
|
|
| G
|
Impdh2
|
inosine monophosphate dehydrogenase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IMPDH2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:118,135,204...118,139,892
Ensembl chr 8:118,135,262...118,139,873
|
|
| G
|
Incenp
|
inner centromere protein
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of INCENP mRNA Acrylamide results in decreased expression of INCENP mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:215,945,558...216,017,247
Ensembl chr 1:215,948,283...215,977,084
|
|
| G
|
Inf2
|
inverted formin 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of INF2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:137,470,259...137,497,039
Ensembl chr 6:137,470,286...137,497,039
|
|
| G
|
Ing3
|
inhibitor of growth family, member 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ING3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:51,439,218...51,469,502
Ensembl chr 4:51,443,763...51,470,951
|
|
| G
|
Inhba
|
inhibin subunit beta A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of INHBA mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
|
|
| G
|
Inhbb
|
inhibin subunit beta B
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of INHBB mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr13:33,083,671...33,089,373
Ensembl chr13:33,083,671...33,089,609
|
|
| G
|
Inhbe
|
inhibin subunit beta E
|
increases expression
|
ISO
|
Acrylamide results in increased expression of INHBE mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:65,061,531...65,064,519
Ensembl chr 7:65,061,531...65,064,519
|
|
| G
|
Inhca
|
inhibitor of carbonic anhydrase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of INHCA mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:112,715,733...112,753,950
Ensembl chr 8:112,702,085...112,766,829
|
|
| G
|
Inka1
|
inka box actin regulator 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of INKA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:117,552,875...117,554,565
Ensembl chr 8:117,552,875...117,554,565
|
|
| G
|
Ino80d
|
INO80 complex subunit D
|
increases expression
|
ISO
|
Acrylamide results in increased expression of INO80D mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:71,940,941...72,007,879
Ensembl chr 9:71,951,031...72,040,232
|
|
| G
|
Ino80e
|
INO80 complex subunit E
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of INO80E mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:190,891,315...190,902,902
Ensembl chr 1:190,891,936...190,902,541
|
|
| G
|
Inpp5a
|
inositol polyphosphate-5-phosphatase A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of INPP5A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:203,619,676...203,810,035
Ensembl chr 1:203,619,637...203,810,028
|
|
| G
|
Inpp5b
|
inositol polyphosphate-5-phosphatase B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of INPP5B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:142,281,454...142,345,993
Ensembl chr 5:142,281,418...142,345,991
|
|
| G
|
Inpp5d
|
inositol polyphosphate-5-phosphatase D
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of INPP5D mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:95,735,533...95,840,584
Ensembl chr 9:95,735,530...95,840,589
|
|
| G
|
Inpp5e
|
inositol polyphosphate-5-phosphatase E
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of INPP5E mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:29,614,868...29,627,542
Ensembl chr 3:29,614,868...29,627,542
|
|
| G
|
Inpp5j
|
inositol polyphosphate-5-phosphatase J
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of INPP5J mRNA Acrylamide results in decreased expression of INPP5J mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr14:82,597,789...82,608,930
Ensembl chr14:82,597,790...82,609,678
|
|
| G
|
Ins1
|
insulin 1
|
decreases expression multiple interactions
|
EXP ISO
|
Acrylamide results in decreased expression of INS1 mRNA; Acrylamide results in decreased expression of INS1 protein [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1A protein; [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein; [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased phosphorylation of ACACA protein; [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK2 protein; [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK1 protein; [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK3 protein; Acrylamide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA]; Acrylamide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of TFAP2A mRNA]; Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA mRNA]; Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein]; Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN protein]; Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA]; Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein]; Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SREBF1 protein]; Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CEBPB protein]
|
CTD |
PMID:30409764 PMID:31644924 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
| G
|
Ins2
|
insulin 2
|
multiple interactions
|
EXP
|
4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of EIF2A protein]; 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of ERN1 protein]; [Acrylamide co-treated with INS protein] results in decreased activity of CAT1 protein; [Acrylamide co-treated with INS protein] results in decreased activity of GPX1 protein; [Acrylamide co-treated with INS protein] results in decreased activity of SOD1 protein; [Acrylamide co-treated with INS protein] results in decreased expression of GCK protein; [Acrylamide co-treated with INS protein] results in decreased expression of HNF4A mRNA; [Acrylamide co-treated with INS protein] results in increased activity of GOT1 protein; [Acrylamide co-treated with INS protein] results in increased activity of GPT protein; [Acrylamide co-treated with INS protein] results in increased activity of LDH protein; [Acrylamide co-treated with INS protein] results in increased expression of CASP3 protein; [Acrylamide co-treated with INS protein] results in increased expression of CD36 mRNA; [Acrylamide co-treated with INS protein] results in increased expression of G6PC mRNA; [Acrylamide co-treated with INS protein] results in increased expression of KEAP1 mRNA; [Acrylamide co-treated with INS protein] results in increased expression of LPO protein; [Acrylamide co-treated with INS protein] results in increased expression of NFE2L2 mRNA; [Acrylamide co-treated with INS protein] results in increased expression of NOS1 mRNA; [Acrylamide co-treated with INS protein] results in increased expression of NR1H3 mRNA; [Acrylamide co-treated with INS protein] results in increased expression of PEPCK mRNA; [Acrylamide co-treated with INS protein] results in increased expression of SREBF2 mRNA; [Acrylamide co-treated with INS protein] results in increased expression of TNF mRNA; [Acrylamide co-treated with INS protein] results in increased expression of TNF protein; [INS co-treated with Acrylamide] results in increased cleavage of CASP3 protein; [INS co-treated with Acrylamide] results in increased expression of ATF4 protein; [INS co-treated with Acrylamide] results in increased expression of BAX protein; [INS co-treated with Acrylamide] results in increased expression of DDIT3 protein; [INS co-treated with Acrylamide] results in increased expression of HSPA5 protein; [INS co-treated with Acrylamide] results in increased expression of TRAF2 protein; [INS co-treated with Acrylamide] results in increased phosphorylation of EIF2A protein; [INS co-treated with Acrylamide] results in increased phosphorylation of EIF2AK3 protein; [INS co-treated with Acrylamide] results in increased phosphorylation of ERN1 protein; Acetylcysteine inhibits the reaction [[INS co-treated with Acrylamide] results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of EIF2A protein]; Acetylcysteine inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of ERN1 protein]; ERN1 protein promotes the reaction [[INS co-treated with Acrylamide] results in increased cleavage of CASP3 protein]; ERN1 protein promotes the reaction [[INS co-treated with Acrylamide] results in increased expression of TRAF2 protein]; GSK2656157 inhibits the reaction [[INS co-treated with Acrylamide] results in increased expression of ATF4 protein]; GSK2656157 inhibits the reaction [[INS co-treated with Acrylamide] results in increased expression of BAX protein]; GSK2656157 inhibits the reaction [[INS co-treated with Acrylamide] results in increased expression of DDIT3 protein]; GSK2656157 inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of EIF2A protein]; INS promotes the reaction [Acrylamide results in decreased expression of BCL2 mRNA]; INS promotes the reaction [Acrylamide results in increased expression of ATF4 mRNA]; INS promotes the reaction [Acrylamide results in increased expression of BAX mRNA]; INS promotes the reaction [Acrylamide results in increased expression of CASP3 mRNA]; INS promotes the reaction [Acrylamide results in increased expression of DDIT3 mRNA]; INS promotes the reaction [Acrylamide results in increased expression of EIF2A mRNA]; INS promotes the reaction [Acrylamide results in increased expression of EIF2AK3 mRNA]; INS promotes the reaction [Acrylamide results in increased expression of ERN1 mRNA]; INS promotes the reaction [Acrylamide results in increased expression of HSPA5 mRNA]
|
CTD |
PMID:38604440 |
|
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
|
|
| G
|
Insig1
|
insulin induced gene 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of INSIG1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778
|
|
| G
|
Insl3
|
insulin-like 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of INSL3 mRNA
|
CTD |
PMID:22459607 |
|
NCBI chr16:18,432,668...18,434,539
|
|
| G
|
Insyn1
|
inhibitory synaptic factor 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of INSYN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:67,799,989...67,810,685
Ensembl chr 8:67,799,304...67,814,536
|
|
| G
|
Insyn2a
|
inhibitory synaptic factor 2A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of INSYN2A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:199,127,735...199,183,077
Ensembl chr 1:198,962,151...199,182,799
|
|
| G
|
Ints1
|
integrator complex subunit 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of INTS1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:19,975,166...19,999,893
Ensembl chr12:19,975,171...19,999,900
|
|
| G
|
Ints10
|
integrator complex subunit 10
|
increases expression
|
EXP
|
Acrylamide results in increased expression of INTS10 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:25,682,818...25,735,840
Ensembl chr16:25,682,050...25,734,528
|
|
| G
|
Ints2
|
integrator complex subunit 2
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of INTS2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:71,529,021...71,576,529
Ensembl chr10:71,401,151...71,575,206
|
|
| G
|
Ints3
|
integrator complex subunit 3
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of INTS3 mRNA Acrylamide results in decreased expression of INTS3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:178,157,015...178,209,263
Ensembl chr 2:178,157,015...178,209,137
|
|
| G
|
Ints5
|
integrator complex subunit 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of INTS5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:215,218,012...215,222,790
Ensembl chr 1:215,218,017...215,223,240
|
|
| G
|
Ints6l
|
integrator complex subunit 6 like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of INTS6L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:139,295,490...139,363,090
Ensembl chr X:139,295,512...139,359,161
|
|
| G
|
Invs
|
inversin
|
increases expression
|
EXP
|
Acrylamide results in increased expression of INVS mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:67,406,511...67,559,355
Ensembl chr 5:67,406,485...67,559,350
|
|
| G
|
Ip6k1
|
inositol hexakisphosphate kinase 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of IP6K1 mRNA Acrylamide results in increased expression of IP6K1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 8:117,594,177...117,613,266
Ensembl chr 8:117,594,317...117,613,274
|
|
| G
|
Ip6k2
|
inositol hexakisphosphate kinase 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of IP6K2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:118,362,154...118,388,668
Ensembl chr 8:118,362,795...118,388,667
|
|
| G
|
Ipo4
|
importin 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IPO4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:33,087,321...33,097,241
Ensembl chr15:33,087,321...33,097,241
|
|
| G
|
Ipo9
|
importin 9
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IPO9 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:49,362,244...49,414,477
Ensembl chr13:49,365,716...49,414,477
|
|
| G
|
Iqank1
|
IQ motif and ankyrin repeat containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IQANK1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:109,605,642...109,639,854
Ensembl chr 7:109,605,703...109,639,853
|
|
| G
|
Iqcd
|
IQ motif containing D
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of IQCD mRNA Acrylamide results in decreased expression of DRC10 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr12:41,616,107...41,633,244
Ensembl chr12:41,616,107...41,623,352
|
|
| G
|
Iqcn
|
IQ motif containing N
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IQCN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:18,750,492...18,766,184
Ensembl chr16:18,750,353...18,767,534
|
|
| G
|
Iqgap1
|
IQ motif containing GTPase activating protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IQGAP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:144,088,788...144,178,989
Ensembl chr 1:144,088,793...144,179,043
|
|
| G
|
Iqgap2
|
IQ motif containing GTPase activating protein 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IQGAP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:28,629,558...28,904,649
Ensembl chr 2:28,629,558...28,904,649
|
|
| G
|
Iqgap3
|
IQ motif containing GTPase activating protein 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IQGAP3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:175,840,001...175,881,799
Ensembl chr 2:175,839,949...175,881,797
|
|
| G
|
Iqsec1
|
IQ motif and Sec7 domain ArfGEF 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IQSEC1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:124,725,917...125,045,351
Ensembl chr 4:124,725,917...125,045,550
|
|
| G
|
Iqsec3
|
IQ motif and Sec7 domain ArfGEF 3
|
affects expression
|
EXP
|
Acrylamide affects the expression of IQSEC3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:156,283,040...156,379,396
Ensembl chr 4:156,283,043...156,379,396
|
|
| G
|
Iqub
|
IQ motif and ubiquitin domain containing
|
affects expression
|
EXP
|
Acrylamide affects the expression of IQUB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:53,897,336...53,962,279
Ensembl chr 4:53,897,332...53,954,925
|
|
| G
|
Irak1
|
interleukin-1 receptor-associated kinase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IRAK1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:156,920,081...156,929,825
|
|
| G
|
Irak1bp1
|
interleukin-1 receptor-associated kinase 1 binding protein 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IRAK1BP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:92,608,468...92,628,377
Ensembl chr 8:92,611,843...92,628,377
|
|
| G
|
Irak3
|
interleukin-1 receptor-associated kinase 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IRAK3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:57,538,522...57,600,166
Ensembl chr 7:57,539,557...57,598,706
|
|
| G
|
Ireb2
|
iron responsive element binding protein 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IREB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:64,124,152...64,207,702
Ensembl chr 8:64,154,945...64,205,520
|
|
| G
|
Irf1
|
interferon regulatory factor 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IRF1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947
|
|
| G
|
Irf2
|
interferon regulatory factor 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IRF2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:52,171,855...52,283,620
Ensembl chr16:52,164,442...52,282,627
|
|
| G
|
Irf4
|
interferon regulatory factor 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IRF4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:33,930,460...33,948,842
Ensembl chr17:33,930,471...33,948,730
|
|
| G
|
Irf6
|
interferon regulatory factor 6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IRF6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:107,200,876...107,220,083
Ensembl chr13:107,200,731...107,220,049
|
|
| G
|
Irgc
|
immunity related GTPase cinema
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IRGC mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:89,148,056...89,151,838
Ensembl chr 1:89,147,624...89,153,921
|
|
| G
|
Irgm
|
immunity-related GTPase M
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IRGM mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:33,734,640...33,742,720
Ensembl chr10:33,732,961...33,743,228
|
|
| G
|
Irgq
|
immunity-related GTPase Q
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IRGQ mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:89,251,846...89,259,799
Ensembl chr 1:89,239,205...89,259,799
|
|
| G
|
Irs1
|
insulin receptor substrate 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IRS1 mRNA
|
CTD |
PMID:28959563 PMID:31644924 |
|
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538
|
|
| G
|
Irs2
|
insulin receptor substrate 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of IRS2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:85,190,310...85,214,543
Ensembl chr16:85,190,111...85,214,543
|
|
| G
|
Irs4
|
insulin receptor substrate 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IRS4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:110,132,490...110,148,473
Ensembl chr X:110,132,405...110,149,088
|
|
| G
|
Irx1
|
iroquois homeobox 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IRX1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:33,123,122...33,128,951
Ensembl chr 1:33,123,122...33,128,951
|
|
| G
|
Irx4
|
iroquois homeobox 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IRX4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:31,859,101...31,868,089
Ensembl chr 1:31,859,101...31,868,089
|
|
| G
|
Irx5
|
iroquois homeobox 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of IRX5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:30,812,033...30,816,885
Ensembl chr19:30,797,202...30,815,029
|
|
| G
|
Isg20
|
interferon stimulated exonuclease gene 20
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ISG20 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:142,234,729...142,246,403
Ensembl chr 1:142,236,137...142,246,401
|
|
| G
|
Islr2
|
immunoglobulin superfamily containing leucine-rich repeat 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ISLR2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:67,504,042...67,512,125
Ensembl chr 8:67,504,037...67,513,708
|
|
| G
|
Isyna1
|
inositol-3-phosphate synthase 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of ISYNA1 mRNA Acrylamide results in decreased expression of ISYNA1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr16:18,873,119...18,876,116
Ensembl chr16:18,873,121...18,875,955
|
|
| G
|
Itga1
|
integrin subunit alpha 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ITGA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:48,379,181...48,545,336
Ensembl chr 2:48,386,249...48,545,284
|
|
| G
|
Itga3
|
integrin subunit alpha 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ITGA3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:80,486,998...80,522,548
Ensembl chr10:80,486,999...80,518,901
|
|
| G
|
Itga6
|
integrin subunit alpha 6
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of ITGA6 mRNA Acrylamide results in decreased expression of ITGA6 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:77,012,168...77,097,076
Ensembl chr 3:77,017,766...77,097,076
|
|
| G
|
Itga7
|
integrin subunit alpha 7
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ITGA7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:1,944,447...1,973,347
Ensembl chr 7:1,944,460...1,973,339
|
|
| G
|
Itgae
|
integrin subunit alpha E
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ITGAE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:58,203,331...58,262,606
Ensembl chr10:58,203,364...58,262,606
|
|
| G
|
Itgam
|
integrin subunit alpha M
|
increases expression multiple interactions
|
EXP ISO
|
Acrylamide results in increased expression of ITGAM mRNA Gallic Acid inhibits the reaction [Acrylamide results in increased expression of ITGAM protein]
|
CTD |
PMID:28959563 PMID:31073625 PMID:37037409 |
|
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
| G
|
Itgav
|
integrin subunit alpha V
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ITGAV mRNA
|
CTD |
PMID:22197712 |
|
NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:89,245,095...89,333,511
|
|
| G
|
Itgb8
|
integrin subunit beta 8
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ITGB8 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:146,267,982...146,351,245
Ensembl chr 6:146,165,484...146,351,245
|
|
| G
|
Itih1
|
inter-alpha trypsin inhibitor, heavy chain 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ITIH1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:6,128,696...6,142,813
Ensembl chr16:6,128,698...6,142,853
|
|
| G
|
Itih4
|
inter-alpha-trypsin inhibitor heavy chain 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ITIH4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:6,086,985...6,102,162
Ensembl chr16:6,086,973...6,102,160
|
|
| G
|
Itln1
|
intelectin 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ITLN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:86,464,641...86,490,655
Ensembl chr13:86,464,669...86,490,651
|
|
| G
|
Itpa
|
inosine triphosphatase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of ITPA mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:138,338,549...138,350,329
Ensembl chr 3:138,338,349...138,350,329
|
|
| G
|
Itpkb
|
inositol-trisphosphate 3-kinase B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ITPKB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:94,601,072...94,696,180
Ensembl chr13:94,601,167...94,696,179
|
|
| G
|
Itpr1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
multiple interactions
|
EXP
|
Acrylamide promotes the reaction [elaidic acid promotes the reaction [ITPR1 protein binds to HSPA9 protein]]; Acrylamide promotes the reaction [ITPR1 protein binds to HSPA9 protein]; elaidic acid promotes the reaction [Acrylamide promotes the reaction [ITPR1 protein binds to HSPA9 protein]]
|
CTD |
PMID:38740238 |
|
NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:142,743,334...143,066,504
|
|
| G
|
Itpr3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
multiple interactions decreases expression
|
ISO EXP
|
acetylleucyl-leucyl-norleucinal inhibits the reaction [Acrylamide results in decreased expression of ITPR3 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Acrylamide results in decreased expression of ITPR3 protein] Acrylamide results in increased ubiquitination of and results in increased degradation of ITPR3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Acrylamide results in decreased expression of ITPR3 protein]
|
CTD |
PMID:37353096 |
|
NCBI chr20:5,138,553...5,204,189
Ensembl chr20:5,118,834...5,204,184
|
|
| G
|
Itsn1
|
intersectin 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of ITSN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:44,464,515...44,646,598
Ensembl chr11:44,513,186...44,646,598
|
|
| G
|
Ivd
|
isovaleryl-CoA dehydrogenase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IVD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:126,305,584...126,326,016
Ensembl chr 3:126,305,364...126,328,160
|
|
| G
|
Iyd
|
iodotyrosine deiodinase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of IYD mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:42,410,130...42,426,386
|
|
| G
|
Izumo4
|
IZUMO family member 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of IZUMO4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:9,657,975...9,661,699
Ensembl chr 7:9,657,203...9,660,794
|
|
| G
|
Jade2
|
jade family PHD finger 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of JADE2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:36,576,187...36,625,129
Ensembl chr10:36,576,187...36,623,532
|
|
| G
|
Jak1
|
Janus kinase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of JAK1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:120,896,046...120,996,758
|
|
| G
|
Jak2
|
Janus kinase 2
|
increases expression multiple interactions
|
ISO EXP
|
Acrylamide results in increased expression of JAK2 mRNA Acrylamide results in increased expression of and results in increased phosphorylation of JAK2 protein Acrylamide results in increased expression of JAK2 protein
|
CTD |
PMID:38152866 |
|
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
|
|
| G
|
Jam2
|
junctional adhesion molecule 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of JAM2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr11:37,316,287...37,366,517
Ensembl chr11:37,317,511...37,367,510
|
|
| G
|
Jam3
|
junctional adhesion molecule 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of JAM3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:33,767,606...33,828,451
Ensembl chr 8:33,767,607...33,828,623
|
|
| G
|
Jazf1
|
JAZF zinc finger 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of JAZF1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:83,210,054...83,513,790
Ensembl chr 4:83,210,058...83,513,644
|
|
| G
|
Jdp2
|
Jun dimerization protein 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of JDP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:110,988,927...111,033,392
Ensembl chr 6:110,992,806...111,033,392
|
|
| G
|
Jkampl
|
JNK1/MAPK8 associated membrane protein like
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of JKAMPL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:107,078,531...107,079,631
Ensembl chr 4:107,077,359...107,080,150
|
|
| G
|
Jmjd4
|
jumonji domain containing 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of JMJD4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:44,734,047...44,742,296
Ensembl chr10:44,734,070...44,742,296
|
|
| G
|
Jmjd6
|
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of JMJD6 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:102,539,935...102,545,986
Ensembl chr10:102,539,894...102,545,986
|
|
| G
|
Jmy
|
junction mediating and regulatory protein, p53 cofactor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of JMY mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:26,401,047...26,465,959
Ensembl chr 2:26,409,969...26,465,649
|
|
| G
|
Josd1
|
Josephin domain containing 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of JOSD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:113,110,709...113,124,632
Ensembl chr 7:113,110,717...113,124,632
|
|
| G
|
Jph1
|
junctophilin 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of JPH1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:6,813,553...6,920,488
Ensembl chr 5:6,813,602...6,906,241
|
|
| G
|
Jph2
|
junctophilin 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of JPH2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:172,414,246...172,478,678
Ensembl chr 3:172,414,256...172,478,348
|
|
| G
|
Jph3
|
junctophilin 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of JPH3 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr19:66,702,497...66,763,948
Ensembl chr19:66,702,680...66,763,937
|
|
| G
|
Jph4
|
junctophilin 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of JPH4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:32,549,536...32,558,859
Ensembl chr15:32,549,555...32,558,859
|
|
| G
|
Jrk
|
Jrk helix-turn-helix protein
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of JRK mRNA Acrylamide results in decreased expression of JRK mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:108,479,646...108,484,329
Ensembl chr 7:108,453,398...108,495,813
|
|
| G
|
Jrkl
|
JRK-like
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of JRKL mRNA Acrylamide results in decreased expression of JRKL mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 8:18,505,808...18,508,704
Ensembl chr 8:18,480,815...18,514,962
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
increases expression
|
ISO
|
Acrylamide results in increased expression of JUN protein
|
CTD |
PMID:20025956 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Junb
|
JunB proto-oncogene, AP-1 transcription factor subunit
|
increases expression
|
ISO
|
Acrylamide results in increased expression of JUNB mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218
|
|
| G
|
Jup
|
junction plakoglobin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of JUP mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:85,800,812...85,827,881
Ensembl chr10:85,800,814...85,827,429
|
|
| G
|
Kank1
|
KN motif and ankyrin repeat domains 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KANK1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:232,381,720...232,500,834
Ensembl chr 1:232,445,658...232,500,839
|
|
| G
|
Kars1
|
lysyl-tRNA synthetase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KARS1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:56,867,096...56,886,151
Ensembl chr19:56,867,096...56,886,073
|
|
| G
|
Kat2b
|
lysine acetyltransferase 2B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KAT2B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:6,799,101...6,903,616
Ensembl chr 9:6,799,145...6,903,616
|
|
| G
|
Katnal2
|
katanin catalytic subunit A1 like 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KATNAL2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:72,806,967...72,883,091
Ensembl chr18:72,806,900...72,883,256
|
|
| G
|
Katnb1
|
katanin regulatory subunit B1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KATNB1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:9,927,249...9,946,750
Ensembl chr19:9,927,249...9,946,738
|
|
| G
|
Katnbl1
|
katanin regulatory subunit B1 like 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KATNBL1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:119,638,068...119,680,179
Ensembl chr 3:119,638,107...119,680,173
|
|
| G
|
Kazn
|
kazrin, periplakin interacting protein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KAZN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:159,675,803...160,666,084
Ensembl chr 5:159,675,803...160,664,154
|
|
| G
|
Kbtbd8
|
kelch repeat and BTB domain containing 8
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KBTBD8 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:129,232,781...129,245,608
Ensembl chr 4:129,232,027...129,245,605
|
|
| G
|
Kcmf1
|
potassium channel modulatory factor 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KCMF1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:106,447,974...106,508,359
Ensembl chr 4:106,447,981...106,508,359
|
|
| G
|
Kcna1
|
potassium voltage-gated channel subfamily A member 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of KCNA1 mRNA Acrylamide results in decreased expression of KCNA1 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 4:161,150,378...161,160,051
Ensembl chr 4:161,147,418...161,160,044
|
|
| G
|
Kcna7
|
potassium voltage-gated channel subfamily A member 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCNA7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:105,022,549...105,028,041
Ensembl chr 1:105,022,549...105,028,041
|
|
| G
|
Kcnab1
|
potassium voltage-gated channel subfamily A regulatory beta subunit 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCNAB1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:151,446,975...151,913,636
Ensembl chr 2:151,446,947...151,913,636
|
|
| G
|
Kcnab3
|
potassium voltage-gated channel subfamily A regulatory beta subunit 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KCNAB3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:54,546,638...54,555,209
Ensembl chr10:54,546,618...54,553,357
|
|
| G
|
Kcnb2
|
potassium voltage-gated channel subfamily B member 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of KCNB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:8,340,085...8,811,184
Ensembl chr 5:8,351,961...8,783,179
|
|
| G
|
Kcnc1
|
potassium voltage-gated channel subfamily C member 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KCNC1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:106,039,247...106,081,034
Ensembl chr 1:106,039,237...106,081,033
|
|
| G
|
Kcnc2
|
potassium voltage-gated channel subfamily C member 2
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of KCNC2 mRNA Acrylamide results in increased expression of KCNC2 mRNA
|
CTD |
PMID:28959563 PMID:30807115 PMID:32763439 |
|
NCBI chr 7:49,586,274...49,770,212
Ensembl chr 7:49,586,136...49,770,212
|
|
| G
|
Kcnd1
|
potassium voltage-gated channel subfamily D member 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KCND1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:17,333,612...17,349,255
Ensembl chr X:17,333,612...17,347,799
|
|
| G
|
Kcnd3
|
potassium voltage-gated channel subfamily D member 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCND3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:195,626,316...195,843,690
Ensembl chr 2:195,626,316...195,843,690
|
|
| G
|
Kcne1
|
potassium voltage-gated channel subfamily E regulatory subunit 1
|
multiple interactions
|
ISO
|
KCNE1 protein promotes the reaction [Acrylamide analog results in decreased activity of KCNQ1 protein]
|
CTD |
PMID:16904708 |
|
NCBI chr11:45,066,875...45,080,024
Ensembl chr11:45,064,162...45,081,247
|
|
| G
|
Kcne2
|
potassium voltage-gated channel subfamily E regulatory subunit 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KCNE2 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr11:45,003,468...45,015,942
Ensembl chr11:45,014,406...45,016,168
|
|
| G
|
Kcne5
|
potassium voltage-gated channel subfamily E regulatory subunit 5
|
affects expression
|
EXP
|
Acrylamide affects the expression of KCNE5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:110,727,234...110,727,849
Ensembl chr X:110,726,282...110,728,047
|
|
| G
|
Kcnf1
|
potassium voltage-gated channel modifier subfamily F member 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KCNF1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:45,691,028...45,693,706
Ensembl chr 6:45,688,623...45,695,536
|
|
| G
|
Kcng1
|
potassium voltage-gated channel modifier subfamily G member 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KCNG1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:177,379,593...177,412,986
Ensembl chr 3:177,392,031...177,411,507
|
|
| G
|
Kcng4
|
potassium voltage-gated channel modifier subfamily G member 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCNG4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:64,585,252...64,598,025
Ensembl chr19:64,585,954...64,597,888
|
|
| G
|
Kcnh3
|
potassium voltage-gated channel subfamily H member 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCNH3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:132,244,492...132,262,725
Ensembl chr 7:132,244,880...132,262,721
|
|
| G
|
Kcnh4
|
potassium voltage-gated channel subfamily H member 4
|
affects expression
|
EXP
|
Acrylamide affects the expression of KCNH4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:86,168,644...86,188,476
Ensembl chr10:86,168,644...86,188,476
|
|
| G
|
Kcnh7
|
potassium voltage-gated channel subfamily H member 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCNH7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:67,737,900...68,230,950
Ensembl chr 3:67,747,063...68,230,741
|
|
| G
|
Kcnip1
|
potassium voltage-gated channel interacting protein 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KCNIP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:18,723,726...19,093,025
Ensembl chr10:18,723,726...19,093,087
|
|
| G
|
Kcnip2
|
potassium voltage-gated channel interacting protein 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of KCNIP2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:254,590,172...254,614,437
Ensembl chr 1:254,590,175...254,613,898
|
|
| G
|
Kcnip3
|
potassium voltage-gated channel interacting protein 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KCNIP3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:135,130,331...135,196,031
Ensembl chr 3:135,132,119...135,196,216
|
|
| G
|
Kcnj11
|
potassium inwardly-rectifying channel, subfamily J, member 11
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of KCNJ11 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:105,727,473...105,731,167
Ensembl chr 1:105,727,570...105,731,169
|
|
| G
|
Kcnj13
|
potassium inwardly-rectifying channel, subfamily J, member 13
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KCNJ13 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 9:95,509,228...95,528,400
Ensembl chr 9:95,510,877...95,520,817
|
|
| G
|
Kcnj3
|
potassium inwardly-rectifying channel, subfamily J, member 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KCNJ3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:60,353,990...60,518,110
Ensembl chr 3:60,354,146...60,518,104
|
|
| G
|
Kcnj4
|
potassium inwardly-rectifying channel, subfamily J, member 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KCNJ4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:112,927,494...112,954,547
Ensembl chr 7:112,922,532...112,954,826
|
|
| G
|
Kcnj8
|
potassium inwardly-rectifying channel, subfamily J, member 8
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCNJ8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:177,239,908...177,246,531
|
|
| G
|
Kcnk10
|
potassium two pore domain channel subfamily K member 10
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCNK10 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:123,419,778...123,555,820
Ensembl chr 6:123,423,950...123,555,614
|
|
| G
|
Kcnk15
|
potassium two pore domain channel subfamily K member 15
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCNK15 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:172,934,659...172,940,877
Ensembl chr 3:172,934,544...172,940,877
|
|
| G
|
Kcnk16
|
potassium two pore domain channel subfamily K member 16
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KCNK16 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:4,069,495...4,098,836
Ensembl chr15:4,091,691...4,098,834
|
|
| G
|
Kcnk2
|
potassium two pore domain channel subfamily K member 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCNK2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:103,297,387...103,494,686
Ensembl chr13:103,297,393...103,494,686
|
|
| G
|
Kcnk5
|
potassium two pore domain channel subfamily K member 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCNK5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:4,171,625...4,213,896
Ensembl chr15:4,171,610...4,213,897
|
|
| G
|
Kcnma1
|
potassium calcium-activated channel subfamily M alpha 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KCNMA1 mRNA
|
CTD |
PMID:35690182 |
|
NCBI chr15:351,065...1,057,117
Ensembl chr15:351,659...1,057,117
|
|
| G
|
Kcnmb1
|
potassium calcium-activated channel subfamily M regulatory beta subunit 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCNMB1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:19,062,014...19,119,005
Ensembl chr10:19,062,291...19,073,204
|
|
| G
|
Kcnmb2
|
potassium calcium-activated channel subfamily M regulatory beta subunit 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCNMB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:116,598,511...116,903,886
Ensembl chr 2:116,599,387...116,903,854
|
|
| G
|
Kcnn3
|
potassium calcium-activated channel subfamily N member 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KCNN3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:177,227,276...177,378,849
Ensembl chr 2:177,234,327...177,379,693
|
|
| G
|
Kcnq1
|
potassium voltage-gated channel subfamily Q member 1
|
decreases activity increases expression multiple interactions
|
ISO
|
Acrylamide analog results in decreased activity of KCNQ1 protein Acrylamide results in increased expression of KCNQ1 mRNA KCNE1 protein promotes the reaction [Acrylamide analog results in decreased activity of KCNQ1 protein]
|
CTD |
PMID:16904708 PMID:32763439 |
|
NCBI chr 1:207,721,134...208,054,073
Ensembl chr 1:207,721,131...208,054,072
|
|
| G
|
Kcnq2
|
potassium voltage-gated channel subfamily Q member 2
|
multiple interactions increases activity affects activity
|
ISO
|
Acrylamide analog affects the activity of [KCNQ2 protein binds to KCNQ3 protein] Acrylamide analog results in increased activity of KCNQ2 protein Acrylamide analog affects the activity of KCNQ2 protein
|
CTD |
PMID:15139767 PMID:15357987 PMID:15603955 PMID:16904708 |
|
NCBI chr 3:188,572,345...188,631,391
Ensembl chr 3:188,572,926...188,631,302
|
|
| G
|
Kcnq3
|
potassium voltage-gated channel subfamily Q member 3
|
multiple interactions decreases expression
|
ISO EXP
|
Acrylamide analog affects the activity of [KCNQ2 protein binds to KCNQ3 protein] Acrylamide results in decreased expression of KCNQ3 mRNA
|
CTD |
PMID:16904708 PMID:28959563 |
|
NCBI chr 7:99,614,089...99,914,736
Ensembl chr 7:99,619,544...99,914,610
|
|
| G
|
Kcnq4
|
potassium voltage-gated channel subfamily Q member 4
|
increases activity
|
ISO
|
Acrylamide analog results in increased activity of KCNQ4 protein
|
CTD |
PMID:16904708 |
|
NCBI chr 5:139,560,366...139,612,212
Ensembl chr 5:139,560,366...139,612,102
|
|
| G
|
Kcnq5
|
potassium voltage-gated channel subfamily Q member 5
|
increases activity
|
ISO
|
Acrylamide analog results in increased activity of KCNQ5 protein
|
CTD |
PMID:16904708 |
|
NCBI chr 9:31,326,595...31,892,399
Ensembl chr 9:31,329,497...31,891,304
|
|
| G
|
Kcns3
|
potassium voltage-gated channel, modifier subfamily S, member 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCNS3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:39,527,410...39,584,105
Ensembl chr 6:39,523,777...39,618,848
|
|
| G
|
Kcnt2
|
potassium sodium-activated channel subfamily T member 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KCNT2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:54,214,831...54,609,889
Ensembl chr13:54,215,307...54,607,924
|
|
| G
|
Kctd1
|
potassium channel tetramerization domain containing 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCTD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:6,396,947...6,591,026
Ensembl chr18:6,396,947...6,515,191
|
|
| G
|
Kctd10
|
potassium channel tetramerization domain containing 10
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KCTD10 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:47,890,777...47,909,391
Ensembl chr12:47,890,819...47,909,390
|
|
| G
|
Kctd11
|
potassium channel tetramerization domain containing 11
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KCTD11 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:55,101,292...55,103,455
Ensembl chr10:55,100,801...55,103,583
|
|
| G
|
Kctd13
|
potassium channel tetramerization domain containing 13
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KCTD13 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:190,965,073...190,983,381
Ensembl chr 1:190,965,075...190,985,419
|
|
| G
|
Kctd14
|
potassium channel tetramerization domain containing 14
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KCTD14 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:161,172,906...161,177,914
Ensembl chr 1:161,171,451...161,178,413
|
|
| G
|
Kctd17
|
potassium channel tetramerization domain containing 17
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KCTD17 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:111,859,556...111,891,869
Ensembl chr 7:111,859,256...111,870,692
|
|
| G
|
Kctd3
|
potassium channel tetramerization domain containing 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KCTD3 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr13:103,041,488...103,080,069
Ensembl chr13:103,041,490...103,080,009
|
|
| G
|
Kctd5
|
potassium channel tetramerization domain containing 5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KCTD5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:13,583,781...13,609,762
Ensembl chr10:13,583,781...13,610,062
|
|
| G
|
Kctd8
|
potassium channel tetramerization domain containing 8
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KCTD8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:39,127,210...39,372,118
Ensembl chr14:39,127,379...39,372,078
|
|
| G
|
Kctd9
|
potassium channel tetramerization domain containing 9
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KCTD9 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:46,117,211...46,145,258
Ensembl chr15:46,117,874...46,145,266
|
|
| G
|
Kdf1
|
keratinocyte differentiation factor 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KDF1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:151,028,152...151,039,753
Ensembl chr 5:151,029,149...151,039,752
|
|
| G
|
Kdm2a
|
lysine demethylase 2A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KDM2A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:211,041,859...211,125,749
Ensembl chr 1:211,041,885...211,084,479
|
|
| G
|
Kdm4a
|
lysine demethylase 4A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KDM4A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:136,958,178...137,004,942
Ensembl chr 5:136,958,178...137,004,951
|
|
| G
|
Kdm4b
|
lysine demethylase 4B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KDM4B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:1,245,885...1,324,384
Ensembl chr 9:1,245,899...1,324,384
|
|
| G
|
Kdm4d
|
lysine demethylase 4D
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KDM4D mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:19,561,253...19,586,412
Ensembl chr 8:19,548,676...19,587,331
|
|
| G
|
Kdm5a
|
lysine demethylase 5A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KDM5A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:155,238,124...155,316,121
Ensembl chr 4:155,238,044...155,316,121
|
|
| G
|
Keap1
|
Kelch-like ECH-associated protein 1
|
affects expression multiple interactions increases expression
|
EXP ISO
|
Acrylamide affects the expression of KEAP1 protein [Acrylamide co-treated with INS protein] results in increased expression of KEAP1 mRNA Acrylamide results in increased expression of KEAP1 mRNA [NLRP3 gene mutant form affects the susceptibility to Acrylamide] which results in increased expression of KEAP1 protein; Acrylamide inhibits the reaction [Streptozocin results in increased expression of KEAP1 mRNA]
|
CTD |
PMID:29426002 PMID:32014472 PMID:34896238 PMID:38604440 |
|
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
|
|
| G
|
Kel
|
Kell metallo-endopeptidase (Kell blood group)
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KEL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:71,534,882...71,552,297
Ensembl chr 4:71,534,882...71,552,306
|
|
| G
|
Kera
|
keratocan
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KERA mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:34,284,100...34,291,555
Ensembl chr 7:34,284,100...34,291,555
|
|
| G
|
Khdc4
|
KH domain containing 4, pre-mRNA splicing factor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KHDC4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:176,446,895...176,475,405
Ensembl chr 2:176,446,910...176,475,392
|
|
| G
|
Khdrbs1
|
KH RNA binding domain containing, signal transduction associated 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KHDRBS1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:147,337,048...147,374,604
Ensembl chr 5:147,347,904...147,373,448
|
|
| G
|
Kif11
|
kinesin family member 11
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KIF11 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:244,494,916...244,589,250
Ensembl chr 1:244,494,875...244,589,250
|
|
| G
|
Kif13b
|
kinesin family member 13B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KIF13B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:43,084,059...43,241,719
Ensembl chr15:43,080,910...43,241,719
|
|
| G
|
Kif14
|
kinesin family member 14
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KIF14 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:50,478,646...50,542,256
Ensembl chr13:50,478,721...50,542,248
|
|
| G
|
Kif16b
|
kinesin family member 16B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KIF16B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:150,428,233...150,707,755
Ensembl chr 3:150,366,838...150,707,770
|
|
| G
|
Kif17
|
kinesin family member 17
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KIF17 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:155,765,592...155,802,941
Ensembl chr 5:155,765,592...155,803,247
|
|
| G
|
Kif18a
|
kinesin family member 18A
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of KIF18A mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 3:116,219,007...116,279,378
Ensembl chr 3:116,219,007...116,279,227
|
|
| G
|
Kif18b
|
kinesin family member 18B
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of KIF18B mRNA Acrylamide results in decreased expression of KIF18B mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:88,370,520...88,392,388
Ensembl chr10:88,370,524...88,389,691
|
|
| G
|
Kif1b
|
kinesin family member 1B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KIF1B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:164,890,778...165,025,848
Ensembl chr 5:164,894,763...165,008,841
|
|
| G
|
Kif1c
|
kinesin family member 1C
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KIF1C mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:55,913,010...55,942,220
Ensembl chr10:55,913,093...55,942,220
|
|
| G
|
Kif20a
|
kinesin family member 20A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KIF20A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,504,072...26,512,909
|
|
| G
|
Kif20b
|
kinesin family member 20B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KIF20B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:241,840,898...241,896,451
Ensembl chr 1:241,840,987...241,896,451
|
|
| G
|
Kif22
|
kinesin family member 22
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KIF22 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:191,065,875...191,080,955
Ensembl chr 1:191,065,875...191,080,878
|
|
| G
|
Kif23
|
kinesin family member 23
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KIF23 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:71,293,439...71,321,911
Ensembl chr 8:71,293,482...71,320,856
|
|
| G
|
Kif24
|
kinesin family member 24
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KIF24 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:61,357,078...61,423,882
Ensembl chr 5:61,357,940...61,399,379
|
|
| G
|
Kif26a
|
kinesin family member 26A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KIF26A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:137,035,986...137,072,027
Ensembl chr 6:137,033,789...137,072,022
|
|
| G
|
Kif26b
|
kinesin family member 26B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KIF26B mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr13:92,815,427...93,221,071
Ensembl chr13:92,815,427...93,215,453
|
|
| G
|
Kif27
|
kinesin family member 27
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KIF27 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:6,304,960...6,383,745
Ensembl chr17:6,304,989...6,375,182
|
|
| G
|
Kif2a
|
kinesin family member 2A
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of KIF2A mRNA Acrylamide results in decreased expression of KIF2A mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 2:40,101,548...40,164,780
Ensembl chr 2:40,101,548...40,186,618
|
|
| G
|
Kif2c
|
kinesin family member 2C
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of KIF2C mRNA Acrylamide results in decreased expression of KIF2C protein Acrylamide results in decreased expression of KIF2C mRNA
|
CTD |
PMID:28959563 PMID:32763439 PMID:38614435 |
|
NCBI chr 5:135,873,925...135,899,267
Ensembl chr 5:135,873,925...135,899,212
|
|
| G
|
Kif4a
|
kinesin family member 4A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KIF4A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:69,761,803...69,864,335
Ensembl chr X:69,761,883...69,864,335
|
|
| G
|
Kif6
|
kinesin family member 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KIF6 mRNA
|
CTD |
PMID:38614435 |
|
NCBI chr 9:18,573,925...18,870,789
Ensembl chr 9:18,573,789...18,870,729
|
|
| G
|
Kif7
|
kinesin family member 7
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KIF7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:143,041,206...143,067,873
Ensembl chr 1:143,049,036...143,067,890
|
|
| G
|
Kifbp
|
kinesin family binding protein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KIFBP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:31,055,625...31,075,232
Ensembl chr20:31,055,626...31,075,201
|
|
| G
|
Kifc1
|
kinesin family member C1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of KIFC1 mRNA Acrylamide results in decreased expression of KIFC1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr20:5,000,929...5,018,967
Ensembl chr20:5,000,648...5,018,988
|
|
| G
|
Kifc3
|
kinesin family member C3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KIFC3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:9,831,159...9,926,405
Ensembl chr19:9,831,159...9,926,405
|
|
| G
|
Kirrel2
|
kirre like nephrin family adhesion molecule 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KIRREL2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:94,836,243...94,846,119
Ensembl chr 1:94,836,243...94,846,119
|
|
| G
|
Kiss1
|
KiSS-1 metastasis-suppressor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KISS1 protein
|
CTD |
PMID:38614435 |
|
NCBI chr13:47,327,159...47,332,759
Ensembl chr13:47,327,004...47,332,906
|
|
| G
|
Kiss1r
|
KISS1 receptor
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KISS1R mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:10,435,766...10,439,424
Ensembl chr 7:10,435,766...10,439,424
|
|
| G
|
Kit
|
KIT proto-oncogene receptor tyrosine kinase
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of KIT mRNA Acrylamide results in decreased expression of KIT mRNA
|
CTD |
PMID:22459607 PMID:32763439 |
|
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812
|
|
| G
|
Kitlg
|
KIT ligand
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KITLG mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793
|
|
| G
|
Kl
|
Klotho
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KL mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr12:5,326,003...5,367,016
Ensembl chr12:5,325,959...5,367,015
|
|
| G
|
Klb
|
klotho beta
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KLB mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr14:43,253,963...43,304,532
Ensembl chr14:43,253,255...43,304,515
|
|
| G
|
Klc4
|
kinesin light chain 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KLC4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:21,834,765...21,848,676
Ensembl chr 9:21,835,092...21,848,675
|
|
| G
|
Klf1
|
KLF transcription factor 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of KLF1 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr19:40,155,476...40,158,651
Ensembl chr19:40,155,480...40,158,607
|
|
| G
|
Klf10
|
KLF transcription factor 10
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KLF10 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr 7:71,352,612...71,358,680
Ensembl chr 7:71,350,573...71,358,948
|
|
| G
|
Klf11
|
KLF transcription factor 11
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KLF11 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:47,014,312...47,026,152
Ensembl chr 6:47,014,326...47,037,044
|
|
| G
|
Klf12
|
KLF transcription factor 12
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KLF12 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr15:83,037,548...83,469,998
Ensembl chr15:83,045,463...83,670,640
|
|
| G
|
Klf14
|
KLF transcription factor 14
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KLF14 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:60,521,363...60,524,285
Ensembl chr 4:60,521,363...60,524,285
|
|
| G
|
Klf15
|
KLF transcription factor 15
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KLF15 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:124,522,909...124,542,373
|
|
| G
|
Klf16
|
KLF transcription factor 16
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KLF16 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:9,789,185...9,799,004
Ensembl chr 7:9,775,042...9,798,999
|
|
| G
|
Klf4
|
KLF transcription factor 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KLF4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:75,074,236...75,078,592
|
|
| G
|
Klf5
|
KLF transcription factor 5
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of KLF5 mRNA Acrylamide results in increased expression of KLF5 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr15:82,472,081...82,487,267
Ensembl chr15:82,472,065...82,487,262
|
|
| G
|
Klf7
|
KLF transcription factor 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KLF7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:72,927,485...73,020,167
Ensembl chr 9:72,933,136...73,020,056
|
|
| G
|
Klf8
|
KLF transcription factor 8
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KLF8 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:21,329,081...21,508,720
|
|
| G
|
Klhdc3
|
kelch domain containing 3
|
affects expression
|
EXP
|
Acrylamide affects the expression of KLHDC3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:21,799,870...21,806,337
Ensembl chr 9:21,799,729...21,806,334
|
|
| G
|
Klhl12
|
kelch-like family member 12
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KLHL12 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:48,451,920...48,485,638
Ensembl chr13:48,455,227...48,485,641
|
|
| G
|
Klhl15
|
kelch-like family member 15
|
affects expression increases expression
|
EXP ISO
|
Acrylamide affects the expression of KLHL15 mRNA Acrylamide results in increased expression of KLHL15 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr X:62,987,762...63,043,980
Ensembl chr X:62,989,426...63,039,870
|
|
| G
|
Klhl17
|
kelch-like family member 17
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KLHL17 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:172,095,701...172,101,945
Ensembl chr 5:172,094,940...172,101,195
|
|
| G
|
Klhl21
|
kelch-like family member 21
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KLHL21 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:167,797,621...167,806,276
Ensembl chr 5:167,797,591...167,806,276
|
|
| G
|
Klhl23
|
kelch-like family member 23
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KLHL23 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:74,988,778...75,002,347
Ensembl chr 3:74,988,704...75,024,200
|
|
| G
|
Klhl25
|
kelch-like family member 25
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of KLHL25 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:139,134,655...139,159,898
Ensembl chr 1:139,122,977...139,165,970
|
|
| G
|
Klhl26
|
kelch-like family member 26
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KLHL26 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:18,986,095...19,011,297
Ensembl chr16:18,985,865...19,011,297
|
|
| G
|
Klhl3
|
kelch-like family member 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KLHL3 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr17:6,528,114...6,651,338
Ensembl chr17:6,528,487...6,651,338
|
|
| G
|
Klhl31
|
kelch-like family member 31
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of KLHL31 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 8:87,395,878...87,419,236
Ensembl chr 8:87,395,869...87,419,258
|
|
| G
|
Klhl32
|
kelch-like family member 32
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of KLHL32 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:43,117,861...43,365,080
Ensembl chr 5:43,122,167...43,365,042
|
|
| G
|
Klhl38
|
kelch-like family member 38
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KLHL38 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:91,744,634...91,753,843
Ensembl chr 7:91,734,345...91,753,826
|
|
| G
|
Klhl41
|
kelch-like family member 41
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KLHL41 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:74,842,118...74,855,244
|
|
| G
|
Klk1
|
kallikrein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KLK1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:103,779,152...103,783,270
Ensembl chr 1:103,779,164...103,783,270
|
|
| G
|
Klk1c8
|
kallikrein 1-related peptidase C8
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KLK1C8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:103,684,293...103,688,155
Ensembl chr 1:103,684,293...103,688,155
|
|
| G
|
Klk6
|
kallikrein related-peptidase 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KLK6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:103,415,411...103,422,682
Ensembl chr 1:103,416,886...103,422,690
|
|
| G
|
Klk7
|
kallikrein-related peptidase 7
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KLK7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:103,403,206...103,407,907
Ensembl chr 1:103,403,212...103,407,907
|
|
| G
|
Klk8
|
kallikrein related-peptidase 8
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KLK8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:103,388,352...103,395,195
Ensembl chr 1:103,388,352...103,395,195
|
|
| G
|
Klra2
|
killer cell lectin-like receptor, subfamily A, member 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KLRA2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:166,604,723...166,717,294
Ensembl chr 4:166,598,713...166,717,344
|
|
| G
|
Klra22
|
killer cell lectin-like receptor subfamily A, member 22
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KLRA22 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:165,721,602...165,743,025
Ensembl chr 4:165,721,602...165,751,546
|
|
| G
|
Kmt2c
|
lysine methyltransferase 2C
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KMT2C mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 4:10,353,698...10,755,965
Ensembl chr 4:10,353,735...10,568,620
|
|
| G
|
Kmt2d
|
lysine methyltransferase 2D
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KMT2D mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 7:131,859,696...131,901,032
Ensembl chr 7:131,859,696...131,900,072
|
|
| G
|
Kmt2e
|
lysine methyltransferase 2E
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KMT2E mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:12,550,570...12,655,329
Ensembl chr 4:12,550,570...12,619,721
|
|
| G
|
Kmt5a
|
lysine methyltransferase 5A
|
decreases expression increases expression
|
ISO
|
Acrylamide results in decreased expression of KMT5A protein Acrylamide results in increased expression of KMT5A mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr12:37,800,339...37,823,706
Ensembl chr12:37,800,344...37,823,783
|
|
| G
|
Kmt5b
|
lysine methyltransferase 5B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KMT5B protein
|
CTD |
PMID:30807115 |
|
NCBI chr 1:210,429,672...210,479,042
Ensembl chr 1:210,430,127...210,479,035
|
|
| G
|
Kmt5c
|
lysine methyltransferase 5C
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KMT5C protein
|
CTD |
PMID:30807115 |
|
NCBI chr 1:78,128,325...78,135,931
Ensembl chr 1:78,128,325...78,135,931
|
|
| G
|
Kndc1
|
kinase non-catalytic C-lobe domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KNDC1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:204,119,597...204,167,967
Ensembl chr 1:204,119,659...204,167,965
|
|
| G
|
Kng1
|
kininogen 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KNG1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:91,317,354...91,340,148
Ensembl chr11:91,317,355...91,340,148
|
|
| G
|
Knl1
|
kinetochore scaffold 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of KNL1 mRNA Acrylamide results in decreased expression of KNL1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:126,483,498...126,545,774
Ensembl chr 3:126,483,544...126,545,774
|
|
| G
|
Knop1
|
lysine-rich nucleolar protein 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KNOP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:182,611,758...182,630,610
Ensembl chr 1:182,611,758...182,630,901
|
|
| G
|
Kntc1
|
kinetochore associated 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KNTC1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:38,429,925...38,500,564
Ensembl chr12:38,429,925...38,500,457
|
|
| G
|
Kpna1
|
karyopherin subunit alpha 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KPNA1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr11:78,221,165...78,279,778
Ensembl chr11:78,222,884...78,267,067
|
|
| G
|
Kpna3
|
karyopherin subunit alpha 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KPNA3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:39,712,375...39,786,127
Ensembl chr15:39,712,381...39,786,319
|
|
| G
|
Kprp
|
keratinocyte proline-rich protein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KPRP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:181,125,530...181,129,828
Ensembl chr 2:181,125,530...181,129,828
|
|
| G
|
Krcc1
|
lysine-rich coiled-coil 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KRCC1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:104,819,958...104,832,987
Ensembl chr 4:104,819,190...104,855,484
|
|
| G
|
Kri1
|
KRI1 homolog
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KRI1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:28,093,175...28,107,576
Ensembl chr 8:28,093,175...28,107,557
|
|
| G
|
Krt12
|
keratin 12
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KRT12 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:84,866,965...84,874,265
Ensembl chr10:84,866,965...84,874,265
|
|
| G
|
Krt13
|
keratin 13
|
affects expression
|
EXP
|
Acrylamide affects the expression of KRT13 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:85,552,287...85,556,499
Ensembl chr10:85,552,287...85,556,499
|
|
| G
|
Krt14
|
keratin 14
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KRT14 protein
|
CTD |
PMID:33211169 |
|
NCBI chr10:85,638,182...85,642,450
|
|
| G
|
Krt17
|
keratin 17
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KRT17 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:85,679,068...85,683,792
Ensembl chr10:85,679,070...85,683,787
|
|
| G
|
Krt18
|
keratin 18
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KRT18 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848 Ensembl chr10:135,035,982...135,039,848
|
|
| G
|
Krt28
|
keratin 28
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KRT28 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:84,814,516...84,824,857
Ensembl chr10:84,814,516...84,824,857
|
|
| G
|
Krt33a
|
keratin 33A
|
increases expression decreases expression
|
EXP
|
Acrylamide results in increased expression of KRT33A mRNA Acrylamide results in decreased expression of KRT33B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:85,442,988...85,447,947
Ensembl chr10:85,442,988...85,447,947
|
|
| G
|
Krt4
|
keratin 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KRT4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:134,924,753...134,931,050
Ensembl chr 7:134,924,753...134,930,713
|
|
| G
|
Krt5
|
keratin 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KRT5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:134,724,840...134,730,569
Ensembl chr 7:134,724,840...134,730,569
|
|
| G
|
Krt72
|
keratin 72
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KRT72 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:134,789,082...134,799,547
Ensembl chr 7:134,789,082...134,799,547
|
|
| G
|
Krt73
|
keratin 73
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KRT73 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:134,806,517...134,815,028
Ensembl chr 7:134,806,517...134,815,028
|
|
| G
|
Krt75
|
keratin 75
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KRT75 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:134,565,826...134,576,074
Ensembl chr 7:134,565,826...134,576,074
|
|
| G
|
Krt8
|
keratin 8
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of KRT8 mRNA Acrylamide results in decreased expression of KRT8 mRNA
|
CTD |
PMID:28959563 PMID:35032568 |
|
NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403
|
|
| G
|
Krt90
|
keratin 90
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of KRT90 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:134,555,972...134,565,420
Ensembl chr 7:134,556,526...134,565,359
|
|
| G
|
Krtap13
|
keratin associated protein 13
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KRTAP13 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr11:41,561,053...41,561,595
Ensembl chr11:41,561,071...41,561,595
|
|
| G
|
Krtap16-5
|
keratin associated protein 16-5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KRTAP16-5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:41,735,430...41,736,014
Ensembl chr11:41,735,430...41,736,014
|
|
| G
|
Krtap24-1
|
keratin associated protein 24-1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of KRTAP24-1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr11:41,418,239...41,420,789
Ensembl chr11:41,419,009...41,419,755
|
|
| G
|
Krtap31-2
|
keratin associated protein 31-2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of KRTAP31-2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr10:85,350,328...85,351,311
Ensembl chr10:85,350,381...85,350,863
|
|
| G
|
Krtcap2
|
keratinocyte associated protein 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of KRTCAP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:176,952,167...176,956,163
Ensembl chr 2:176,949,809...176,956,163
|
|
| G
|
Krtcap3
|
keratinocyte associated protein 3
|
affects expression
|
EXP
|
Acrylamide affects the expression of KRTCAP3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:30,840,906...30,842,500
Ensembl chr 6:30,840,906...30,842,475
|
|
| G
|
Ksr1
|
kinase suppressor of ras 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of KSR1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:64,459,786...64,596,083
Ensembl chr10:64,459,786...64,596,082
|
|
| G
|
Ky
|
kyphoscoliosis peptidase
|
affects expression
|
EXP
|
Acrylamide affects the expression of KY mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:111,965,862...112,005,206
Ensembl chr 8:111,965,862...112,005,206
|
|
| G
|
L1cam
|
L1 cell adhesion molecule
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of L1CAM mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:156,748,597...156,775,116
Ensembl chr X:156,748,597...156,775,077
|
|
| G
|
L2hgdh
|
L-2-hydroxyglutarate dehydrogenase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of L2HGDH mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:93,900,427...93,941,534
Ensembl chr 6:93,900,427...93,941,534
|
|
| G
|
L3mbtl3
|
L3MBTL histone methyl-lysine binding protein 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of L3MBTL3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:20,807,679...20,908,609
Ensembl chr 1:20,808,973...20,908,608
|
|
| G
|
Lacc1
|
laccase domain containing 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LACC1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr15:58,799,477...58,816,840
Ensembl chr15:58,786,637...58,816,840
|
|
| G
|
Lag3
|
lymphocyte activating 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LAG3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:159,398,930...159,407,001
Ensembl chr 4:159,398,932...159,406,669
|
|
| G
|
Lama1
|
laminin subunit alpha 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LAMA1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:115,139,548...115,263,620
Ensembl chr 9:115,139,548...115,264,251
|
|
| G
|
Lama4
|
laminin subunit alpha 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LAMA4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:43,946,898...44,087,972
Ensembl chr20:43,946,898...44,087,972
|
|
| G
|
Lama5
|
laminin subunit alpha 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LAMA5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:187,647,904...187,695,974
Ensembl chr 3:187,647,904...187,696,173
|
|
| G
|
Lamc1
|
laminin subunit gamma 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LAMC1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:67,924,872...68,051,986
Ensembl chr13:67,924,872...68,051,986
|
|
| G
|
Lamc2
|
laminin subunit gamma 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LAMC2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:67,835,199...67,894,694
Ensembl chr13:67,835,199...67,895,102
|
|
| G
|
Lamp1
|
lysosomal-associated membrane protein 1
|
increases expression decreases expression multiple interactions
|
ISO
|
Acrylamide results in increased expression of LAMP1 mRNA Acrylamide results in decreased expression of LAMP1 protein TFEB protein inhibits the reaction [Acrylamide results in decreased expression of LAMP1 protein]
|
CTD |
PMID:32763439 PMID:37172712 |
|
NCBI chr16:83,058,131...83,082,843
Ensembl chr16:83,058,385...83,075,159
|
|
| G
|
Lamtor3
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LAMTOR3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:229,084,795...229,097,028
Ensembl chr 2:229,084,858...229,099,383
|
|
| G
|
Lancl2
|
LanC like glutathione S-transferase 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LANCL2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:88,771,974...88,813,920
Ensembl chr 4:88,773,437...88,832,899
|
|
| G
|
Lap3
|
leucine aminopeptidase 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LAP3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:69,820,907...69,839,891
Ensembl chr14:69,820,908...69,839,891
|
|
| G
|
Large1
|
LARGE xylosyl- and glucuronyltransferase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LARGE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:11,609,004...12,057,174
Ensembl chr19:11,609,004...12,054,707
|
|
| G
|
Larp4
|
La ribonucleoprotein 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LARP4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:132,983,276...133,031,514
Ensembl chr 7:132,980,385...133,029,633
|
|
| G
|
Las1l
|
LAS1-like, ribosome biogenesis factor
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of LAS1L mRNA Acrylamide results in decreased expression of LAS1L mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr X:64,861,472...64,883,221
Ensembl chr X:64,861,258...64,883,308
|
|
| G
|
Lat2
|
linker for activation of T cells family, member 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LAT2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:27,740,647...27,754,760
Ensembl chr12:27,740,654...27,755,843
|
|
| G
|
Lats2
|
large tumor suppressor kinase 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LATS2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:35,940,632...35,992,225
Ensembl chr15:35,940,632...35,980,842
|
|
| G
|
Lbp
|
lipopolysaccharide binding protein
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LBP mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:167,373,924...167,401,518
|
|
| G
|
Lbx2
|
ladybird homeobox 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LBX2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:117,149,690...117,151,575
Ensembl chr 4:117,149,690...117,151,575
|
|
| G
|
Lca5l
|
lebercilin LCA5 like
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LCA5L mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:48,930,127...48,964,613
Ensembl chr11:48,930,127...48,964,551
|
|
| G
|
Lcat
|
lecithin cholesterol acyltransferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LCAT mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:50,744,598...50,748,064
Ensembl chr19:50,744,601...50,748,081
|
|
| G
|
Lcn4
|
lipocalin 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LCN4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:30,197,267...30,200,829
Ensembl chr 3:30,197,327...30,200,196
|
|
| G
|
Lcn8
|
lipocalin 8
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LCN8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:28,866,061...28,869,045
Ensembl chr 3:28,866,061...28,869,045
|
|
| G
|
Lcorl
|
ligand dependent nuclear receptor corepressor-like
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LCORL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:69,482,919...69,620,269
Ensembl chr14:69,518,837...69,587,177
|
|
| G
|
Ldb2
|
LIM domain binding 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LDB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:70,489,243...70,810,573
Ensembl chr14:70,489,620...70,810,574
|
|
| G
|
Ldha
|
lactate dehydrogenase A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LDHA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521
|
|
| G
|
Ldlr
|
low density lipoprotein receptor
|
increases expression multiple interactions
|
ISO
|
Acrylamide results in increased expression of LDLR mRNA Acrylamide inhibits the reaction [Streptozocin results in decreased expression of LDLR mRNA]
|
CTD |
PMID:34896238 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
| G
|
Ldlrad3
|
low density lipoprotein receptor class A domain containing 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LDLRAD3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:108,694,528...108,936,330
Ensembl chr 3:108,694,528...108,936,368
|
|
| G
|
Ldlrad4
|
low density lipoprotein receptor class A domain containing 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LDLRAD4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:63,789,089...64,118,166
Ensembl chr18:63,790,440...64,113,064
|
|
| G
|
Ldoc1
|
LDOC1, regulator of NFKB signaling
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LDOC1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:144,837,879...145,110,607
Ensembl chr X:144,837,865...145,111,017
|
|
| G
|
Leap2
|
liver enriched antimicrobial peptide 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LEAP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:38,081,001...38,082,073
Ensembl chr10:38,081,001...38,082,073
|
|
| G
|
Lef1
|
lymphoid enhancer binding factor 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LEF1 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929
|
|
| G
|
Lekr1
|
leucine, glutamate and lysine rich 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of LEKR1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:152,195,003...152,376,389
Ensembl chr 2:152,201,182...152,370,542
|
|
| G
|
Lemd1
|
LEM domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LEMD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:46,183,860...46,250,105
Ensembl chr13:46,218,085...46,250,562
|
|
| G
|
Lemd3
|
LEM domain containing 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LEMD3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:58,300,556...58,389,485
Ensembl chr 7:58,316,851...58,384,707
|
|
| G
|
Leng1
|
leukocyte receptor cluster member 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LENG1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:74,467,343...74,472,275
Ensembl chr 1:74,467,326...74,472,280
|
|
| G
|
Leng8
|
leukocyte receptor cluster member 8
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LENG8 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:79,113,038...79,124,868
Ensembl chr 1:79,113,038...79,124,738
|
|
| G
|
Letm2
|
leucine zipper and EF-hand containing transmembrane protein 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LETM2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:73,171,768...73,192,336
Ensembl chr16:73,167,727...73,192,373
|
|
| G
|
Lfng
|
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LFNG mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:19,144,474...19,152,951
Ensembl chr12:19,124,662...19,152,918
|
|
| G
|
Lgals3bp
|
galectin 3 binding protein
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of LGALS3BP mRNA Acrylamide results in decreased expression of LGALS3BP mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:104,118,510...104,127,848
Ensembl chr10:104,118,510...104,127,848
|
|
| G
|
Lgals9
|
galectin 9
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LGALS9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:64,405,044...64,428,249
Ensembl chr10:64,405,044...64,428,070
|
|
| G
|
Lgi1
|
leucine-rich, glioma inactivated 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LGI1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:245,455,691...245,497,036
Ensembl chr 1:245,455,599...245,499,095
|
|
| G
|
Lgi2
|
leucine-rich repeat LGI family, member 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LGI2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:62,628,746...62,656,231
Ensembl chr14:62,596,150...62,656,188
|
|
| G
|
Lgmn
|
legumain
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LGMN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:127,308,913...127,347,355
Ensembl chr 6:127,308,913...127,347,328
|
|
| G
|
Lgr5
|
leucine rich repeat containing G protein coupled receptor 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LGR5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:52,973,151...53,107,964
Ensembl chr 7:52,974,332...53,108,163
|
|
| G
|
Lhb
|
luteinizing hormone subunit beta
|
increases expression multiple interactions decreases expression
|
EXP
|
Acrylamide results in increased expression of LHB protein naringin inhibits the reaction [Acrylamide results in decreased expression of LHB protein]; Selenium inhibits the reaction [Acrylamide results in increased expression of LHB protein]
|
CTD |
PMID:22459607 PMID:36598108 PMID:37987225 |
|
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445
|
|
| G
|
Lhcgr
|
luteinizing hormone/choriogonadotropin receptor
|
increases expression decreases expression
|
EXP
|
Acrylamide results in increased expression of LHCGR mRNA Acrylamide results in decreased expression of LHCGR mRNA
|
CTD |
PMID:22459607 PMID:28959563 |
|
NCBI chr 6:11,415,361...11,480,834
Ensembl chr 6:11,415,415...11,478,061
|
|
| G
|
Lhfpl1
|
LHFPL tetraspan subfamily member 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of LHFPL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:113,612,200...113,670,060
Ensembl chr X:113,612,200...113,670,060
|
|
| G
|
Lhfpl5
|
LHFPL tetraspan subfamily member 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LHFPL5 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr20:6,634,058...6,644,264
Ensembl chr20:6,633,979...6,644,657
|
|
| G
|
Lhfpl7
|
LHFPL tetraspan subfamily member 7
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LHFPL7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:49,053,607...49,057,890
Ensembl chr12:49,053,740...49,057,890
|
|
| G
|
Lhpp
|
phospholysine phosphohistidine inorganic pyrophosphate phosphatase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LHPP mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:196,833,516...196,924,687
Ensembl chr 1:196,833,523...196,924,871
|
|
| G
|
Lhx5
|
LIM homeobox 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LHX5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:41,786,746...41,795,183
Ensembl chr12:41,786,746...41,795,183
|
|
| G
|
Lhx9
|
LIM homeobox 9
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LHX9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:52,941,207...52,961,436
Ensembl chr13:52,941,210...52,962,266
|
|
| G
|
Lias
|
lipoic acid synthetase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LIAS mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:43,230,369...43,247,469
Ensembl chr14:43,230,375...43,247,423
|
|
| G
|
Liat1
|
ligand of ATE1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LIAT1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:61,370,698...61,374,438
Ensembl chr10:61,370,766...61,374,436
|
|
| G
|
Lif
|
LIF, interleukin 6 family cytokine
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of LIF mRNA
|
CTD |
PMID:28959563 PMID:35690182 |
|
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053
|
|
| G
|
Lig1
|
DNA ligase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LIG1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:83,243,043...83,281,707
Ensembl chr 1:83,219,545...83,281,708
|
|
| G
|
Lig3
|
DNA ligase 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LIG3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:68,215,371...68,238,705
Ensembl chr10:68,215,407...68,238,704
|
|
| G
|
Lilra5
|
leukocyte immunoglobulin like receptor A5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LILRA5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:79,011,865...79,073,860
Ensembl chr 1:79,045,546...79,050,111
|
|
| G
|
Lim2
|
lens intrinsic membrane protein 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LIM2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:102,974,188...102,980,358
Ensembl chr 1:102,974,188...102,980,358
|
|
| G
|
Limd2
|
LIM domain containing 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LIMD2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:91,590,079...91,592,747
Ensembl chr10:91,590,082...91,592,439
|
|
| G
|
Lin52
|
lin-52 DREAM MuvB core complex component
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LIN52 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:109,829,896...109,927,122
Ensembl chr 6:109,830,131...109,925,310
|
|
| G
|
Lin54
|
lin-54 DREAM MuvB core complex component
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LIN54 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:9,434,093...9,514,091
Ensembl chr14:9,434,112...9,492,106
|
|
| G
|
Lin7b
|
lin-7 homolog B, crumbs cell polarity complex component
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of LIN7B mRNA Acrylamide results in decreased expression of LIN7B mRNA
|
CTD |
PMID:28959563 PMID:30807115 PMID:32763439 |
|
NCBI chr 1:104,983,368...104,986,795
Ensembl chr 1:104,982,771...104,986,078
|
|
| G
|
Lin7c
|
lin-7 homolog C, crumbs cell polarity complex component
|
affects expression
|
EXP
|
Acrylamide affects the expression of LIN7C mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:116,859,425...116,872,363
Ensembl chr 3:116,860,282...116,872,363
|
|
| G
|
Lipe
|
lipase E, hormone sensitive type
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LIPE mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:90,093,433...90,112,117
Ensembl chr 1:90,093,433...90,112,117
|
|
| G
|
Lipn
|
lipase, family member N
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LIPN mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:240,998,154...241,016,658
Ensembl chr 1:240,998,154...241,016,658
|
|
| G
|
Lipt2
|
lipoyl(octanoyl) transferase 2
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of LIPT2 mRNA Acrylamide results in decreased expression of LIPT2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:163,916,695...163,919,022
Ensembl chr 1:163,916,695...163,919,022
|
|
| G
|
Litaf
|
lipopolysaccharide-induced TNF factor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LITAF mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:5,163,258...5,199,930
Ensembl chr10:5,163,242...5,199,930
|
|
| G
|
Lix1l
|
limb and CNS expressed 1 like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LIX1L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:186,824,864...186,850,761
Ensembl chr 2:186,824,884...186,850,759
|
|
| G
|
Llgl1
|
LLGL scribble cell polarity complex component 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of LLGL1 mRNA Acrylamide results in decreased expression of LLGL1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:45,878,936...45,893,609
Ensembl chr10:45,879,012...45,893,603
|
|
| G
|
Lman2l
|
lectin, mannose-binding 2-like
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LMAN2L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:46,157,596...46,181,151
Ensembl chr 9:46,157,596...46,181,207
|
|
| G
|
Lmbr1l
|
limb development membrane protein 1-like
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LMBR1L mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:131,940,081...131,958,832
Ensembl chr 7:131,940,081...131,955,402
|
|
| G
|
Lmbrd2
|
LMBR1 domain containing 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LMBRD2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:59,916,736...59,978,739
Ensembl chr 2:59,916,749...59,978,738
|
|
| G
|
Lmf1
|
lipase maturation factor 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LMF1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:15,094,432...15,188,665
Ensembl chr10:15,098,138...15,188,664
|
|
| G
|
Lmln
|
leishmanolysin like peptidase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LMLN mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr11:81,161,330...81,230,972
Ensembl chr11:81,161,330...81,229,447
|
|
| G
|
Lmnb1
|
lamin B1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LMNB1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:52,373,939...52,413,284
Ensembl chr18:52,373,757...52,413,283
|
|
| G
|
Lmnb2
|
lamin B2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LMNB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:9,443,308...9,459,468
Ensembl chr 7:9,440,128...9,459,342
|
|
| G
|
Lmntd2
|
lamin tail domain containing 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LMNTD2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:205,744,694...205,750,460
Ensembl chr 1:205,744,697...205,748,738
|
|
| G
|
Lmo2
|
LIM domain only 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LMO2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:110,810,162...110,832,895
Ensembl chr 3:110,809,912...110,833,075
|
|
| G
|
Lmod1
|
leiomodin 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LMOD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:49,305,693...49,347,970
Ensembl chr13:49,305,830...49,348,116
|
|
| G
|
Lmx1a
|
LIM homeobox transcription factor 1 alpha
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LMX1A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:82,367,493...82,511,157
Ensembl chr13:82,367,933...82,511,154
|
|
| G
|
Lnx1
|
ligand of numb-protein X 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LNX1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr14:33,868,517...33,971,217
Ensembl chr14:33,868,571...33,971,217
|
|
| G
|
LOC102546572
|
zinc finger protein 709-like
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ZNF136 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:12,496,595...12,519,259
Ensembl chr 7:12,504,501...12,519,295
|
|
| G
|
LOC120095812
|
U6 spliceosomal RNA
|
increases expression
|
ISO
|
Acrylamide results in increased expression of RNU6-945P mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:96,865,585...96,865,691
Ensembl chr11:96,865,585...96,865,691
|
|
| G
|
LOC130046242
|
uncharacterized LOC130046242
|
increases expression
|
ISO
|
Acrylamide results in increased expression of ZNF57 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:8,663,437...8,669,068
Ensembl chr 7:8,663,217...8,667,271
|
|
| G
|
Lonp2
|
lon peptidase 2, peroxisomal
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LONP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:36,580,736...36,672,242
Ensembl chr19:36,580,736...36,672,242
|
|
| G
|
Lonrf3
|
LON peptidase N-terminal domain and ring finger 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LONRF3 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr X:120,430,975...120,469,648
Ensembl chr X:120,430,996...120,464,572
|
|
| G
|
Lox
|
lysyl oxidase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LOX mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:48,162,889...48,175,640
Ensembl chr18:48,165,688...48,239,810
|
|
| G
|
Loxhd1
|
lipoxygenase homology PLAT domains 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LOXHD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:73,093,142...73,245,784
Ensembl chr18:73,093,142...73,245,784
|
|
| G
|
Loxl1
|
lysyl oxidase-like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LOXL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:67,587,636...67,612,224
Ensembl chr 8:67,587,636...67,612,224
|
|
| G
|
Loxl2
|
lysyl oxidase-like 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LOXL2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:51,091,547...51,182,843
Ensembl chr15:51,069,997...51,182,842
|
|
| G
|
Loxl3
|
lysyl oxidase-like 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LOXL3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:117,098,358...117,114,673
Ensembl chr 4:117,099,635...117,115,046
|
|
| G
|
Loxl4
|
lysyl oxidase-like 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LOXL4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:251,345,445...251,365,640
Ensembl chr 1:251,347,238...251,365,577
|
|
| G
|
Lpcat4
|
lysophosphatidylcholine acyltransferase 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LPCAT4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:119,499,128...119,507,275
Ensembl chr 3:119,499,128...119,507,362
|
|
| G
|
Lpl
|
lipoprotein lipase
|
multiple interactions
|
ISO
|
Acrylamide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA]; Acrylamide promotes the reaction [Dietary Fats results in increased expression of LPL mRNA]
|
CTD |
PMID:30409764 |
|
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107
|
|
| G
|
Lpo
|
lactoperoxidase
|
multiple interactions
|
EXP
|
[Acrylamide co-treated with INS protein] results in increased expression of LPO protein
|
CTD |
PMID:38604440 |
|
NCBI chr10:73,104,170...73,124,683
Ensembl chr10:73,104,188...73,123,456
|
|
| G
|
Lpxn
|
leupaxin
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LPXN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:219,353,319...219,387,743
Ensembl chr 1:219,353,708...219,387,742
|
|
| G
|
Lratd1
|
LRAT domain containing 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LRATD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:42,646,515...42,650,988
Ensembl chr 6:42,640,190...42,651,204
|
|
| G
|
Lrfn1
|
leucine rich repeat and fibronectin type III domain containing 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LRFN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:92,866,864...92,888,984
Ensembl chr 1:92,874,827...92,888,982
|
|
| G
|
Lrfn3
|
leucine rich repeat and fibronectin type III domain containing 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LRFN3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:94,744,315...94,751,001
Ensembl chr 1:94,744,321...94,751,178
|
|
| G
|
Lrif1
|
ligand dependent nuclear receptor interacting factor 1
|
affects expression increases expression
|
EXP ISO
|
Acrylamide affects the expression of LRIF1 mRNA Acrylamide results in increased expression of LRIF1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:196,919,606...197,010,713
Ensembl chr 2:196,919,151...197,010,717
|
|
| G
|
Lrig3
|
leucine-rich repeats and immunoglobulin-like domains 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LRIG3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:63,701,724...63,751,898
Ensembl chr 7:63,701,778...63,752,261
|
|
| G
|
Lrp2bp
|
Lrp2 binding protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LRP2BP mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:52,976,005...53,001,952
Ensembl chr16:52,976,006...53,001,699
|
|
| G
|
Lrp8
|
LDL receptor related protein 8
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LRP8 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:127,792,236...127,864,207
Ensembl chr 5:127,792,299...127,864,207
|
|
| G
|
Lrpprc
|
leucine-rich pentatricopeptide repeat containing
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LRPPRC mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 6:15,612,638...15,695,113
Ensembl chr 6:15,612,655...15,695,116
|
|
| G
|
Lrrc10b
|
leucine rich repeat containing 10B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LRRC10B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:216,521,402...216,522,630
Ensembl chr 1:216,520,677...216,524,310
|
|
| G
|
Lrrc14
|
leucine rich repeat containing 14
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LRRC14 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:110,311,384...110,317,757
Ensembl chr 7:110,311,369...110,317,760
|
|
| G
|
Lrrc14b
|
leucine rich repeat containing 14B
|
affects expression
|
EXP
|
Acrylamide affects the expression of LRRC14B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:30,748,103...30,754,236
Ensembl chr 1:30,749,746...30,755,258
|
|
| G
|
Lrrc15
|
leucine rich repeat containing 15
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LRRC15 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:83,974,708...83,989,157
Ensembl chr11:83,974,695...83,989,146
|
|
| G
|
Lrrc17
|
leucine rich repeat containing 17
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LRRC17 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:14,393,632...14,424,048
Ensembl chr 4:14,393,640...14,424,048
|
|
| G
|
Lrrc2
|
leucine rich repeat containing 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LRRC2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:119,814,514...119,847,587
Ensembl chr 8:119,814,509...119,847,583
|
|
| G
|
Lrrc20
|
leucine rich repeat containing 20
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LRRC20 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:29,965,673...30,071,185
Ensembl chr20:29,972,001...30,071,184
|
|
| G
|
Lrrc24
|
leucine rich repeat containing 24
|
affects expression
|
EXP
|
Acrylamide affects the expression of LRRC24 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:110,317,935...110,325,201
Ensembl chr 7:110,317,020...110,325,074
|
|
| G
|
Lrrc28
|
leucine rich repeat containing 28
|
increases expression decreases expression
|
EXP
|
Acrylamide results in increased expression of LRRC28 mRNA Acrylamide results in decreased expression of LRRC28 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:130,526,757...130,655,991
Ensembl chr 1:130,537,930...130,655,949
|
|
| G
|
Lrrc34
|
leucine rich repeat containing 34
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LRRC34 mRNA
|
CTD |
PMID:32151602 |
|
NCBI chr 2:114,680,787...114,702,961
Ensembl chr 2:114,680,094...114,702,961
|
|
| G
|
Lrrc39
|
leucine rich repeat containing 39
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of LRRC39 mRNA Acrylamide results in increased expression of LRRC39 mRNA
|
CTD |
PMID:28959563 PMID:30807115 PMID:32763439 |
|
NCBI chr 2:207,201,039...207,220,375
Ensembl chr 2:207,201,042...207,220,371
|
|
| G
|
Lrrc3b
|
leucine rich repeat containing 3B
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of LRRC3B mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr15:12,404,309...12,481,618
Ensembl chr15:12,336,369...12,481,866
|
|
| G
|
Lrrc42
|
leucine rich repeat containing 42
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of LRRC42 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:127,243,484...127,264,599
Ensembl chr 5:127,243,486...127,264,599
|
|
| G
|
Lrrc45
|
leucine rich repeat containing 45
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LRRC45 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:106,492,846...106,500,751
Ensembl chr10:106,492,592...106,500,751
|
|
| G
|
Lrrc51
|
leucine rich repeat containing 51
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LRRC51 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:165,690,617...165,709,837
Ensembl chr 1:165,690,111...165,698,842
|
|
| G
|
Lrrc55
|
leucine rich repeat containing 55
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LRRC55 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:90,676,547...90,687,392
Ensembl chr 3:90,680,160...90,685,280
|
|
| G
|
Lrrc56
|
leucine rich repeat containing 56
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LRRC56 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:205,729,402...205,744,754
Ensembl chr 1:205,729,409...205,744,759
|
|
| G
|
Lrrc59
|
leucine rich repeat containing 59
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LRRC59 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:80,069,162...80,083,820
Ensembl chr10:80,069,120...80,084,079
|
|
| G
|
Lrrc71
|
leucine rich repeat containing 71
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LRRC71 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:175,492,682...175,505,334
Ensembl chr 2:175,492,682...175,505,334
|
|
| G
|
Lrrc73
|
leucine rich repeat containing 73
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of LRRC73 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 9:22,223,735...22,227,867
Ensembl chr 9:22,223,152...22,226,736
|
|
| G
|
Lrrc74a
|
leucine rich repeat containing 74A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LRRC74A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:112,117,226...112,147,152
Ensembl chr 6:112,117,241...112,148,068
|
|
| G
|
Lrrc75b
|
leucine rich repeat containing 75B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LRRC75B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:13,099,741...13,105,942
Ensembl chr20:13,094,809...13,109,532
|
|
| G
|
Lrrc8a
|
leucine rich repeat containing 8 VRAC subunit A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LRRC8A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:33,902,299...33,934,989
Ensembl chr 3:33,908,268...33,933,625
|
|
| G
|
Lrrc8c
|
leucine rich repeat containing 8 VRAC subunit C
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LRRC8C mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:4,528,721...4,621,259
Ensembl chr14:4,531,823...4,620,049
|
|
| G
|
Lrrc8d
|
leucine rich repeat containing 8 VRAC subunit D
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LRRC8D mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:4,335,114...4,411,549
Ensembl chr14:4,332,130...4,445,639
|
|
| G
|
Lrrcc1
|
leucine rich repeat and coiled-coil centrosomal protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LRRCC1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:88,746,904...88,781,532
Ensembl chr 2:88,746,443...88,781,542
|
|
| G
|
Lrrfip1
|
LRR binding FLII interacting protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LRRFIP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:99,039,590...99,167,805
Ensembl chr 9:99,039,614...99,167,779
|
|
| G
|
Lrriq3
|
leucine-rich repeats and IQ motif containing 3
|
affects expression
|
EXP
|
Acrylamide affects the expression of LRRIQ3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:246,778,759...246,871,284
Ensembl chr 2:246,778,984...246,880,668
|
|
| G
|
Lrrk2
|
leucine-rich repeat kinase 2
|
multiple interactions increases expression
|
ISO
|
Acrylamide promotes the reaction [NFATC2 protein binds to LRRK2 protein]; Acrylamide results in increased expression of and results in increased phosphorylation of LRRK2 protein; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Acrylamide results in increased expression of LRRK2 protein]; LRRK2 promotes the reaction [Acrylamide results in increased expression of NFATC2 protein]; LRRK2 promotes the reaction [Acrylamide results in increased secretion of IL1B protein]; LRRK2 promotes the reaction [Acrylamide results in increased secretion of IL6 protein]; LRRK2 promotes the reaction [Acrylamide results in increased secretion of NOS2 protein]; TLR2 protein promotes the reaction [Acrylamide results in increased expression of LRRK2 protein] Acrylamide results in increased expression of LRRK2 mRNA; Acrylamide results in increased expression of LRRK2 protein
|
CTD |
PMID:37037409 |
|
NCBI chr 7:124,706,246...124,867,234
Ensembl chr 7:124,706,080...124,867,239
|
|
| G
|
Lrrtm1
|
leucine rich repeat transmembrane neuronal 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of LRRTM1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:111,246,213...111,295,638
Ensembl chr 4:111,235,054...111,276,818
|
|
| G
|
Lrrtm2
|
leucine rich repeat transmembrane neuronal 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LRRTM2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:27,091,919...27,096,967
Ensembl chr18:27,091,919...27,096,967
|
|
| G
|
Lrrtm4
|
leucine rich repeat transmembrane neuronal 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LRRTM4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:114,103,783...114,894,696
Ensembl chr 4:114,103,870...114,109,726
|
|
| G
|
Lsamp
|
limbic system-associated membrane protein
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of LSAMP mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr11:72,053,285...74,223,019
Ensembl chr11:72,053,285...72,702,134
|
|
| G
|
Lsm1
|
LSM1 homolog, mRNA degradation associated
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LSM1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:72,980,075...72,991,581
Ensembl chr16:72,979,686...73,022,396
|
|
| G
|
Lsm14a
|
LSM14A mRNA processing body assembly factor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LSM14A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:96,101,990...96,146,578
Ensembl chr 1:96,101,992...96,146,448
|
|
| G
|
Lsm2
|
LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LSM2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:3,848,120...3,853,298
Ensembl chr20:3,848,119...3,851,891
|
|
| G
|
Lsm3
|
LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LSM3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:125,578,185...125,584,429
Ensembl chr 4:125,578,185...125,584,429
|
|
| G
|
Lsm4
|
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LSM4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:18,789,466...18,795,164
Ensembl chr16:18,789,467...18,794,886
|
|
| G
|
Lsm5
|
LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LSM5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:87,281,260...87,284,476
Ensembl chr 4:87,281,260...87,284,476 Ensembl chr 6:87,281,260...87,284,476
|
|
| G
|
Lsm6
|
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LSM6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:46,002,592...46,017,152
|
|
| G
|
Lsmem1
|
leucine-rich single-pass membrane protein 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LSMEM1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:62,978,880...62,988,750
Ensembl chr 6:62,978,885...62,988,750
|
|
| G
|
Lsmem2
|
leucine-rich single-pass membrane protein 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LSMEM2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:117,144,498...117,149,300
Ensembl chr 8:117,144,464...117,149,185
|
|
| G
|
Lsp1
|
lymphocyte-specific protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LSP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:207,044,157...207,077,891
Ensembl chr 1:207,044,159...207,077,893
|
|
| G
|
Lsr
|
lipolysis stimulated lipoprotein receptor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LSR mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:95,313,830...95,329,471
Ensembl chr 1:95,313,033...95,329,354
|
|
| G
|
Lss
|
lanosterol synthase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LSS mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,073,543...12,118,253
|
|
| G
|
Lta
|
lymphotoxin alpha
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LTA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,623,527...3,625,533
|
|
| G
|
Ltb4r
|
leukotriene B4 receptor
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LTB4R mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:33,233,120...33,235,636
Ensembl chr15:33,232,820...33,235,637
|
|
| G
|
Ltbp2
|
latent transforming growth factor beta binding protein 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LTBP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:110,161,029...110,261,586
Ensembl chr 6:110,161,029...110,257,298
|
|
| G
|
Ltbp4
|
latent transforming growth factor beta binding protein 4
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of LTBP4 mRNA Acrylamide results in decreased expression of LTBP4 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:91,727,769...91,759,822
Ensembl chr 1:91,727,769...91,760,006
|
|
| G
|
Ltc4s
|
leukotriene C4 synthase
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of LTC4S mRNA
|
CTD |
PMID:28959563 PMID:35032568 |
|
NCBI chr10:35,060,002...35,066,466
Ensembl chr10:35,061,437...35,063,768
|
|
| G
|
Ltv1
|
LTV1 ribosome biogenesis factor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LTV1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:9,385,834...9,398,557
Ensembl chr 1:9,385,830...9,398,677
|
|
| G
|
Lurap1
|
leucine rich adaptor protein 1
|
affects expression
|
EXP
|
Acrylamide affects the expression of LURAP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:134,855,643...134,865,366
Ensembl chr 5:134,855,224...134,865,459
|
|
| G
|
Lurap1l
|
leucine rich adaptor protein 1-like
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LURAP1L mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:100,402,921...100,455,479
Ensembl chr 5:100,407,483...100,455,478
|
|
| G
|
Lxn
|
latexin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LXN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:154,037,604...154,043,473
Ensembl chr 2:154,037,292...154,043,488
|
|
| G
|
Ly6d
|
lymphocyte antigen 6 family member D
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LY6D mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:108,532,207...108,533,943
Ensembl chr 7:108,532,215...108,533,716
|
|
| G
|
Ly6g5b
|
lymphocyte antigen 6 family member G5B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LY6G5B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:3,710,132...3,712,193
Ensembl chr20:3,710,710...3,712,192
|
|
| G
|
Ly6g6c
|
lymphocyte antigen 6 family member G6C
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LY6G6C mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:3,758,290...3,760,987
Ensembl chr20:3,758,290...3,762,927
|
|
| G
|
Ly6h
|
lymphocyte antigen 6 family member H
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LY6H mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:109,139,527...109,142,108
Ensembl chr 7:109,139,527...109,246,799
|
|
| G
|
Lyar
|
Ly1 antibody reactive
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LYAR mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:76,789,193...76,802,973
Ensembl chr14:76,789,200...76,802,765
|
|
| G
|
Lyc2
|
lysozyme C type 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LYC2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:54,773,009...54,780,352
Ensembl chr 7:54,772,934...54,780,676
|
|
| G
|
Lyg1
|
lysozyme G1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LYG1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:47,666,938...47,678,687
Ensembl chr 9:47,666,938...47,678,687
|
|
| G
|
Lynx1
|
Ly6/neurotoxin 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LYNX1 mRNA
|
CTD |
PMID:29261810 |
|
NCBI chr 7:108,521,783...108,527,012
Ensembl chr 7:108,521,780...108,527,130
|
|
| G
|
Lypd1
|
Ly6/Plaur domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LYPD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:39,874,937...39,922,385
Ensembl chr13:39,879,096...39,922,338
|
|
| G
|
Lypd6
|
Ly6/Plaur domain containing 6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of LYPD6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:54,896,618...55,041,928
Ensembl chr 3:54,896,575...55,041,929
|
|
| G
|
Lyrm1
|
LYR motif containing 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LYRM1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:183,715,941...183,736,406
Ensembl chr 1:183,715,468...183,736,406
|
|
| G
|
Lyrm2
|
LYR motif containing 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LYRM2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:51,994,540...51,996,818
Ensembl chr 5:51,994,543...51,997,979
|
|
| G
|
Lyrm9
|
LYR motif containing 9
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of LYRM9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:64,223,732...64,237,791
Ensembl chr10:64,223,757...64,237,796
|
|
| G
|
Lyst
|
lysosomal trafficking regulator
|
increases expression
|
ISO
|
Acrylamide results in increased expression of LYST mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:93,225,509...93,427,650
Ensembl chr17:93,225,540...93,427,650
|
|
| G
|
Lyzl6
|
lysozyme-like 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of LYZL6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:89,044,375...89,049,210
Ensembl chr10:89,044,375...89,049,210
|
|
| G
|
Mab21l2
|
mab-21 like 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MAB21L2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:174,244,538...174,247,620
Ensembl chr 2:174,238,828...174,252,064
|
|
| G
|
Mab21l3
|
mab-21 like 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MAB21L3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:191,937,451...191,960,204
Ensembl chr 2:191,937,451...191,960,204
|
|
| G
|
Macir
|
macrophage immunometabolism regulator
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MACIR mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:105,868,072...105,888,128
Ensembl chr 9:105,866,641...105,889,758
|
|
| G
|
Maco1
|
macoilin 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MACO1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:152,296,107...152,358,684
Ensembl chr 5:152,296,558...152,358,684
|
|
| G
|
Macrod1
|
mono-ADP ribosylhydrolase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MACROD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:213,675,413...213,831,571
Ensembl chr 1:213,675,406...213,816,348
|
|
| G
|
Macrod2
|
mono-ADP ribosylhydrolase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MACROD2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 3:148,173,821...150,191,077
Ensembl chr 3:148,173,829...150,188,058
|
|
| G
|
Mad1l1
|
mitotic arrest deficient 1 like 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MAD1L1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:19,434,782...19,744,574
Ensembl chr12:19,434,746...19,744,567
|
|
| G
|
Mad2l1
|
mitotic arrest deficient 2 like 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MAD2L1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:97,236,419...97,247,603
Ensembl chr 4:97,236,503...97,243,222
|
|
| G
|
Mad2l1bp
|
MAD2L1 binding protein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MAD2L1BP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:22,329,699...22,334,024
Ensembl chr 9:22,329,698...22,335,016
|
|
| G
|
Mad2l2
|
mitotic arrest deficient 2 like 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MAD2L2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:163,846,678...163,859,851
Ensembl chr 5:163,846,687...163,859,851
|
|
| G
|
Mafa
|
MAF bZIP transcription factor A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MAFA mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:109,313,021...109,315,813
Ensembl chr 7:109,313,121...109,315,760
|
|
| G
|
Mafb
|
MAF bZIP transcription factor B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MAFB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:169,417,890...169,419,810
Ensembl chr 3:169,416,945...169,419,975
|
|
| G
|
Maff
|
MAF bZIP transcription factor F
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MAFF mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147
|
|
| G
|
Mafg
|
MAF bZIP transcription factor G
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MAFG mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:106,401,633...106,410,159
|
|
| G
|
Mafk
|
MAF bZIP transcription factor K
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of MAFK mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr12:19,948,473...19,970,351
Ensembl chr12:19,948,476...19,959,192
|
|
| G
|
Mag
|
myelin-associated glycoprotein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MAG mRNA
|
CTD |
PMID:36328537 |
|
NCBI chr 1:95,275,728...95,291,133
Ensembl chr 1:95,275,635...95,291,060
|
|
| G
|
Magea13
|
MAGE family member A13
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MAGEA11 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:142,106,603...142,112,462
Ensembl chr X:142,106,603...142,112,457
|
|
| G
|
Mageb1l1
|
MAGE family member B1-like 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MAGEB1L1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:54,837,396...54,847,437
Ensembl chr X:54,837,396...54,847,437
|
|
| G
|
Maged1
|
MAGE family member D1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MAGED1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:63,416,464...63,423,167
Ensembl chr X:63,416,466...63,423,112
|
|
| G
|
Magee1
|
MAGE family member E1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MAGEE1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:74,254,848...74,258,395
Ensembl chr X:74,254,958...74,258,371
|
|
| G
|
Mageh1
|
MAGE family member H1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MAGEH1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:21,725,709...21,726,965
Ensembl chr X:21,718,669...21,727,219
|
|
| G
|
Magi2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MAGI2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:15,278,518...16,762,427
Ensembl chr 4:15,278,518...16,762,199
|
|
| G
|
Magix
|
MAGI family member, X-linked
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MAGIX mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:17,496,092...17,504,370
Ensembl chr X:17,496,225...17,504,369
|
|
| G
|
Maip1
|
matrix AAA peptidase interacting protein 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MAIP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:66,473,159...66,481,089
Ensembl chr 9:66,472,960...66,482,833
|
|
| G
|
Mal
|
mal, T-cell differentiation protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MAL mRNA
|
CTD |
PMID:36328537 |
|
NCBI chr 3:135,317,664...135,341,423
Ensembl chr 3:135,317,664...135,341,423
|
|
| G
|
Mall
|
mal, T-cell differentiation protein-like
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MALL mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 3:135,381,180...135,404,136
Ensembl chr 3:135,377,410...135,404,066
|
|
| G
|
Mamdc4
|
MAM domain containing 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MAMDC4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:28,780,523...28,789,139
Ensembl chr 3:28,780,523...28,789,139
|
|
| G
|
Maml3
|
mastermind-like transcriptional coactivator 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MAML3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:137,871,267...138,288,615
Ensembl chr 2:137,871,267...138,287,960
|
|
| G
|
Mamstr
|
MEF2 activating motif and SAP domain containing transcriptional regulator
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MAMSTR mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:105,246,172...105,252,759
Ensembl chr 1:105,246,950...105,252,757
|
|
| G
|
Man1c1
|
mannosidase, alpha, class 1C, member 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MAN1C1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:152,057,839...152,197,737
Ensembl chr 5:152,057,967...152,197,138
|
|
| G
|
Man2a1
|
mannosidase, alpha, class 2A, member 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MAN2A1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:111,698,913...111,855,257
Ensembl chr 9:111,698,913...111,867,850
|
|
| G
|
Man2a2
|
mannosidase, alpha, class 2A, member 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MAN2A2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:143,712,157...143,736,624
Ensembl chr 1:143,716,072...143,736,562
|
|
| G
|
Man2b2
|
mannosidase, alpha, class 2B, member 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of MAN2B2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:78,193,797...78,218,802
Ensembl chr14:78,193,725...78,227,724
|
|
| G
|
Man2c1
|
mannosidase, alpha, class 2C, member 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MAN2C1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:66,434,480...66,445,649
Ensembl chr 8:66,434,421...66,445,648
|
|
| G
|
Manf
|
mesencephalic astrocyte-derived neurotrophic factor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MANF mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:116,427,053...116,430,259
Ensembl chr 8:116,427,048...116,429,910
|
|
| G
|
Mansc1
|
MANSC domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MANSC1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:169,170,164...169,190,379
Ensembl chr 4:169,170,164...169,189,864
|
|
| G
|
Maob
|
monoamine oxidase B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MAOB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:8,490,405...8,594,065
Ensembl chr X:8,490,344...8,594,375
|
|
| G
|
Map1a
|
microtubule-associated protein 1A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MAP1A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:128,716,907...128,736,638
Ensembl chr 3:128,716,940...128,740,159
|
|
| G
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MAP1LC3A mRNA
|
CTD |
PMID:34569336 |
|
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850
|
|
| G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
decreases expression multiple interactions increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MAP1LC3B mRNA Acrylamide results in increased expression of and results in increased lipidation of MAP1LC3B protein; TFEB protein inhibits the reaction [Acrylamide results in increased expression of and results in increased lipidation of MAP1LC3B protein] Acrylamide results in increased expression of MAP1LC3B mRNA
|
CTD |
PMID:28959563 PMID:32763439 PMID:37172712 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
| G
|
Map2
|
microtubule-associated protein 2
|
decreases expression increases expression multiple interactions
|
EXP
|
Acrylamide results in decreased expression of MAP2 protein Acrylamide results in increased expression of MAP2 protein calpeptin inhibits the reaction [Acrylamide results in decreased expression of MAP2 protein]; calpeptin inhibits the reaction [Acrylamide results in increased expression of MAP2 protein]
|
CTD |
PMID:29524570 PMID:30096436 |
|
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
|
|
| G
|
Map2k1
|
mitogen activated protein kinase kinase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MAP2K1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184
|
|
| G
|
Map2k4
|
mitogen activated protein kinase kinase 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MAP2K4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:50,842,348...50,947,063
Ensembl chr10:50,844,034...50,947,185
|
|
| G
|
Map3k10
|
mitogen activated protein kinase kinase kinase 10
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MAP3K10 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:92,083,376...92,101,676
Ensembl chr 1:92,083,376...92,101,676
|
|
| G
|
Map3k13
|
mitogen-activated protein kinase kinase kinase 13
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MAP3K13 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:92,596,436...92,741,717
Ensembl chr11:92,601,738...92,739,663
|
|
| G
|
Map3k14
|
mitogen-activated protein kinase kinase kinase 14
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MAP3K14 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:88,665,417...88,715,669
Ensembl chr10:88,665,417...88,715,592
|
|
| G
|
Map3k6
|
mitogen-activated protein kinase kinase kinase 6
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of MAP3K6 mRNA Acrylamide results in decreased expression of MAP3K6 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:150,724,029...150,736,113
Ensembl chr 5:150,724,216...150,736,111
|
|
| G
|
Map3k7cl
|
MAP3K7 C-terminal like
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MAP3K7CL mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr11:40,276,839...40,321,848
Ensembl chr11:40,277,688...40,321,847
|
|
| G
|
Map3k9
|
mitogen-activated protein kinase kinase kinase 9
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MAP3K9 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:107,155,008...107,220,304
Ensembl chr 6:107,161,534...107,220,061
|
|
| G
|
Map4
|
microtubule-associated protein 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MAP4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:118,800,393...118,942,805
Ensembl chr 8:118,804,022...118,942,805
|
|
| G
|
Map7d1
|
MAP7 domain containing 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MAP7D1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:143,812,467...143,837,597
Ensembl chr 5:143,811,924...143,837,021
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions increases phosphorylation decreases phosphorylation increases expression
|
ISO EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK1 protein]; [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK1 protein; Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK1 protein]; Acrylamide promotes the reaction [Dietary Fats results in increased phosphorylation of MAPK1 protein]; Curcumin inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK1 protein] acadesine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK1 protein]; PRKCA protein affects the reaction [Acrylamide results in increased phosphorylation of MAPK1 protein]; Rutin inhibits the reaction [Acrylamide results in decreased phosphorylation of MAPK1 protein] Acrylamide results in increased expression of MAPK1 protein modified form
|
CTD |
PMID:25531190 PMID:29426002 PMID:30409764 PMID:31081568 PMID:33421551 PMID:33545342 PMID:36565847 PMID:36657526 More...
|
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk11
|
mitogen-activated protein kinase 11
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of MAPK11 mRNA Acrylamide results in decreased expression of MAPK11 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:122,098,120...122,105,023
Ensembl chr 7:122,098,121...122,105,038
|
|
| G
|
Mapk12
|
mitogen-activated protein kinase 12
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of MAPK12 mRNA Acrylamide results in decreased expression of MAPK12 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:122,085,647...122,096,307
Ensembl chr 7:122,085,913...122,096,307
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
increases expression multiple interactions
|
EXP
|
Acrylamide results in increased expression of MAPK14 mRNA naringin inhibits the reaction [Acrylamide results in increased expression of MAPK14 mRNA]; Selenium inhibits the reaction [Acrylamide results in increased expression of MAPK14 mRNA]
|
CTD |
PMID:36598108 PMID:37987225 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Mapk15
|
mitogen-activated protein kinase 15
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MAPK15 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:109,575,619...109,595,339
Ensembl chr 7:109,575,561...109,595,346
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions increases phosphorylation decreases phosphorylation decreases expression increases expression
|
ISO EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK3 protein]; [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK3 protein; Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK3 protein]; Acrylamide promotes the reaction [Dietary Fats results in increased phosphorylation of MAPK3 protein]; Curcumin inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK3 protein] acadesine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK3 protein]; Rutin inhibits the reaction [Acrylamide results in decreased phosphorylation of MAPK3 protein] Acrylamide results in decreased expression of MAPK3 mRNA Acrylamide results in increased expression of MAPK3 protein modified form
|
CTD |
PMID:25531190 PMID:29426002 PMID:30409764 PMID:31081568 PMID:32763439 PMID:33421551 PMID:33545342 PMID:36565847 PMID:36657526 More...
|
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions increases expression increases phosphorylation
|
ISO EXP
|
Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK8 protein]; Curcumin inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK8 protein]; pyrazolanthrone inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK8 protein] Acrylamide results in increased expression of MAPK8 protein modified form
|
CTD |
PMID:25531190 PMID:29426002 PMID:31081568 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
multiple interactions increases expression increases phosphorylation
|
ISO EXP
|
Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK9 protein] Acrylamide results in increased expression of MAPK9 protein modified form
|
CTD |
PMID:25531190 PMID:29426002 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Mapkapk3
|
MAPK activated protein kinase 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MAPKAPK3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:116,808,429...116,842,228
Ensembl chr 8:116,808,429...116,842,228
|
|
| G
|
Mapkbp1
|
mitogen activated protein kinase binding protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MAPKBP1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:127,401,612...127,452,152
Ensembl chr 3:127,401,612...127,449,983
|
|
| G
|
Mapt
|
microtubule-associated protein tau
|
decreases expression increases phosphorylation increases expression multiple interactions
|
EXP ISO
|
Acrylamide results in decreased expression of MAPT mRNA Acrylamide results in increased phosphorylation of MAPT protein Acrylamide results in increased expression of MAPT protein calpeptin inhibits the reaction [Acrylamide results in increased expression of MAPT protein]
|
CTD |
PMID:28959563 PMID:29261810 PMID:30096436 PMID:32763439 PMID:33421551 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
|
|
| G
|
Marchf11
|
membrane associated ring-CH-type finger 11
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MARCHF11 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:78,628,793...78,730,164
Ensembl chr 2:78,628,191...78,755,104
|
|
| G
|
Marchf4
|
membrane associated ring-CH-type finger 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MARCHF4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:81,527,703...81,647,448
Ensembl chr 9:81,527,703...81,647,448
|
|
| G
|
Marcks
|
myristoylated alanine rich protein kinase C substrate
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MARCKS mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882
|
|
| G
|
Marf1
|
meiosis regulator and mRNA stability factor 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MARF1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr10:1,395,271...1,439,974
Ensembl chr10:1,395,282...1,439,974
|
|
| G
|
Marveld1
|
MARVEL domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MARVELD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:250,903,342...250,907,393
Ensembl chr 1:250,903,342...250,907,393
|
|
| G
|
Marveld2
|
MARVEL domain containing 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MARVELD2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:33,474,750...33,498,225
Ensembl chr 2:33,462,950...33,498,077
|
|
| G
|
Marveld3
|
MARVEL domain containing 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MARVELD3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:54,818,180...54,832,871
Ensembl chr19:54,818,180...54,832,871
|
|
| G
|
Masp1
|
MBL associated serine protease 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MASP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:90,839,081...90,909,922
Ensembl chr11:90,839,061...90,917,470
|
|
| G
|
Masp2
|
MBL associated serine protease 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MASP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:164,319,017...164,332,686
Ensembl chr 5:164,308,991...164,332,705
|
|
| G
|
Mastl
|
microtubule associated serine/threonine kinase-like
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MASTL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:90,158,592...90,195,550
Ensembl chr17:90,160,068...90,195,564
|
|
| G
|
Mat2a
|
methionine adenosyltransferase 2A
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MAT2A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:106,048,043...106,053,612
Ensembl chr 4:106,038,254...106,053,645
|
|
| G
|
Matcap1
|
microtubule associated tyrosine carboxypeptidase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MATCAP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:50,067,978...50,076,715
Ensembl chr19:50,069,015...50,076,709
|
|
| G
|
Matn2
|
matrilin 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MATN2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:67,380,140...67,529,767
Ensembl chr 7:67,380,168...67,530,153
|
|
| G
|
Matn3
|
matrilin 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MATN3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:37,467,729...37,487,776
Ensembl chr 6:37,467,729...37,487,776
|
|
| G
|
Mavs
|
mitochondrial antiviral signaling protein
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MAVS mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:138,904,673...138,919,129
Ensembl chr 3:138,904,771...138,919,126
|
|
| G
|
Max
|
MYC associated factor X
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MAX mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:101,369,989...101,395,333
Ensembl chr 6:101,369,988...101,395,549
|
|
| G
|
Maz
|
MYC associated zinc finger protein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MAZ mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:191,060,271...191,065,722
Ensembl chr 1:191,060,280...191,065,339
|
|
| G
|
Mb
|
myoglobin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MB mRNA
|
CTD |
PMID:28606764 PMID:28959563 |
|
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:110,640,512...110,647,958
|
|
| G
|
Mblac1
|
metallo-beta-lactamase domain containing 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MBLAC1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:22,185,142...22,186,404
Ensembl chr12:22,184,917...22,200,899
|
|
| G
|
Mblac2
|
metallo-beta-lactamase domain containing 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MBLAC2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:13,721,752...13,764,558
Ensembl chr 2:13,721,360...13,766,626
|
|
| G
|
Mbnl2
|
muscleblind-like splicing regulator 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MBNL2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:103,792,134...103,949,827
Ensembl chr15:103,792,152...103,949,827
|
|
| G
|
Mbnl3
|
muscleblind-like splicing regulator 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MBNL3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:135,526,256...135,621,499
Ensembl chr X:135,532,494...135,621,976
|
|
| G
|
Mboat2
|
membrane bound O-acyltransferase domain containing 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MBOAT2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:47,199,751...47,326,215
Ensembl chr 6:47,199,774...47,326,208
|
|
| G
|
Mboat7
|
membrane bound O-acyltransferase domain containing 7
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MBOAT7 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:74,440,618...74,454,896
Ensembl chr 1:74,439,660...74,454,894
|
|
| G
|
Mbp
|
myelin basic protein
|
affects expression
|
EXP
|
Acrylamide affects the expression of MBP mRNA
|
CTD |
PMID:22954530 |
|
NCBI chr18:78,130,652...78,241,174
Ensembl chr18:78,130,325...78,241,174
|
|
| G
|
Mbtps2
|
membrane-bound transcription factor peptidase, site 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MBTPS2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr X:41,225,956...41,290,030
Ensembl chr X:41,254,335...41,277,701
|
|
| G
|
Mc1r
|
melanocortin 1 receptor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MC1R mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:68,360,950...68,363,877
Ensembl chr19:68,360,950...68,363,877
|
|
| G
|
Mcam
|
melanoma cell adhesion molecule
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MCAM mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:53,376,197...53,384,406
|
|
| G
|
Mcm10
|
minichromosome maintenance 10 replication initiation factor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MCM10 mRNA
|
CTD |
PMID:30807115 PMID:35032568 |
|
NCBI chr17:78,172,049...78,197,644
Ensembl chr17:78,175,398...78,197,636
|
|
| G
|
Mcm2
|
minichromosome maintenance complex component 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MCM2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:122,903,682...122,918,094
|
|
| G
|
Mcm3
|
minichromosome maintenance complex component 3
|
increases expression decreases expression
|
ISO
|
Acrylamide results in increased expression of MCM3 protein Acrylamide results in decreased expression of MCM3 mRNA
|
CTD |
PMID:20025956 PMID:32763439 |
|
NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:30,715,602...30,733,746
|
|
| G
|
Mcm4
|
minichromosome maintenance complex component 4
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MCM4 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr11:98,762,599...98,776,300
Ensembl chr11:98,762,634...98,776,536
|
|
| G
|
Mcm9
|
minichromosome maintenance 9 homologous recombination repair factor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MCM9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:33,369,325...33,472,243
Ensembl chr20:33,387,611...33,472,243
|
|
| G
|
Mcmdc2
|
minichromosome maintenance domain containing 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MCMDC2 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 5:14,071,609...14,120,435
Ensembl chr 5:14,080,968...14,120,351
|
|
| G
|
Mcpt8
|
mast cell protease 8
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MCPT8 mRNA
|
CTD |
PMID:22197712 |
|
NCBI chr15:33,769,575...33,772,633
|
|
| G
|
Mcu
|
mitochondrial calcium uniporter
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MCU mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:27,960,520...28,123,103
Ensembl chr20:27,961,327...28,123,103
|
|
| G
|
Mdc1
|
mediator of DNA damage checkpoint 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MDC1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:2,898,496...2,914,960
Ensembl chr20:2,900,308...2,914,960
|
|
| G
|
Mdfi
|
MyoD family inhibitor
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MDFI mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 9:20,654,359...20,672,768
Ensembl chr 9:20,654,417...20,672,767
|
|
| G
|
Mdga1
|
MAM domain containing glycosylphosphatidylinositol anchor 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of MDGA1 mRNA Acrylamide results in decreased expression of MDGA1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr20:7,901,856...7,965,834
Ensembl chr20:7,901,856...7,965,834
|
|
| G
|
Mdh1
|
malate dehydrogenase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MDH1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:99,831,934...99,847,227
Ensembl chr14:99,831,615...99,847,232
|
|
| G
|
Mdh2
|
malate dehydrogenase 2
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of MDH2 mRNA Acrylamide results in decreased expression of MDH2 protein
|
CTD |
PMID:28959563 PMID:39082229 |
|
NCBI chr12:26,530,886...26,543,841
Ensembl chr12:26,530,881...26,543,841
|
|
| G
|
Mdm1
|
Mdm1 nuclear protein
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of MDM1 mRNA Acrylamide results in decreased expression of MDM1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:55,615,459...55,651,889
Ensembl chr 7:55,615,608...55,651,888
|
|
| G
|
Me2
|
malic enzyme 2
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of ME2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr18:69,626,073...69,676,218
Ensembl chr18:69,626,087...69,676,218
|
|
| G
|
Me3
|
malic enzyme 3
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of ME3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:152,946,595...153,148,026
Ensembl chr 1:152,946,628...153,148,026
|
|
| G
|
Meaf6
|
MYST/Esa1-associated factor 6
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MEAF6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:142,628,281...142,653,076
Ensembl chr 5:142,628,968...142,656,293
|
|
| G
|
Mecom
|
MDS1 and EVI1 complex locus
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MECOM mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 2:114,837,815...115,393,052
Ensembl chr 2:114,837,840...115,393,038
|
|
| G
|
Med13
|
mediator complex subunit 13
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MED13 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:71,584,354...71,674,614
Ensembl chr10:71,584,354...71,673,901
|
|
| G
|
Med16
|
mediator complex subunit 16
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MED16 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:10,449,273...10,461,797
Ensembl chr 7:10,449,186...10,461,797
|
|
| G
|
Med18
|
mediator complex subunit 18
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MED18 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:149,947,345...149,952,672
Ensembl chr 5:149,946,908...149,952,808
|
|
| G
|
Med22
|
mediator complex subunit 22
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MED22 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:30,631,829...30,636,911
Ensembl chr 3:30,631,829...30,636,911
|
|
| G
|
Med24
|
mediator complex subunit 24
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MED24 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:84,160,866...84,198,607
Ensembl chr10:84,160,866...84,186,379
|
|
| G
|
Med26
|
mediator complex subunit 26
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MED26 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:17,333,770...17,384,797
Ensembl chr16:17,327,734...17,383,603
|
|
| G
|
Med30
|
mediator complex subunit 30
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MED30 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:85,894,638...85,916,373
Ensembl chr 7:85,894,605...85,917,973
|
|
| G
|
Med8
|
mediator complex subunit 8
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MED8 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:137,234,028...137,234,912
Ensembl chr 5:137,229,367...137,246,666
|
|
| G
|
Mef2a
|
myocyte enhancer factor 2a
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MEF2A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:130,258,083...130,392,819
Ensembl chr 1:130,260,339...130,392,162
|
|
| G
|
Mef2c
|
myocyte enhancer factor 2C
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MEF2C mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:15,708,732...15,871,639
Ensembl chr 2:15,708,924...15,871,640
|
|
| G
|
Mef2d
|
myocyte enhancer factor 2D
|
affects expression
|
EXP
|
Acrylamide affects the expression of MEF2D mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:175,904,332...175,933,451
Ensembl chr 2:175,903,959...175,930,760
|
|
| G
|
Megf10
|
multiple EGF-like domains 10
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MEGF10 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:52,803,292...52,953,431
Ensembl chr18:52,847,781...52,950,675
|
|
| G
|
Megf11
|
multiple EGF-like-domains 11
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MEGF11 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:73,787,568...74,113,228
Ensembl chr 8:73,787,397...74,111,690
|
|
| G
|
Megf6
|
multiple EGF-like-domains 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MEGF6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:170,020,699...170,121,557
Ensembl chr 5:170,020,778...170,121,554
|
|
| G
|
Megf8
|
multiple EGF-like-domains 8
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MEGF8 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:90,030,057...90,079,423
Ensembl chr 1:90,030,388...90,079,422
|
|
| G
|
Mei4
|
meiotic double-stranded break formation protein 4
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MEI4 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 8:91,645,791...91,819,776
Ensembl chr 8:91,645,791...91,819,776
|
|
| G
|
Meis1
|
Meis homeobox 1
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MEIS1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr14:97,356,949...97,499,646
Ensembl chr14:97,322,748...97,495,083
|
|
| G
|
Meis3
|
Meis homeobox 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MEIS3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:85,986,602...86,000,873
Ensembl chr 1:85,990,050...86,000,873
|
|
| G
|
Melk
|
maternal embryonic leucine zipper kinase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MELK mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:63,336,151...63,396,254
Ensembl chr 5:63,336,106...63,396,247
|
|
| G
|
Mepe
|
matrix extracellular phosphoglycoprotein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MEPE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:5,725,308...5,736,858
Ensembl chr14:5,725,175...5,736,996
|
|
| G
|
Mertk
|
MER proto-oncogene, tyrosine kinase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MERTK mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:136,391,936...136,498,366
Ensembl chr 3:136,383,560...136,500,192
|
|
| G
|
Mest
|
mesoderm specific transcript
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MEST mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:60,321,814...60,332,288
Ensembl chr 4:60,316,102...60,333,509
|
|
| G
|
Met
|
MET proto-oncogene, receptor tyrosine kinase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MET mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821
|
|
| G
|
Metrn
|
meteorin, glial cell differentiation regulator
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of METRN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:15,321,200...15,323,218
Ensembl chr10:15,321,200...15,323,642
|
|
| G
|
Mettl18
|
methyltransferase 18, RPL3 N3(tau)-histidine
|
increases expression
|
EXP
|
Acrylamide results in increased expression of METTL18 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:78,879,053...78,881,226
Ensembl chr13:78,838,447...78,912,730
|
|
| G
|
Mettl25
|
methyltransferase like 25
|
increases expression
|
EXP
|
Acrylamide results in increased expression of METTL25 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:42,948,934...43,029,610
Ensembl chr 7:42,948,934...43,029,809
|
|
| G
|
Mettl26
|
methyltransferase like 26
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of METTL26 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:15,393,554...15,448,003
Ensembl chr10:15,398,654...15,441,062
|
|
| G
|
Mettl8
|
methyltransferase 8, tRNA N3-cytidine
|
increases expression
|
ISO
|
Acrylamide results in increased expression of METTL8 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 3:76,140,465...76,271,367
Ensembl chr 3:76,144,178...76,271,400
|
|
| G
|
Mex3c
|
mex-3 RNA binding family member C
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MEX3C mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:69,442,850...69,463,843
Ensembl chr18:69,442,152...69,463,846
|
|
| G
|
Mex3d
|
mex-3 RNA binding family member D
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MEX3D mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:9,976,253...9,983,383
Ensembl chr 7:9,976,253...9,983,383
|
|
| G
|
Mfap2
|
microfibril associated protein 2
|
affects expression decreases expression
|
EXP ISO
|
Acrylamide affects the expression of MFAP2 mRNA Acrylamide results in decreased expression of MFAP2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:158,595,121...158,603,283
Ensembl chr 5:158,597,512...158,610,656
|
|
| G
|
Mfap3l
|
microfibril associated protein 3 like
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MFAP3L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:34,422,490...34,465,544
Ensembl chr16:34,426,696...34,441,709
|
|
| G
|
Mfng
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MFNG mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:112,191,288...112,209,129
Ensembl chr 7:112,161,071...112,209,129
|
|
| G
|
Mfrp
|
membrane frizzled-related protein
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MFRP mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 8:53,342,483...53,347,696
Ensembl chr 8:53,342,534...53,347,861
|
|
| G
|
Mfsd1
|
major facilitator superfamily domain containing 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MFSD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:154,156,167...154,176,209
Ensembl chr 2:154,156,166...154,177,086
|
|
| G
|
Mfsd11
|
major facilitator superfamily domain containing 11
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of MFSD11 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr10:102,554,409...102,573,866
Ensembl chr10:102,555,050...102,573,439
|
|
| G
|
Mfsd12
|
major facilitator superfamily domain containing 12
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MFSD12 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:8,998,050...9,004,724
Ensembl chr 7:8,998,050...9,004,724
|
|
| G
|
Mfsd13a
|
major facilitator superfamily domain containing 13A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of SLC68A1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:255,158,338...255,177,731
Ensembl chr 1:255,152,543...255,177,733
|
|
| G
|
Mfsd3
|
major facilitator superfamily domain containing 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of SLC33A2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:110,300,254...110,304,108
Ensembl chr 7:110,302,018...110,304,112
|
|
| G
|
Mfsd4b2
|
major facilitator superfamily domain containing 4B2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of SLC60A2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:44,899,164...44,907,624
Ensembl chr20:44,899,164...44,907,624
|
|
| G
|
Mfsd5
|
major facilitator superfamily domain containing 5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MFSD5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:135,287,683...135,289,964
Ensembl chr 7:135,269,076...135,290,342
|
|
| G
|
Mfsd6
|
major facilitator superfamily domain containing 6
|
affects expression
|
EXP
|
Acrylamide affects the expression of MFSD6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:56,265,152...56,350,449
Ensembl chr 9:56,265,237...56,350,446
|
|
| G
|
Mgam
|
maltase-glucoamylase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MGAM mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:70,408,263...70,568,752
Ensembl chr 4:70,408,263...70,568,752
|
|
| G
|
Mgarp
|
mitochondria-localized glutamic acid-rich protein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MGARP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:137,582,152...137,590,294
Ensembl chr 2:137,582,152...137,590,481
|
|
| G
|
Mgat3
|
beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MGAT3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:113,614,011...113,640,201
Ensembl chr 7:113,598,059...113,643,481
|
|
| G
|
Mgat4b
|
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MGAT4B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:35,049,421...35,060,307
Ensembl chr10:35,050,512...35,060,309
|
|
| G
|
Mgat5
|
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MGAT5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:41,228,327...41,516,462
Ensembl chr13:41,228,360...41,516,461
|
|
| G
|
Mgat5b
|
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MGAT5B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:102,619,559...102,689,023
Ensembl chr10:102,619,559...102,689,017
|
|
| G
|
Mgst3
|
microsomal glutathione S-transferase 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MGST3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:82,059,480...82,080,418
Ensembl chr13:82,059,480...82,080,575
|
|
| G
|
Miat
|
myocardial infarction associated transcript
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MIAT mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:50,075,026...50,090,259
|
|
| G
|
Mib1
|
MIB E3 ubiquitin protein ligase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MIB1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:2,075,309...2,199,774
Ensembl chr18:2,075,309...2,193,475
|
|
| G
|
Mical1
|
microtubule associated monooxygenase, calponin and LIM domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MICAL1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:46,547,983...46,568,487
Ensembl chr20:46,556,536...46,568,487
|
|
| G
|
Micall1
|
MICAL-like 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MICALL1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 7:112,557,192...112,587,618
Ensembl chr 7:112,557,192...112,587,618
|
|
| G
|
Micb
|
MHC class I polypeptide-related sequence B
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MICB mRNA Acrylamide results in increased expression of MICB mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:87,623,826...87,641,075
Ensembl chr 1:87,623,826...87,640,872
|
|
| G
|
Mid1
|
midline 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MID1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:27,678,248...28,053,049
Ensembl chr X:27,681,867...27,906,105
|
|
| G
|
Mid2
|
midline 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MID2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:109,143,057...109,245,257
Ensembl chr X:109,143,253...109,245,255
|
|
| G
|
Mief2
|
mitochondrial elongation factor 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of MIEF2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:45,907,576...45,913,658
Ensembl chr10:45,908,706...45,913,658
|
|
| G
|
Mien1
|
migration and invasion enhancer 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MIEN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:83,931,485...83,932,778
Ensembl chr10:83,930,955...83,932,778
|
|
| G
|
Mier1
|
MIER1 transcriptional regulator
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MIER1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:123,105,114...123,156,653
Ensembl chr 5:123,104,915...123,156,656
|
|
| G
|
Mier3
|
MIER family member 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MIER3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:45,021,167...45,049,745
Ensembl chr 2:45,021,283...45,049,745
|
|
| G
|
Mif
|
macrophage migration inhibitory factor
|
affects expression
|
EXP
|
Acrylamide affects the expression of MIF mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
|
|
| G
|
Mif4gd
|
MIF4G domain containing
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MIF4GD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:101,346,120...101,350,584
Ensembl chr10:101,346,123...101,350,169
|
|
| G
|
Mindy1
|
MINDY lysine 48 deubiquitinase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MINDY1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:185,550,026...185,561,987
Ensembl chr 2:185,548,993...185,561,986
|
|
| G
|
Mindy4
|
MINDY lysine 48 deubiquitinase 4
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MINDY4 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:85,689,049...85,797,553
Ensembl chr 4:85,675,899...85,795,160
|
|
| G
|
Minpp1
|
multiple inositol-polyphosphate phosphatase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MINPP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:239,766,809...239,793,023
Ensembl chr 1:239,767,286...239,793,015
|
|
| G
|
Mipol1
|
mirror-image polydactyly 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MIPOL1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:80,490,330...80,825,413
Ensembl chr 6:80,490,312...80,825,413
|
|
| G
|
Mir193b
|
microRNA 193b
|
multiple interactions decreases expression
|
EXP
|
[MIR193B mRNA co-treated with Acrylamide] results in decreased expression of FOXO3 protein; MIR193B mRNA inhibits the reaction [Acrylamide results in decreased expression of CCND1 mRNA]; MIR193B mRNA inhibits the reaction [Acrylamide results in decreased expression of CCND1 protein]; MIR193B mRNA inhibits the reaction [Acrylamide results in increased expression of CDKN1A mRNA]; MIR193B mRNA inhibits the reaction [Acrylamide results in increased expression of CDKN1A protein]; MIR193B mRNA inhibits the reaction [Acrylamide results in increased expression of FOXO3 mRNA] Acrylamide results in decreased expression of MIR193B mRNA
|
CTD |
PMID:33582169 |
|
NCBI chr10:1,824,944...1,825,026
Ensembl chr10:1,824,944...1,825,026
|
|
| G
|
Mir9-2hg
|
Mir9-2 host gene
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MIR9-2HG mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:15,909,918...16,100,226
Ensembl chr 2:15,928,032...15,937,468
|
|
| G
|
Mirlet7bhg
|
Mirlet7b host gene
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MIRLET7BHG mRNA
|
CTD |
PMID:32763439 |
|
|
|
| G
|
Mis18bp1
|
MIS18 binding protein 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of MIS18BP1 mRNA Acrylamide results in decreased expression of MIS18BP1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 6:88,918,743...88,968,225
Ensembl chr 6:88,918,745...88,967,629
|
|
| G
|
Misp3
|
MISP family member 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MISP3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:41,043,408...41,046,761
Ensembl chr19:41,044,765...41,052,107
|
|
| G
|
Mitd1
|
microtubule interacting and trafficking domain containing 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MITD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:47,609,743...47,621,033
Ensembl chr 9:47,609,744...47,621,033
|
|
| G
|
Mki67
|
marker of proliferation Ki-67
|
decreases expression increases expression
|
ISO EXP
|
Acrylamide results in decreased expression of MKI67 mRNA; Acrylamide results in decreased expression of MKI67 protein Acrylamide results in increased expression of MKI67 mRNA
|
CTD |
PMID:20734998 PMID:28959563 PMID:32763439 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
| G
|
Mknk1
|
MAPK interacting serine/threonine kinase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MKNK1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:134,554,881...134,594,392
Ensembl chr 5:134,554,943...134,594,393
|
|
| G
|
Mks1
|
MKS transition zone complex subunit 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MKS1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:73,152,599...73,167,451
Ensembl chr10:73,153,186...73,163,886
|
|
| G
|
Mlf1
|
myeloid leukemia factor 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MLF1 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr 2:153,958,060...153,991,705
Ensembl chr 2:153,958,546...153,994,220
|
|
| G
|
Mlip
|
muscular LMNA-interacting protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MLIP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:86,815,491...87,085,117
Ensembl chr 8:86,814,798...87,082,408
|
|
| G
|
Mllt6
|
MLLT6, PHD finger containing
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MLLT6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:83,152,317...83,175,264
Ensembl chr10:83,153,698...83,175,250
|
|
| G
|
Mlnr
|
motilin receptor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of TRHR2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:67,317,269...67,340,508
Ensembl chr19:67,322,133...67,327,323
|
|
| G
|
Mlph
|
melanophilin
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MLPH mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:98,955,036...98,990,566
Ensembl chr 9:98,955,141...98,990,556
|
|
| G
|
Mlycd
|
malonyl-CoA decarboxylase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MLYCD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:64,356,582...64,372,447
Ensembl chr19:64,356,223...64,372,446
|
|
| G
|
Mmab
|
metabolism of cobalamin associated B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MMAB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:47,819,757...47,833,127
Ensembl chr12:47,819,724...47,833,118
|
|
| G
|
Mmachc
|
metabolism of cobalamin associated C
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MMACHC mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:135,403,094...135,409,285
Ensembl chr 5:135,402,404...135,409,235
|
|
| G
|
Mmadhc
|
metabolism of cobalamin associated D
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MMADHC mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 3:55,117,832...55,135,735
Ensembl chr 3:55,117,833...55,135,851
|
|
| G
|
Mmgt2
|
membrane magnesium transporter 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MMGT2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:47,842,722...47,859,787
Ensembl chr10:47,842,198...47,882,564
|
|
| G
|
Mmp11
|
matrix metallopeptidase 11
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MMP11 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:12,730,284...12,739,067
Ensembl chr20:12,730,277...12,739,290
|
|
| G
|
Mmp13
|
matrix metallopeptidase 13
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MMP13 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:12,782,813...12,793,105
|
|
| G
|
Mmp14
|
matrix metallopeptidase 14
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MMP14 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893
|
|
| G
|
Mmp15
|
matrix metallopeptidase 15
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MMP15 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:9,669,506...9,691,000
Ensembl chr19:9,669,506...9,691,000
|
|
| G
|
Mmp16
|
matrix metallopeptidase 16
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MMP16 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:36,109,265...36,353,252
Ensembl chr 5:36,109,265...36,353,252
|
|
| G
|
Mmp17
|
matrix metallopeptidase 17
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MMP17 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:32,710,504...32,735,418
Ensembl chr12:32,710,504...32,735,414
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
affects expression
|
EXP
|
Acrylamide affects the expression of MMP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MMP9 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mms19
|
MMS19 homolog, cytosolic iron-sulfur assembly component
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MMS19 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:250,706,595...250,743,604
Ensembl chr 1:250,706,595...250,743,582
|
|
| G
|
Mms22l
|
MMS22-like, DNA repair protein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MMS22L mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:42,994,382...43,110,371
Ensembl chr 5:42,994,359...43,110,369
|
|
| G
|
Mn1
|
MN1 proto-oncogene, transcriptional regulator
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MN1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:50,841,632...50,880,795
Ensembl chr12:50,841,632...50,880,795
|
|
| G
|
Mob1a
|
MOB kinase activator 1A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MOB1A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:117,389,278...117,406,255
Ensembl chr 4:117,389,186...117,406,250
|
|
| G
|
Mob2
|
MOB kinase activator 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MOB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:206,522,523...206,579,502
Ensembl chr 1:206,522,523...206,579,449
|
|
| G
|
Mocs2
|
molybdenum cofactor synthesis 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MOCS2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:48,237,655...48,249,394
Ensembl chr 2:48,237,655...48,249,394
|
|
| G
|
Mogat1
|
monoacylglycerol O-acyltransferase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MOGAT1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:87,429,427...87,436,977
Ensembl chr 9:87,405,119...87,436,977
|
|
| G
|
Mogs
|
mannosyl-oligosaccharide glucosidase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MOGS mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:117,179,335...117,182,738
Ensembl chr 4:117,179,335...117,182,744
|
|
| G
|
Mok
|
MOK protein kinase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MOK mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:135,645,018...135,675,894
Ensembl chr 6:135,645,018...135,676,174
|
|
| G
|
Mon1b
|
MON1 homolog B, secretory trafficking associated
|
affects expression
|
EXP
|
Acrylamide affects the expression of MON1B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:58,526,503...58,534,478
Ensembl chr19:58,526,326...58,533,950
|
|
| G
|
Morc2
|
MORC family CW-type zinc finger 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MORC2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:82,752,444...82,794,980
Ensembl chr14:82,752,018...82,794,979
|
|
| G
|
Morc4
|
MORC family CW-type zinc finger 4
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MORC4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:108,269,197...108,317,611
Ensembl chr X:108,269,383...108,317,553
|
|
| G
|
Morf4l2
|
mortality factor 4 like 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MORF4L2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:104,874,850...104,885,946
Ensembl chr X:104,852,693...104,892,855
|
|
| G
|
Morn2
|
MORN repeat containing 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MORN2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:20,471,036...20,477,520
|
|
| G
|
Mospd1
|
motile sperm domain containing 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MOSPD1 mRNA Acrylamide results in increased expression of MOSPD1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr X:138,019,719...138,047,475
Ensembl chr14:86,500,797...86,503,187 Ensembl chr X:86,500,797...86,503,187
|
|
| G
|
Mospd2
|
motile sperm domain containing 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MOSPD2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:33,052,063...33,105,550
Ensembl chr X:33,052,004...33,107,635
|
|
| G
|
Mov10
|
Mov10 RNA helicase
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of MOV10 mRNA Acrylamide results in decreased expression of MOV10 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:194,982,014...195,003,513
Ensembl chr 2:194,982,014...195,003,442
|
|
| G
|
Mpdu1
|
mannose-P-dolichol utilization defect 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MPDU1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:54,873,467...54,880,536
Ensembl chr10:54,873,473...54,879,195
|
|
| G
|
Mpdz
|
multiple PDZ domain crumbs cell polarity complex component
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MPDZ mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:100,812,121...100,966,566
Ensembl chr 5:100,812,124...100,966,504
|
|
| G
|
Mpg
|
N-methylpurine-DNA glycosylase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MPG mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:15,900,697...15,906,981
Ensembl chr10:15,899,635...15,907,052
|
|
| G
|
Mphosph6
|
M phase phosphoprotein 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MPHOSPH6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:62,768,909...62,778,874
Ensembl chr19:62,768,909...62,778,950
|
|
| G
|
Mphosph9
|
M-phase phosphoprotein 9
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MPHOSPH9 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:37,936,442...38,007,053
Ensembl chr12:37,936,885...38,003,348
|
|
| G
|
Mpi
|
mannose phosphate isomerase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MPI mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:66,843,802...66,852,108
Ensembl chr 8:66,844,116...66,852,016
|
|
| G
|
Mpnd
|
MPN domain containing
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MPND mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:926,714...933,620
Ensembl chr 9:925,799...933,616
|
|
| G
|
Mpo
|
myeloperoxidase
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MPO mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Mpp2
|
MAGUK p55 scaffold protein 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MPP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:87,511,638...87,544,710
Ensembl chr10:87,511,638...87,544,029
|
|
| G
|
Mpp3
|
MAGUK p55 scaffold protein 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MPP3 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr10:87,445,905...87,475,461
Ensembl chr10:87,445,905...87,474,811
|
|
| G
|
Mpp4
|
MAGUK p55 scaffold protein 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MPP4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:68,063,867...68,103,050
Ensembl chr 9:68,063,867...68,106,128
|
|
| G
|
Mpped1
|
metallophosphoesterase domain containing 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MPPED1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:116,811,841...116,891,789
Ensembl chr 7:116,811,721...116,891,778
|
|
| G
|
Mpv17l2
|
MPV17 mitochondrial inner membrane protein like 2
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MPV17L2 mRNA Acrylamide results in increased expression of MPV17L2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr16:18,713,690...18,718,191
Ensembl chr16:18,715,849...18,718,708
|
|
| G
|
Mrc1
|
mannose receptor, C type 1
|
decreases expression multiple interactions increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MRC1 mRNA NFE2L2 protein affects the reaction [Acrylamide results in increased expression of MRC1 mRNA]
|
CTD |
PMID:28959563 PMID:33872730 PMID:35032568 |
|
NCBI chr17:82,157,725...82,239,411
Ensembl chr17:82,157,705...82,239,410
|
|
| G
|
Mrc2
|
mannose receptor, C type 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MRC2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:90,761,751...90,823,055
Ensembl chr10:90,761,878...90,823,055
|
|
| G
|
Mrgprf
|
MAS related GPR family member F
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MRGPRF mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:209,893,384...209,902,852
Ensembl chr 1:209,892,450...209,903,614
|
|
| G
|
Mrm3
|
mitochondrial rRNA methyltransferase 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MRM3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:61,594,155...61,623,659
Ensembl chr10:61,593,999...61,600,865
|
|
| G
|
Mro
|
maestro
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MRO mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:69,723,764...69,742,815
Ensembl chr18:69,725,798...69,743,031
|
|
| G
|
Mroh1
|
maestro heat-like repeat family member 1
|
increases expression decreases expression
|
ISO
|
Acrylamide results in increased expression of MROH1 mRNA Acrylamide results in decreased expression of MROH1 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr 7:109,979,344...110,052,800
Ensembl chr 7:109,983,337...110,052,801
|
|
| G
|
Mroh2a
|
maestro heat-like repeat family member 2A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MROH2A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:96,262,307...96,309,036
Ensembl chr 9:96,262,271...96,301,635
|
|
| G
|
Mroh2b
|
maestro heat-like repeat family member 2B
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MROH2B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:55,731,445...55,791,566
Ensembl chr 2:55,731,453...55,791,558
|
|
| G
|
Mrpl12
|
mitochondrial ribosomal protein L12
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MRPL12 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:106,256,746...106,261,249
Ensembl chr10:106,256,547...106,263,088
|
|
| G
|
Mrpl13
|
mitochondrial ribosomal protein L13
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MRPL13 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:88,841,265...88,862,821
Ensembl chr 7:88,841,266...88,862,848
|
|
| G
|
Mrpl18
|
mitochondrial ribosomal protein L18
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MRPL18 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:50,384,951...50,389,769
Ensembl chr 1:50,384,367...50,389,763
|
|
| G
|
Mrpl19
|
mitochondrial ribosomal protein L19
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MRPL19 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:116,079,654...116,083,883
Ensembl chr 4:116,079,654...116,083,883
|
|
| G
|
Mrpl2
|
mitochondrial ribosomal protein L2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MRPL2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:21,830,834...21,834,607
Ensembl chr 9:21,830,835...21,834,641
|
|
| G
|
Mrpl24
|
mitochondrial ribosomal protein L24
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MRPL24 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:175,680,872...175,687,107
Ensembl chr 2:175,681,070...175,688,660
|
|
| G
|
Mrpl3
|
mitochondrial ribosomal protein L3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MRPL3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:114,548,970...114,572,330
Ensembl chr 8:114,548,970...114,573,996
|
|
| G
|
Mrpl30
|
mitochondrial ribosomal protein L30
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MRPL30 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:47,621,226...47,631,986
Ensembl chr 9:47,621,227...47,633,484
|
|
| G
|
Mrpl33
|
mitochondrial ribosomal protein L33
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MRPL33 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 6:30,545,794...30,553,987
Ensembl chr 6:30,545,794...30,553,987
|
|
| G
|
Mrpl40
|
mitochondrial ribosomal protein L40
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MRPL40 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:95,637,751...95,643,587
Ensembl chr11:95,637,712...95,643,586
|
|
| G
|
Mrpl43
|
mitochondrial ribosomal protein L43
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MRPL43 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:253,816,009...253,817,441
Ensembl chr 1:253,816,009...253,817,441
|
|
| G
|
Mrpl45
|
mitochondrial ribosomal protein L45
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MRPL45 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:82,805,039...82,816,862
Ensembl chr10:82,804,874...82,816,139
|
|
| G
|
Mrpl46
|
mitochondrial ribosomal protein L46
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MRPL46 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:142,108,266...142,117,030
Ensembl chr 1:142,106,531...142,117,030
|
|
| G
|
Mrpl47
|
mitochondrial ribosomal protein L47
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MRPL47 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:117,436,199...117,447,790
Ensembl chr 2:117,428,621...117,447,517
|
|
| G
|
Mrpl49
|
mitochondrial ribosomal protein L49
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MRPL49 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:212,775,357...212,779,364
Ensembl chr 1:212,775,357...212,779,888
|
|
| G
|
Mrpl52
|
mitochondrial ribosomal protein L52
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MRPL52 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:31,852,927...31,856,160
Ensembl chr15:31,852,760...31,856,162
|
|
| G
|
Mrpl57
|
mitochondrial ribosomal protein L57
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MRPL57 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:36,086,457...36,087,319
Ensembl chr15:36,086,457...36,087,298
|
|
| G
|
Mrpl58
|
mitochondrial ribosomal protein L58
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MRPL58 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:101,145,342...101,151,838
Ensembl chr10:101,145,162...101,151,838
|
|
| G
|
Mrps18b
|
mitochondrial ribosomal protein S18B
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MRPS18B mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr20:2,842,978...2,849,065
Ensembl chr20:2,842,528...2,849,065
|
|
| G
|
Mrps22
|
mitochondrial ribosomal protein S22
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MRPS22 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:108,063,468...108,076,638
Ensembl chr 8:108,063,471...108,076,638
|
|
| G
|
Mrps26
|
mitochondrial ribosomal protein S26
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MRPS26 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:138,222,324...138,223,987
Ensembl chr 3:138,222,165...138,223,987
|
|
| G
|
Mrps28
|
mitochondrial ribosomal protein S28
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MRPS28 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:94,728,034...94,858,641
Ensembl chr 2:94,762,904...94,766,152
|
|
| G
|
Mrps33
|
mitochondrial ribosomal protein S33
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MRPS33 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:69,563,501...69,572,317
Ensembl chr 4:69,563,503...69,572,177
|
|
| G
|
Mrps5
|
mitochondrial ribosomal protein S5
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MRPS5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:135,274,333...135,290,577
Ensembl chr 3:135,274,493...135,291,640
|
|
| G
|
Mrps6
|
mitochondrial ribosomal protein S6
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MRPS6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:44,778,667...44,834,420
Ensembl chr11:44,781,554...44,834,962
|
|
| G
|
Mrrf
|
mitochondrial ribosome recycling factor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MRRF mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:39,884,530...39,941,317
Ensembl chr 3:39,884,359...39,967,397
|
|
| G
|
Mrtfb
|
myocardin related transcription factor B
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MRTFB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:1,623,887...1,789,658
Ensembl chr10:1,623,940...1,789,658
|
|
| G
|
Mrto4
|
MRT4 homolog, ribosome maturation factor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MRTO4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:156,884,985...156,891,738
Ensembl chr 5:156,884,985...156,891,738
|
|
| G
|
Msgn1
|
mesogenin 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MSGN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:39,631,868...39,632,508
Ensembl chr 6:39,631,584...39,632,538
|
|
| G
|
Msh2
|
mutS homolog 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MSH2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503
|
|
| G
|
Msh5
|
mutS homolog 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MSH5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:3,779,180...3,797,996
Ensembl chr20:3,781,578...3,797,994
|
|
| G
|
Msl2
|
MSL complex subunit 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MSL2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:110,555,579...110,642,096
Ensembl chr 8:110,555,271...110,647,889
|
|
| G
|
Msr1
|
macrophage scavenger receptor 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MSR1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr16:59,421,250...59,507,070
Ensembl chr16:59,421,057...59,507,070
|
|
| G
|
Msra
|
methionine sulfoxide reductase A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MSRA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:42,514,818...42,853,278
Ensembl chr15:42,527,045...42,853,279
|
|
| G
|
Msrb2
|
methionine sulfoxide reductase B2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MSRB2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr17:86,882,750...86,908,392
Ensembl chr17:86,882,394...86,908,391
|
|
| G
|
Mst1
|
macrophage stimulating 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MST1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:117,646,485...117,652,016
Ensembl chr 8:117,647,438...117,652,015
|
|
| G
|
Mstn
|
myostatin
|
affects expression
|
EXP
|
Acrylamide affects the expression of MSTN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:55,944,513...55,950,913
Ensembl chr 9:55,944,513...55,950,913
|
|
| G
|
Msx1
|
msh homeobox 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MSX1 mRNA
|
CTD |
PMID:35032568 |
|
NCBI chr14:77,185,802...77,189,735
Ensembl chr14:77,185,802...77,189,735
|
|
| G
|
Msx2
|
msh homeobox 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MSX2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr17:11,102,284...11,107,949
Ensembl chr17:11,102,247...11,107,945
|
|
| G
|
Mt-co1
|
mitochondrially encoded cytochrome c oxidase I
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COX1 protein
|
CTD |
PMID:39082229 |
|
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,309...6,853
|
|
| G
|
Mt-nd5
|
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of ND5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr MT:11,736...13,565
Ensembl chr MT:11,721...13,553
|
|
| G
|
Mt1a
|
metallothionein 1A
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MT1A mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200 Ensembl chr X:79,695,809...79,696,200 Ensembl chr19:79,695,809...79,696,200
|
|
| G
|
Mt2
|
metallothionein 2
|
increases expression decreases expression multiple interactions
|
EXP ISO
|
Acrylamide results in increased expression of MT2A mRNA Acrylamide results in decreased expression of MT2A mRNA [Acrylamide co-treated with aluminum chloride] results in increased expression of MT2A mRNA
|
CTD |
PMID:25858877 PMID:28959563 PMID:32763439 |
|
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
|
|
| G
|
Mta1
|
metastasis associated 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MTA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:137,999,845...138,038,696
Ensembl chr 6:137,999,915...138,038,696
|
|
| G
|
Mtap
|
methylthioadenosine phosphorylase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MTAP mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:108,990,270...109,036,494
Ensembl chr 5:108,988,830...109,055,214
|
|
| G
|
Mtarc1
|
mitochondrial amidoxime reducing component 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MTARC1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:98,854,235...98,894,208
Ensembl chr13:98,871,289...98,894,252
|
|
| G
|
Mterf2
|
mitochondrial transcription termination factor 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MTERF2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 7:20,485,901...20,495,979
Ensembl chr 7:20,485,461...20,548,043
|
|
| G
|
Mtf1
|
metal-regulatory transcription factor 1
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of MTF1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:142,347,024...142,391,810
Ensembl chr 5:142,347,054...142,391,810
|
|
| G
|
Mtfp1
|
mitochondrial fission process 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MTFP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:83,192,013...83,195,853
Ensembl chr14:83,192,021...83,195,927
|
|
| G
|
Mtfr1l
|
mitochondrial fission regulator 1-like
|
affects expression
|
EXP
|
Acrylamide affects the expression of MTFR1L mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:152,020,617...152,030,417
Ensembl chr 5:152,020,622...152,030,417
|
|
| G
|
Mtfr2
|
mitochondrial fission regulator 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MTFR2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:16,942,814...16,958,218
|
|
| G
|
Mtg1
|
mitochondrial ribosome-associated GTPase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MTG1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:204,361,176...204,373,917
Ensembl chr 1:204,361,147...204,373,924
|
|
| G
|
Mtg2
|
mitochondrial ribosome-associated GTPase 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MTG2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:187,543,166...187,558,973
Ensembl chr 3:187,543,178...187,558,989
|
|
| G
|
Mthfd1
|
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of MTHFD1 mRNA Acrylamide results in decreased expression of MTHFD1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 6:100,713,510...100,781,013
Ensembl chr 6:100,713,681...100,781,957
|
|
| G
|
Mthfd2
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of MTHFD2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350
|
|
| G
|
Mthfd2l
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MTHFD2L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:17,374,139...17,455,508
Ensembl chr14:17,374,144...17,454,322
|
|
| G
|
Mtif2
|
mitochondrial translational initiation factor 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MTIF2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:107,465,719...107,486,663
Ensembl chr14:107,466,861...107,487,003
|
|
| G
|
Mtmr10
|
myotubularin related protein 10
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MTMR10 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:127,271,139...127,322,621
Ensembl chr 1:127,270,870...127,322,621
|
|
| G
|
Mtmr11
|
myotubularin related protein 11
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MTMR11 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:186,410,851...186,421,024
Ensembl chr 2:186,412,291...186,421,026
|
|
| G
|
Mtmr14
|
myotubularin related protein 14
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MTMR14 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 4:147,942,604...147,985,649
Ensembl chr 4:147,942,622...147,985,649
|
|
| G
|
Mtmr7
|
myotubularin related protein 7
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MTMR7 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:58,344,755...58,435,682
Ensembl chr16:58,344,767...58,436,615
|
|
| G
|
Mtnr1a
|
melatonin receptor 1A
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MTNR1A mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr16:53,876,964...53,896,421
Ensembl chr16:53,876,964...53,896,421
|
|
| G
|
Mto1
|
mitochondrial tRNA translation optimization 1
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of MTO1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 8:88,188,918...88,215,516
Ensembl chr 8:88,190,259...88,215,509
|
|
| G
|
Mtor
|
mechanistic target of rapamycin kinase
|
decreases phosphorylation decreases expression multiple interactions
|
EXP ISO
|
Acrylamide results in decreased phosphorylation of MTOR protein Acrylamide results in decreased expression of MTOR mRNA PRKCD protein affects the reaction [Acrylamide results in decreased phosphorylation of MTOR protein]
|
CTD |
PMID:33545342 PMID:34569336 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
| G
|
Mtr
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MTR mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr17:62,911,705...62,996,544
Ensembl chr17:62,911,771...62,996,541
|
|
| G
|
Mtrf1
|
mitochondrial translation release factor 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MTRF1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:61,185,958...61,213,783
Ensembl chr15:61,186,183...61,214,356
|
|
| G
|
Mtrf1l
|
mitochondrial translation release factor 1 like
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MTRF1L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:44,614,162...44,626,367
Ensembl chr 1:44,615,921...44,626,178
|
|
| G
|
Mtrfr
|
mitochondrial translation release factor in rescue
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MTRFR mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr12:37,922,532...37,936,219
Ensembl chr12:37,919,398...37,936,219
|
|
| G
|
Mttp
|
microsomal triglyceride transfer protein
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MTTP mRNA Acrylamide results in increased expression of MTTP mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 2:229,286,501...229,327,650
Ensembl chr 2:229,286,501...229,327,650
|
|
| G
|
Mtx1
|
Metaxin 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MTX1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:176,913,225...176,919,148
Ensembl chr 2:176,913,225...176,918,824
|
|
| G
|
Muc1
|
mucin 1, cell surface associated
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MUC1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491
|
|
| G
|
Muc4
|
mucin 4, cell surface associated
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MUC4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:81,513,321...81,575,200
|
|
| G
|
Mucl3
|
mucin like 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MUCL3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:3,105,360...3,113,278
Ensembl chr20:3,105,360...3,113,278
|
|
| G
|
Mug2
|
murinoglobulin 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of PZP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:156,836,140...156,908,972
|
|
| G
|
Mug6
|
murinoglobulin 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of CPAMD8 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:157,004,905...157,085,187
Ensembl chr 4:157,004,905...157,085,250
|
|
| G
|
Mus81
|
MUS81 structure-specific endonuclease subunit
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MUS81 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:212,219,793...212,225,214
Ensembl chr 1:212,219,795...212,225,068
|
|
| G
|
Mustn1
|
musculoskeletal, embryonic nuclear protein 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MUSTN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:6,079,355...6,081,608
Ensembl chr16:6,079,277...6,081,586
|
|
| G
|
Mutyh
|
mutY DNA glycosylase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MUTYH mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:135,510,666...135,522,777
Ensembl chr 5:135,517,695...135,522,776
|
|
| G
|
Mvb12a
|
multivesicular body subunit 12A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MVB12A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:18,286,231...18,291,096
Ensembl chr16:18,286,231...18,292,583
|
|
| G
|
Mvk
|
mevalonate kinase
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of MVK mRNA Acrylamide results in decreased expression of MVK mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr12:47,802,002...47,819,503
Ensembl chr12:47,802,002...47,819,503
|
|
| G
|
Mvp
|
major vault protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MVP mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:191,025,259...191,052,866
Ensembl chr 1:191,025,268...191,052,873
|
|
| G
|
Mx1
|
MX dynamin like GTPase 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MX1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:50,269,056...50,294,699
Ensembl chr11:50,269,057...50,292,904
|
|
| G
|
Mx2
|
MX dynamin like GTPase 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MX2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:50,375,101...50,399,373
Ensembl chr11:50,375,191...50,402,478
|
|
| G
|
Mxd1
|
max dimerization protein 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MXD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:120,654,731...120,678,972
Ensembl chr 4:120,654,731...120,675,129
|
|
| G
|
Mxd3
|
Max dimerization protein 3
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of MXD3 mRNA Acrylamide results in decreased expression of MXD3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr17:9,306,552...9,310,278
Ensembl chr17:9,302,321...9,310,278
|
|
| G
|
Mxi1
|
MAX interactor 1, dimerization protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MXI1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:262,329,274...262,389,037
Ensembl chr 1:262,328,875...262,389,036
|
|
| G
|
Mxra8
|
matrix remodeling associated 8
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MXRA8 mRNA Acrylamide results in increased expression of MXRA8 mRNA
|
CTD |
PMID:28959563 PMID:30807115 PMID:32763439 |
|
NCBI chr 5:171,731,153...171,735,879
Ensembl chr 5:171,731,353...171,735,879
|
|
| G
|
Myadml2
|
myeloid-associated differentiation marker-like 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYADML2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:106,420,856...106,425,899
Ensembl chr10:106,421,419...106,426,224
|
|
| G
|
Mybbp1a
|
MYB binding protein 1a
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MYBBP1A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:57,555,458...57,565,819
Ensembl chr10:57,555,452...57,566,041
|
|
| G
|
Mybl2
|
MYB proto-oncogene like 2
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of MYBL2 mRNA Acrylamide results in decreased expression of MYBL2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:172,124,765...172,153,221
Ensembl chr 3:172,116,550...172,153,221
|
|
| G
|
Mybpc1
|
myosin binding protein C1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYBPC1 mRNA
|
CTD |
PMID:28606764 |
|
NCBI chr 7:24,817,770...24,903,681
Ensembl chr 7:24,817,561...24,903,544
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MYC mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Mycbpap
|
Mycbp associated protein
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MYCBPAP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:79,947,200...79,967,857
Ensembl chr10:79,947,200...79,967,918
|
|
| G
|
Mydgf
|
myeloid-derived growth factor
|
affects expression
|
EXP
|
Acrylamide affects the expression of MYDGF mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:1,086,825...1,095,968
Ensembl chr 9:1,086,825...1,095,968
|
|
| G
|
Myef2
|
myelin expression factor 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MYEF2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:132,791,694...132,827,572
Ensembl chr 3:132,791,694...132,827,523
|
|
| G
|
Myh1
|
myosin heavy chain 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYH1 mRNA
|
CTD |
PMID:28606764 |
|
NCBI chr10:52,384,810...52,408,698
Ensembl chr10:52,384,908...52,409,047
|
|
| G
|
Myh3
|
myosin heavy chain 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MYH3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:52,269,185...52,293,000
Ensembl chr10:52,269,185...52,293,000
|
|
| G
|
Myh4
|
myosin heavy chain 4
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MYH4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:52,422,148...52,445,296
Ensembl chr10:52,421,951...52,445,294
|
|
| G
|
Myl1
|
myosin, light chain 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYL1 mRNA
|
CTD |
PMID:22197712 PMID:28606764 |
|
Ensembl chr 9:75,887,227...75,907,971
|
|
| G
|
Myl11
|
myosin light chain 11
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYLPF mRNA
|
CTD |
PMID:22197712 PMID:28606764 |
|
NCBI chr 1:191,257,432...191,263,046
Ensembl chr 1:191,256,196...191,263,045
|
|
| G
|
Myl4
|
myosin, light chain 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYL4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:89,949,733...89,985,308
Ensembl chr10:89,949,404...89,985,308
|
|
| G
|
Myl6
|
myosin light chain 6
|
affects expression
|
EXP
|
Acrylamide affects the expression of MYL6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:1,495,301...1,498,512
Ensembl chr 7:1,495,747...1,498,344
|
|
| G
|
Mylip
|
myosin regulatory light chain interacting protein
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of MYLIP mRNA Acrylamide results in increased expression of MYLIP mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr17:19,492,826...19,514,490
Ensembl chr17:19,492,826...19,514,471
|
|
| G
|
Mylk
|
myosin light chain kinase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MYLK mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr11:79,288,243...79,535,450
Ensembl chr11:79,288,243...79,535,659
|
|
| G
|
Mylk2
|
myosin light chain kinase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MYLK2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:161,836,705...161,848,609
Ensembl chr 3:161,836,740...161,848,607
|
|
| G
|
Mylk3
|
myosin light chain kinase 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYLK3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:37,858,298...37,916,805
Ensembl chr19:37,865,141...37,915,827
|
|
| G
|
Mynn
|
myoneurin
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MYNN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:114,708,150...114,726,450
Ensembl chr 2:114,708,156...114,725,452
|
|
| G
|
Myo15a
|
myosin XVA
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MYO15A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:45,776,907...45,835,473
Ensembl chr10:45,776,907...45,835,473
|
|
| G
|
Myo15b
|
myosin XVB
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MYO15B mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:101,587,672...101,625,092
Ensembl chr10:101,587,672...101,625,092
|
|
| G
|
Myo18a
|
myosin XVIIIa
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of MYO18A mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:63,152,303...63,253,543
Ensembl chr10:63,152,103...63,253,543
|
|
| G
|
Myo1b
|
myosin Ib
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MYO1B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:57,182,059...57,344,335
Ensembl chr 9:57,181,987...57,344,328
|
|
| G
|
Myo1f
|
myosin IF
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYO1F mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:15,065,530...15,116,087
Ensembl chr 7:15,065,530...15,116,087
|
|
| G
|
Myo3b
|
myosin IIIB
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYO3B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:75,228,017...75,636,272
Ensembl chr 3:75,228,017...75,636,272
|
|
| G
|
Myo5b
|
myosin Vb
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MYO5B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:70,313,717...70,613,918
Ensembl chr18:70,311,990...70,613,918
|
|
| G
|
Myo5c
|
myosin VC
|
increases expression
|
EXP
|
Acrylamide results in increased expression of MYO5C mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:84,870,031...84,946,996
Ensembl chr 8:84,870,043...84,946,996
|
|
| G
|
Myo9b
|
myosin IXb
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYO9B mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:17,979,374...18,064,100
Ensembl chr16:17,979,439...18,064,332
|
|
| G
|
Myom2
|
myomesin 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MYOM2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr16:81,222,467...81,295,025
Ensembl chr16:81,221,938...81,295,162
|
|
| G
|
Myom3
|
myomesin 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYOM3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:153,276,306...153,326,847
Ensembl chr 5:153,276,261...153,326,839
|
|
| G
|
Myorg
|
myogenesis regulating glycosidase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of MYORG mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:61,452,956...61,460,500
Ensembl chr 5:61,432,418...61,460,581
|
|
| G
|
Myot
|
myotilin
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYOT mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:36,956,119...36,975,728
Ensembl chr18:36,956,191...36,976,265
|
|
| G
|
Myoz1
|
myozenin 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYOZ1 mRNA
|
CTD |
PMID:28606764 |
|
NCBI chr15:3,693,576...3,700,831
Ensembl chr15:3,693,613...3,700,826
|
|
| G
|
Myoz3
|
myozenin 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYOZ3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr18:56,296,565...56,316,582
Ensembl chr18:56,296,565...56,316,582
|
|
| G
|
Myt1
|
myelin transcription factor 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MYT1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:189,263,569...189,327,844
Ensembl chr 3:189,263,467...189,327,844
|
|
| G
|
N4bp2l1
|
NEDD4 binding protein 2-like 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of N4BP2L1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:4,938,199...4,965,003
Ensembl chr12:4,927,142...4,963,045
|
|
| G
|
Naa16
|
N(alpha)-acetyltransferase 16, NatA auxiliary subunit
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NAA16 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:61,120,704...61,179,979
Ensembl chr15:61,120,704...61,180,146
|
|
| G
|
Naa40
|
N(alpha)-acetyltransferase 40, NatD catalytic subunit
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NAA40 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:213,842,686...213,860,079
Ensembl chr 1:213,842,686...213,860,047
|
|
| G
|
Naa80
|
N(alpha)-acetyltransferase 80, NatH catalytic subunit
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NAA80 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:117,132,957...117,136,207
Ensembl chr 8:117,133,494...117,136,207
|
|
| G
|
Naaa
|
N-acylethanolamine acid amidase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NAAA mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr14:16,061,599...16,080,703
Ensembl chr14:16,061,583...16,080,702
|
|
| G
|
Naalad2
|
N-acetylated alpha-linked acidic dipeptidase 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NAALAD2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:23,682,499...23,756,066
Ensembl chr 8:23,683,395...23,756,060
|
|
| G
|
Nab2
|
Ngfi-A binding protein 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NAB2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:65,382,863...65,389,527
Ensembl chr 7:65,382,863...65,389,255
|
|
| G
|
Nabp1
|
nucleic acid binding protein 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NABP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:57,570,326...57,625,926
Ensembl chr 9:57,618,505...57,626,052
|
|
| G
|
Nacad
|
NAC alpha domain containing
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NACAD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:85,679,215...85,688,742
Ensembl chr14:85,679,215...85,688,147
|
|
| G
|
Nacc2
|
NACC family member 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NACC2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:29,278,077...29,345,098
Ensembl chr 3:29,281,190...29,344,840
|
|
| G
|
Naga
|
alpha-N-acetylgalactosaminidase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NAGA mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:115,726,438...115,735,494
Ensembl chr 7:115,726,624...115,736,828
|
|
| G
|
Nagk
|
N-acetylglucosamine kinase
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NAGK mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 4:117,838,761...117,846,304
Ensembl chr 4:117,838,826...117,847,836
|
|
| G
|
Naglu
|
N-acetyl-alpha-glucosaminidase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NAGLU mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:86,501,864...86,509,333
Ensembl chr10:86,501,836...86,509,315
|
|
| G
|
Naif1
|
nuclear apoptosis inducing factor 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NAIF1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:36,138,982...36,145,414
Ensembl chr 3:36,138,982...36,145,414
|
|
| G
|
Naip5
|
NLR family, apoptosis inhibitory protein 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NAIP5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:33,289,785...33,342,807
Ensembl chr 2:33,282,466...33,323,401
|
|
| G
|
Nanog
|
Nanog homeobox
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NANOG mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:157,615,687...157,623,061
Ensembl chr 4:157,615,687...157,623,061
|
|
| G
|
Nanos1
|
nanos C2HC-type zinc finger 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NANOS1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:269,883,713...269,887,611
Ensembl chr 1:269,883,536...269,895,417
|
|
| G
|
Nanos3
|
nanos C2HC-type zinc finger 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NANOS3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:40,889,531...40,893,699
Ensembl chr19:40,882,845...40,894,263
|
|
| G
|
Nap1l2
|
nucleosome assembly protein 1-like 2
|
decreases expression increases expression
|
ISO
|
Acrylamide results in decreased expression of NAP1L2 mRNA Acrylamide results in increased expression of NAP1L2 mRNA
|
CTD |
PMID:30807115 PMID:32763439 |
|
NCBI chr X:72,239,849...72,242,247
Ensembl chr X:72,238,310...72,242,464
|
|
| G
|
Naprt
|
nicotinate phosphoribosyltransferase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NAPRT mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:109,457,328...109,460,817
Ensembl chr 7:109,457,378...109,460,817
|
|
| G
|
Nars1
|
asparaginyl-tRNA synthetase 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NARS1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:60,259,506...60,275,782
Ensembl chr18:60,259,516...60,275,782
|
|
| G
|
Nat14
|
N-acetyltransferase 14
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NAT14 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:77,939,430...77,941,950
|
|
| G
|
Nat8
|
N-acetyltransferase 8
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NAT8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:119,836,986...119,837,764
Ensembl chr 4:119,835,645...119,843,159
|
|
| G
|
Nat8f2
|
N-acetyltransferase 8 (GCN5-related) family member 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NAT8F2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:119,877,449...119,880,685
Ensembl chr 4:119,877,465...119,890,291
|
|
| G
|
Nat8f5
|
N-acetyltransferase 8 (GCN5-related) family member 5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NAT8F5 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 4:119,817,788...119,842,503
Ensembl chr 4:119,816,735...119,863,953
|
|
| G
|
Nat9
|
N-acetyltransferase 9
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NAT9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:100,921,306...100,926,646
Ensembl chr10:100,921,307...100,926,689
|
|
| G
|
Natd1
|
N-acetyltransferase domain containing 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NATD1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:46,079,650...46,089,829
Ensembl chr10:46,079,653...46,089,829
|
|
| G
|
Naxd
|
NAD(P)HX dehydratase
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NAXD mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:84,689,776...84,706,256
Ensembl chr16:84,688,243...84,706,411
|
|
| G
|
Naxe
|
NAD(P)HX epimerase
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NAXE mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:175,816,824...175,818,903
Ensembl chr 2:175,816,824...175,818,889
|
|
| G
|
Nbeal2
|
neurobeachin-like 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NBEAL2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:119,481,608...119,511,997
Ensembl chr 8:119,481,608...119,514,384
|
|
| G
|
Nbl1
|
NBL1, DAN family BMP antagonist
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of NBL1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 5:156,601,986...156,613,182
Ensembl chr 5:156,601,986...156,613,186
|
|
| G
|
Ncald
|
neurocalcin delta
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NCALD mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:70,417,683...70,849,763
Ensembl chr 7:70,419,433...70,849,482
|
|
| G
|
Ncam1
|
neural cell adhesion molecule 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NCAM1 mRNA
|
CTD |
PMID:20708675 |
|
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:58,762,116...59,061,971
|
|
| G
|
Ncam2
|
neural cell adhesion molecule 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NCAM2 mRNA
|
CTD |
PMID:36328537 PMID:36801352 |
|
NCBI chr11:33,591,748...34,078,788
Ensembl chr11:33,591,713...34,078,788
|
|
| G
|
Ncapd2
|
non-SMC condensin I complex, subunit D2
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of NCAPD2 mRNA Acrylamide results in decreased expression of NCAPD2 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 4:159,655,051...159,677,938
Ensembl chr 4:159,655,051...159,677,938
|
|
| G
|
Ncaph
|
non-SMC condensin I complex, subunit H
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of NCAPH mRNA Acrylamide results in decreased expression of NCAPH mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 3:134,825,271...134,852,502
Ensembl chr 3:134,825,271...134,852,502
|
|
| G
|
Ncaph2
|
non-SMC condensin II complex, subunit H2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NCAPH2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:122,302,550...122,319,570
Ensembl chr 7:122,300,252...122,319,569
|
|
| G
|
Ncf2
|
neutrophil cytosolic factor 2
|
increases expression decreases expression
|
ISO
|
Acrylamide results in increased expression of NCF2 mRNA Acrylamide results in decreased expression of NCF2 mRNA
|
CTD |
PMID:30807115 PMID:35690182 |
|
NCBI chr13:67,505,492...67,536,015
Ensembl chr13:67,505,375...67,536,149
|
|
| G
|
Nckipsd
|
NCK interacting protein with SH3 domain
|
affects expression
|
EXP
|
Acrylamide affects the expression of NCKIPSD mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:118,390,121...118,401,121
Ensembl chr 8:118,390,159...118,401,118
|
|
| G
|
Ncoa2
|
nuclear receptor coactivator 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NCOA2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 5:10,618,712...10,852,776
Ensembl chr 5:10,618,722...10,852,776
|
|
| G
|
Ncoa7
|
nuclear receptor coactivator 7
|
affects expression increases expression
|
EXP ISO
|
Acrylamide affects the expression of NCOA7 mRNA Acrylamide results in increased expression of NCOA7 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:28,674,614...28,835,891
Ensembl chr 1:28,675,426...28,835,886
|
|
| G
|
Ncr1
|
natural cytotoxicity triggering receptor 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NCR1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:78,657,409...78,665,255
Ensembl chr 1:78,659,262...78,703,273
|
|
| G
|
Ncr3
|
natural cytotoxicity triggering receptor 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NCR3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:3,642,912...3,648,425
Ensembl chr20:3,642,912...3,644,188
|
|
| G
|
Ncstn
|
nicastrin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NCSTN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr13:87,062,827...87,078,839
Ensembl chr13:87,062,831...87,078,839
|
|
| G
|
Ndc80
|
NDC80 kinetochore complex component
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of NDC80 mRNA Acrylamide results in decreased expression of NDC80 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 9:118,853,806...118,887,582
Ensembl chr 9:118,853,806...118,887,568
|
|
| G
|
Nde1
|
nudE neurodevelopment protein 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NDE1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:1,347,010...1,391,167
Ensembl chr10:1,347,018...1,383,447
|
|
| G
|
Ndfip1
|
Nedd4 family interacting protein 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NDFIP1 mRNA
|
CTD |
PMID:29261810 |
|
NCBI chr18:30,516,931...30,567,199
Ensembl chr18:30,516,981...30,568,471
|
|
| G
|
Ndn
|
necdin, MAGE family member
|
decreases expression affects methylation
|
ISO
|
Acrylamide results in decreased expression of NDN mRNA Acrylamide affects the methylation of NDN gene
|
CTD |
PMID:32763439 PMID:35032568 |
|
NCBI chr 1:125,261,059...125,262,658
Ensembl chr 1:125,260,997...125,262,785
|
|
| G
|
Ndp
|
norrin cystine knot growth factor NDP
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of NDP mRNA Acrylamide results in decreased expression of NDP mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr X:8,379,569...8,404,019
Ensembl chr X:8,379,569...8,406,802
|
|
| G
|
Ndrg2
|
NDRG family member 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NDRG2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:27,074,481...27,087,376
Ensembl chr15:27,074,481...27,083,125
|
|
| G
|
Ndrg3
|
NDRG family member 3
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NDRG3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:166,007,556...166,070,981
Ensembl chr 3:165,890,091...166,049,887
|
|
| G
|
Ndrg4
|
NDRG family member 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NDRG4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:9,357,470...9,393,465
Ensembl chr19:9,357,470...9,392,972
|
|
| G
|
Ndst1
|
N-deacetylase and N-sulfotransferase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NDST1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr18:56,407,308...56,470,007
Ensembl chr18:56,411,200...56,448,612
|
|
| G
|
Ndst2
|
N-deacetylase and N-sulfotransferase 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NDST2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:3,612,775...3,623,061
Ensembl chr15:3,612,775...3,623,061
|
|
| G
|
Ndufa11
|
NADH:ubiquinone oxidoreductase subunit A11
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NDUFA11 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:1,637,614...1,641,673
Ensembl chr 9:1,637,595...1,642,727
|
|
| G
|
Ndufa4l2
|
NDUFA4, mitochondrial complex associated like 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of COXFA4L2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:65,242,169...65,244,296
Ensembl chr 7:65,242,135...65,244,277
|
|
| G
|
Ndufa9
|
NADH:ubiquinone oxidoreductase subunit A9
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NDUFA9 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:161,345,398...161,374,188
Ensembl chr 4:161,345,400...161,375,025
|
|
| G
|
Ndufaf3
|
NADH:ubiquinone oxidoreductase complex assembly factor 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NDUFAF3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:118,139,891...118,141,723
Ensembl chr 8:118,139,892...118,141,723
|
|
| G
|
Ndufb5
|
NADH:ubiquinone oxidoreductase subunit B5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NDUFB5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:117,447,605...117,461,943
Ensembl chr 2:117,447,035...117,461,590
|
|
| G
|
Ndufb8
|
NADH:ubiquinone oxidoreductase subunit B8
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NDUFB8 protein
|
CTD |
PMID:39082229 |
|
NCBI chr 1:253,357,878...253,362,936
Ensembl chr 1:253,357,841...253,362,936
|
|
| G
|
Ndufs8
|
NADH:ubiquinone oxidoreductase core subunit S8
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NDUFS8 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:210,569,823...210,573,707
Ensembl chr 1:210,569,824...210,572,971
|
|
| G
|
Neb
|
nebulin
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NEB mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:57,022,822...57,220,752
Ensembl chr 3:57,022,822...57,220,709
|
|
| G
|
Necab2
|
N-terminal EF-hand calcium binding protein 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NECAB2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:64,409,627...64,436,371
Ensembl chr19:64,409,751...64,436,369
|
|
| G
|
Necab3
|
N-terminal EF-hand calcium binding protein 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NECAB3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 3:163,509,682...163,524,598
Ensembl chr 3:163,509,683...163,524,155
|
|
| G
|
Necap2
|
NECAP endocytosis associated 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NECAP2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:158,653,347...158,665,761
Ensembl chr 5:158,653,347...158,666,901
|
|
| G
|
Nectin1
|
nectin cell adhesion molecule 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NECTIN1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:52,998,662...53,061,745
Ensembl chr 8:52,998,662...53,086,664
|
|
| G
|
Nectin3
|
nectin cell adhesion molecule 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NECTIN3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr11:67,825,296...67,931,999
Ensembl chr11:67,827,137...67,871,383
|
|
| G
|
Nectin4
|
nectin cell adhesion molecule 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NECTIN4 mRNA
|
CTD |
PMID:30807115 PMID:35690182 |
|
NCBI chr13:86,335,027...86,354,152
Ensembl chr13:86,335,831...86,353,967
|
|
| G
|
Nefl
|
neurofilament light chain
|
increases expression multiple interactions
|
EXP
|
Acrylamide results in increased expression of NEFL mRNA; Acrylamide results in increased expression of NEFL protein NGF protein promotes the reaction [Acrylamide results in increased expression of NEFL protein]
|
CTD |
PMID:10678756 |
|
NCBI chr15:46,477,330...46,481,203
Ensembl chr15:46,458,204...46,482,515
|
|
| G
|
Nefm
|
neurofilament medium chain
|
multiple interactions increases expression
|
EXP
|
Dexamethasone inhibits the reaction [Acrylamide results in increased expression of NEFM protein]; Dexamethasone inhibits the reaction [NGF protein promotes the reaction [Acrylamide results in increased expression of NEFM protein]]; NGF protein promotes the reaction [Acrylamide results in increased expression of NEFM protein]; staurosporine aglycone inhibits the reaction [Acrylamide results in increased expression of NEFM protein] Acrylamide results in increased expression of NEFM mRNA; Acrylamide results in increased expression of NEFM protein
|
CTD |
PMID:10678756 PMID:28959563 |
|
NCBI chr15:46,535,857...46,541,161
Ensembl chr15:46,535,517...46,541,163
|
|
| G
|
Nek11
|
NIMA-related kinase 11
|
increases expression decreases expression
|
ISO
|
Acrylamide results in increased expression of NEK11 mRNA Acrylamide results in decreased expression of NEK11 mRNA
|
CTD |
PMID:32763439 PMID:35032568 |
|
NCBI chr 8:114,646,010...114,905,242
Ensembl chr 8:114,646,018...114,905,162
|
|
| G
|
Nek2
|
NIMA-related kinase 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NEK2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:105,936,809...105,950,054
Ensembl chr13:105,936,788...105,950,056
|
|
| G
|
Nek6
|
NIMA-related kinase 6
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NEK6 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:42,693,994...42,766,026
Ensembl chr 3:42,693,971...42,767,773
|
|
| G
|
Nell2
|
neural EGFL like 2
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of NELL2 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr 7:128,222,333...128,542,127
Ensembl chr 7:128,078,103...128,651,917
|
|
| G
|
Nemf
|
nuclear export mediator factor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NEMF mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 6:93,527,690...93,571,863
Ensembl chr 6:93,527,704...93,571,863
|
|
| G
|
Nemp1
|
nuclear envelope integral membrane protein 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NEMP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:65,399,297...65,424,054
Ensembl chr 7:65,399,381...65,424,055
|
|
| G
|
Nes
|
nestin
|
decreases expression
|
ISO EXP
|
Acrylamide results in decreased expression of NES mRNA
|
CTD |
PMID:32763439 PMID:36328537 |
|
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228
|
|
| G
|
Neu1
|
neuraminidase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NEU1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr20:3,902,120...3,906,383
Ensembl chr20:3,902,120...3,906,383
|
|
| G
|
Neu3
|
neuraminidase 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NEU3 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:163,549,834...163,560,997
Ensembl chr 1:163,549,738...163,561,049
|
|
| G
|
Neu4
|
neuraminidase 4
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NEU4 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:101,844,261...101,849,917
Ensembl chr 9:101,844,261...101,849,917
|
|
| G
|
Neurl1
|
neuralized E3 ubiquitin protein ligase 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NEURL1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:256,008,012...256,094,219
Ensembl chr 1:256,008,160...256,094,224
|
|
| G
|
Neurl4
|
neuralized E3 ubiquitin protein ligase 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NEURL4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:55,123,471...55,135,971
Ensembl chr10:55,124,324...55,136,223
|
|
| G
|
Neurog2
|
neurogenin 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NEUROG2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:218,767,205...218,769,772
Ensembl chr 2:218,765,949...218,769,784
|
|
| G
|
Nexmif
|
neurite extension and migration factor
|
affects expression
|
EXP
|
Acrylamide affects the expression of NEXMIF mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:73,153,786...73,284,943
Ensembl chr X:73,153,786...73,178,639
|
|
| G
|
Nexn
|
nexilin (F actin binding protein)
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NEXN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:243,846,736...243,878,268
Ensembl chr 2:243,846,433...243,887,114
|
|
| G
|
Nf1
|
neurofibromin 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NF1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:64,803,986...65,037,086
Ensembl chr10:64,804,266...65,034,946
|
|
| G
|
Nfat5
|
nuclear factor of activated T-cells 5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NFAT5 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:52,108,982...52,196,418
Ensembl chr19:52,109,483...52,196,418
|
|
| G
|
Nfatc2
|
nuclear factor of activated T-cells 2
|
increases expression multiple interactions
|
ISO
|
Acrylamide results in increased expression of NFATC2 mRNA Acrylamide promotes the reaction [NFATC2 protein binds to LRRK2 protein]; Acrylamide results in increased expression of and results in increased phosphorylation of NFATC2 protein; LRRK2 promotes the reaction [Acrylamide results in increased expression of NFATC2 protein]
|
CTD |
PMID:37037409 |
|
NCBI chr 3:177,615,189...177,747,493
Ensembl chr 3:177,618,314...177,747,380
|
|
| G
|
Nfatc3
|
nuclear factor of activated T-cells 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NFATC3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr19:50,870,464...50,944,992
Ensembl chr19:50,870,489...50,944,992
|
|
| G
|
Nfatc4
|
nuclear factor of activated T-cells 4
|
decreases expression affects methylation
|
ISO
|
Acrylamide results in decreased expression of NFATC4 mRNA Acrylamide affects the methylation of NFATC4 gene
|
CTD |
PMID:32763439 PMID:35032568 |
|
NCBI chr15:33,256,912...33,284,522
Ensembl chr15:33,274,153...33,285,582
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
increases expression affects response to substance multiple interactions decreases expression affects localization
|
ISO EXP
|
Acrylamide results in increased expression of NFE2L2 mRNA; Acrylamide results in increased expression of NFE2L2 protein NFE2L2 protein affects the susceptibility to Acrylamide [Acrylamide co-treated with Streptozocin] results in decreased expression of NFE2L2 mRNA; [NFE2L2 protein affects the susceptibility to Acrylamide] which affects the expression of IL1B mRNA; [NFE2L2 protein affects the susceptibility to Acrylamide] which affects the expression of NOS2 mRNA; [NFE2L2 protein affects the susceptibility to Acrylamide] which affects the expression of TNF mRNA; Acrylamide results in increased expression of and affects the localization of NFE2L2 protein; NFE2L2 protein affects the reaction [Acrylamide results in increased expression of IL4R mRNA]; NFE2L2 protein affects the reaction [Acrylamide results in increased expression of MRC1 mRNA]; NFE2L2 protein affects the reaction [Acrylamide results in increased expression of RETNLA mRNA]; NLRP3 gene mutant form promotes the reaction [Acrylamide results in increased expression of and affects the localization of NFE2L2 protein] 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Acrylamide results in increased expression of NFE2L2 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Acrylamide results in increased expression of NFE2L2 protein]; [Acrylamide co-treated with INS protein] results in increased expression of NFE2L2 mRNA; Acetylcysteine promotes the reaction [Acrylamide results in increased expression of and affects the localization of NFE2L2 protein]; Acrylamide results in increased expression of and affects the localization of NFE2L2 protein; NFE2L2 protein promotes the reaction [Acrylamide results in increased expression of RELA protein]; pyrazolanthrone inhibits the reaction [Acrylamide results in increased expression of NFE2L2 protein]; Rutin inhibits the reaction [Acrylamide results in decreased expression of NFE2L2 protein]; U 0126 inhibits the reaction [Acrylamide results in increased expression of NFE2L2 protein] Acrylamide results in decreased expression of NFE2L2 mRNA; Acrylamide results in decreased expression of NFE2L2 protein Acrylamide affects the localization of NFE2L2 protein salvin inhibits the reaction [Acrylamide results in decreased expression of NFE2L2 mRNA]; salvin inhibits the reaction [Acrylamide results in decreased expression of NFE2L2 protein]
|
CTD |
PMID:27836571 PMID:28159594 PMID:28526328 PMID:28959563 PMID:29426002 PMID:32014472 PMID:32763439 PMID:33872730 PMID:34896238 PMID:36657526 PMID:38604440 More...
|
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfe2l3
|
NFE2 like bZIP transcription factor 3
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NFE2L3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:81,837,404...81,865,258
Ensembl chr 4:81,837,404...81,865,532
|
|
| G
|
Nfic
|
nuclear factor I/C
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NFIC mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:8,928,423...8,963,455
Ensembl chr 7:8,904,117...8,963,409
|
|
| G
|
Nfil3
|
nuclear factor, interleukin 3 regulated
|
increases expression decreases expression
|
EXP ISO
|
Acrylamide results in increased expression of NFIL3 mRNA Acrylamide results in decreased expression of NFIL3 mRNA
|
CTD |
PMID:28959563 PMID:30807115 |
|
NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,432,198...12,450,826
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NFKB1 mRNA
|
CTD |
PMID:38614435 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Nfkb2
|
nuclear factor kappa B subunit 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NFKB2 mRNA
|
CTD |
PMID:38152866 |
|
NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
increases expression multiple interactions increases phosphorylation
|
EXP
|
Acrylamide results in increased expression of NFKBIA protein alpha-Tocopherol inhibits the reaction [Acrylamide results in increased phosphorylation of NFKBIA protein]
|
CTD |
PMID:29426002 PMID:38242491 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nfkbib
|
NFKB inhibitor beta
|
increases expression
|
EXP ISO
|
Acrylamide results in increased expression of NFKBIB mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:93,173,817...93,181,387
Ensembl chr 1:93,173,820...93,326,366
|
|
| G
|
Nfkbid
|
NFKB inhibitor delta
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NFKBID mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:94,808,459...94,824,726
Ensembl chr 1:94,808,453...94,817,861
|
|
| G
|
Nfkbie
|
NFKB inhibitor epsilon
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NFKBIE mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:22,941,037...22,947,872
Ensembl chr 9:22,941,040...22,947,872
|
|
| G
|
Nfrkb
|
nuclear factor related to kappa B binding protein
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NFRKB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 8:38,089,574...38,121,506
Ensembl chr 8:38,089,999...38,121,501
|
|
| G
|
Nfyb
|
nuclear transcription factor Y subunit beta
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NFYB mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:22,852,543...22,868,116
Ensembl chr 7:22,852,546...22,882,294
|
|
| G
|
Nfyc
|
nuclear transcription factor Y subunit gamma
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NFYC mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 5:139,622,020...139,690,545
Ensembl chr 5:139,622,020...139,679,884
|
|
| G
|
Ngdn
|
neuroguidin
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NGDN mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:32,459,898...32,467,260
Ensembl chr15:32,399,109...32,467,260
|
|
| G
|
Ngef
|
neuronal guanine nucleotide exchange factor
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NGEF mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 9:95,594,823...95,692,381
Ensembl chr 9:95,594,823...95,692,251
|
|
| G
|
Ngf
|
nerve growth factor
|
multiple interactions increases expression
|
EXP
|
Dexamethasone inhibits the reaction [NGF protein promotes the reaction [Acrylamide results in increased expression of NEFM protein]]; ferrostatin-1 promotes the reaction [Acrylamide results in increased expression of NGF mRNA]; NGF protein promotes the reaction [Acrylamide results in increased expression of NEFL protein]; NGF protein promotes the reaction [Acrylamide results in increased expression of NEFM protein]
|
CTD |
PMID:10678756 PMID:36154307 |
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
| G
|
Ngfr
|
nerve growth factor receptor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NGFR mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
|
|
| G
|
Nhlh2
|
nescient helix loop helix 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NHLH2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:192,132,848...192,138,186
Ensembl chr 2:192,132,686...192,138,186
|
|
| G
|
Nhlrc2
|
NHL repeat containing 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NHLRC2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:265,594,915...265,655,647
Ensembl chr 1:265,594,915...265,676,143
|
|
| G
|
Nhlrc3
|
NHL repeat containing 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NHLRC3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:139,678,127...139,692,423
Ensembl chr 2:139,679,866...139,692,691
|
|
| G
|
Niban1
|
niban apoptosis regulator 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NIBAN1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:66,224,219...66,377,728
Ensembl chr13:66,224,021...66,377,724
|
|
| G
|
Nicn1
|
nicolin 1, tubulin polyglutamylase complex subunit
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NICN1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:117,854,210...117,860,185
Ensembl chr 8:117,854,933...117,860,184
|
|
| G
|
Nicol1
|
NELL2 interacting cell ontogeny regulator 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NICOL1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:80,992,697...80,994,213
Ensembl chr14:80,992,697...80,994,213
|
|
| G
|
Nid1
|
nidogen 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of NID1 mRNA Acrylamide results in increased expression of NID1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr17:93,069,013...93,142,416
Ensembl chr17:93,069,278...93,142,386
|
|
| G
|
Nif3l1
|
NGG1 interacting factor 3 like 1
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NIF3L1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 9:67,474,286...67,494,350
Ensembl chr 9:67,474,351...67,494,350
|
|
| G
|
Nifk
|
nucleolar protein interacting with the FHA domain of MKI67
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of MKI67IP mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr13:31,946,119...31,955,950
Ensembl chr13:31,946,108...31,959,561
|
|
| G
|
Ninj2
|
ninjurin 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NINJ2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:154,978,660...155,080,860
Ensembl chr 4:155,073,295...155,080,860
|
|
| G
|
Ninl
|
ninein-like
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NINL mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:160,208,757...160,275,077
Ensembl chr 3:160,196,883...160,275,108
|
|
| G
|
Nipa1
|
NIPA magnesium transporter 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NIPA1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:115,608,221...116,010,503
Ensembl chr 1:115,974,481...116,010,812
|
|
| G
|
Nipa2
|
NIPA magnesium transporter 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NIPA2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:115,935,759...115,960,034
Ensembl chr 1:115,936,063...115,959,913
|
|
| G
|
Nipal2
|
NIPA-like domain containing 2
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NIPAL2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 7:67,659,628...67,771,105
Ensembl chr 7:67,659,628...67,769,959
|
|
| G
|
Nipbl
|
NIPBL, cohesin loading factor
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NIPBL mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 2:59,126,676...59,314,841
Ensembl chr 2:59,126,676...59,293,277
|
|
| G
|
Nipsnap1
|
nipsnap homolog 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NIPSNAP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:83,957,714...83,981,579
Ensembl chr14:83,957,702...83,981,576
|
|
| G
|
Nisch
|
nischarin
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NISCH mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr16:6,370,809...6,407,104
Ensembl chr16:6,370,809...6,407,387
|
|
| G
|
Nkain4
|
Sodium/potassium transporting ATPase interacting 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NKAIN4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:188,430,862...188,451,561
Ensembl chr 3:188,430,243...188,453,760
|
|
| G
|
Nkd1
|
NKD inhibitor of WNT signaling pathway 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NKD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr19:34,649,803...34,722,846
|
|
| G
|
Nkd2
|
NKD inhibitor of WNT signaling pathway 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NKD2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 1:31,268,856...31,299,390
Ensembl chr 1:31,272,519...31,299,387
|
|
| G
|
Nkiras1
|
NFKB inhibitor interacting Ras-like 1
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of NKIRAS1 mRNA Acrylamide results in increased expression of NKIRAS1 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr15:9,924,316...9,934,538
Ensembl chr15:9,924,326...9,935,877
|
|
| G
|
Nkiras2
|
NFKB inhibitor interacting Ras-like 2
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NKIRAS2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:86,055,029...86,062,398
Ensembl chr10:86,058,285...86,062,392
|
|
| G
|
Nkrf
|
NFKB repressing factor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NKRF mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr X:120,992,038...121,010,251
Ensembl chr X:120,992,038...121,010,251
|
|
| G
|
Nktr
|
natural killer cell triggering receptor
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NKTR mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 8:130,255,541...130,298,001
Ensembl chr 8:130,259,461...130,298,008
|
|
| G
|
Nkx2-5
|
NK2 homeobox 5
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NKX2-5 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:16,844,888...16,851,458
Ensembl chr10:16,848,582...16,851,452
|
|
| G
|
Nkx2-6
|
NK2 homeobox 6
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NKX2-6 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:50,852,965...50,857,060
Ensembl chr15:50,852,646...50,857,059
|
|
| G
|
Nkx3-1
|
NK3 homeobox 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NKX3-1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr15:50,883,661...50,886,253
Ensembl chr15:50,883,597...50,886,251
|
|
| G
|
Nkx3-2
|
NK3 homeobox 2
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NKX3-2 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr14:73,396,198...73,398,585
Ensembl chr14:73,395,619...73,399,558
|
|
| G
|
Nkx6-2
|
NK6 homeobox 2
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NKX6-2 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:203,811,582...203,813,122
Ensembl chr 1:203,811,582...203,813,122
|
|
| G
|
Nle1
|
notchless homolog 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NLE1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:68,331,609...68,342,562
Ensembl chr10:68,331,609...68,340,386
|
|
| G
|
Nlgn1
|
neuroligin 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NLGN1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:110,184,987...111,110,316
Ensembl chr 2:110,186,573...110,909,984
|
|
| G
|
Nlgn3
|
neuroligin 3
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NLGN3 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr X:70,469,251...70,497,380
Ensembl chr X:70,469,457...70,497,379
|
|
| G
|
Nln
|
neurolysin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NLN mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:36,867,436...36,966,749
Ensembl chr 2:36,853,551...36,966,680
|
|
| G
|
Nlrc4
|
NLR family, CARD domain containing 4
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of NLRC4 mRNA Acrylamide results in increased expression of NLRC4 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 6:26,743,658...26,771,783
Ensembl chr 6:26,743,698...26,770,563
|
|
| G
|
Nlrp1a
|
NLR family, pyrin domain containing 1A
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NLRP1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:56,277,134...56,332,229
Ensembl chr10:56,277,134...56,323,880
|
|
| G
|
Nlrp3
|
NLR family, pyrin domain containing 3
|
decreases expression affects response to substance multiple interactions increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of NLRP3 mRNA NLRP3 gene mutant form affects the susceptibility to Acrylamide [NLRP3 gene mutant form affects the susceptibility to Acrylamide] which results in increased expression of HMOX1 protein; [NLRP3 gene mutant form affects the susceptibility to Acrylamide] which results in increased expression of KEAP1 protein; [NLRP3 gene mutant form affects the susceptibility to Acrylamide] which results in increased expression of NQO1 protein; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Acrylamide results in increased expression of NLRP3 protein]; NLRP3 gene mutant form inhibits the reaction [Acrylamide results in increased expression of CASP1 protein]; NLRP3 gene mutant form inhibits the reaction [Acrylamide results in increased expression of IL18 protein]; NLRP3 gene mutant form inhibits the reaction [Acrylamide results in increased expression of IL1B protein modified form]; NLRP3 gene mutant form inhibits the reaction [Acrylamide results in increased expression of IL1B protein]; NLRP3 gene mutant form inhibits the reaction [Acrylamide results in increased expression of NLRP3 protein]; NLRP3 gene mutant form inhibits the reaction [Acrylamide results in increased expression of PYCARD protein]; NLRP3 gene mutant form promotes the reaction [Acrylamide results in increased expression of and affects the localization of NFE2L2 protein]; NLRP3 protein promotes the reaction [Acrylamide results in increased expression of IL18 protein]; NLRP3 protein promotes the reaction [Acrylamide results in increased expression of IL1B protein modified form]; NLRP3 protein promotes the reaction [Acrylamide results in increased expression of IL1B protein]; NLRP3 protein promotes the reaction [Acrylamide results in increased expression of PYCARD protein] Acrylamide results in increased expression of NLRP3 mRNA; Acrylamide results in increased expression of NLRP3 protein
|
CTD |
PMID:28959563 PMID:31073625 PMID:32014472 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
|
|
| G
|
Nlrp5
|
NLR family, pyrin domain containing 5
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NLRP5 mRNA
|
CTD |
PMID:36599426 PMID:36997053 |
|
NCBI chr 1:76,811,044...76,872,964
Ensembl chr 1:76,810,108...77,077,580
|
|
| G
|
Nmb
|
neuromedin B
|
decreases expression increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of NMB mRNA Acrylamide results in increased expression of NMB mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr 1:144,278,678...144,290,523
Ensembl chr 1:144,278,453...144,281,422
|
|
| G
|
Nme4
|
NME/NM23 nucleoside diphosphate kinase 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NME4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:15,619,106...15,622,961
Ensembl chr10:15,619,106...15,623,098
|
|
| G
|
Nmral1
|
NmrA like redox sensor 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NMRAL1 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:11,348,080...11,356,621
Ensembl chr10:11,348,213...11,356,620
|
|
| G
|
Nmrk1
|
nicotinamide riboside kinase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NMRK1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 1:225,475,975...225,503,414
Ensembl chr 1:225,475,830...225,503,602
|
|
| G
|
Nmt1
|
N-myristoyltransferase 1
|
increases expression
|
EXP
|
Acrylamide results in increased expression of NMT1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:88,488,918...88,525,496
Ensembl chr10:88,488,990...88,522,729
|
|
| G
|
Nmu
|
neuromedin U
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NMU mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr14:32,198,789...32,226,397
Ensembl chr14:32,198,943...32,226,632
|
|
| G
|
Nmur2
|
neuromedin U receptor 2
|
affects methylation
|
ISO
|
Acrylamide affects the methylation of NMUR2 gene
|
CTD |
PMID:35032568 |
|
NCBI chr10:40,666,824...40,682,679
Ensembl chr10:40,645,101...40,682,679
|
|
| G
|
Noc4l
|
nucleolar complex associated 4 homolog
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NOC4L mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr12:51,675,852...51,680,392
Ensembl chr12:51,675,838...51,680,390
|
|
| G
|
Noct
|
nocturnin
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NOCT mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 2:137,422,074...137,442,282
Ensembl chr 2:137,422,074...137,442,282
|
|
| G
|
Nod1
|
nucleotide-binding oligomerization domain containing 1
|
decreases expression increases expression
|
EXP
|
Acrylamide results in decreased expression of NOD1 mRNA Acrylamide results in increased expression of NOD1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr 4:85,391,142...85,442,281
Ensembl chr 4:85,391,151...85,441,674
|
|
| G
|
Nog
|
noggin
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NOG mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr10:74,625,874...74,627,501
Ensembl chr10:74,625,875...74,628,103
|
|
| G
|
Nol3
|
nucleolar protein 3
|
decreases expression
|
EXP ISO
|
Acrylamide results in decreased expression of NOL3 mRNA
|
CTD |
PMID:28959563 PMID:32763439 |
|
NCBI chr19:50,066,493...50,068,175
Ensembl chr19:50,063,986...50,068,722
|
|
| G
|
Nop2
|
NOP2 nucleolar protein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NOP2 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 4:159,618,894...159,630,697
Ensembl chr 4:159,618,966...159,630,697
|
|
| G
|
Nop53
|
NOP53 ribosome biogenesis factor
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NOP53 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 1:85,757,271...85,765,089
Ensembl chr 1:85,756,586...85,765,089
|
|
| G
|
Nop56
|
NOP56 ribonucleoprotein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NOP56 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 3:137,926,187...137,934,971
Ensembl chr 3:137,929,646...137,934,959
|
|
| G
|
Nop58
|
NOP58 ribonucleoprotein
|
increases expression
|
ISO
|
Acrylamide results in increased expression of NOP58 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 9:68,614,992...68,638,911
Ensembl chr 9:68,615,010...68,638,909
|
|
| G
|
Nop9
|
NOP9 nucleolar protein
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NOP9 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr15:33,213,786...33,222,147
Ensembl chr15:33,213,789...33,222,147
|
|
| G
|
Nos1
|
nitric oxide synthase 1
|
decreases expression multiple interactions increases expression
|
EXP ISO
|
Acrylamide results in decreased expression of NOS1 mRNA; Acrylamide results in decreased expression of NOS1 protein [Acrylamide co-treated with INS protein] results in increased expression of NOS1 mRNA Acrylamide results in increased expression of NOS1 mRNA Acrylamide inhibits the reaction [Streptozocin results in increased expression of NOS1 mRNA]
|
CTD |
PMID:15977197 PMID:28959563 PMID:34896238 PMID:38604440 |
|
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
increases expression increases secretion multiple interactions
|
EXP ISO
|
Acrylamide results in increased expression of NOS2 mRNA; Acrylamide results in increased expression of NOS2 protein Acrylamide results in increased secretion of NOS2 protein [NFE2L2 protein affects the susceptibility to Acrylamide] which affects the expression of NOS2 mRNA; Gallic Acid inhibits the reaction [Acrylamide results in increased secretion of NOS2 protein]; LRRK2 promotes the reaction [Acrylamide results in increased secretion of NOS2 protein]
|
CTD |
PMID:15977197 PMID:31073625 PMID:33872730 PMID:37037409 PMID:38152866 PMID:38614435 More...
|
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Notch1
|
notch receptor 1
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NOTCH1 mRNA
|
CTD |
PMID:30807115 |
|
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:29,676,171...29,721,613
|
|
| G
|
Notch3
|
notch receptor 3
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NOTCH3 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr 7:11,783,550...11,834,585
Ensembl chr 7:11,784,272...11,834,778
|
|
| G
|
Notch4
|
notch receptor 4
|
decreases expression
|
ISO
|
Acrylamide results in decreased expression of NOTCH4 mRNA
|
CTD |
PMID:32763439 |
|
NCBI chr20:4,164,969...4,189,072
Ensembl chr20:4,161,730...4,189,072
|
|
| G
|
Noxo1
|
NADPH oxidase organizer 1
|
decreases expression
|
EXP
|
Acrylamide results in decreased expression of NOXO1 mRNA
|
CTD |
PMID:28959563 |
|
NCBI chr10:14,226,473...14,230,541
Ensembl chr10:14,228,205...14,230,541
|
|
| G
|
Npas2
|
neuronal PAS domain protein 2
|
decreases expression
|
|